% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-04}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 3983.

\begin{enumerate}[leftmargin=*]
\item Chwyl Christina, Bazinet Alissa, Wilson-Poe Adrianne R., Hoffman Kim, Pertl Kellie, Wolf R. Cameron, Korthuis P. Todd, Luoma Jason B. (2026). \textit{Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study}. Neuroethics. [published; Crossref]. \href{https://doi.org/10.1007/s12152-026-09645-5}{doi:10.1007/s12152-026-09645-5}.
\item Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C. (2026). \textit{Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00530}{doi:10.1556/2054.2026.00530}.
\item Amiel Sharchaton, Shilat Parsha, Sara P. Azerrad, Yaron Dekel, Nisreen Rabah, Tomáš Páleníček, Eyal Kurzbaum (2026). \textit{Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions}. Journal of Fungi. [published; OpenAlex]. \href{https://doi.org/10.3390/jof12070486}{doi:10.3390/jof12070486}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Alaina M. Jaster, Joseph J. Hennessey, Tanner L. Anderson, Anna Tsyrulnikov, Amartya Pradhan, Gina Giorgio, Elijah Z. Ullman (2026). \textit{Reducing Research Harms: Analysis and Recommendations for Researching Schedule I Substances Under the HALT Fentanyl Act}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280109}{doi:10.38126/jspg280109}.
\item Elena Koning, Jérémie Richard, Aaron Keshen (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions}. International Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Seale M. (2026). \textit{Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-10208910/v1}{doi:10.21203/rs.3.rs-10208910/v1}.
\item University of Wisconsin, Madison (2026). \textit{Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07360301}{source link}.
\item Busby Mattha (2026). \textit{Psilocybin helps woman with Alzheimer's}. New Scientist. [published; Crossref]. \href{https://doi.org/10.1016/s0262-4079(26)01034-1}{doi:10.1016/s0262-4079(26)01034-1}.
\item Schüller Thomas (2026). \textit{Meskalin / Mescaline}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21113821}{doi:10.5281/zenodo.21113821}.
\item Schüller Thomas (2026). \textit{DMT und Ayahuasca / DMT and Ayahuasca}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21113899}{doi:10.5281/zenodo.21113899}.
\item Schüller Thomas (2026). \textit{DMT und Ayahuasca / DMT and Ayahuasca}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21113898}{doi:10.5281/zenodo.21113898}.
\item Armando Ordaz-Hernández, M. Corona-Ramírez, Israel Jesús Orlando Guerrero (2026). \textit{Neuroestimulantes naturales: de rituales ancestrales a terapias de vanguardia}. Revista CienciaUANL. [published; OpenAlex]. \href{https://doi.org/10.29105/cienciauanl29.138-5}{doi:10.29105/cienciauanl29.138-5}.
\item Schüller Thomas (2026). \textit{Meskalin / Mescaline}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21113820}{doi:10.5281/zenodo.21113820}.
\item Érika A. Chillogallo-Torres, Marcos D. Calle-Morán, Karen P. Cando-Andrade, Álex R. Morocho-Malla, E. Noemí Luzuriaga-Rodríguez (2026). \textit{Usos recreativos, medicinales y etnobotánicos de hongos alucinógenos: una revisión}. Multidisciplinary Collaborative Journal. [published; OpenAlex]. \href{https://doi.org/10.70881/mcj/v4/n3/164}{doi:10.70881/mcj/v4/n3/164}.
\item Mellica Askari, Varun Surapaneni (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Haley M Hummel, Alexia N Obrochta, David C. R. Kerr, Anita Cservenka (2026). \textit{Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/00220426261466154}{doi:10.1177/00220426261466154}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y. (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item Centre Hospitalier Universitaire de Nīmes (2026). \textit{Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07638553}{source link}.
\item Sunstone Medical (2026). \textit{A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06902974}{source link}.
\item Unknown authors (2026). \textit{Psilocybin shows mixed results for patients with treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; Crossref]. \href{https://doi.org/10.1002/pu.31461}{doi:10.1002/pu.31461}.
\item Unknown authors (2026). \textit{Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessation}. The Brown University Psychopharmacology Update. [published; Crossref]. \href{https://doi.org/10.1002/pu.31467}{doi:10.1002/pu.31467}.
\item Jalalian-Javadpour Marzieh, Yekta Batool Ghorbani, Reyhani Niloufar, Hajizamani Shadi, Azizi Ali, Azad Najma Khoshrooz, Mohammadi Hamidreza, Vaseghi Salar (2026). \textit{Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review}. Journal of Affective Disorders Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.jadr.2026.101098}{doi:10.1016/j.jadr.2026.101098}.
\item Orsini DK, Wong S, Di Luch S, Chan B, Vasudeva S, Lovell GFM, Le GH, Jones BDM, Chisamore N, Mollica A, Johnson DE, Kaczmarek ES, Goel A, Burke MJ, Mansur R, McIntyre RS, Husain MI, Rosenblat JD. (2026). \textit{Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0255}{doi:10.1001/jamapsychiatry.2026.0255}.
\item Plourde L, Chang SL, Nguyen O, Garel N, Farzin H, Stephan JF, Fallu JS, Dorval M, P3A Research Group (2026). \textit{Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.}. Palliative medicine. [published; PubMed]. \href{https://doi.org/10.1177/02692163261446141}{doi:10.1177/02692163261446141}.
\item Akbar RJ, Stringer AD, Wiah S, Dachepalli M, Daws SE, Inan S, Rawls SM. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL. (2026). \textit{MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d6cp00943c}{doi:10.1039/d6cp00943c}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Sharp T, Ippolito A (2026). \textit{Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70050}{doi:10.1111/bph.70050}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Qureshi O, Cowley J, Pegg A, Cooper AJ, Gordon J, Brady CA, Belli A, Butterworth S, Upthegrove R, Andrews N, Barnes NM (2026). \textit{Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70138}{doi:10.1111/bph.70138}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Fleury S, Nautiyal KM. (2026). \textit{Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03488-5}{doi:10.1038/s41380-026-03488-5}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Hondebrink L, Faber K, Kader A, Jagpal PS, Arif T, Hermanns-Clausen M (2026). \textit{Recreational drug poisonings reported to six European poison centres from 2021 to 2024.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2628073}{doi:10.1080/15563650.2026.2628073}.
\item Silvester A, Hampton S, May TW, Holmes GD, Leang YH (2026). \textit{Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2640196}{doi:10.1080/15563650.2026.2640196}.
\item Artna E, Sandhu G, Chisamore N, Lipsitz O, Kaczmarek ES, Johnson DE, Rosenblat JD, Sediqzadah S (2026). \textit{Psychedelics as a potential treatment for borderline personality disorder: A narrative review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2026.117152}{doi:10.1016/j.psychres.2026.117152}.
\item Arikci D, Borgulya J, Straumann I, Vizeli P, Luethi D, Thomann J, Rudin D, Vukalovic I, Eckert A, Liechti ME, Holze F (2026). \textit{Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02428-9}{doi:10.1038/s41386-026-02428-9}.
\item Giri Y, Furst P, Loo CK, Clark SR, Tibrewal P (2026). \textit{Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674261450390}{doi:10.1177/00048674261450390}.
\item University of Colorado, Denver (2026). \textit{A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07516405}{source link}.
\item Lorenzo Pasquini, Jakub Vohryzek, Anira Escrichs, Yonatan Sanz Perl, Adrián Ponce-Alvarez, Sebastian Idesis, Manesh Girn, Leor Roseman, Jennifer Mitchell, Adam Gazzaley, Morten Kringelbach, David Nutt, Taylor Lyons, Robin L. Carhart-Harris, Gustavo Deco (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Guillermo Saúl Escobar Cornejo, Julián Corredor-Gamba, Yoly Rodriguez-Rojas, Fernando P. Cárdenas (2026). \textit{The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin}. Revista de Neuro-Psiquiatría. [published; OpenAlex]. \href{https://doi.org/10.20453/rnp.v89i2.7539}{doi:10.20453/rnp.v89i2.7539}.
\item David K. Sjöström, Olea Schau Rybäck, Emma Claesdotter Knutsson, Petri Kajonius, Oskar Jensen Sondén, Per Carlbring, Johannes Björkstrand, Pouya Movahed (2026). \textit{Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0352246}{doi:10.1371/journal.pone.0352246}.
\item Ladislavová L, Kútná V, Mazochová K, Šíchová K, Danda H, Lhotková E, Uttl L, Brejtr V, Syrová K, Mazoch V, Horsley R, Páleníček T. (2026). \textit{Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2026.174231}{doi:10.1016/j.pbb.2026.174231}.
\item Daisuke Ibi, Rika Takaba, Keisuke Yoshida, R. Kawase, Hiroko Kitagawa, Momoko Matsushita, Kana Ito, Shoya Uno, Fumiya Nishimura, Shinji Kitagaki, Masayuki Hiramatsu (2026). \textit{Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress}. Neuropsychopharmacology Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/npr2.70152}{doi:10.1002/npr2.70152}.
\item Wang Y, Wang H, Lin C, Wang X (2026). \textit{Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2535785123}{doi:10.1073/pnas.2535785123}.
\item Cielo A. Estela-Fernández, Reem Mohamed Yousif Elsheikh, D F Beatrice, Abdullah A. Alhendal, Chinonso Irene Ewe, Sebastian Y. Montesinos, Jocelyn Wensel, Anushka Prakash Mishra, Asma Ahmed Yousif, Hossam Tharwat Ali (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations}. Neuropsychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. University of Groningen research database (University of Groningen / Centre for Information Technology). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b}{source link}.
\item Thileepan Naren, Suzanne Nielsen, Myfanwy Graham (2026). \textit{MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/aa.ffmxwhc4v}{doi:10.64628/aa.ffmxwhc4v}.
\item Yale University (2026). \textit{The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610369}{source link}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item Unknown authors (2026). \textit{Phase 1 trial suggests benefit of psilocybin in OCD treatment}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31474}{doi:10.1002/pu.31474}.
\item Yiğit Özaydın, Buket Canlan Ozaydin (2026). \textit{Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261456196}{doi:10.1177/02698811261456196}.
\item Y J Du, Xinyi Zhao, Yishan Yao, Yunfeng Li, Guyan Wang, Liming Zhang (2026). \textit{Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261453819}{doi:10.1177/02698811261453819}.
\item M. Fernández-Guarino, Nicolás Yagüe-Septién, Laura Marín-Ochoa, María Luisa Hernández-Bule, Stefano Bacci, Ana Banzo, Daniel Peña-Jiménez (2026). \textit{Skin on Drugs: Psychotropic Compounds in Cutaneous Biology}. International Journal of Molecular Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/ijms27135808}{doi:10.3390/ijms27135808}.
\item Unity Health Toronto (2026). \textit{Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06386003}{source link}.
\item University of California, San Diego (2026). \textit{Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06814522}{source link}.
\item Dagnino, P. C.; Acero-Pousa, I.; Carhart-Harris, R.; Erritzoe, D.; Nutt, D. J.; Kringelbach, M. L.; Sanz Perl, Y.; Deco, G. (2026). \textit{Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.22.733731}{doi:10.64898/2026.06.22.733731}.
\item Petit B, Michrafy I, Nafie J, Dyer GE, Marshall EM, Riquelme C, Cabrera-Pardo JR, Strother JA, Loesgen S (2026). \textit{Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.}. Journal of natural products. [published; PubMed]. \href{https://doi.org/10.1021/acs.jnatprod.6c00531}{doi:10.1021/acs.jnatprod.6c00531}.
\item Flavia Giaffone de Paiva Ferreira, João Ariel Bonar Fernandes, Renato Filev, Dartiu Xavier da Silveira, Thiago Marques Fidalgo (2026). \textit{The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261453850}{doi:10.1177/02698811261453850}.
\item Priest M, Kilmer B, Senator B, Setodji CM. (2026). \textit{U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/42368324}{source link}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06884514}{source link}.
\item Anthony P King (2026). \textit{A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07104916}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin Administration With 5-HT1a Blockade}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565493}{source link}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Guidetti C, Fava M, Papakostas GI. (2026). \textit{Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03722-0}{doi:10.1038/s41380-026-03722-0}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06200155}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06801041}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07227909}{source link}.
\item McCulloch DE, Olsen AS, Ozenne B, Larsen K, Stenbæk DS, Armand S, Madsen MK, Knudsen GM, Fisher PM. (2026). \textit{Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-026-74215-5}{doi:10.1038/s41467-026-74215-5}.
\item Uskovich K, Hays HL, Badeti J, Rine NI, Michaels NL, Ding K, Smith GA (2026). \textit{Unintentional ingestion of recreational drugs among young children, 2000-2024.}. BMC public health. [published; PubMed]. \href{https://doi.org/10.1186/s12889-026-28233-z}{doi:10.1186/s12889-026-28233-z}.
\item Yale University (2026). \textit{Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07449351}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07048743}{source link}.
\item University of Virginia (2026). \textit{Psilocybin-Assisted Therapy for Prolonged Grief}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06724289}{source link}.
\item Seillier L, Seillier A, Zvolska MA, Šlamberová R. (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group (2026). \textit{Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2669671}{doi:10.1080/15563650.2026.2669671}.
\item Roswell Park Cancer Institute (2026). \textit{Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06827054}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06407635}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06416085}{source link}.
\item Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R. (2026). \textit{Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9880403/v1}{doi:10.21203/rs.3.rs-9880403/v1}.
\item Sabani Astrit, Khatak Adnan (2026). \textit{Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence}. Annals of Medicine \& Surgery. [published; Crossref]. \href{https://doi.org/10.1097/ms9.0000000000005244}{doi:10.1097/ms9.0000000000005244}.
\item Berg CJ, McCready DM, LoParco CR, Schubel LC, Romm KF, Thakkar S, Williams J, Cavazos-Rehg PA, Yang YT. (2026). \textit{Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2026.2685527}{doi:10.1080/02791072.2026.2685527}.
\item Apollonio DE, Dennehy CE, Tsourounis C, Wakefield T. (2026). \textit{Marketing by online tobacco retailers: An observational cross-sectional study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.18332/tid/220983}{doi:10.18332/tid/220983}.
\item Bazzichi L, Di Carlo M, Salaffi F, Farah S, Porta F, Ablin JN, Varrassi G, Galli F, Fornasari D, Carotti M, Alciati A, Pellegrino G, Batticciotto A, Lucini D, Casale R, Di Franco M, Sarzi-Puttini P, Iannuccelli C, Pain Study Group of the Italian Society of Rheumatology (SIR). (2026). \textit{Therapeutic advances in fibromyalgia: one year in review 2026.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.55563/clinexprheumatol/xscnij}{doi:10.55563/clinexprheumatol/xscnij}.
\item Dong M, Zhang Y, Cao M, Shi T, Li L, Zong X, Wang C. (2026). \textit{DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules31122143}{doi:10.3390/molecules31122143}.
\item Leeman Lawrence, Armstrong Maya, Menashi Dara, Nayo-Washington Hanifa, Marseille Elliot, Herrera Janus, Romero Crystal, Page-Reeves Janet (2026). \textit{Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico}. Frontiers in Public Health. [published; Crossref]. \href{https://doi.org/10.3389/fpubh.2026.1845943}{doi:10.3389/fpubh.2026.1845943}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O. (2026). \textit{Psilocybin's kinematic effect on manual dexterity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-026-07106-8}{doi:10.1007/s00213-026-07106-8}.
\item Potoczna M, Kasica N, Chmielewska-Krzesińska M, Dybalska-Szczepanek J, Wąsowicz K, Sokołowska E, Podlasz P. (2026). \textit{Anxiety-related platform in zebrafish (Danio rerio) larvae: An integrated analysis of behavioural and molecular assay in drug screening research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2026.119680}{doi:10.1016/j.biopha.2026.119680}.
\item Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G. (2026). \textit{Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.12.731811}{doi:10.64898/2026.06.12.731811}.
\item Manoj Doss (2026). \textit{The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079852}{source link}.
\item Brigham and Women's Hospital (2026). \textit{Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296094}{source link}.
\item Unknown authors (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA}. SAIMSARA Journal. [published; Crossref]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Labra-Lorenzana Angel, Lima-Sánchez Dania Nimbe, Delaflor-Wagner Christian Alejandro, Martínez-Hernández Diana, Ramos-Jiménez Christian, Toledo-Lozano Christian Gabriel (2026). \textit{Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis}. Psychiatry International. [published; Crossref]. \href{https://doi.org/10.3390/psychiatryint7030137}{doi:10.3390/psychiatryint7030137}.
\item Wanke Michał, Matuszewski Paweł, Siuda Piotr (2026). \textit{“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse}. Drugs, Habits and Social Policy. [published; Crossref]. \href{https://doi.org/10.1108/dhs-01-2026-0003}{doi:10.1108/dhs-01-2026-0003}.
\item Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC. (2026). \textit{Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jclp.70167}{doi:10.1002/jclp.70167}.
\item Bhavaraju Kirshna Prasad, Mason Natasha L., Mallaroni Pablo, Heinke Dietmar, Toennes Stefan W., Ramaekers Johannes G., Amico Enrico (2026). \textit{Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin}. Network Neuroscience. [published; Crossref]. \href{https://doi.org/10.1162/netn.a.594}{doi:10.1162/netn.a.594}.
\item Cheung K, Propes C, Yaden DB. (2026). \textit{Balancing safety and access in Oregon's psilocybin services.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2026.105384}{doi:10.1016/j.drugpo.2026.105384}.
\item Abrahms ZN, Majdi M, Madsen SM, Morton CJ, Sen AK, Fried NB, Sawyer LE, Cegielski ER, Spezzano SJ, Jones JA. (2026). \textit{Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ymben.2026.102490}{doi:10.1016/j.ymben.2026.102490}.
\item Guimarães AL, Beserra FR, Cruz L, Bienemmann B, Freind JMK, Guinle V, Rodrigues RS, Regalado JA, Mograbi DC (2026). \textit{Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.}. Clinical therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.clinthera.2026.05.012}{doi:10.1016/j.clinthera.2026.05.012}.
\item Qarni Z, Richard J. (2026). \textit{Altered States, Enhanced Potential: Psychedelics and Physical Performance}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/txgq2\_v2}{doi:10.31234/osf.io/txgq2\_v2}.
\item Qarni Z, Richard J. (2026). \textit{Altered States, Enhanced Potential: Psychedelics and Physical Performance}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/txgq2\_v1}{doi:10.31234/osf.io/txgq2\_v1}.
\item Unknown authors (2026). \textit{Altered States, Enhanced Potential: Psychedelics and Physical Performance}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/txgq2\_v2}{source link}.
\item Jajcay N, Vejmola Č, Korčák J, Tylš F, Viktorinová M, Viktorin V, Bravermanová A, Androvičová R, Balíková M, Horáček J, Brunovský M, Hlinka J, Páleníček T. (2026). \textit{EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.09.731183}{doi:10.64898/2026.06.09.731183}.
\item Allen J, Jupp B, Baker TL, Haskali MB, Brkljača R, Plummer Z, Sun M, Brand J, Christie BR, Debert CT, McDonald SJ, O'Brien TJ, Casillas-Espinosa PM, Shultz SR. (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item Mingardi J, Molteni R, Bifari F. (2026). \textit{Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2026.108290}{doi:10.1016/j.phrs.2026.108290}.
\item Tobel T, Cone A, Choquette E, Garland M, Johnson M, Mink K, Lynch C, Frohlich J, Feinstein J, Reggente N, Khalsa SS. (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6mj8n\_v2}{doi:10.31234/osf.io/6mj8n\_v2}.
\item Carhart-Harris RL. (2026). \textit{The entropic brain today.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/brain/awag206}{doi:10.1093/brain/awag206}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v2}{source link}.
\item Raikkerus H, Bujour A, Kennedy M, Tiihonen J. (2026). \textit{The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2026.10088}{doi:10.1017/neu.2026.10088}.
\item Yale University (2026). \textit{Psilocybin as a Treatment for Chronic Pain in Smokers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07118332}{source link}.
\item Bryson Alexander, Bhagavan Chiranth, Carter Olivia, Nielsen Glenn, Berlowitz David, Issak Sara, Attard Zachary, Eleftheriadis Dina, Oliver Gina, Mayne Deanne, Roebuck Greg, Rucker James, Butler Matthew, Kanaan Richard (2026). \textit{Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)}. Neurology. [published; Crossref]. \href{https://doi.org/10.1212/wnl.0000000000212934}{doi:10.1212/wnl.0000000000212934}.
\item Gillet M, Doudeau N, Vilain F, Sadat K, Morvan Y, Frajerman A. (2026). \textit{Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/07067437261457220}{doi:10.1177/07067437261457220}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item Jennifer Mitchell (2026). \textit{A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07386730}{source link}.
\item Pines AR, Zhang X, Kochalka J, Vesuna SS, Kauvar IV, Rajasekharan D, Reneau TR, Akiki TJ, Hack LM, Siegel JS, Williams LM. (2026). \textit{Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.2522000123}{doi:10.1073/pnas.2522000123}.
\item Robin Carhart-Harris, PhD, MA (2026). \textit{Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05698511}{source link}.
\item VA Office of Research and Development (2026). \textit{A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07226232}{source link}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R. (2026). \textit{Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-026-01685-1}{doi:10.1007/s11920-026-01685-1}.
\item Domnauer C, Dentinger BTM. (2026). \textit{Phylogenomic systematics of Lanmaoa (Boletaceae) reveals cryptic diversity, resolves global evolutionary relationships, and suggests a novel psychoactive lineage.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00275514.2026.2670968}{doi:10.1080/00275514.2026.2670968}.
\item Ahmadian-Moghadam S, Roshan-Milani S, Saboory E. (2026). \textit{Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-04151-x}{doi:10.1038/s41398-026-04151-x}.
\item Tarbi EC, Bhatia I, Balach N, Buehler S, Demeo-Meres M, Gramling C, Thambi T, Hart J, Reblin M, Rizzo DM, Gramling R, Agrawal M, Manetta E. (2026). \textit{Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare14111589}{doi:10.3390/healthcare14111589}.
\item Graham M, Ge Y, Pacula RL, Pessar SC, Wilkins C, Hall W, Hammond D. (2026). \textit{A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2026.105348}{doi:10.1016/j.drugpo.2026.105348}.
\item Yale University (2026). \textit{Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05370911}{source link}.
\item Robin Carhart-Harris, PhD, MA (2026). \textit{2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06626139}{source link}.
\item Boehnke KF, Pouyan N, Aday JS. (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Shah S, Morrin H. (2026). \textit{Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-026-08137-3}{doi:10.1186/s12888-026-08137-3}.
\item Kelly CM, Fradet M, Bostian CM, Donnelly A, Ellis S, Ostacher M, Aaronson S, Suppes T. (2026). \textit{Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.122063}{doi:10.1016/j.jad.2026.122063}.
\item Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F. (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Dorval M, Audet-Croteau V, Chang SL, Masse-Grenier M, Tremblay A, Bénard E, Chapdelaine A, Garel N, Guertin JR. (2026). \textit{Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare14111559}{doi:10.3390/healthcare14111559}.
\item University of Calgary (2026). \textit{The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06768944}{source link}.
\item Carter D, Reardon I, Swain J, Vando L. (2026). \textit{Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9839240/v1}{doi:10.21203/rs.3.rs-9839240/v1}.
\item Ona G, Llagostera C, Alvarez O, Dueñas RM, González D, Soto-Angona O. (2026). \textit{Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14786419.2026.2683121}{doi:10.1080/14786419.2026.2683121}.
\item Centre for Addiction and Mental Health (2026). \textit{Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512220}{source link}.
\item Usona Institute (2026). \textit{A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06308653}{source link}.
\item University of Pennsylvania (2026). \textit{Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06810310}{source link}.
\item Li EJ, Mosharraf B, Ali H, Noyes M, Doshi P, Wallace C, Petranker R, Adili A, Khan M, Busse JW, MacKillop J, Madden K. (2026). \textit{Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.05.29.26354422}{doi:10.64898/2026.05.29.26354422}.
\item Canady Valerie A. (2026). \textit{Psilocybin shows rapid relief for depression symptoms}. Mental Health Weekly. [published; Crossref]. \href{https://doi.org/10.1002/mhw.34890}{doi:10.1002/mhw.34890}.
\item Wongumpornpinit Vorawut, Ingkaninan Kornkanok, Temkitthawon Prapapan, Waranuch Neti, Copetti Pivetta Rhannanda, Zuo Jieyu, Araujo Gabriel Lima Barros de, Bou-Chacra Nádia, Somayaji Vijay, Loebenberg Raimar (2026). \textit{Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development}. Journal of Drug Delivery Science and Technology. [published; Crossref]. \href{https://doi.org/10.1016/j.jddst.2026.108228}{doi:10.1016/j.jddst.2026.108228}.
\item Unknown authors (2026). \textit{Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”}. Drug Science, Policy and Law. [published; Crossref]. \href{https://doi.org/10.1177/20503245261459447}{doi:10.1177/20503245261459447}.
\item Brinzei Octavian Victor (2026). \textit{Comparative medico-legal frameworks for psilocybin regulation: A March 2026 update}. Drug Science, Policy and Law. [published; Crossref]. \href{https://doi.org/10.1177/20503245261458143}{doi:10.1177/20503245261458143}.
\item Sidovar Matthew, O'Connor Shane J., Orsini Lucinda (2026). \textit{EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE}. Value in Health. [published; Crossref]. \href{https://doi.org/10.1016/j.jval.2026.03.422}{doi:10.1016/j.jval.2026.03.422}.
\item Jungwirth Johannes, Westenhöfer Samuel, Aicher Helena D., Provaznikova Barbora, Kronenberg Golo, Seifritz Erich, Prinz Susanne, Olbrich Sebastian (2026). \textit{Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study}. The Lancet Regional Health - Europe. [published; Crossref]. \href{https://doi.org/10.1016/j.lanepe.2026.101719}{doi:10.1016/j.lanepe.2026.101719}.
\item Mallard Austin, Harbour Jessica, Pappano Catherine, Mancuso Mary, Kilbourn Kristin, Fischer Stacy M. (2026). \textit{Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network Analysis}. Journal of Pain and Symptom Management. [published; Crossref]. \href{https://doi.org/10.1016/j.jpainsymman.2026.04.025}{doi:10.1016/j.jpainsymman.2026.04.025}.
\item Ziadi Yosr, Park Taehwan (2026). \textit{EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION}. Value in Health. [published; Crossref]. \href{https://doi.org/10.1016/j.jval.2026.03.635}{doi:10.1016/j.jval.2026.03.635}.
\item Stocker K, Hartmann M, Barrett FS, Richards WA, Sepeda ND, Ley L, Becker AM, Holze F, Liechti ME. (2026). \textit{Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/mpr.70073}{doi:10.1002/mpr.70073}.
\item Egger K, Bozsak R, Aicher HD, Sari H, Poetzsch SN, Rominger A, Martin-Soelch C, Smallridge JW, Dornbierer D, Quednow BB, Scheidegger M, Cumming P. (2026). \textit{Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0271678x261454172}{doi:10.1177/0271678x261454172}.
\item Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A. (2026). \textit{Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.70574}{doi:10.1111/ejn.70574}.
\item Fotiadis P, Jang H, Dai R, Li D, Cofré R, Timmermann C, Mashour GA, Hudetz AG, Huang Z. (2026). \textit{Reorganization of Human Brain Waves Across Diverse States of Consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.27.728182}{doi:10.64898/2026.05.27.728182}.
\item Miller CWT, Kozak Z. (2026). \textit{Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1521/pdps.2026.54.2.308}{doi:10.1521/pdps.2026.54.2.308}.
\item Poppe C, Lyck L, Bechtold L, Repantis D. (2026). \textit{Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/brb3.71544}{doi:10.1002/brb3.71544}.
\item Rowe T, Hurzeler T, Towers E, Louie E, Morley KC. (2026). \textit{Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/brb3.71533}{doi:10.1002/brb3.71533}.
\item Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, MacDonald A, Ivers JH, Trepel D, Tormey G, Finnegan M, Young GW, Harkin A. (2026). \textit{Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyag028}{doi:10.1093/ijnp/pyag028}.
\item Barajas DA, Carter HCN, Tomedi MR, Lam HY, Deloatch TN, Reynolds GD, Castaneto MS, Ke P. (2026). \textit{Studies on enzymatic hydrolysis of psilocin-O-glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkag030}{doi:10.1093/jat/bkag030}.
\item Vicentini AB, de Paula CC, Silva Reis JA, Bouso JC, Hallak JEC, Dos Santos RG. (2026). \textit{Classic psychedelics and personality: An updated systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item University of Washington (2026). \textit{A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07336238}{source link}.
\item Hood Alex, Elkins Gary (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Hampsey E, Martin K, Kalfas M, Benson L, Wihlborg S, Jelen L, Young AH, Rucker J. (2026). \textit{A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261453938}{doi:10.1177/02698811261453938}.
\item Brendstrup-Brix K, Ozenne B, Fisher PM, Stenbæk DS, Petersen AS, Armand S, McCulloch DE, Marstrand-Joergensen MR, Ulv Larsen SM, Johansen A, Jensen RH, Knudsen GM, Madsen MK. (2026). \textit{Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261449380}{doi:10.1177/02698811261449380}.
\item Pei G. (2026). \textit{A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradox.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41421-026-00906-4}{doi:10.1038/s41421-026-00906-4}.
\item Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M. (2026). \textit{Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03657-6}{doi:10.1038/s41380-026-03657-6}.
\item Lin Wei, Chen Hong, Li Yuanyuan (2026). \textit{Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy}. Journal of Raman Spectroscopy. [published; Crossref]. \href{https://doi.org/10.1002/jrs.70178}{doi:10.1002/jrs.70178}.
\item Atiq MA, Weisman E, Guerra RB, Martinez LL, Yaden DB, Barrett FS, Nayak S, Sayali C. (2026). \textit{Psilocybin-induced neurocardiogenic syncope: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-026-07079-8}{doi:10.1007/s00213-026-07079-8}.
\item Belinger L, Rieser NM, Engeli EJE, Becciolini L, Clamote M, Pribis M, Saissi F, Florineth GA, Hehl NL, Herdener M, Preller KH. (2026). \textit{Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2026.112879}{doi:10.1016/j.euroneuro.2026.112879}.
\item LoParco CR, Rossheim ME, Tillett KK, Cui Y, Johnson M, Speer M, Mihelich D, Amdeta H, Ndisebuye D, Berg CJ. (2026). \textit{Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15288/jsad.26-00013}{doi:10.15288/jsad.26-00013}.
\item Lago M, Cerveira M, Simonet JX. (2026). \textit{Transient multidomain functional improvement in advanced Alzheimer's disease following high-dose psilocybin-containing mushroom administration: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2026.1813281}{doi:10.3389/fnins.2026.1813281}.
\item NYU Langone Health (2026). \textit{Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07607938}{source link}.
\item Mertens LJ, Betzler F, Brand M, Evens R, Jungaberle A, Jungaberle H, Kärtner L, Majić T, Schmitz CN, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Harder H, Kirchen N, Kulakova E, Kunz LC, Meijer A, Rohrmoser B, Wellek S, Berger MM, Koslowski M, Gründer G. (2026). \textit{Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000552272}{doi:10.1159/000552272}.
\item Singh J, Mruthyunjaya P. (2026). \textit{Correction: Catatonia Associated With First-Time Psilocybin Exposure: A Case Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.c439}{doi:10.7759/cureus.c439}.
\item Emory University (2026). \textit{The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07332143}{source link}.
\item Rahman T. (2026). \textit{Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and Retrieval}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202605.1558.v1}{doi:10.20944/preprints202605.1558.v1}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Spanagel R, Vollenweider FX, Preller KH, Meinhardt MW. (2026). \textit{Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03961-3}{doi:10.1038/s41398-026-03961-3}.
\item Berg CJ, LoParco CR, Rossheim ME, McCready DM, Langan L, Platt E, Romm KF, Johnson M, Speer MB, Burris S, Cavazos-Rehg PA. (2026). \textit{Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2026.113218}{doi:10.1016/j.drugalcdep.2026.113218}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2026). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-026-02450-x}{doi:10.1038/s41386-026-02450-x}.
\item Zhang T, Lin C, Wang X. (2026). \textit{Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.6c00146}{doi:10.1021/acsptsci.6c00146}.
\item Bralic N, Bragagnolo E, Palner M. (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gf7bq\_v1}{doi:10.31234/osf.io/gf7bq\_v1}.
\item Unknown authors (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Unknown authors (2026). \textit{Psilocybin}. Reactions Weekly. [published; Crossref]. \href{https://doi.org/10.1007/s40278-026-95077-4}{doi:10.1007/s40278-026-95077-4}.
\item University of Colorado, Denver (2026). \textit{Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06230757}{source link}.
\item University of New Mexico (2026). \textit{Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07506395}{source link}.
\item Novelli L, Stoliker D, Barta T, Greaves MD, Chopra S, Jackson J, Kwee J, Pang JC, Williams ML, Razi A. (2026). \textit{PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41597-026-07312-1}{doi:10.1038/s41597-026-07312-1}.
\item Cavallaro N, Rai P, Akins D, Soltanpour S, Nasseef MT, Ortiz RJ, Utama R, Cody CR, Mistry A, Brenhouse HC, Kulkarni PP, Ferris CF. (2026). \textit{Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12264-026-01632-3}{doi:10.1007/s12264-026-01632-3}.
\item Washington University School of Medicine (2026). \textit{A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07582120}{source link}.
\item Millay T, Kodali M, Cottler L. (2026). \textit{265 Self-reported rates of psilocybin use in North Florida, 2012 to present}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC13172864}{source link}.
\item Huels E, Smith S, Liu T, Pal D. (2026). \textit{361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized pain}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC13172966}{source link}.
\item Beichmann K, Catzeflis P, Aicher HD, Seragnoli F, Calder A, Amrani A, Hasler G. (2026). \textit{Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253261448745}{doi:10.1177/20451253261448745}.
\item University of California, Los Angeles (2026). \textit{Psilocybin-assisted Cognitive Behavioral Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227612}{source link}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Cocaine Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02037126}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06299319}{source link}.
\item Conn K, Wong N, Sunnetci S, Al Siyabi A, McCoy K, Huang K, Greaves E, Milton LK, Kuhlmann L, Maguire S, Foldi CJ. (2026). \textit{Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine function}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.14.725265}{doi:10.64898/2026.05.14.725265}.
\item Unknown authors (2026). \textit{Corrigendum to: "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674261450797}{doi:10.1177/00048674261450797}.
\item Yang KH, Rasmussen M, Bhatt K, Satybaldiyeva N, Kepner W, Moore AA, Bergstrom J. (2026). \textit{Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2026.2673845}{doi:10.1080/02791072.2026.2673845}.
\item Unknown authors (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1177/28314425261461057}{doi:10.1177/28314425261461057}.
\item Wolff M, Kangaslampi S, Zeifman R, Spangemacher M. (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8s7xk\_v2}{doi:10.31234/osf.io/8s7xk\_v2}.
\item Cohen J, Parbo P, Ørskov PT, Wildgruber D, Kreifelts B, kirk u, Gerke O, Madsen MK, Palner M. (2026). \textit{Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3b9fx\_v1}{doi:10.31234/osf.io/3b9fx\_v1}.
\item Alan Davis (2026). \textit{Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07216404}{source link}.
\item University of Calgary (2026). \textit{Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06885996}{source link}.
\item Unknown authors (2026). \textit{Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/3b9fx\_v1}{source link}.
\item Geller JA, Pacilio R, Downey AE, Ragnhildstveit A, Raymond-Flesch M, Knatz-Peck S, Gukasyan N. (2026). \textit{Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-026-01679-z}{doi:10.1007/s11920-026-01679-z}.
\item Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Son T, Farb N, Petranker R. (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2026.12000}{doi:10.1192/bjo.2026.12000}.
\item van der Vaart A, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Suppes T, Sackeim HA, Aaronson ST. (2026). \textit{Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.26m16338}{doi:10.4088/jcp.26m16338}.
\item Yu F, Tafur J, Moreno F, Dahmer S. (2026). \textit{Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2026.1777387}{doi:10.3389/fpsyt.2026.1777387}.
\item Francisco A Moreno (2026). \textit{A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07347405}{source link}.
\item University of Wisconsin, Madison (2026). \textit{Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05322954}{source link}.
\item COMPASS Pathways (2026). \textit{A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07570654}{source link}.
\item Kosiarski Bartłomiej, Skrzypek Anna, Markowicz Patrycja, Zbrożek Mikołaj, Biłyk Krzysztof, Hutkowski Maciej, Chwostek Zuzanna, Maruchniak Hanna, Marzec Wiktoria, Biedroń Paulina (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; Crossref]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ. (2026). \textit{Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9283280/v1}{doi:10.21203/rs.3.rs-9283280/v1}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms27104229}{doi:10.3390/ijms27104229}.
\item University Medical Center Groningen (2026). \textit{The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06782724}{source link}.
\item Tarailis P, Griskova-Bulanova I. (2026). \textit{Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.05.723034}{doi:10.64898/2026.05.05.723034}.
\item Reid Matthew, Yaffe Abigail, Geithner Ian, Rebman Alison, Aucott John, Garcia-Romeu Albert (2026). \textit{1020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme Disease}. SLEEPJ. [published; Crossref]. \href{https://doi.org/10.1093/sleep/zsag091.1019}{doi:10.1093/sleep/zsag091.1019}.
\item Reid Matthew, Weisman Eli, Martinez Luis Luna, Coon William, Barrett Frederick (2026). \textit{1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power}. SLEEPJ. [published; Crossref]. \href{https://doi.org/10.1093/sleep/zsag091.1079}{doi:10.1093/sleep/zsag091.1079}.
\item Vidot Denise, Diggs Bria-Necole, Baral Amrit, Thompson Michelle, Jean-Louis Girardin (2026). \textit{0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study}. SLEEPJ. [published; Crossref]. \href{https://doi.org/10.1093/sleep/zsag091.0408}{doi:10.1093/sleep/zsag091.0408}.
\item Pasquini Lorenzo, Girn Manesh, Kettner Hannes, Ostrand Avery, Allison Kate, Valtierra Christian, Lucas Will, McConnell Patrick, Miller Catriona, Griffith Sydney, Weinstein Dawn, Anderson Brian, Rosati Andrea, Mitchell Jennifer, Carhart-Harris Robin (2026). \textit{Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer study}. JoCN Forum. [published; Crossref]. \href{https://doi.org/10.21428/8e6ba8ef.1db8272c}{doi:10.21428/8e6ba8ef.1db8272c}.
\item Vamvakopoulou IA, Nicholls D, Nutt DJ, Di Simplicio M. (2026). \textit{Exploring new avenues: Psychedelic-assisted therapy for young people.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/bcp.70579}{doi:10.1002/bcp.70579}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05710237}{source link}.
\item Zachar Kinga, Sito Maksymilian, Jurkowski Filip, Wójcik Łukasz, Gawron Natalia, Bojanowski Hubert Tomasz, Dobracka Aleksandra, Marczak Zuzanna, Jarowicz Monika, Czmyr Jędrzej (2026). \textit{Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review}. Journal of Education, Health and Sport. [published; Crossref]. \href{https://doi.org/10.12775/jehs.2026.91.70672}{doi:10.12775/jehs.2026.91.70672}.
\item Nuwer R (2026). \textit{Magic mushroom compound shows promise against cocaine addiction.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.aei6155}{doi:10.1126/science.aei6155}.
\item Forsyth D, Faraone N, Lamarre SG, Currie S. (2026). \textit{The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnbeh.2026.1767175}{doi:10.3389/fnbeh.2026.1767175}.
\item Sunstone Medical (2026). \textit{A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05947383}{source link}.
\item University of North Carolina, Chapel Hill (2026). \textit{Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06303739}{source link}.
\item Stanford University (2026). \textit{A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07479550}{source link}.
\item University of Nebraska (2026). \textit{An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal Cancers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220046}{source link}.
\item Lyons T, Spriggs M, Kerkelä L, Rosas FE, Roseman L, Mediano PAM, Timmermann C, Oestreich L, Pagni BA, Zeifman RJ, Hampshire A, Trender W, Douglass HM, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall MB, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2026). \textit{Human brain changes after first psilocybin use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-026-71962-3}{doi:10.1038/s41467-026-71962-3}.
\item Usona Institute (2026). \textit{A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04353921}{source link}.
\item University of Washington (2026). \textit{A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565909}{source link}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item University of California, Los Angeles (2026). \textit{Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07566104}{source link}.
\item Yang KH, Satybaldiyeva N, Kepner W, Friedman J, Ping S, Leas EC. (2026). \textit{Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.amepre.2026.108381}{doi:10.1016/j.amepre.2026.108381}.
\item Sayali Ceyda, Weisman Eli, Barrett Frederick (2026). \textit{Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder}. JoCN Forum. [published; Crossref]. \href{https://doi.org/10.21428/8e6ba8ef.31e358f9}{doi:10.21428/8e6ba8ef.31e358f9}.
\item Simonsson O, Lyons T, Marks J, Kettner H, Roseman L, Haijen E, Kaelen M, Carhart-Harris R. (2026). \textit{Effects of psychedelic use on authoritarian attitudes revisited.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261443677}{doi:10.1177/02698811261443677}.
\item Lakshmi N Yatham (2026). \textit{Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06943573}{source link}.
\item Yale University (2026). \textit{Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06624137}{source link}.
\item Mauney Erin, Zambrano Juliana, Clukey Jenna, Burton-Murray Helen, Datko Michael, Napadow Vitaly, Kuo Braden, King Franklin (2026). \textit{Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS}. Gastrointestinal Endoscopy. [published; Crossref]. \href{https://doi.org/10.1016/s0016-5107(26)04363-4}{doi:10.1016/s0016-5107(26)04363-4}.
\item Herman Melissa (2026). \textit{Sex-Specific Effects of Psilocin on Paraventricular Nucleus of the Thalamus (PVT) Circuitry and Threat Responding Behavior in Male and Female Rats}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.055}{doi:10.1016/j.biopsych.2026.03.055}.
\item LaMalfa Kayleigh, Pizzagalli Diego A., Bergman Jack, Thomas Christopher W., Kangas Brian (2026). \textit{Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/j.jpet.2026.104267}{doi:10.1016/j.jpet.2026.104267}.
\item Holze Friederike, Arikci Denis, Thomann Jan, Rudin Deborah, Luethi Dino, Liechti Matthias E. (2026). \textit{Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy Participants}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.056}{doi:10.1016/j.biopsych.2026.03.056}.
\item Hayduk Sean, Stringer Amy, Zagorski Satoria, Ward Sara Jane (2026). \textit{PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/j.jpet.2026.104282}{doi:10.1016/j.jpet.2026.104282}.
\item Schuler Heike, Zhou Delong, Savignac Chloé, Cvetkovska Vedrana, Tse Yiu-Chung, Meccia Juliet, Bzdok Danilo, Bagot Rosemary (2026). \textit{Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal Cortexh}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.054}{doi:10.1016/j.biopsych.2026.03.054}.
\item Bradley Ellen, Kelley D Parker, Picard Martin, Szigeti Balazs, Sakai Kimberly, Fernandes Gisele, Ostrem Jill, Tanner Caroline, Finley Patrick, Ludwig Connie, Llerena Katiah, Busby Zach, McKernan Amber, Zuzuarregui Jose Rafael, Bock Meredith, Wang Aliss, Penn Andrew, Woolley Josh, O'Donovan Aoife (2026). \textit{356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.590}{doi:10.1016/j.biopsych.2026.03.590}.
\item Poulin Joshua, Viulet Nic, Liu Ashley, MacIntosh Bradley J., Nestor Sean M. (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Unknown authors (2026). \textit{Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in rats}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v8isupii.46826}{doi:10.51126/revsalus.v8isupii.46826}.
\item Hecker L, Kleinhenz J M, Coarfa C, Kato K (2026). \textit{C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases}. American Journal of Respiratory and Critical Care Medicine. [published; Crossref]. \href{https://doi.org/10.1093/ajrccm/aamag162.144}{doi:10.1093/ajrccm/aamag162.144}.
\item Yockey R. Andrew, Amis Amber, Devier Elise, Apu Aminul, Hoopsick Rachel (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA}. AJPM Focus. [published; Crossref]. \href{https://doi.org/10.1016/j.focus.2026.100518}{doi:10.1016/j.focus.2026.100518}.
\item Hennessey Joseph, Mantsch John, McCorvy John (2026). \textit{Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/j.jpet.2026.104291}{doi:10.1016/j.jpet.2026.104291}.
\item Unknown authors (2026). \textit{Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v8isupii.46635}{doi:10.51126/revsalus.v8isupii.46635}.
\item Mauney Erin, Zambrano Juliana, Clukey Jenna, Burton-Murray Helen, Datko Michael, Napadow Vitaly, Kuo Braden, King Franklin (2026). \textit{Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS}. Gastroenterology. [published; Crossref]. \href{https://doi.org/10.1016/s0016-5085(26)04432-x}{doi:10.1016/s0016-5085(26)04432-x}.
\item Signor Anna, Colognesi Martina, Finzi Giovanna, Gabbia Daniela, Mattarei Andrea, Comai Stefano, Pasut Gianfranco, Folli Franco, Manfredi Paolo, De Martin Sara (2026). \textit{SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models}. Journal of Hepatology. [published; Crossref]. \href{https://doi.org/10.1016/s0168-8278(26)01861-1}{doi:10.1016/s0168-8278(26)01861-1}.
\item Pagni Broc, Ross Stephen, Kim Yuna, Bogenschutz Michael (2026). \textit{6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.240}{doi:10.1016/j.biopsych.2026.03.240}.
\item Unknown authors (2026). \textit{Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening Study}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v8isupii.46839}{doi:10.51126/revsalus.v8isupii.46839}.
\item Gupta Gyandev, Yadav Ravina (2026). \textit{Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical}. JOURNAL OF ADVANCE AND FUTURE RESEARCH. [published; Crossref]. \href{https://doi.org/10.56975/jaafr.v4i5.509087}{doi:10.56975/jaafr.v4i5.509087}.
\item Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F (2026). \textit{Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389581}{doi:10.1177/02698811251389581}.
\item Mertens LJ, Koslowski M, Betzler F, Brand M, Evens R, Kärtner L, Jungaberle A, Jungaberle H, Majic T, Schmitz CN, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Kirchen N, Kulakova E, Kunz L, Meijer A, Rohrmoser B, Wellek S, Berger MM, Gründer G. (2026). \textit{Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0132}{doi:10.1001/jamapsychiatry.2026.0132}.
\item Hudson JI, Pope HG. (2026). \textit{Enlightenment in a Pill-Testing the Efficacy of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0070}{doi:10.1001/jamapsychiatry.2026.0070}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Hendricks PS, Lappan SN, Shelton RC, Lahti AC, Cropsey KL, Johnson MW, Bradley M, Simonsson O, Davis LL, Grossman DH, Ortiz CE. (2026). \textit{Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2026.11029}{doi:10.1001/jamanetworkopen.2026.11029}.
\item Bonar EE. (2026). \textit{Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical Appraisal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2026.11042}{doi:10.1001/jamanetworkopen.2026.11042}.
\item Simonsson O, Sun S, Wesseldijk LW, Ullén F, Osika W, Mosing MA (2026). \textit{Associations between psychedelic use and migraine history in Swedish twins.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449385}{doi:10.1177/02698811261449385}.
\item Filiz ES, Stringer D, Kellermann V, Olive RR, Said O, Mutwalli H, Bektas S, Akkese MN, Ireland K, Beishon-Murley D, Khor JWT, Allman L, Kotze N, Carter B, Tyrrell-Bunge E, Rowlands K, Keeler JL, Ivin G, Simic M, Sually DS, Bentley J, Young AH, Madden S, Byford S, Landau S, Treasure J, Schmidt U, Nicholls D, Lawrence V, Himmerich H (2026). \textit{Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study.}. Health technology assessment (Winchester, England). [published; PubMed]. \href{https://doi.org/10.3310/gjhh0812}{doi:10.3310/gjhh0812}.
\item Yngwe H, Plavén-Sigray P, Ekman CJ, Henje E, Berglund A, Tiger M, Beckman M, Lundberg J. (2026). \textit{Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2026.12589}{doi:10.1001/jamanetworkopen.2026.12589}.
\item Silva MH. (2026). \textit{New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/bdr2.70048}{doi:10.1002/bdr2.70048}.
\item Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A. (2026). \textit{Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cnr2.70587}{doi:10.1002/cnr2.70587}.
\item Kwiatos N, Ossel S, Mutti FG. (2026). \textit{Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202500898}{doi:10.1002/cbic.202500898}.
\item Bergh MS, Bogen IL, Vevelstad M, Øiestad ÅML. (2026). \textit{Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkag015}{doi:10.1093/jat/bkag015}.
\item Briggs D, Sease TB, Menou R, Perkins DR. (2026). \textit{Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin Consumption.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/bs16050686}{doi:10.3390/bs16050686}.
\item University Hospital, Basel, Switzerland (2026). \textit{Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05883540}{source link}.
\item Joshua Woolley, MD, PhD (2026). \textit{A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05351541}{source link}.
\item Marini S, De Berardis D. (2026). \textit{The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1998.v1}{doi:10.20944/preprints202604.1998.v1}.
\item Zajaczkowski M, Koutsoftidis S, Sheeraz M, Barsakcioglu DY, Jia T, McGeady CA, Kundu A, Pizzi M, Tatti F, Bashford J, Bhavesh P, Farina D, Drakakis E. (2026). \textit{A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary Experiments}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9266175/v1}{doi:10.21203/rs.3.rs-9266175/v1}.
\item Magnani L, Ghirotto L, Fesce F, Re T, Tanzi S, Amerio A, Costanza A. (2026). \textit{Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/spcare-2025-005689}{doi:10.1136/spcare-2025-005689}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Rockhill KM, Bemis EA, Schow N, Olsen HA, Beekman K, Fox EJ, Monte AA, Black JC. (2026). \textit{Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2196/86059}{doi:10.2196/86059}.
\item Chaganti J, Siefried KJ, Vyakaranam VS, Acheson L, Brett J. (2026). \textit{"Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a9364}{doi:10.3174/ajnr.a9364}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2026). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s42003-026-10065-7}{doi:10.1038/s42003-026-10065-7}.
\item Salinsky LM, Fox JL, Diaz KC, Timmons BC, Ferguson SM. (2026). \textit{Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9306429/v1}{doi:10.21203/rs.3.rs-9306429/v1}.
\item Low ZXB. (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Portland VA Research Foundation, Inc (2026). \textit{Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04982796}{source link}.
\item Usona Institute (2026). \textit{A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03866174}{source link}.
\item Kyle Greenway (2026). \textit{Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07373535}{source link}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Cahuasqui-Mendoza Deivid Antonio (2026). \textit{Psilocybin as an alternative to conventional treatments: A systematic review}. Gaceta Médica de Caracas. [published; Crossref]. \href{https://doi.org/10.47307/gmc.2026.134.s2.32}{doi:10.47307/gmc.2026.134.s2.32}.
\item Yang KH, Eun A, Palamar JJ. (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20251343}{doi:10.1176/appi.ajp.20251343}.
\item Baral A, Pan Y, Hlaing WM, Garcia-Romeu A, Pinheiro PS, Vidot DC. (2026). \textit{Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s10552-026-02172-x}{doi:10.1007/s10552-026-02172-x}.
\item Matthews Nicholass KJ, Flis I, Hanley ME, Knight ME, Lane SM, Littlejohn G, Thom MDF, Billington RA, Boden R, Cummins R, Green BJ, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis JS. (2026). \textit{Wherefore the Magic? The Evolutionary Role of Psilocybin in Nature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ece3.73522}{doi:10.1002/ece3.73522}.
\item Sheheitli H, Hermosillo R, Grimsrud G, Madison T, Dominguez OM, Nelson S, Fair D, Nahas Z. (2026). \textit{Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition time.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/netn.a.537}{doi:10.1162/netn.a.537}.
\item Knox CA, Woodburn SC, Gilbert AD, Schlotzhauer JM, Kwan AC. (2026). \textit{Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.21.720014}{doi:10.64898/2026.04.21.720014}.
\item Feldman R, Audette M, Leacock PR, Theobald J. (2026). \textit{A25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajem.2026.04.033}{doi:10.1016/j.ajem.2026.04.033}.
\item University of Colorado, Denver (2026). \textit{Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06430541}{source link}.
\item Khosravi Mohsen, De Berardis Domenico, Tusconi Massimo (2026). \textit{The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes}. Mental Wellness. [published; Crossref]. \href{https://doi.org/10.4081/mw.2026.40}{doi:10.4081/mw.2026.40}.
\item Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari (2026). \textit{Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials}. Open Access Indonesian Journal of Medical Reviews. [published; Crossref]. \href{https://doi.org/10.37275/oaijmr.v6i2.883}{doi:10.37275/oaijmr.v6i2.883}.
\item Yacoub J, Bray E, Bayyat J, Glatfelter GC, Leake A, Buitrago EM, Maitland AD, Partilla J, Cavalco NG, Schalk SS, Lammers JC, Baumann MH, McCorvy J, Leahy JW, Gulick D, Witowski CG, von Salm JL. (2026). \textit{Serotonergic Polypharmacology of 2-Halogenated Tryptamines}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.16.718915}{doi:10.64898/2026.04.16.718915}.
\item Drange S, Cohen J, Johansen SS, Dunkley B, Palner M. (2026). \textit{Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2026.1819962}{doi:10.3389/fpsyt.2026.1819962}.
\item Johns Hopkins University (2026). \textit{Open Label Psilocybin Brain Stimulation and Imaging Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06835699}{source link}.
\item Brinzei OV. (2026). \textit{Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1423.v1}{doi:10.20944/preprints202604.1423.v1}.
\item Bysiek A, Szpręgiel I, Wojtas A, Maćkowiak M, Wawrzczak-Bargieła A, Leśkiewicz M, Trojan E, Kamińska K, Kumorek W, Bilecki W, Gołembiowska K. (2026). \textit{Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111710}{doi:10.1016/j.pnpbp.2026.111710}.
\item Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L. (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item King's College London (2026). \textit{Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05723276}{source link}.
\item Davoudian PA, Jiang Q, Knox CA, Savalia NK, Shao L, Wilson J, Weiner AM, Chong CW, Liao C, Nothnagel JD, Sakurai T, Kwan AC. (2026). \textit{Psilocybin reshapes cortical inhibition through selective interneuron recruitment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.16.718963}{doi:10.64898/2026.04.16.718963}.
\item Norris JJ. (2026). \textit{Substance use predictors of arrest and self-reported criminal behavior in the United States: The role of psychedelics and rarely used drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261436577}{doi:10.1177/02698811261436577}.
\item Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O. (2026). \textit{Psilocybin’s Kinematic Effect on Manual Dexterity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9291780/v1}{doi:10.21203/rs.3.rs-9291780/v1}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Vélez Rodríguez Jean C., Duquesne-Maldonado Yanice, Hernández Torres Julián M., Da'Luz Sant'Ana Istoni, Nazario Cruz M. (2026). \textit{Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00519}{doi:10.1556/2054.2026.00519}.
\item Keenan RJ, Haque RT, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds SE, Foldi CJ, Cowley MA. (2026). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03995-7}{doi:10.1038/s41398-026-03995-7}.
\item Back AL, McGregor BA, Thorn LL, Harvey K, Blom D, Callan G, Guy J, Kumar S, Hershberg R, Layer M, Levin J, Myers S, Perez J, Salmonson K, Thompson P, Whinney J. (2026). \textit{A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpubh.2026.1810904}{doi:10.3389/fpubh.2026.1810904}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2026). \textit{CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06319378}{source link}.
\item Olsen AS, Larsen K, McCulloch DE, Ganz M, Madsen MK, Ozenne B, Knudsen GM, Rehman Nu, Fisher PM. (2026). \textit{Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.09.717379}{doi:10.64898/2026.04.09.717379}.
\item Penberthy J. Kim, A. Wise Fatma, Cherup Nicholas, Penberthy J. Morgan, Mitchell Evaline, Burns Madeline, Akinlade Oluwafunmilayo, Chung David, Parmar Harshit, Singer Jonathan (2026). \textit{Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol}. Psychoactives. [published; Crossref]. \href{https://doi.org/10.3390/psychoactives5020012}{doi:10.3390/psychoactives5020012}.
\item Qiao YX, Dai W, Yao YS, Wei QQ, Yue CX, Yin YY, Li YF, Zhang LM. (2026). \textit{The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse model.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111698}{doi:10.1016/j.pnpbp.2026.111698}.
\item Rundquist Eric, Monasterio López Diego Nicolás, Oyarzo Alvarado Juan Jonathan, Carhart-Harris Robin, Pasquini Lorenzo, Vinson Erin, Girn Manesh, Ostrand Avery, Allison Kate, Kettner Hannes, Miller Catriona, Griffith Sydney, Gazzaley Adam, Rosati Andrea, Mitchell Jennifer (2026). \textit{Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin}. Philosophical Psychology. [published; Crossref]. \href{https://doi.org/10.1080/09515089.2026.2657452}{doi:10.1080/09515089.2026.2657452}.
\item Veysi A, Atanasovski D, Ardalan M, Motamed N, Eriksson E. (2026). \textit{Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2026.10075}{doi:10.1017/neu.2026.10075}.
\item Effinger DP, Hoffman JL, Quadir SG, Rollison CS, Toedt D, Echeveste Sanchez M, High MW, Hodge CW, Herman MA. (2026). \textit{Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-026-71481-1}{doi:10.1038/s41467-026-71481-1}.
\item Morel NS, Stenbaek DS, Lundberg J, Beckman M. (2026). \textit{Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-026-09124-8}{doi:10.1186/s12909-026-09124-8}.
\item Rumph JT, Winquist A, Troeschel AN, Pulver S, Schnall AH, Ebersole J, Yeh M, Burt B, Federman SL, Klontz K, Dasenbrock C, Leahy HL, Brady S, Stuteville H, Patel K, Daniel J, Chang A (2026). \textit{Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.}. MMWR. Morbidity and mortality weekly report. [published; PubMed]. \href{https://doi.org/10.15585/mmwr.mm7513a2}{doi:10.15585/mmwr.mm7513a2}.
\item Baker JJ, Kogan E, Ma S, Lu J, Zuo Y. (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item University of California, Los Angeles (2026). \textit{Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06102434}{source link}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F. (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Singleton S. Parker, Sevchik Brooke L., Lahey Analiese, Cuijpers Pim, Harrer Mathias, Jones Megan T., Nayak Sandeep M., Strain Eric C., Vandekar Simon N., Dworkin Robert H., Scott J. Cobb, Satterthwaite Theodore D. (2026). \textit{A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression}. Nature Mental Health. [published; Crossref]. \href{https://doi.org/10.1038/s44220-026-00630-8}{doi:10.1038/s44220-026-00630-8}.
\item Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA, Bzdok D. (2026). \textit{An international mega-analysis of psychedelic drug effects on brain circuit function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-026-04287-9}{doi:10.1038/s41591-026-04287-9}.
\item Singh J, Mruthyunjaya P. (2026). \textit{Catatonia Associated With First-Time Psilocybin Exposure: A Case Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.106474}{doi:10.7759/cureus.106474}.
\item University of Wisconsin, Madison (2026). \textit{Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06692192}{source link}.
\item University of Wisconsin, Madison (2026). \textit{Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05866471}{source link}.
\item Lerer L. (2026). \textit{Psilocybin and human longevity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41514-026-00380-y}{doi:10.1038/s41514-026-00380-y}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06180759}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05546658}{source link}.
\item Millay Tamara, Kodali Monica Bhargavi, Cottler Linda (2026). \textit{265 Self-reported rates of psilocybin use in North Florida, 2012 to present}. Journal of Clinical and Translational Science. [published; Crossref]. \href{https://doi.org/10.1017/cts.2026.10464}{doi:10.1017/cts.2026.10464}.
\item Huels Emma, Smith Sara, Liu Tiecheng, Pal Dinesh (2026). \textit{361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized pain}. Journal of Clinical and Translational Science. [published; Crossref]. \href{https://doi.org/10.1017/cts.2026.10531}{doi:10.1017/cts.2026.10531}.
\item Buchanan Christine (2026). \textit{26-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORT}. JACC. [published; Crossref]. \href{https://doi.org/10.1016/j.jacc.2026.02.3249}{doi:10.1016/j.jacc.2026.02.3249}.
\item Richmond Linda M. (2026). \textit{MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!}. Psychiatric News. [published; Crossref]. \href{https://doi.org/10.1176/appi.pn.2026.04.4.3}{doi:10.1176/appi.pn.2026.04.4.3}.
\item Pichler H. (2026). \textit{Psilocybin: Wirksam, aber kein Wundermittel.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-026-5871-5}{doi:10.1007/s15006-026-5871-5}.
\item Meshkat Shakila, Jha Manish K., Bhat Venkat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. Focus. [published; Crossref]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Bhatt KV, Friedman J, Benster L, Narasimhan R, Yang K, Mishra J, Weissman CR, Ramanathan D. (2026). \textit{Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s10597-026-01620-x}{doi:10.1007/s10597-026-01620-x}.
\item Adams DR, Xu KY, Cabassa LJ (2026). \textit{Psychedelic-Assisted Therapy: Breakthrough for Whom?}. Psychiatric services (Washington, D.C.). [published; PubMed]. \href{https://doi.org/10.1176/appi.ps.26077010}{doi:10.1176/appi.ps.26077010}.
\item Kazdan J, Ladha KS, Husain MI. (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Grant JE, Boutouis S, O'Brien M, Avila L, Neelapu M, Ehsan D. (2026). \textit{An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/wnf.0000000000000683}{doi:10.1097/wnf.0000000000000683}.
\item Berman P, Höfer J, Mehlman H, Almekias-Siegl E, Khersonsky O, Dong Y, Heinig U, Sulimani L, Hao LK, Cohen S, Peleg Y, Meir S, Rogachev I, Meiri D, Fleishman SJ, Aharoni A. (2026). \textit{Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/sciadv.aeb3034}{doi:10.1126/sciadv.aeb3034}.
\item Black JC, Bau GE, Cook RR, Bemis EA, Monte AA. (2026). \textit{Psilocybin Trends in States That Decriminalized Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.2026.1952}{doi:10.1001/jama.2026.1952}.
\item Schober S, Dorfmann L, Walther K, Blei F, Chadeayne AR, Gressler M, Bartram S, O'Connor SE, Hoffmeister D. (2026). \textit{Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.70318}{doi:10.1002/cbic.70318}.
\item Maltman JL, González-Maeso J. (2026). \textit{Reshaping human neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7554/elife.110981}{doi:10.7554/elife.110981}.
\item Jurowski K, Kobylarz D, Noga M. (2026). \textit{In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5'-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-026-04365-4}{doi:10.1007/s00204-026-04365-4}.
\item Albert OM, Arthur A. (2026). \textit{Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20420986261436104}{doi:10.1177/20420986261436104}.
\item Geraci J, Viirre E, Qorri B, Pani L. (2026). \textit{Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2026.1777613}{doi:10.3389/fphar.2026.1777613}.
\item Sunnybrook Health Sciences Centre (2026). \textit{Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06072898}{source link}.
\item Indiana University (2026). \textit{Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07499583}{source link}.
\item Wolff M, Kangaslampi S, Zeifman R, Spangemacher M. (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8s7xk\_v1}{doi:10.31234/osf.io/8s7xk\_v1}.
\item Unknown authors (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8s7xk\_v1}{source link}.
\item Smith KA, Harcourt E, Cipriani A. (2026). \textit{Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.2026.10612}{doi:10.1192/bjp.2026.10612}.
\item Catchlove SJ, Oliver K, Savic M, Arunogiri S. (2026). \textit{Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.70403}{doi:10.1111/add.70403}.
\item Knibb G, Ward R, Christiansen P, Roberts CA. (2026). \textit{Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-Stigma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/10826084.2026.2643418}{doi:10.1080/10826084.2026.2643418}.
\item Varela YM, de O Tavares VD, Delgado LM, de Faria HAT, Menezes LQ, Almeida RM, Agrícola P, de Carvalho BS, Bienemann B, Falchi-Carvalho M, Cavalcanti-Ribeiro P, Palhano-Fontes F, Fernandes-Osterhold G, de Araujo DB, Galvão-Coelho N. (2026). \textit{Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-025-02188-5}{doi:10.1007/s00406-025-02188-5}.
\item Federal University of Latin American Integration (2026). \textit{Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06898606}{source link}.
\item Schmidt Malin, Hoffrichter Anne, Davoudi Mahnaz, Horschitz Sandra, Lau Thorsten, Meinhardt Marcus W, Spanagel Rainer, Ladewig Julia, Köhr Georg, Koch Philipp (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. eLife. [published; Crossref]. \href{https://doi.org/10.7554/elife.104006.3}{doi:10.7554/elife.104006.3}.
\item Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt MW, Spanagel R, Ladewig J, Köhr G, Koch P. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7554/elife.104006}{doi:10.7554/elife.104006}.
\item Johnson JD, Tian R, Etemadi Y, Li Z. (2026). \textit{Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory Cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.26.714498}{doi:10.64898/2026.03.26.714498}.
\item Pagni BA, Ross S, Mennenga S, Bhatt SR, Zeifman R, Petridis P, Carrithers B, Worth L, Podrebarac S, Owens L, O'Donnell K, Roberts DE, Kim Y, Bogenschutz M. (2026). \textit{Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7xfek\_v1}{doi:10.31234/osf.io/7xfek\_v1}.
\item Unknown authors (2026). \textit{Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7xfek\_v1}{source link}.
\item Mäki-Marttunen V. (2026). \textit{Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s42003-026-09912-4}{doi:10.1038/s42003-026-09912-4}.
\item Skalski P, Pękacka-Falkowska K, Pluto-Prądzyńska A, Owecki MK. (2026). \textit{Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci16040358}{doi:10.3390/brainsci16040358}.
\item Anders Fink-Jensen, MD, DMSci (2026). \textit{The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05416229}{source link}.
\item Medical University of Vienna (2026). \textit{Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07490353}{source link}.
\item Patil SA, Hunsberger HC. (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Gillet A, Geron C, Vitello MM, Lejeune N. (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF. (2026). \textit{Integrated 5-HT2A -TrkB and G protein signaling in serotonergic psychedelic responses}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Croal M, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Soares JC, Somers M, Tsai J, Wahba M, Williams E, Young AH, Young MB, Zisook S, Malievskaia E. (2026). \textit{The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.121662}{doi:10.1016/j.jad.2026.121662}.
\item Nößler Denis (2026). \textit{Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12}. EvidenzUpdate. [published; Crossref]. \href{https://doi.org/10.69156/quick/2026.03.00011}{doi:10.69156/quick/2026.03.00011}.
\item Kishi T, Sakuma K, Hatano M, Uchida H, Iwata N. (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.121675}{doi:10.1016/j.jad.2026.121675}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07484906}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731621}{source link}.
\item Portes MAM, Bertoglio LJ. (2026). \textit{Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2026.2644865}{doi:10.1080/02791072.2026.2644865}.
\item Anchesi I, Raffaele I, Astorino MF, Lui M, Calabrò M, Cipriano GL. (2026). \textit{Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms27062811}{doi:10.3390/ijms27062811}.
\item Brusky B, M'Bailara K, Alla F, Barrault M. (2026). \textit{Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261424204}{doi:10.1177/02698811261424204}.
\item Sun Mingyu, Zhao Xiaoyu, Kong Fandi, Wang Jinsong, Lu Yunchang, Tong Liang (2026). \textit{Raman Activity Investigation and Utilization of Psilocybin}. Journal of Raman Spectroscopy. [published; Crossref]. \href{https://doi.org/10.1002/jrs.70133}{doi:10.1002/jrs.70133}.
\item Komarczewska Anna, Kociński Michał, Iglewski Patryk, Pietrasz Michał, Idziński Jakub, Lubomska Anna (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Farré-Colomés À, Rublinetska O, Soto-Angona Ó. (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Matsukubo J, Friesen EL, MacDonald-Spracklin R, Iseman R, Solmi M, Fiedorowicz JG, Fischer B, Myran DT. (2026). \textit{Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17269/s41997-026-01178-x}{doi:10.17269/s41997-026-01178-x}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06660381}{source link}.
\item Gustavo Vazquez (2026). \textit{Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06818994}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07211438}{source link}.
\item Ziadi Y, Park T. (2026). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.vhri.2026.101605}{doi:10.1016/j.vhri.2026.101605}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04123314}{source link}.
\item Sungheetha Akey, Rajesh Sharma R., Aroba Oluwasegun Julius, Mahapatra Sheila, Mahendhiran P. D. (2026). \textit{Explainable AI framework for psilocybin depression treatment optimization}. Frontiers in Computer Science. [published; Crossref]. \href{https://doi.org/10.3389/fcomp.2025.1652190}{doi:10.3389/fcomp.2025.1652190}.
\item Lyons FE, Rockhill KM, Fox EJ, Bemis EA, Black JC, Monte AA, Dart RC. (2026). \textit{Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2026.2644863}{doi:10.1080/02791072.2026.2644863}.
\item Johns Hopkins University (2026). \textit{Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04620759}{source link}.
\item Crocq MA, Auby P. (2026). \textit{The renaissance of research on psychedelics in child and adolescent psychopharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13034-026-01069-6}{doi:10.1186/s13034-026-01069-6}.
\item Moreno FA, Allen KE, Wiegand CB, Dunne R, Prickett JI, Bayze B, Allen JJB. (2026). \textit{A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261424214}{doi:10.1177/02698811261424214}.
\item Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J. (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item McAlpine R, Jaglinska M, Jedlovszky K, Kuc J, Castro A, Piot A, Timmermann C, Skipper JI, Sacchet MD, Kamboj SK. (2026). \textit{Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2025-107512}{doi:10.1136/bmjopen-2025-107512}.
\item University of Alabama at Birmingham (2026). \textit{Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227742}{source link}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Chronic Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05068791}{source link}.
\item Yale University (2026). \textit{Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06442423}{source link}.
\item Unknown authors (2026). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1080/02791072.2025.2454474.}{doi:10.1080/02791072.2025.2454474.}.
\item Luoma JB, Hoffman K, Wilson-Poe A, Levander X, Bazinet A, Cook R, McCarty D, Pertl K, Bielavitz S, Gregoire D, Wolf C, Jarlais DD, Harrison HV, Stauffer C, Korthuis P. (2026). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4jm2n\_v1}{doi:10.31234/osf.io/4jm2n\_v1}.
\item Bradshaw AJ, Sharp C, Van Der Merwe B, Tremble KS, Dentinger BTM (2026). \textit{Discovery of the closest free-living relative of the domesticated 'magic mushroom' Psilocybe cubensis in Africa.}. Proceedings. Biological sciences. [published; PubMed]. \href{https://doi.org/10.1098/rspb.2025.2270}{doi:10.1098/rspb.2025.2270}.
\item Chauhan SB, Akhtar N, Jain C, Singh I. (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M. (2026). \textit{Age moderates the relationship between psychedelics use and mental health in naturalistic settings}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9022170/v1}{doi:10.21203/rs.3.rs-9022170/v1}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Suzanne "Sue" Sisley MD (2026). \textit{An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07275970}{source link}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Rebecchi Kevin (2026). \textit{“Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A33-month retrospective case report}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00320}{doi:10.1556/2054.2025.00320}.
\item Shah S, Morrin H. (2026). \textit{Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8919841/v1}{doi:10.21203/rs.3.rs-8919841/v1}.
\item Priest M, Kilmer B, Ramchand R, Atshan S. (2026). \textit{Psilocybin microdosing in the United States: Insights from a nationally representative survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.70368}{doi:10.1111/add.70368}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Poh C, Head C, Nunez JJ, Lapadat L, Morton E, Collaborative RESearch Team to Study Psychosocial Issues in Bipolar Disorder (CREST.BD), Michalak EE. (2026). \textit{5 Years of bipolar disorder conversations on Reddit: Methods, key topics and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0338622}{doi:10.1371/journal.pone.0338622}.
\item Koning E, Gamberg S, Keshen A. (2026). \textit{Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale \& Considerations for Protocol Development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/bs16030376}{doi:10.3390/bs16030376}.
\item NYU Langone Health (2026). \textit{Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06760533}{source link}.
\item Thomas JE, Dellarole A, Caballero J. (2026). \textit{Efficacy and risks of psychedelics in treatment of posttraumatic stress disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ajhp/zxag062}{doi:10.1093/ajhp/zxag062}.
\item Ohio State University (2026). \textit{Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05554094}{source link}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Griškova-Bulanova I, Vejmola Č, Páleníček T. (2026). \textit{Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1152/jn.00519.2025}{doi:10.1152/jn.00519.2025}.
\item Psyence Australia Pty Ltd (2026). \textit{A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07072728}{source link}.
\item Marissa Raymond-Flesch, MD, MPH (2026). \textit{Study of Psilocybin for Anorexia in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06399263}{source link}.
\item Wood BJ, Vest MF, Carfagno C, Bartley KR, Sharma P, Halberstadt AL, Blough BE, Murnane KS. (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item Williamson SE, Burkhartzmeyer EK, Faley MT, Ohana RF, Guzei IA, Valley M, Cali JJ, Sherwood AM. (2026). \textit{Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00879}{doi:10.1021/acschemneuro.5c00879}.
\item Senānāyaka R. (2026). \textit{Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific Comparisons}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9c6xg\_v1}{doi:10.31234/osf.io/9c6xg\_v1}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05301608}{source link}.
\item Unknown authors (2026). \textit{Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific Comparisons}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9c6xg\_v1}{source link}.
\item Johnson MW, Naudé GP, Hendricks PS, Garcia-Romeu A. (2026). \textit{Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2026.0972}{doi:10.1001/jamanetworkopen.2026.0972}.
\item Corder Greg, Rogers Sophie, Oswell Corinna (2026). \textit{Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic Pain}. The Journal of Pain. [published; Crossref]. \href{https://doi.org/10.1016/j.jpain.2025.105705}{doi:10.1016/j.jpain.2025.105705}.
\item Richmond Linda M. (2026). \textit{MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More}. Psychiatric News. [published; Crossref]. \href{https://doi.org/10.1176/appi.pn.2026.03.3.5}{doi:10.1176/appi.pn.2026.03.3.5}.
\item Wrathall David J., Gosnell Hannah, Wickson Fern, Spanger Erika, Associates* (2026). \textit{Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward}. Action Research. [published; Crossref]. \href{https://doi.org/10.1177/14767503251404263}{doi:10.1177/14767503251404263}.
\item Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA (2026). \textit{Meaning and Psychedelics in Palliative Care: A Narrative Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2025.10.015}{doi:10.1016/j.jpainsymman.2025.10.015}.
\item Lewis S. (2026). \textit{Psilocybin shapes neural plasticity in selective brain networks.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41583-025-01019-9}{doi:10.1038/s41583-025-01019-9}.
\item Koutrouli IRA, Brejtr V, Schwendt M, Witek K, Charalambous C, Aleksič K, Miniariková N, Lhotková E, Toman M, Nikolič M, Jurok R, Cihlářová P, Mazoch V, Ryšánek P, Kuchař M, Šíchová K, Páleníček T. (2026). \textit{Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.70111}{doi:10.1111/adb.70111}.
\item Girault N, Quiroga L, Jedrecy S, Bertin S, Djonouma N, Fossati P. (2026). \textit{[Perspectives opened up by the physiopathological understanding of psychiatric disorders].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/41878960}{source link}.
\item Mosurinjohn S, Ascough R (2026). \textit{Psychedelics, Eleusis, and the Invention of Religious Experience.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251361835}{doi:10.1177/28314425251361835}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X. (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item Beaussant Y, Sager Z, Brennan C, Kristan I, Ljuslin M, Mazzola E, Macdonald D, Murphy ME, Nigam K, Rinaldi AD, Sanders J, Schaefer KG, Sholevar R, Summer L, Waliji-Banglawala A, Yudilevich-Espinoza S, Tulsky JA. (2026). \textit{Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/spcare-2025-005773}{doi:10.1136/spcare-2025-005773}.
\item Gearin A, Docherty J, Sun X, Cheung EH, Tanuseputro P. (2026). \textit{Psychedelic therapy and cultural humility.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03913-x}{doi:10.1038/s41398-026-03913-x}.
\item Li T, Reynolds EE, Wang Z, Torrens-Spence MP, Weng JK, Wang Y. (2026). \textit{Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s42003-026-09756-y}{doi:10.1038/s42003-026-09756-y}.
\item Shokr MM, Fawzy MN, Abdelaziz AM. (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Yonezawa K, Hirata M, Takano H, Kusudo K, Tomiyama S, Harada L, Suzuki K, Nutt DJ, Uchida H, Tani H. (2026). \textit{Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/pcn.70042}{doi:10.1111/pcn.70042}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06041152}{source link}.
\item Gabriella Gobbi (2026). \textit{The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07433452}{source link}.
\item Garcia-Romeu A, Naudé GP, Rebman AW, So S, Yaffe A, Geithner I, Kozero EA, Yang T, Soloski MJ, Aucott JN. (2026). \textit{Pilot study of psilocybin in patients with post-treatment lyme disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-026-38091-9}{doi:10.1038/s41598-026-38091-9}.
\item Courtes AC, Myers B, Daly N, Jones G, Soares JC, Zarate CA, Machado-Vieira R. (2026). \textit{Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2026.02.011}{doi:10.1016/j.genhosppsych.2026.02.011}.
\item Ishii M, Zervas M. (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. ScienceOpen Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A. (2026). \textit{Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251364182}{doi:10.1177/28314425251364182}.
\item Johns Hopkins University (2026). \textit{Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06005662}{source link}.
\item Johns Hopkins University (2026). \textit{Safety for Home Administration of Microdose Psilocybin Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06450210}{source link}.
\item Johns Hopkins University (2026). \textit{Investigation of Psychedelic Effects in Psychoactive Substances}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06772753}{source link}.
\item Shultz S, Allen J, O'Regan G, Brand J, Liknaitzky P, O'Brien T, Christie B, McDonald S. (2026). \textit{Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8555503/v1}{doi:10.21203/rs.3.rs-8555503/v1}.
\item Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A. (2026). \textit{Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8319478/v1}{doi:10.21203/rs.3.rs-8319478/v1}.
\item Jacobs E, Zahid Z, Hinkle J, Nayak S, Yaden DB. (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Montoy JCC, Wang RC, Coker AR, Anderson BT. (2026). \textit{Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2026.113059}{doi:10.1016/j.drugalcdep.2026.113059}.
\item Chwyl C, Bazinet A, Wilson-Poe A, Hoffman K, Pertl K, McCrimmon S, Korthuis P, Luoma JB. (2026). \textit{Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/mdz73\_v2}{doi:10.31234/osf.io/mdz73\_v2}.
\item Unknown authors (2026). \textit{Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mdz73\_v2}{source link}.
\item McDowell Jordan, Middleton Jada, Bluett Alanna, Kozachenko Alisa, Attar Bayan, Saini Yuvraj, Burke Jennifer, McPhee Cayden, Mutahera Mutahera, Ahmed Talya, Ibrahim Nabila, Atukwatsibwe Gilbert, Adhikari Sulabha, Esmaili Mohammad, Yambayamba Jean-Vital (2026). \textit{Effects of Psilocybin and Select Pharmaceutical Interactions}. MacEwan University Student eJournal. [published; Crossref]. \href{https://doi.org/10.31542/bcek6t76}{doi:10.31542/bcek6t76}.
\item Nogueira M, García-Hernández S, Roberto GS, Rodrigues DC. (2026). \textit{Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2026.105198}{doi:10.1016/j.drugpo.2026.105198}.
\item Sahoo I, Masadi S, Maheswari A, Utama R, Abeer MI, Soltanpour S, Nasseef MT, Chukwuemeka T, Sinhal N, Pandit J, Ortiz RJ, Cavallaro N, Brengel E, Kulkarni PP, Gitcho MA, Ferris CF. (2026). \textit{Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-026-02356-8}{doi:10.1038/s41386-026-02356-8}.
\item Albertyn CP, Richard J, Shore RJ, Carlson LE. (2026). \textit{Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yrgkf\_v1}{doi:10.31234/osf.io/yrgkf\_v1}.
\item Yvan Beaussant, MD, MSci (2026). \textit{Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04950608}{source link}.
\item Unknown authors (2026). \textit{Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yrgkf\_v1}{source link}.
\item Khan Z, Weaver S, Dando RV, Schlag AK, Neill JC, Wainwright V. (2026). \textit{Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10497323261419338}{doi:10.1177/10497323261419338}.
\item Knatz Peck S, Brewerton TD. (2026). \textit{Rebuttal to "Questioning the recovery of dissociated traumatic memories under psilocybin".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-026-01532-x}{doi:10.1186/s40337-026-01532-x}.
\item Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb N, Petranker R. (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2025.10968}{doi:10.1192/bjo.2025.10968}.
\item Abramowitz JS, Abramovitch A, McKay D, Draffin A. (2026). \textit{Management of obsessive-compulsive disorder in adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2024-083443}{doi:10.1136/bmj-2024-083443}.
\item Kase M, Kaup KK, Aru J. (2026). \textit{Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251412012}{doi:10.1177/02698811251412012}.
\item Minauro-Sanmiguel F, Vargas-Perez H. (2026). \textit{Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroscience.2026.02.028}{doi:10.1016/j.neuroscience.2026.02.028}.
\item Weintraub MJ, Jeffrey JK, Ichinose MC, Bergman RL, Shapiro B, Barnett G, Artin H, Lynn M, Salimian A, Grody S, Ramesh R, Eales L, Grob CS, Miklowitz DJ. (2026). \textit{Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.121423}{doi:10.1016/j.jad.2026.121423}.
\item McNaughton N, Shadli SM, Beaglehole B, Glue P. (2026). \textit{Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/snz2.70002}{doi:10.1002/snz2.70002}.
\item Sutherland MH, Nicholas CR, Lennertz RC, Wenthur CJ, Krause BM, Sauder CJ, Riedner BA, Smith RF, Hutson PR, Raison CL, Banks MI. (2026). \textit{Electrophysiological effects of psilocybin co-administered with midazolam.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03894-x}{doi:10.1038/s41398-026-03894-x}.
\item Murray Z, Lewies A, Wentzel JF, Schutte-Smith M, Erasmus E, Noreljaleel A, Visser H, Wilhelm A, Issahaku AR. (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item Dolenec P, Pelčić G, Pilipović K, Mršić-Pelčić J, Hrkać AH. (2026). \textit{Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph19020316}{doi:10.3390/ph19020316}.
\item MycoMedica Life Sciences PBC (2026). \textit{A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07050368}{source link}.
\item Johns Hopkins University (2026). \textit{Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07053917}{source link}.
\item Goldy SP, Sepeda ND, Hilbert SN, Bari BA, Garcia-Romeu A, Gukasyan N, Barrett FS, Yaden DB, Nayak SM. (2026). \textit{Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2026.117010}{doi:10.1016/j.psychres.2026.117010}.
\item Trent Emerick (2026). \textit{Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07406828}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07405606}{source link}.
\item Hicks Matthew, Hicks Olivia, Bradley Ryan, Zwickey Heather (2026). \textit{Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00485}{doi:10.1556/2054.2026.00485}.
\item Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C. (2026). \textit{Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8733841/v1}{doi:10.21203/rs.3.rs-8733841/v1}.
\item He Z, Wang Y, Chen J, Cheng J, Feng Y, Niu S, Yan J. (2026). \textit{Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-025-02165-y}{doi:10.1007/s00406-025-02165-y}.
\item Kaczmarek ES, Rodrigues NB, Chisamore N, Doyle Z, Meshkat S, Blainey MG, Brudner R, Ali S, Teopiz KM, McIntyre RS, Rosenblat JD. (2026). \textit{Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.121385}{doi:10.1016/j.jad.2026.121385}.
\item Shnayder S, Agin-Liebes G, Hubert T, Ching THW, Hokanson J, Pittenger C, Kelmendi B, Adams T. (2026). \textit{Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/d94hb\_v1}{doi:10.31234/osf.io/d94hb\_v1}.
\item Unknown authors (2026). \textit{Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/d94hb\_v1}{source link}.
\item Habelt B. (2026). \textit{The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2026.1779055}{doi:10.3389/fpsyg.2026.1779055}.
\item Chwyl C, Bazinet A, Wilson-Poe A, Hoffman K, Pertl K, McCrimmon S, Korthuis P, Luoma JB. (2026). \textit{Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/mdz73\_v1}{doi:10.31234/osf.io/mdz73\_v1}.
\item Bhagavan C, Carter O, Bryson A, Dandash O, Kanaan R. (2026). \textit{Psychedelics in functional disorders: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111642}{doi:10.1016/j.pnpbp.2026.111642}.
\item Hadassah Medical Organization (2026). \textit{Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079930}{source link}.
\item TRYP Therapeutics (2026). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06206265}{source link}.
\item Nantes University Hospital (2026). \textit{Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07391332}{source link}.
\item Tom A, Reddy BSC, Sethi MIS, Math SB. (2026). \textit{India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02537176261416347}{doi:10.1177/02537176261416347}.
\item Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS. (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Lewis BR, Reid MJ, Novick AM, Byrne K, Niciu MJ, Fonzo GA, Meyer TD, Feifel D, El-Mallakh RS, Soares J, Suppes T, Barrett FS. (2026). \textit{Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251413490}{doi:10.1177/02698811251413490}.
\item Frontiers Editorial Office. (2026). \textit{Retraction: Acute psilocybin increased cortical activities in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2026.1787833}{doi:10.3389/fnins.2026.1787833}.
\item Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R. (2026). \textit{Acute psilocin increased cortical activity in rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Shadani Sheida, Greaves Erika, Andrews Zane B., Foldi Claire J. (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics. [published; Crossref]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Gregersen Anton T., Whelan Tobias, Golden Caroline, Blackmore Thomas, Palner Mikael (2026). \textit{Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot Study}. Psychedelic Medicine. [published; Crossref]. \href{https://doi.org/10.1177/28314425251386879}{doi:10.1177/28314425251386879}.
\item Bostancıklıoğlu M, Kaplan DS, Bal R, Yiğit E, Ulusal H, Temiz E. (2026). \textit{MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2026.01.016}{doi:10.1016/j.biopsych.2026.01.016}.
\item Mallaroni P, Singleton SP, Mason NL, Satterthwaite TD, Ramaekers JG. (2026). \textit{Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03447-0}{doi:10.1038/s41380-026-03447-0}.
\item Ben-Zion Z, Simon G, Lazebnik T. (2026). \textit{Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8682370/v1}{doi:10.21203/rs.3.rs-8682370/v1}.
\item Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer JF, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L. (2026). \textit{Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2026.116992}{doi:10.1016/j.psychres.2026.116992}.
\item Müller Thomas (2026). \textit{Psilocybin wirkt bei therapieresistenter Depression}. DNP - Die Neurologie \& Psychiatrie. [published; Crossref]. \href{https://doi.org/10.1007/s15202-025-6636-1}{doi:10.1007/s15202-025-6636-1}.
\item Zandonai Thomas, Venturini Sofia, Corazza Ornella (2026). \textit{Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?}. Performance Enhancement \& Health. [published; Crossref]. \href{https://doi.org/10.1016/j.peh.2025.100386}{doi:10.1016/j.peh.2025.100386}.
\item Encantado Jorge, Carvalho Laura C., Mota Pedro, Cunha Catarina, Garcia-Romeu Albert, Johnson Matthew W., Teixeira Pedro J. (2026). \textit{Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).}. Professional Psychology: Research and Practice. [published; Crossref]. \href{https://doi.org/10.1037/pro0000664}{doi:10.1037/pro0000664}.
\item Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN (2026). \textit{Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251389090}{doi:10.1177/07067437251389090}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O (2026). \textit{Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2025.105105}{doi:10.1016/j.drugpo.2025.105105}.
\item Ham R, Gardner J, Carter A, Liknaitzky P. (2026). \textit{Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/brb3.71262}{doi:10.1002/brb3.71262}.
\item Halm S. (2026). \textit{Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/brb3.71265}{doi:10.1002/brb3.71265}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Roser P. (2026). \textit{[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.23785/tu.2026.01.006}{doi:10.23785/tu.2026.01.006}.
\item Kala K, Bederska-Lojewska D, Lazur J, Gasior K, Maslanka A, Szewczyk A, Sulkowska-Ziaja K, Turek J, Szewczyk B, Pilc A, Muszynska B. (2026). \textit{Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26402/jpp.2026.1.07}{doi:10.26402/jpp.2026.1.07}.
\item Komarczewska Anna Maria, Matusiak Filip, Brzoza Klaudia, Kociński Michał, Iglewski Patryk, Pietrasz Michał (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; Crossref]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2026). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Kristensen J. (2026). \textit{Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03844-7}{doi:10.1038/s41398-026-03844-7}.
\item Siwek L, Nowocien M, Balajewicz B, Samborska A, Szukalska S, Karczewska M, Lichwala K, Wróblewski K, Wróblewska P. (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item Magar V, Robbins M, Fernández Lobo Blanco ÓML, Ali IL, Anderson B, Grob C, Henningfield JE, Kryskow P, Kuiper H, Loizaga-Velder A, Rush B, Volat M, Iron Rope S. (2026). \textit{Indigenous Knowledge Systems \& Psychedelic Science: Towards Ethical and Reciprocal Collaboration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251387104}{doi:10.1177/02698811251387104}.
\item Downar J, Lapenskie J, Anderson K, Parsons G, Polskaia N, Lalumiere G, Lawlor P. (2026). \textit{PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02692163261416269}{doi:10.1177/02692163261416269}.
\item Tsang VWL, Roney C, Kryskow P, Dames S. (2026). \textit{Improving access to psilocybin-assisted therapy: barriers, challenges, and recommendations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpubh.2026.1767210}{doi:10.3389/fpubh.2026.1767210}.
\item Rebensburg P. (2026). \textit{Psilocybin and the Evolutionary Significance of Altered Neural States: Interaction-Based Perspectives Beyond Deterrence Models}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2v66q}{doi:10.32942/x2v66q}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Zafar RR, Kleine P, Kurtin D, Wall M, Erritzoe D. (2026). \textit{High hopes? Precision psychedelic addiction medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1681795}{doi:10.3389/fpsyt.2025.1681795}.
\item Bruyère Health Research Institute. (2026). \textit{PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07063862}{source link}.
\item Back Anthony L., McGregor Bonnie A., Billingsley Lindsay, Blom Dianna, Callan George, Myers Susanna, Guy John, Kumar Sameet, Layer Melissa, Levin Jackie, Perez Juliana, Thompson Peter, Salmonson Kathy, Whinney Joseph, Thorn Leslie Lazar (2026). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study}. Psychedelic Medicine. [published; Crossref]. \href{https://doi.org/10.1177/28314425251404460}{doi:10.1177/28314425251404460}.
\item Raza M, Kaur J. (2026). \textit{A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.102421}{doi:10.7759/cureus.102421}.
\item Ip CT, Olbrich S, de Bardeci M, Monn A, Ort A, Smallridge JW, Vollenweider F. (2026). \textit{Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111626}{doi:10.1016/j.pnpbp.2026.111626}.
\item Banzato M, Colognesi M, Lucatello L, Comai S, Pasut G, Capolongo F, Orian L, Biasutto L, Signor A, Gabbia D, Manfredi PL, De Martin S, Mattarei A. (2026). \textit{Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jmedchem.5c01797}{doi:10.1021/acs.jmedchem.5c01797}.
\item Shiju S, Tirumala R, Marseille E. (2026). \textit{Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.rcsop.2026.100709}{doi:10.1016/j.rcsop.2026.100709}.
\item Kerr-Gaffney J, Myrtle S, Askari F, Bird C, Modlin NL, Young AH, Rucker J. (2026). \textit{Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251408769}{doi:10.1177/02698811251408769}.
\item Scott Rishika, Smith James (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; Crossref]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Syed OA, Tsang B, Nestor SM, Lipsman N, Husain MI, Alam F, Giacobbe P. (2026). \textit{Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2026.106573}{doi:10.1016/j.neubiorev.2026.106573}.
\item NYU Langone Health (2026). \textit{A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796062}{source link}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Žuljević MF, Mijatović A, Orhanović R, Goasdoué G, Gujinović D. (2026). \textit{Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jclinepi.2026.112170}{doi:10.1016/j.jclinepi.2026.112170}.
\item Baylor College of Medicine (2026). \textit{The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06888128}{source link}.
\item Gregory NS, Girard TE, Ram A, Casey AB, Malenka RC, Tawfik VL, Heifets BD. (2026). \textit{No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-026-68763-z}{doi:10.1038/s41467-026-68763-z}.
\item Prusti SP, Salian R, Das AK, Kumbhakar P. (2026). \textit{Mushroom-Derived Carbon Nanosheets for Efficient Photothermal De-Icing Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.langmuir.5c05324}{doi:10.1021/acs.langmuir.5c05324}.
\item Chwyl C, Spata A, Lucas W, Luoma JB. (2026). \textit{Mindset over molecule: comparing self-transcendent and mystical experiences across recreational psilocybin, MDMA, and cannabis use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40359-025-03921-4}{doi:10.1186/s40359-025-03921-4}.
\item Haghdoost F, Bahceci D, Delcourt C, Wijeratne T, Jensen RH, Cincinnato C, Tomlinson S, Wold B, Polito V, Carcel C, Ashraf U, Jenkins B, Petersen AS, Ray JC, Schindler EAD, Tsang B, Gianacas C, Rodgers A. (2026). \textit{Patient perspectives on research gaps in cluster headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/head.70031}{doi:10.1111/head.70031}.
\item Domi A, Lucente E, Cadeddu D, Bengtsson N, Smedler E, Adermark L. (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Olejnik P, Kamińska K, Gołembiowska K, Kasarełło K. (2026). \textit{Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-026-00824-y}{doi:10.1007/s43440-026-00824-y}.
\item Mills L, Rossell SL, Carruthers SP. (2026). \textit{Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.121220}{doi:10.1016/j.jad.2026.121220}.
\item He MQ, Yang WQ, Phurbu D, Liu F, Li JX, Cao B, Zhao RL. (2026). \textit{﻿Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3897/imafungus.17.167329}{doi:10.3897/imafungus.17.167329}.
\item Doyle Z, Chisamore N, Kaczmarek ES, Johnson DE, Brudner RM, Weiglein G, Blainey MG, Bawks J, Riva-Cambrin J, Sethi R, McIntyre RS, Rosenblat JD. (2026). \textit{Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2026.01.001}{doi:10.1016/j.genhosppsych.2026.01.001}.
\item Garcia Garcia M, Belahda D, Graux C, Serrand C, Igounenc N, Sergent F, Mura T, Luquiens A. (2026). \textit{Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.121215}{doi:10.1016/j.jad.2026.121215}.
\item Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Baker Kelsey, Gooley Ted, Kaelen Mendel, Harvey Kalin, Guy John M., Myers Susanna, Perez Juliana, Thompson Peter, Billingsley Lindsay, Sesnon Cheryl (2026). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study}. Psychedelic Medicine. [published; Crossref]. \href{https://doi.org/10.1177/28314425251413856}{doi:10.1177/28314425251413856}.
\item Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS. (2026). \textit{Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01256-7}{doi:10.1007/s40263-025-01256-7}.
\item Swieczkowski D, Kwaśny A, Sadko K, Cubała WJ. (2026). \textit{Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.112746}{doi:10.1016/j.euroneuro.2025.112746}.
\item Tobel T, Cone A, Choquette E, Garland M, Johnson M, Mink K, Lynch C, Frohlich J, Feinstein J, Reggente N, Khalsa SS. (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6mj8n\_v1}{doi:10.31234/osf.io/6mj8n\_v1}.
\item Kelmendi B, Adams T, Ching THW, Grazioplene R, Kichuk S, Fram G, Patel P, Eilbott J, D’Amico E, Shnayder S, Martins B, Bohner C, Amoroso L, Jankovsky A, DePalmer G, Valentine G, Agin-Liebes G, Hokanson J, Pittenger C. (2026). \textit{Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/atfum\_v1}{doi:10.31234/osf.io/atfum\_v1}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v1}{source link}.
\item Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES. (2026). \textit{Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.01.14.699553}{doi:10.64898/2026.01.14.699553}.
\item Unknown authors (2026). \textit{Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/atfum\_v1}{source link}.
\item Durns T, Iannuzzi G. (2026). \textit{Contextualizing Violence Risk Associated With Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.focus.20250027}{doi:10.1176/appi.focus.20250027}.
\item Jacobsen CF, Stenbæk DS, Poulsen S, Armand S. (2026). \textit{The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.prcp.20250113}{doi:10.1176/appi.prcp.20250113}.
\item COMPASS Pathways (2026). \textit{A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05711940}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06656702}{source link}.
\item Renner AC, Kargbo RB. (2026). \textit{Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00780}{doi:10.1021/acsmedchemlett.5c00780}.
\item University of California, San Diego (2026). \textit{Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05224336}{source link}.
\item Sobieraj J, Sleziak J, Szyszka M, Błażejewska M, Łukańko K, Soczomska P, Bodziony K, Piotrowski P. (2026). \textit{Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpubh.2025.1734137}{doi:10.3389/fpubh.2025.1734137}.
\item Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4242829/v3}{doi:10.21203/rs.3.rs-4242829/v3}.
\item Barovic A, Pittiglio MK, Barrett JM, Aretz CDJ, Tesfatsion TT, Ramirez GA, Cruces W. (2026). \textit{Presence of 4-Hydroxy-N-methyl-N-ethyltryptamine in Commercially Available Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.5c10889}{doi:10.1021/acsomega.5c10889}.
\item Kandilakis CL, Papatheodoropoulos C. (2026). \textit{Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00892}{doi:10.1021/acschemneuro.5c00892}.
\item Maltby CJ, Klein AK, Paschen E, Pinto J, Dvorak D, Hedde JR, Hanks AN, Bianchi M, Hughes ZA. (2026). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Cornelius T, Barba T. (2026). \textit{Associations of Couples' Psychedelic Use with Shared Reality and Relational Well-Being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2607729}{doi:10.1080/02791072.2025.2607729}.
\item Jorgenson DM, Santos Leon E, Vakkalanka JP, Krispin S, Radke JB. (2026). \textit{Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15563650.2025.2599402}{doi:10.1080/15563650.2025.2599402}.
\item Kościuk Z, Szpręgiel I, Bysiek A, Gołembiowska K. (2026). \textit{The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-025-00817-3}{doi:10.1007/s43440-025-00817-3}.
\item Marques MG, Patarroyo-Rodriguez L, Singh B. (2026). \textit{Psilocybin and Bipolar Depression: Promise and Prudence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01255-8}{doi:10.1007/s40263-025-01255-8}.
\item Dallery J, Miller JL, Boissoneault J, Harvey L, Ives L, Knerr A, Blaes S, Ransom MN, Munson M, Gilligan JP, Silverman MH, Guzzo PR, Loeser B. (2026). \textit{An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-025-01508-3}{doi:10.1186/s40337-025-01508-3}.
\item Slot J, Bradshaw A, Dentinger B, Borovička J, Konkel Z, Rockefeller A, Bollinger I. (2026). \textit{The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in Psilocybe}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.30.697041}{doi:10.64898/2025.12.30.697041}.
\item Sancilio FD, Dariani M, Chavda P, Rajagopal HM, Tomlinson L. (2026). \textit{Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2607726}{doi:10.1080/02791072.2025.2607726}.
\item Moshfeghinia R, Mostafavi S, Jazi K, Ghasemi AR, Khosravaninezhad Y, Narayanan S, Ahmadi J, Pasalar M. (2026). \textit{The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40359-025-03935-y}{doi:10.1186/s40359-025-03935-y}.
\item McGuire AL, Neitzke-Spruill L, Robinson JO, Beit CS, Singh N, Mathai DS, Averill LA. (2026). \textit{Reported Safety Practices of Publicly Advertised Psychedelic Retreats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.52505}{doi:10.1001/jamanetworkopen.2025.52505}.
\item Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM. (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.54843}{doi:10.1001/jamanetworkopen.2025.54843}.
\item de la Fuente Revenga M, González-Maeso J. (2026). \textit{Snapshot IP1 Detection Following 5-HT2A Receptor Stimulation in the Mouse Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00932}{doi:10.1021/acschemneuro.5c00932}.
\item Schuman HDM, Mina R, Barkova S, Nguyen T, Deleemans JM, Carlson LE (2025). \textit{Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".}. Global advances in integrative medicine and health. [published; PubMed]. \href{https://doi.org/10.1177/27536130261459354}{doi:10.1177/27536130261459354}.
\item Martínez-Álvarez N., Erkizia-Santamaría I., Tomás-Alvarado A., Erdozain A.M., Meana J.J., Ortega J.E. (2025). \textit{Preclinical evaluation of psilocybin as an anti-inflammatory agent}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.105853}{doi:10.1016/j.nsa.2025.105853}.
\item Benes M., Gregus D., Adamek P., Palenicek T., Horacek J. (2025). \textit{Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.106823}{doi:10.1016/j.nsa.2025.106823}.
\item Toalombo-Eugenio Graciela Estefanía, Carrillo-Zavala Katheryne Viviana, Mayorga-Núñez Verónica Giovanna (2025). \textit{Psilocibina en cuidados paliativos: revisión sistemática de los efectos a nivel emocional y espiritual-existenciales}. Revista Metropolitana de Ciencias Aplicadas. [published; Crossref]. \href{https://doi.org/10.62452/hx8sfs74}{doi:10.62452/hx8sfs74}.
\item Ollari O., Whelan T.P., Ellis C.L., Khalil N., Moruzzi F., Murphy D.G.M., Daly E., Mason L., Puts N., McAlonan G.M. (2025). \textit{Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2026.106903}{doi:10.1016/j.nsa.2026.106903}.
\item Sellitti F., Weber C., Tamura É., Li Z., Thomann J., Luethi D., Simmler L.D. (2025). \textit{Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.106574}{doi:10.1016/j.nsa.2025.106574}.
\item Totomanova I., Haijen E.C.H.M., Hurks P.P.M., Mason N.L., Kuypers K.P.C. (2025). \textit{Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.106822}{doi:10.1016/j.nsa.2025.106822}.
\item O'shea A., Ramaekers J.G., Schreiber R., Briedé J.J., Krauskopf J., Mason N., Verheijen M.C.T. (2025). \textit{Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.106576}{doi:10.1016/j.nsa.2025.106576}.
\item Weber C., Sellitti F., Ziming L., von Arx J., Simmler L.D. (2025). \textit{Behavioral and neuronal effects of psilocybin in mice}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.106575}{doi:10.1016/j.nsa.2025.106575}.
\item Islas-Vargas J, Armenta S, Rivera-Román ÁA, Hernández-León S, Méndez-Hernández JE, Arce-Cervantes O. (2025). \textit{Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609383879}{source link}.
\item Thomas K. (2025). \textit{Toxicology and Pharmacological Interactions of Classic Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_508}{doi:10.1007/7854\_2024\_508}.
\item Holze F, Liechti ME, Müller F. (2025). \textit{Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_510}{doi:10.1007/7854\_2024\_510}.
\item Viljoen G, Betzler F (2025). \textit{Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_534}{doi:10.1007/7854\_2024\_534}.
\item Bradberry MM, Appelbaum PS, Gukasyan N. (2025). \textit{Informed Consent in Psychedelic-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_559}{doi:10.1007/7854\_2024\_559}.
\item Windsor C, Kreynes AE, Chilton JS, Chioffi WA, Niebergall C, Dodds K. (2025). \textit{Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical Profiles.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jaoacint/qsaf007}{doi:10.1093/jaoacint/qsaf007}.
\item Foster K, Morrison I, Daniel S, Antoine J, Thankappan B, De La Haye W, Tyler M, Grant C, Delgoda R. (2025). \textit{Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jaoacint/qsaf072}{doi:10.1093/jaoacint/qsaf072}.
\item Chwyl C, Wilson-Poe AR, Hoffman KA, Bazinet A, Pertl K, Luoma JB, des Jarlais D, Bielavitz S, Korthuis PT (2025). \textit{Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2025.104938}{doi:10.1016/j.drugpo.2025.104938}.
\item Hirschfeld T, Blei F, Stegemann L, van der Gouwe D, Smit-Rigter L. (2025). \textit{Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2025\_606}{doi:10.1007/7854\_2025\_606}.
\item Hutchison KE, Hooper JF, Karoly HC. (2025). \textit{Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2025.3038}{doi:10.1001/jamapsychiatry.2025.3038}.
\item Lewis S (2025). \textit{'Magic' mechanisms underlie psilocybin's effects in chronic pain.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41583-025-00999-y}{doi:10.1038/s41583-025-00999-y}.
\item Kamilar-Britt P, Oliva AB, Earleywine M. (2025). \textit{Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2607724}{doi:10.1080/02791072.2025.2607724}.
\item Moghadam H, Akbari P, Beirami E, Nabavifard S, Ameli A, Valian N. (2025). \textit{The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Freitas da Costa B, Hartmann P, Pagnin D. (2025). \textit{Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.70032}{doi:10.1002/hup.70032}.
\item Rasool M, Hannan TM, Imam M. (2025). \textit{Magic mushrooms and mood: Exploring psilocybin as a depression treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.47391/jpma.30858}{doi:10.47391/jpma.30858}.
\item Bröcker AL, Majić T, Montag C. (2025). \textit{Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2026\_613}{doi:10.1007/7854\_2026\_613}.
\item Majić T, Gouzoulis-Mayfrank E, Evens R. (2025). \textit{Classifying Psychedelic-Related Complications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2026\_614}{doi:10.1007/7854\_2026\_614}.
\item Spiti A, Caldirola D, Perna G. (2025). \textit{New Antidepressant Development in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA. (2025). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Shiner B, DuFort V, Peltzman T, Watts BV. (2025). \textit{Rural-Urban Disparities in Access to Interventional Psychiatry Treatments among VA Patients.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/rmh0000333}{doi:10.1037/rmh0000333}.
\item Kucukdereli H, Douglass AM. (2025). \textit{Neuroscience: What doesn't kill you makes you stronger.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2025.11.056}{doi:10.1016/j.cub.2025.11.056}.
\item Mitchell J, Neitzke-Spruill L, Mathai DS, Robinson JO, Kavan Z, Averil LA, McGuire AL. (2025). \textit{From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/tbm/ibag027}{doi:10.1093/tbm/ibag027}.
\item Xia K, Gao T. (2025). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2025). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Evans M, Charrette A (2025). \textit{Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2026.1816932}{doi:10.3389/fnins.2026.1816932}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2025). \textit{Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1834094}{doi:10.3389/fpsyt.2026.1834094}.
\item Scholle P, Wenke Š, Nekovářová T, Zaytseva Y, Tylš F, Brunovský M, Horáček J, Andrashko V, Koudelka V, Viktorinová M, Viktorin V, Hájková K, Kuchař M, Páleníček T. (2025). \textit{The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251389552}{doi:10.1177/02698811251389552}.
\item Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B (2025). \textit{Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002197}{doi:10.1097/jcp.0000000000002197}.
\item Ehmann S, Mosahvili N, White A, Cuzzupe J, Tompkins B, McKibben J, Allen JJ, Gawrysiak M. (2025). \textit{Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6jf49\_v1}{doi:10.31234/osf.io/6jf49\_v1}.
\item Unknown authors (2025). \textit{Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6jf49\_v1}{source link}.
\item Islas-Vargas J, Armenta S, Rivera-Román ÁA, Hernández-León S, Méndez-Hernández JE, Arce-Cervantes O. (2025). \textit{Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11274-025-04758-0}{doi:10.1007/s11274-025-04758-0}.
\item Diehl VJ, Calder AE, Hasler G. (2025). \textit{The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251397306}{doi:10.1177/02698811251397306}.
\item University of Calgary (2025). \textit{A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06615908}{source link}.
\item Rotem Petranker (2025). \textit{Microdosing Psychedelics to Improve Mood}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05259943}{source link}.
\item Christopher MW, Prentice BM, Garrett TJ. (2025). \textit{Distinguishing 4- vs 5-Hydroxy-N,N-Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-Exchange.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jasms.5c00421}{doi:10.1021/jasms.5c00421}.
\item Weiser S, Jung S, Bardl B, Kufs JE, Janevska S, Valiante V, Hoffmeister D, Regestein L. (2025). \textit{Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/bit.70137}{doi:10.1002/bit.70137}.
\item Yale University (2025). \textit{Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07306364}{source link}.
\item Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R, Camacho-Castillo EZ, Bringas-Ortiz SA, Padilla-Cabezutd C. (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ. (2025). \textit{Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm15010253}{doi:10.3390/jcm15010253}.
\item Colognesi M, Gabbia D, Signor A, Sarill M, Centofanti L, Rinaldi A, Cascione L, Nunziata S, Banzato M, Mattarei A, Finzi G, Sonda S, Pendin D, Zanotto I, Comai S, Pasut G, Alajati A, Saponaro M, Bucciarelli L, Lunati ME, Guarato G, Goggi I, La Rosa S, Morano C, Paroni RC, Dei Cas M, Daniele G, Gentilucci M, Pappagallo M, Alimonti A, Manfredi PL, Folli F, De Martin S. (2025). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2025.108080}{doi:10.1016/j.phrs.2025.108080}.
\item Syed OA, Nestor SM, Husain MI, Sinyor M, Alam F, Giacobbe P. (2025). \textit{Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116929}{doi:10.1016/j.psychres.2025.116929}.
\item Schindler EAD, Gottschalk CH, Pittman BP, D'Souza DC. (2025). \textit{Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/head.70024}{doi:10.1111/head.70024}.
\item Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A. (2025). \textit{Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.22.696123}{doi:10.64898/2025.12.22.696123}.
\item Muller S, Cavanna F, de la Fuente LA, Bruno N, D'Amelio TA, Pallavicini C, Tagliazucchi E. (2025). \textit{Psilocybin-induced modulation of visual salience processing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/nc/niaf060}{doi:10.1093/nc/niaf060}.
\item Afsharnia S, Liang V, Lunsky Y, Orsini AP, Tint A, Lin HY. (2025). \textit{Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pmen.0000514}{doi:10.1371/journal.pmen.0000514}.
\item Stocker K, Hartmann M, Schmid Y, Vogt SB, Becker AM, Ley L, Straumann I, Arikci D, Klaiber A, Erne L, Vizeli P, Holze F, Liechti ME. (2025). \textit{The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251397328}{doi:10.1177/02698811251397328}.
\item Sheppard Pratt Health System (2025). \textit{The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220410}{source link}.
\item University of Chicago (2025). \textit{An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05399498}{source link}.
\item Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA. (2025). \textit{A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2025.12.22.25342874}{doi:10.64898/2025.12.22.25342874}.
\item Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J. (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item NYU Langone Health (2025). \textit{Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296328}{source link}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.18.695064}{doi:10.64898/2025.12.18.695064}.
\item Pallavicini C, Llobenes L, Cavanna F, de la Fuente LA, Muller S, Costa M, Gumiy N, Bruno N, D’Amelio T, Basran J, Plowright P, Stolkiner A, Namías M, Gilbert P, Tagliazucchi E. (2025). \textit{A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694940}{doi:10.64898/2025.12.17.694940}.
\item Brett J, Lea T, Knock E, Albert S, Acheson L, Siefried KJ, Job S. (2025). \textit{A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.70284}{doi:10.1111/add.70284}.
\item Carlson LE, Richardson H, Shore R, Albertyn CP, Balneaves LG, Bates A, Burnell M, Chochinov HM, Clements D, Deleemans J, Horlock H, Mathews J, McKenzie M, Savard C, Soares CN, Tu W, Williams M (2025). \textit{The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.}. Current oncology (Toronto, Ont.). [published; PubMed]. \href{https://doi.org/10.3390/curroncol33010007}{doi:10.3390/curroncol33010007}.
\item Palitsky R, Grant GH. (2025). \textit{Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251393983}{doi:10.1177/28314425251393983}.
\item Unknown authors (2025). \textit{Publisher's Note re: "Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions" (doi: 10.1089/psymed.2023.0044).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2025.68798.pn}{doi:10.1089/psymed.2025.68798.pn}.
\item Brach T. (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions: The Great Promise of Psychedelics: Evolving Human Consciousness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251408081}{doi:10.1177/28314425251408081}.
\item Lorenz J, Hawkins S, McCarthy B. (2025). \textit{Griffiths et al.'s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251406251}{doi:10.1177/28314425251406251}.
\item Griffiths RR, Jesse R, Richards WA, Johnson MW, Sepeda ND, Bossis AP, Ross S. (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0044}{doi:10.1089/psymed.2023.0044}.
\item de Wit H. (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et al.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251409219}{doi:10.1177/28314425251409219}.
\item Pargament KI. (2025). \textit{Psilocybin, Spirituality, and the Potential for Personal Transformation: Commentary on Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions by Griffiths et al.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251406613}{doi:10.1177/28314425251406613}.
\item Fleury S, Nautiyal KM. (2025). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03387-1}{doi:10.1038/s41380-025-03387-1}.
\item NYU Langone Health (2025). \textit{Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06349083}{source link}.
\item Koning E, Gamberg S, Keshen A. (2025). \textit{Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale \& Considerations for Protocol Development}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202512.1705.v1}{doi:10.20944/preprints202512.1705.v1}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item COMPASS Pathways (2025). \textit{A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05624268}{source link}.
\item Barbieri A. (2025). \textit{Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/v7pxn\_v1}{doi:10.31234/osf.io/v7pxn\_v1}.
\item Brar G, Burke T, Gribben AD, Harrington C, Thuery G, Kelly JR. (2025). \textit{Psilocybin reporting in media (PRiMe) for the treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/ipm.2025.10142}{doi:10.1017/ipm.2025.10142}.
\item Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S. (2025). \textit{Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02692163251383335}{doi:10.1177/02692163251383335}.
\item Unknown authors (2025). \textit{Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.47626/2237-6089-2025-1273}{doi:10.47626/2237-6089-2025-1273}.
\item Koning E, Bacchi P, Chaves C, Gomes FA, Brietzke E. (2025). \textit{Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.47626/2237-6089-2025-1197}{doi:10.47626/2237-6089-2025-1197}.
\item Dutton M, Schwenn P, Mitchell J, Hoffmann P, Bailey NW, Fitzgerald PB, Lagopoulos J, Can AT. (2025). \textit{Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674251398677}{doi:10.1177/00048674251398677}.
\item Khan FA, Pandupuspitasari NS, Tencomnao T, Chuchawankul S. (2025). \textit{Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120882}{doi:10.1016/j.jad.2025.120882}.
\item Yvan Beaussant, MD, MSci (2025). \textit{Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06001749}{source link}.
\item Renner AC, Kargbo RB. (2025). \textit{Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00714}{doi:10.1021/acsmedchemlett.5c00714}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M. (2025). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Ledwos N, Baer J, Husain MI, Blumberger DM, Patterson R, Hollingdrake E, Cheung E, Hawco C, Zrenner C, Zrenner B, Feusner JD, Rossell SL, Castle DJ, Zai G. (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Greguš D, Hlinka J, Tylš F, Viktorin V, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Nikolič M, Adámek P, Beneš M, Páleníček T, Horáček J. (2025). \textit{Regional specificity of the cingulate cortex thickness association with the intensity of psilocybin experience: a replication study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06983-9}{doi:10.1007/s00213-025-06983-9}.
\item Carhart-Harris R. (2025). \textit{The entropic brain today}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ubzq3\_v1}{doi:10.31234/osf.io/ubzq3\_v1}.
\item Unknown authors (2025). \textit{The entropic brain today}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ubzq3\_v1}{source link}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v2}{doi:10.31234/osf.io/dczw2\_v2}.
\item Unknown authors (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v2}{source link}.
\item Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S. (2025). \textit{Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8079137/v1}{doi:10.21203/rs.3.rs-8079137/v1}.
\item Magee SN, Sereno AC, Echeveste-Sanchez M, Shannon EG, Mohsin A, Mott SE, Faccidomo SP, Hodge CW, Herman MA. (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Ching THW, Stahnke B, Shnayder S, Agin-Liebes G, Adams TG, Amoroso L, Baiz O, Belser A, Bohner C, Burke M, D'Amico E, DePalmer G, Eilbott J, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Purohit P, Schaer H, Sierra YP, Witherow C, Pittenger C, Kelmendi B. (2025). \textit{Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1726818}{doi:10.3389/fpsyt.2025.1726818}.
\item Dwyer J, Johnston RB, O'Callaghan C, Ross M. (2025). \textit{Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.002}{doi:10.1016/j.genhosppsych.2025.12.002}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag.2}{doi:10.32388/xcfsag.2}.
\item Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM. (2025). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Cook SG, Lee S, Ference E, Shi Y, Baimoukhametova D, Rojas-Carvajal M, Hen R, Bains JS, Turi GF, Füzesi T. (2025). \textit{Psilocybin induces sex- and context-specific recruitment of the stress axis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2025.11.031}{doi:10.1016/j.cub.2025.11.031}.
\item Kirlić N, Atli M, Mistry S, Gold M, Goodwin GM. (2025). \textit{The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000002119}{doi:10.1097/jcp.0000000000002119}.
\item Lappan SN, Davis SD. (2025). \textit{Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251404021}{doi:10.1177/28314425251404021}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS. (2025). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS. (2025). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Imperial College London (2025). \textit{Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06798636}{source link}.
\item Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J. (2025). \textit{Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2025.103692}{doi:10.1016/j.eclinm.2025.103692}.
\item Jiang Q, Shao LX, Yao S, Savalia NK, Gilbert AD, Davoudian PA, Nothnagel JD, Tian G, Hung TS, Lai HM, Beier KT, Zeng H, Kwan AC. (2025). \textit{Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cell.2025.11.009}{doi:10.1016/j.cell.2025.11.009}.
\item Ostrand A, Nour M, Timmermann C, Rosati A, Luan LX, Gómez-Emilsson A, Bornemann J, Greenway K, Roseman L, Carhart-Harris R. (2025). \textit{Defining ‘psychedelic’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5ybhk\_v1}{doi:10.31234/osf.io/5ybhk\_v1}.
\item University of British Columbia (2025). \textit{Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05585229}{source link}.
\item NYU Langone Health (2025). \textit{A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05398484}{source link}.
\item Unknown authors (2025). \textit{Defining ‘psychedelic’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5ybhk\_v1}{source link}.
\item Kangaslampi S, Wolff M, Doss MK, Kloft-Heller L, Otgaar H. (2025). \textit{Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-025-01484-8}{doi:10.1186/s40337-025-01484-8}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F. (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Machado T, Rodrigues ASL, Costa J. (2025). \textit{Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251397590}{doi:10.1177/20451253251397590}.
\item Bukovsky D, Amaev A, Song J, Torres-Carmona E, Kyte S, Ueno F, Deluca V, Bowie C, Flint A, Husain I, Graff-Guerrero A, Gerretsen P. (2025). \textit{Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12740486}{source link}.
\item Madhu L, Somayaji Y, Kotian S, Attaluri S, Patel J, Panda P, Rao V, Kodali M, Shankar G, Rao S, Weintraub S, Shuai B, Rao X, Shetty A. (2025). \textit{Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal Neurogenesis}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12739712}{source link}.
\item Buchard A, Seragnoli F, Sabe M, Eskinazi M, Aboulafia T, Furtado L, Briefer J, Roediger E, Penzenstadler L, Zullino D, Thorens G. (2025). \textit{Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8214817/v1}{doi:10.21203/rs.3.rs-8214817/v1}.
\item Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L. (2025). \textit{Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.12.01.25341335}{doi:10.1101/2025.12.01.25341335}.
\item Stirn Judith, Berger Raphael, Hübner Harald, Gmeiner Peter, Klein Christian D. (2025). \textit{Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy}. European Journal of Medicinal Chemistry Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.ejmcr.2025.100278}{doi:10.1016/j.ejmcr.2025.100278}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW. (2025). \textit{Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03231-6}{doi:10.1038/s41380-025-03231-6}.
\item Ferreira J. (2025). \textit{Psilocybin reduces comorbid chronic pain and depression in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41684-025-01663-9}{doi:10.1038/s41684-025-01663-9}.
\item Downey AE, Tai ML, Bradley ER, Woolley JD. (2025). \textit{Sudden Loss of Consciousness Following Psilocybin Ingestion.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20250037}{doi:10.1176/appi.ajp.20250037}.
\item Kleditzsch N, Gattuso JJ, Hannan AJ, Renoir T. (2025). \textit{Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.70351}{doi:10.1111/ejn.70351}.
\item University of Iowa (2025). \textit{Psilocybin vs Ketamine for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06405607}{source link}.
\item Hirsch D, Reed J, Naqvi A, Ngor A, Dugan L, Costa K, Ganasi RS, Truman K, Danovitch I, IsHak WW, Hedrick R. (2025). \textit{Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01248-7}{doi:10.1007/s40263-025-01248-7}.
\item University College, London (2025). \textit{Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06815653}{source link}.
\item University of Texas at Austin (2025). \textit{Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06132178}{source link}.
\item Domżalska M, Kwiatkowska J, Cichoń I, Sokołowska E. (2025). \textit{A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-025-29642-7}{doi:10.1038/s41598-025-29642-7}.
\item Pinhas N, Eidlman N, Barnea A, Peled-Avron L. (2025). \textit{Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106493}{doi:10.1016/j.neubiorev.2025.106493}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M. (2025). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Charles S. Grob, M.D. (2025). \textit{Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05403086}{source link}.
\item Kruger DJ, Mersereau G, Sullivan A, Barron J, Herberholz M, Pouyan N, Aday JS, Boehnke KF. (2025). \textit{Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12954-025-01337-2}{doi:10.1186/s12954-025-01337-2}.
\item Rasheed S, Arif R, Raza AA, Samadi A. (2025). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Johnson DE, Meshkat S, Kaczmarek ES, Rabin JS, Brudner RM, Chisamore N, Doyle Z, Bawks J, Riva-Cambrin J, Mansur RB, Lipsitz O, McIntyre RS, Lanctôt KL, Rosenblat JD. (2025). \textit{Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111565}{doi:10.1016/j.pnpbp.2025.111565}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag}{doi:10.32388/xcfsag}.
\item Aqil M, de Hollander G, Vreugdenhil N, Knapen T, Dumoulin SO. (2025). \textit{Psilocybin alters visual contextual computations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-025-65150-y}{doi:10.1038/s41467-025-65150-y}.
\item Jaster AM, Hadlock TM, Buzzi B, Maltman JL, Silva GM, Saha S, Koseli E, Pondelick AM, Thakur N, Zhang X, Li G, Ledesma-Corvi S, Moore KN, Peterson HR, Fujita B, Zylko AL, Lewis MR, Poklis JL, Halquist MS, Wolstenholme JT, Selley DE, Hamilton PJ, Lu C, Damaj MI, González-Maeso J. (2025). \textit{Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S. (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item Alnagger NLN, Cardone P, Martial C, Perl YS, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason N, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Núñez P, Annen J. (2025). \textit{A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/advs.202511780}{doi:10.1002/advs.202511780}.
\item University of Zurich (2025). \textit{Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06081179}{source link}.
\item Beersheva Mental Health Center (2025). \textit{A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07183748}{source link}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Zhang W, Hwang SY, Luther J. (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item Peggy C Nopoulos (2025). \textit{Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05421065}{source link}.
\item Ioakimidis-MacDougall G, Gardner J, Liknaitzky P. (2025). \textit{Psilocybin Experiential Therapist Training: Insights from a World-First Study}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.11.15.25340324}{doi:10.1101/2025.11.15.25340324}.
\item Rosal SRP, Faber SC. (2025). \textit{Standardization of Psilocybin Dosing in a Natural Product-Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across Sessions}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8000629/v1}{doi:10.21203/rs.3.rs-8000629/v1}.
\item Bhavaraju KP, Mason NL, Mallaroni P, Heinke D, Toennes SW, Ramaekers JG, Amico E. (2025). \textit{Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.17.688834}{doi:10.1101/2025.11.17.688834}.
\item Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed O, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb NAS, Petranker R. (2025). \textit{Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hmnsw\_v1}{doi:10.31234/osf.io/hmnsw\_v1}.
\item Unknown authors (2025). \textit{Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hmnsw\_v1}{source link}.
\item Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ. (2025). \textit{Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03693-w}{doi:10.1038/s41398-025-03693-w}.
\item Kramer HM, Hibicke M, Middleton J, Jaster AM, Kristensen JL, Nichols CD. (2025). \textit{Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-025-02272-3}{doi:10.1038/s41386-025-02272-3}.
\item Oo AP, Tseu S, Ponnusamy A. (2025). \textit{Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.96718}{doi:10.7759/cureus.96718}.
\item Mehtani NJ, Mian MN, Agin-Liebes G, Coker AR, Huebner C, Anderson BT, Mitchell JM. (2025). \textit{Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2583960}{doi:10.1080/02791072.2025.2583960}.
\item Rodríguez L, Morera G, Lupo S, Davyt D, Carrera I, Hernández Dossi G. (2025). \textit{Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.5c07092}{doi:10.1021/acsomega.5c07092}.
\item Renner AC, Kargbo RB. (2025). \textit{Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00661}{doi:10.1021/acsmedchemlett.5c00661}.
\item Wolff M, Kangaslampi S. (2025). \textit{Pharmacodynamic biomarker - or psychotherapeutic process? Comment on "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120637}{doi:10.1016/j.jad.2025.120637}.
\item Zech JM, Richard J, Jones GM (2025). \textit{The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583967}{doi:10.1080/02791072.2025.2583967}.
\item Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO. (2025). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.06.687023}{doi:10.1101/2025.11.06.687023}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M. (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C. (2025). \textit{Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03729-1}{doi:10.1038/s41398-025-03729-1}.
\item Yale University (2025). \textit{Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03554174}{source link}.
\item University of Washington (2025). \textit{A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05847686}{source link}.
\item Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C. (2025). \textit{Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7890051/v1}{doi:10.21203/rs.3.rs-7890051/v1}.
\item Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP. (2025). \textit{Psilocybin and chronic neuropathic pain: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/rapm-2024-105532}{doi:10.1136/rapm-2024-105532}.
\item Soltanzadeh M, Wang Z, Allohverdi SG, Charlton CE, Schmidt A, Vollenweider FX, Diaconescu AO. (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06952-2}{doi:10.1007/s00213-025-06952-2}.
\item Guo C, Luu NNT, Adwer MM, Hosseinzadeh H, Balan V, Yan Y, Lin Y. (2025). \textit{Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ymben.2025.11.002}{doi:10.1016/j.ymben.2025.11.002}.
\item Allen J, Sun M, Baker TL, Dames S, Kryskow P, Christie BR, McDonald SJ, Shultz SR. (2025). \textit{Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03329-x}{doi:10.1038/s41380-025-03329-x}.
\item Bhagavan C, Bryson A, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Eleftheriadis D, Oliver G, Mayne D, Roebuck G, Rucker J, Butler M, Kanaan R. (2025). \textit{Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10042}{doi:10.1017/neu.2025.10042}.
\item Srivastava AB, Gold MS (2025). \textit{A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15111190}{doi:10.3390/brainsci15111190}.
\item Marinis J, Clarke ST, Guerin AA, Guastella AJ, Bedi G. (2025). \textit{Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2025.10847}{doi:10.1192/bjo.2025.10847}.
\item Ehmann S, Hager NM, Regier PS, Jones G, Allen JJ. (2025). \textit{Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/jd2rk\_v1}{doi:10.31234/osf.io/jd2rk\_v1}.
\item Prochazkova L, Marschall J, van Elk M, Rifkin BD, Schon NR, Fiacchino D, Fejer G, Kuchar M, Hommel B. (2025). \textit{Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110732}{doi:10.1016/j.neuropharm.2025.110732}.
\item Unknown authors (2025). \textit{Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1016/j.addbeh.2026.108652}{doi:10.1016/j.addbeh.2026.108652}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Rahmani S, Crupi R, Riley AL, Davidson T (2025). \textit{The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2025.174087}{doi:10.1016/j.pbb.2025.174087}.
\item Luo W, Dai Q, van Beek TA, Zuilhof H, Chen B, Chen Z, Salentijn GI. (2025). \textit{Paper spray and direct mushroom spray mass spectrometry methods for the analysis of psycho-neurological disorder toxins}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609225828}{source link}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G. (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Do A, Cloutier L, Hébert-Tremblay L, Thauvin C. (2025). \textit{Psilocybin use in bipolar disorder: A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120485}{doi:10.1016/j.jad.2025.120485}.
\item Ohio State University (2025). \textit{A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06820723}{source link}.
\item García-Cabrerizo R, Beruete-Fresnillo I, Bergas-Cladera P, García-Fuster MJ. (2025). \textit{Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2025.118720}{doi:10.1016/j.biopha.2025.118720}.
\item Anna Rose Childress, Ph.D. (2025). \textit{A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06786325}{source link}.
\item Richardson C, Chan C, Macgregor E, Hare C, Hannon B, Black S, Schneider E, Buchman D, Wang S, Rac V, Abrahamyan L, Huszti E, Nissim R, Li M, Zimmermann C, Hapke E, Rosenbaum D, Hales S. (2025). \textit{Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40814-025-01706-5}{doi:10.1186/s40814-025-01706-5}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ. (2025). \textit{Provider perspectives on challenges in treatment during psychedelic therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06907-7}{doi:10.1007/s00213-025-06907-7}.
\item Rakić V. (2025). \textit{Love (Drugs), Happiness, and Morality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/bioe.70043}{doi:10.1111/bioe.70043}.
\item Farzin H, Koren B, Ferrier H, Sanders JJ, Garel N. (2025). \textit{Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1478951525100941}{doi:10.1017/s1478951525100941}.
\item Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA. (2025). \textit{A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare13212668}{doi:10.3390/healthcare13212668}.
\item Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P. (2025). \textit{Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111541}{doi:10.1016/j.pnpbp.2025.111541}.
\item Sabnis RW. (2025). \textit{Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00608}{doi:10.1021/acsmedchemlett.5c00608}.
\item University of California, Berkeley (2025). \textit{Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06367738}{source link}.
\item University of California, Berkeley (2025). \textit{Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05265546}{source link}.
\item Uyar A, Forbrich L, Lueken U, Evens R. (2025). \textit{Landscape analysis of pre-registered clinical trials involving classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251371690}{doi:10.1177/02698811251371690}.
\item Martin HM, Cofre R, Destexhe A. (2025). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC. (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202510.1355.v1}{doi:10.20944/preprints202510.1355.v1}.
\item Vale LN, Ibrahim M, Fávaro-Pereira L, Soares JC, Meyer TD. (2025). \textit{Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120437}{doi:10.1016/j.jad.2025.120437}.
\item Prochazkova L, Marschall J, Lippelt DP, Schon NR, Kuchař M, Hommel B. (2025). \textit{Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110722}{doi:10.1016/j.neuropharm.2025.110722}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item Heal DJ, Gosden J, Smith SL. (2025). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, Raines S, Hughes ZA, Austin EW, Klein AK, Leong W, Krol FJ, Graaf AJV, Juachon MJ, Otto ME, Borghans LGJM, Jacobs G, Kruegel AC, Sporn J. (2025). \textit{A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251378512}{doi:10.1177/02698811251378512}.
\item University of Wisconsin, Madison (2025). \textit{Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04161066}{source link}.
\item Shadani S, Greaves E, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.14.682467}{doi:10.1101/2025.10.14.682467}.
\item University of Washington (2025). \textit{A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06644170}{source link}.
\item Johns Hopkins University (2025). \textit{Psilocybin and Affective Function in Chronic Lower Back Pain Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06355414}{source link}.
\item Kolbman N, Huels ER, Nelson A, Summerfield R, Byraju K, Groenhout T, Liu T, Hudetz AG, Vanini G, Pal D. (2025). \textit{Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.12.681880}{doi:10.1101/2025.10.12.681880}.
\item Li R, Yan H, Chen Y, Liu Y, Tang L, Yu J, Liu J, Wang H, Wang S, Cheng J. (2025). \textit{Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045}{doi:10.1021/acs.jmedchem.5c02045}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ. (2025). \textit{Psychedelic 5-HT2A receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-025-02069-z}{doi:10.1038/s41593-025-02069-z}.
\item Agrawal R, Gillie D, Mungenast A, Chytil M, Engel S, Wu MC, Rasmussen K, Salinas E, Olson DE. (2025). \textit{Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00667}{doi:10.1021/acschemneuro.5c00667}.
\item St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Paschall SA, Kuypers KPC, Rootman J, Walsh Z (2025). \textit{Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06913-9}{doi:10.1007/s00213-025-06913-9}.
\item Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders J, Ljuslin M, Guérin B, Sholevar R, Roddy K, Tulsky JA, Agrawal M. (2025). \textit{Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.10.010}{doi:10.1016/j.genhosppsych.2025.10.010}.
\item Oregon Health and Science University (2025). \textit{Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06988319}{source link}.
\item Johansen A, Plavén-Sigray P, Madsen MK, Søndergaard A, Messel C, Geisler M, Nasser A, McCulloch DE, Beliveau V, Vassilieva A, Lund A, Lehel S, Ozenne B, Stenbæk DS, Fisher PM, Svarer C, Knudsen GM. (2025). \textit{Psilocybin’s effect on human brain synaptic plasticity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7469144/v1}{doi:10.21203/rs.3.rs-7469144/v1}.
\item Richardson B, Inserra A, Pileggi M, Prud'Homme T, Bruno V, Wan-Yan-Chan D, Shareghi-Ghahreman I, Nasini S, Strand T, Leyton M, Sonenberg N, De Gregorio D, Sprouse J, Bambico FR, Gobbi G. (2025). \textit{Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111522}{doi:10.1016/j.pnpbp.2025.111522}.
\item Moskovitz M (2025). \textit{The Research Deficit and Expert Disagreement Regarding Music Selection for Psychedelic Assisted Therapy.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00583}{doi:10.1021/acsptsci.5c00583}.
\item Renner AC, Kargbo RB. (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E. (2025). \textit{Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120352}{doi:10.1016/j.jad.2025.120352}.
\item Renner AC, Kargbo RB. (2025). \textit{Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory Innovations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00597}{doi:10.1021/acsmedchemlett.5c00597}.
\item Mallaroni P, Mason NL, Preller KH, Razi A, Ereira S, Ramaekers JG. (2025). \textit{Neurocomputational evidence of sustained Self-Other mergence after psychedelics}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.10.07.25337510}{doi:10.1101/2025.10.07.25337510}.
\item Brown KA, Ajibola MI, Medeiros GC, Gould TD. (2025). \textit{Synaptic priming: A framework for pharmacotherapy in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.09.010}{doi:10.1016/j.neuron.2025.09.010}.
\item Kevin Murnane (2025). \textit{A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899594}{source link}.
\item Centre Hospitalier St Anne (2025). \textit{Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07210112}{source link}.
\item Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E. (2025). \textit{Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7269356/v1}{doi:10.21203/rs.3.rs-7269356/v1}.
\item Ostuni S, Voto P, Birkebak J, Meyer MGE, Geurin Z, Slot JC. (2025). \textit{Panaeolus oligotrophus: A new species from central Florida, with notes on Panaeolus pumilus and Crucispora rhombisperma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00275514.2025.2552612}{doi:10.1080/00275514.2025.2552612}.
\item Schmitz GP, Chiu YT, Foglesong ML, Magee SN, MacKinnon M, König GM, Kostenis E, Hsu LM, Shih YI, Roth BL, Herman MA. (2025). \textit{Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03611-0}{doi:10.1038/s41398-025-03611-0}.
\item Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P (2025). \textit{Harm reduction practises for users of psychedelic drugs: a scoping review.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-025-01264-2}{doi:10.1186/s12954-025-01264-2}.
\item University Hospital, Geneva (2025). \textit{Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164287}{source link}.
\item Meikle S, Carter O, Liknaitzky P, Johansen L, Iyer R, Strauss N, Williams M, Castle D, Rossell SL. (2025). \textit{Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251377187}{doi:10.1177/20451253251377187}.
\item Hammo A, Wisser S, Cichon J. (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Kangaslampi S, Lietz M (2025). \textit{Psychedelics and autobiographical memory - six open questions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06771-5}{doi:10.1007/s00213-025-06771-5}.
\item Johns Hopkins University (2025). \textit{Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06989957}{source link}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD. (2025). \textit{Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2352-4642(25)00208-1}{doi:10.1016/s2352-4642(25)00208-1}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-09671-y}{doi:10.1038/s41586-025-09671-y}.
\item Sabé M, Seragnoli F, Penzenstadler L, Thorens G. (2025). \textit{[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/41575100}{source link}.
\item Hatzipantelis CJ, Liu M, Love A, Leventhal SJ, Maera H, Viswanathan S, Avetisyan E, Belinsky L, Rangel MM, Jain NJ, Kelly M, Copeland C, Khatib YA, Fiehn O, Olson DE, Stolzenberg DS. (2025). \textit{Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-025-64371-5}{doi:10.1038/s41467-025-64371-5}.
\item Du X, Liu J, Wang X, Wang X. (2025). \textit{The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03291-8}{doi:10.1038/s41380-025-03291-8}.
\item Caporuscio C, Poppe C, Gieselmann A, Repantis D. (2025). \textit{Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291725101761}{doi:10.1017/s0033291725101761}.
\item Mathai DS, Robinson JO, Wagner K, Neitzke-Spruill L, Berrones D, Anderberg JL, Frederick RM, Cruz VZ, Muñoz JS, Latin American Trans-Ancestry INitiative for OCD genomics, Brazilian Obsessive-Compulsive Spectrum Disorder Working Group, Rodriguez CI, Averill LA, Crowley JJ, Storch EA, McGuire AL. (2025). \textit{Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.47626/1516-4446-2025-4316}{doi:10.47626/1516-4446-2025-4316}.
\item Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. (2025). \textit{Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/imag.a.907}{doi:10.1162/imag.a.907}.
\item Ham R, Gardner J, Carter A, Liknaitzky P. (2025). \textit{“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4cn5r\_v1}{doi:10.31234/osf.io/4cn5r\_v1}.
\item University of Southern California (2025). \textit{An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06233344}{source link}.
\item Unknown authors (2025). \textit{“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4cn5r\_v1}{source link}.
\item Greguš D, Hlinka J, Tylš F, Viktorin V, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Nikolič M, Adámek P, Beneš M, Páleníček T, Horáček J. (2025). \textit{Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7544401/v1}{doi:10.21203/rs.3.rs-7544401/v1}.
\item Havlik JL, Isaac S, Raman P, Tran N, Hidalgo K, Suppes T. (2025). \textit{Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000002095}{doi:10.1097/jcp.0000000000002095}.
\item Inan S, Morris P, Rawls SM, Daws S. (2025). \textit{Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000856}{doi:10.1097/fbp.0000000000000856}.
\item Healing Advocacy Fund (2025). \textit{Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07189988}{source link}.
\item Keshen A, Touyz S, Lacroix E, Hay P, McElroy SL. (2025). \textit{Innovative Pharmacological Approaches to Eating Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psc.2025.08.014}{doi:10.1016/j.psc.2025.08.014}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V. (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS. (2025). \textit{Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2025.103517}{doi:10.1016/j.eclinm.2025.103517}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Bruno V, López-Canul M, Richardson B, Camarini R, Marcourakis T, Gobbi G. (2025). \textit{High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251368361}{doi:10.1177/02698811251368361}.
\item Schäfer T, Haun F, Rupp B, Hoffmeister D. (2025). \textit{Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/anie.202512017}{doi:10.1002/anie.202512017}.
\item Knock E, Siefried KJ, Bedi G, Albert S, Day RO, Ezard N, Ross M, Liknaitzky P, Brett J. (2025). \textit{Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.70187}{doi:10.1111/add.70187}.
\item Delgado-Sallent C, Ahmed SA, Khawaja-Lopez A, Lee BS, Senne R, Scott BB, Ramirez S. (2025). \textit{Psychedelics Relax Priors and Reshape Orbitofrontal Dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.18.677110}{doi:10.1101/2025.09.18.677110}.
\item Beaglehole B, Manuel J. (2025). \textit{Reappraisal of the hype and hope offered by psilocybin treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26635/6965.7138}{doi:10.26635/6965.7138}.
\item Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL. (2025). \textit{Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pmed.1004519}{doi:10.1371/journal.pmed.1004519}.
\item Calin A, Burlec AF, Mircea C, Macovei I, Hancianu M, Corciova A. (2025). \textit{Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm14186613}{doi:10.3390/jcm14186613}.
\item Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M. (2025). \textit{Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2025.1651898}{doi:10.3389/fphar.2025.1651898}.
\item Johns Hopkins University (2025). \textit{PRoMiSS: Psilocybin and the Role of Music in Set and Setting}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07180108}{source link}.
\item Gründer G, Mertens LJ, Jungaberle A, Jungaberle H, Spangemacher M. (2025). \textit{Compassionate use of psilocybin for treatment-resistant depression in Germany.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(25)00277-9}{doi:10.1016/s2215-0366(25)00277-9}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Kermanshah A, Stapleton M, Mauriello CM, Cobas M, Cordoba Torres IT. (2025). \textit{Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.92568}{doi:10.7759/cureus.92568}.
\item Maastricht University (2025). \textit{The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06368492}{source link}.
\item Hooper JF, Ellingson JM, Hutchison KE. (2025). \textit{Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2025.1648968}{doi:10.3389/fpsyg.2025.1648968}.
\item Pereira Galdino T, Bisneto ABM, Pedro MDS, de Oliveira LC, Luz MA, de Lima AGB, Silva SML, Fook MVL. (2025). \textit{Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.5c05606}{doi:10.1021/acsomega.5c05606}.
\item He Z, Tang R, Feng M, Li X, Zhang C, Li J. (2025). \textit{Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15563650.2025.2552438}{doi:10.1080/15563650.2025.2552438}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A. (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS. (2025). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Sapienza J, Spangaro M, Comai S, Sabé M, La Torre J, Buonarroti M, Cavallaro R, Bosia M (2025). \textit{Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26188949}{doi:10.3390/ijms26188949}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD. (2025). \textit{Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Masjedi NS, Razi A. (2025). \textit{Effective connectivity of the human claustrum: Triple networks, subcortical circuits, and psychedelic modulation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.07.674759}{doi:10.1101/2025.09.07.674759}.
\item Chwyl C, Spata A, Lucas W, Luoma JB. (2025). \textit{Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7266162/v1}{doi:10.21203/rs.3.rs-7266162/v1}.
\item Bélanger A, Chang SL, Stephan JF, Moureaux F, Tapp D, Foxman R, Gagnon P, Hébert J, Farzin H, Dorval M. (2025). \textit{Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare13182290}{doi:10.3390/healthcare13182290}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA. (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML. (2025). \textit{N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-025-02190-4}{doi:10.1038/s41386-025-02190-4}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T. (2025). \textit{Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110679}{doi:10.1016/j.neuropharm.2025.110679}.
\item Wierzbicka M, Kopczyk R, Gerlach A, Rymaszewska J. (2025). \textit{Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1698185}{doi:10.3389/fpsyt.2025.1698185}.
\item Razidlo J, Cataldo N, Wenthur CJ. (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item King's College London (2025). \textit{Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164755}{source link}.
\item Rachel Yehuda (2025). \textit{Processing Intergenerational Trauma With Psilocybin-Assisted Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899165}{source link}.
\item Gushken F, Fidalgo TM, Tardelli VS. (2025). \textit{Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/adm.0000000000001580}{doi:10.1097/adm.0000000000001580}.
\item Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251372449}{doi:10.1177/20451253251372449}.
\item Aday JS, Carhart-Harris R, Boehnke KF. (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yz4cd\_v2}{doi:10.31234/osf.io/yz4cd\_v2}.
\item Unknown authors (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yz4cd\_v2}{source link}.
\item Moreno-Chaparro J, Castañeda-Millán G, Eslava Schmalbach J. (2025). \textit{Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/wnf.0000000000000653}{doi:10.1097/wnf.0000000000000653}.
\item Aday JS, Carhart-Harris R, Boehnke KF. (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yz4cd\_v1}{doi:10.31234/osf.io/yz4cd\_v1}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Mesquita Garcia AC, Teixeira F, Maia LO. (2025). \textit{Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/08980101251374371}{doi:10.1177/08980101251374371}.
\item Brownstien M, Lazar M, Botvinnik A, Pogodin I, Lifschytz T, Lerer B. (2025). \textit{Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03173-z}{doi:10.1038/s41380-025-03173-z}.
\item Khyber Medical University Peshawar (2025). \textit{Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06746441}{source link}.
\item van Breemen RB, Simchuk D, Fritzsche B, Huson D, Kuzdzal SA, Ferguson J. (2025). \textit{Active Constituents of Psilocybin Mushroom Edibles.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.31345}{doi:10.1001/jamanetworkopen.2025.31345}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Beck SA, Barlow C, Engel L, Barratt MJ. (2025). \textit{“Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushrooms}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609301091}{source link}.
\item Chiu I, Tate M, Trujillo D, Suprasert B, Marr A, Arayasirikul S, Wilson EC, Raymond HF, McFarland W. (2025). \textit{Sample composition and HIV prevention indicator differences using physical vs virtual venue recruitment of men who have sex with men in San Francisco.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/aje/kwae443}{doi:10.1093/aje/kwae443}.
\item Montoy JCC, Wang RC, Coker AR, Smollin CG, Anderson BT. (2025). \textit{US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.acepjo.2025.100231}{doi:10.1016/j.acepjo.2025.100231}.
\item Avanceña ALV, Vuong L, Kahn JG, Marseille E. (2025). \textit{Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03556-4}{doi:10.1038/s41398-025-03556-4}.
\item McGowan NM, Rucker JJ, Yehuda R, Agrawal M, Modlin NL, Simmons H, Tofil-Kaluza A, Das S, Goodwin GM. (2025). \textit{Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251362390}{doi:10.1177/02698811251362390}.
\item Nathan Brashares Sackett (2025). \textit{A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06853912}{source link}.
\item Perez GM, Rosenberg BM, Xu W, Oathes DJ. (2025). \textit{Brain changes associated with depression treatment: a meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nicl.2025.103874}{doi:10.1016/j.nicl.2025.103874}.
\item Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB. (2025). \textit{Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0031}{doi:10.1089/psymed.2024.0031}.
\item Islam S, Salam S, Hasan MN. (2025). \textit{Unsupervised Extractive Summarization of Psychedelic User Experience Reports}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.22.25334176}{doi:10.1101/2025.08.22.25334176}.
\item Higgins GA, MacMillan C, de Lannoy I, Tyler C, Slassi M. (2025). \textit{Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251361453}{doi:10.1177/02698811251361453}.
\item Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B. (2025). \textit{Psilocybin: Systematic review of its use in the treatment of depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12436869}{source link}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW. (2025). \textit{Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03182-y}{doi:10.1038/s41380-025-03182-y}.
\item Drewko AJ, Habets RLP, Brunt TM. (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Greaves MD, Barta T, Novelli L, Stoliker D, Razi A. (2025). \textit{Context-dependent structurally informed effective connectivity under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.18.671000}{doi:10.1101/2025.08.18.671000}.
\item Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R. (2025). \textit{Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7420529/v1}{doi:10.21203/rs.3.rs-7420529/v1}.
\item Effinger DP, Schalk SS, King JL, Wallingford JR, O'Connell CK, Calderon JR, Kopecky BJ, McCorvy JD, Thompson SM. (2025). \textit{Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00202}{doi:10.1021/acsptsci.5c00202}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06647056}{source link}.
\item Bilenker D, Avena NM. (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item Holas P, Kamińska J. (2025). \textit{Psychedelic use in Poland: prevalence, correlates and social attitudes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5114/ppn.2025.153566}{doi:10.5114/ppn.2025.153566}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T. (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Johns Hopkins University (2025). \textit{Effects of Psilocybin in Post-Treatment Lyme Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05305105}{source link}.
\item Koenig HG. (2025). \textit{Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00912174251369880}{doi:10.1177/00912174251369880}.
\item COMPASS Pathways (2025). \textit{A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05733546}{source link}.
\item Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE. (2025). \textit{Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6941009/v1}{doi:10.21203/rs.3.rs-6941009/v1}.
\item Madden MB, Schaefgen C, Vedak B, Kwon J, Pedra KSD, Sheats SH, Puche AC, Wolff SBE, Mathur BN. (2025). \textit{Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Li Y, Li H, Wang H, Wang X. (2025). \textit{Exploring the therapeutic potential of psychedelics in treating substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03168-w}{doi:10.1038/s41380-025-03168-w}.
\item Garcia ACM, Maia LO. (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S. (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD. (2025). \textit{Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.13.25333530}{doi:10.1101/2025.08.13.25333530}.
\item Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G. (2025). \textit{Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116697}{doi:10.1016/j.psychres.2025.116697}.
\item Kargbo RB. (2025). \textit{Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00475}{doi:10.1021/acsmedchemlett.5c00475}.
\item Ross ML, Iyer R, Williams ML, Boughey M, O'Callaghan C, Hiscock R, Dwyer J. (2025). \textit{Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.08.001}{doi:10.1016/j.genhosppsych.2025.08.001}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A. (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Im JJH, Sandoe CH (2025). \textit{Psychedelics and Headache Disorders: an Update.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-025-01446-2}{doi:10.1007/s11910-025-01446-2}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG. (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Jiang Q, Shao L, Yao S, Savalia NK, Gilbert AD, Davoudian PA, Nothnagel JD, Tian G, Hung TS, Lai H, Beier KT, Zeng H, Kwan AC. (2025). \textit{Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.06.668927}{doi:10.1101/2025.08.06.668927}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Blest-Hopley G, Pasculli G, Ruffell SGD, Tsang W, Emmanuel O, Pate KM, Kettner H, Roseman L, Erritzoe D, Carhart-Harris R. (2025). \textit{Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1594307}{doi:10.3389/fpsyt.2025.1594307}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Between enhancement and risk: A critical review of psychedelic microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.copsyc.2025.102129}{doi:10.1016/j.copsyc.2025.102129}.
\item Adeyinka D, Forsyth D, Currie S, Faraone N. (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Hultgren J, Hafsteinsson MH, Brulin JG. (2025). \textit{A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.07.020}{doi:10.1016/j.genhosppsych.2025.07.020}.
\item Meacham MC, Mian MN, Wang RC, Coker AR, Anderson BT, Montoy JCC. (2025). \textit{Latent Classes of Lifetime Use of Seven Hallucinogens in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2537040}{doi:10.1080/02791072.2025.2537040}.
\item Małgorzata W, Kopczyk R, Gerlach A, Rymaszewska J. (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Miller M, Meyers M, Krainak K, Lewis SP. (2025). \textit{Interventions to support spirituality among adults with cancer: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00520-025-09787-x}{doi:10.1007/s00520-025-09787-x}.
\item Hitchins K, Reynolds JP. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2025.104909}{doi:10.1016/j.drugpo.2025.104909}.
\item Unknown authors (2025). \textit{519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359785}{source link}.
\item Unknown authors (2025). \textit{631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359594}{source link}.
\item Unknown authors (2025). \textit{317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359800}{source link}.
\item Unknown authors (2025). \textit{164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359495}{source link}.
\item Unknown authors (2025). \textit{620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359512}{source link}.
\item Unknown authors (2025). \textit{426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359596}{source link}.
\item Unknown authors (2025). \textit{694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359587}{source link}.
\item Unknown authors (2025). \textit{363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359530}{source link}.
\item Unknown authors (2025). \textit{229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359778}{source link}.
\item Unknown authors (2025). \textit{205. SYNERGISTIC BEHAVIORAL AND NEUROPLASTIC EFFECTS OF PSILOCYBIN-NMDAR MODULATOR ADMINISTRATION}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359736}{source link}.
\item Unknown authors (2025). \textit{564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359394}{source link}.
\item Unknown authors (2025). \textit{476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359791}{source link}.
\item Unknown authors (2025). \textit{597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359505}{source link}.
\item Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F, Vogt SB, Arikci D, Schmid Y (2025). \textit{Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06772-4}{doi:10.1007/s00213-025-06772-4}.
\item Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M (2025). \textit{Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2025.104604}{doi:10.1016/j.ajp.2025.104604}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM. (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Unknown authors (2025). \textit{Correction to "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.70003}{doi:10.1002/cncr.70003}.
\item Cheung K, Brodie M, Chang SL, Deschamps P, Fallu JS, Farzin H, Hébert J, Stephan JF, Dorval M, Joly Y, P3A Study Group. (2025). \textit{Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/jme.2025.10109}{doi:10.1017/jme.2025.10109}.
\item Liechti ME, Gasser P, Aicher HD, Mueller F, Hawrot T, Schmid Y. (2025). \textit{Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105525}{doi:10.1016/j.nsa.2025.105525}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB. (2025). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. (2025). \textit{Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.07.30.25332422}{doi:10.1101/2025.07.30.25332422}.
\item Zylko AL, Rakoczy RJ, Roberts BF, Wilson M, Powell A, Page A, Heitkamp M, Feist D, Jones JA, McMurray MS. (2025). \textit{Age- and estrous-dependent effects of psilocybin in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110619}{doi:10.1016/j.neuropharm.2025.110619}.
\item Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M. (2025). \textit{Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251363983}{doi:10.1177/28314425251363983}.
\item Sutherland MH, Nicholas CR, Lennertz RC, Wenthur CJ, Krause BM, Sauder CJ, Riedner BA, Smith RF, Hutson PR, Raison CL, Banks MI. (2025). \textit{Electrophysiological effects of psilocybin co-administered with midazolam}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666887}{doi:10.1101/2025.07.25.666887}.
\item Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A. (2025). \textit{Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40519-025-01771-y}{doi:10.1007/s40519-025-01771-y}.
\item Johns Hopkins University (2025). \textit{Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06067737}{source link}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P. (2025). \textit{Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7099164/v1}{doi:10.21203/rs.3.rs-7099164/v1}.
\item Rudy LM, Godlewski MM. (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N. (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Yale University (2025). \textit{Mechanistic Studies of Psilocybin in Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06464367}{source link}.
\item Luquiens A, Belahda D, Graux C, Igounenc N, Serrand C, Rochefort P, Mura T, Sergent F. (2025). \textit{Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.70152}{doi:10.1111/add.70152}.
\item Rodan SC, Meez N, Lloyd-Hurwitz S, Bedoya-Pérez MA, Suraev A, Sommer N, Greenstien K, Maguire S, McGregor IS. (2025). \textit{Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-025-01328-5}{doi:10.1186/s40337-025-01328-5}.
\item Emory University (2025). \textit{The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05506982}{source link}.
\item Yang A, Lv X, Wang H, Wang X. (2025). \textit{Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00509}{doi:10.1021/acschemneuro.5c00509}.
\item Gillespie CM, Bering JM. (2025). \textit{Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2025.07.003}{doi:10.1016/j.jagp.2025.07.003}.
\item Cioe PA, Stang GS, Azam D, Dugal S. (2025). \textit{"I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13722-025-00563-0}{doi:10.1186/s13722-025-00563-0}.
\item Socoró-Garrigosa M, Perl YS, Kringelbach ML, Erritzoe D, Nutt DJ, Carhart-Harris R, Vohryzek J, Deco G. (2025). \textit{Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/nyas.15391}{doi:10.1111/nyas.15391}.
\item Ludbrook G, Bryson N, Taylor B, Hocevar-Trnka J, Johnson MW, Hirman J, Morrish G, Alexander R, Pollack M. (2025). \textit{Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000002047}{doi:10.1097/jcp.0000000000002047}.
\item Cherup NP, Finan PH. (2025). \textit{Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpain.2025.105507}{doi:10.1016/j.jpain.2025.105507}.
\item The University of Texas Health Science Center, Houston (2025). \textit{Acceptability \& Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06706232}{source link}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW. (2025). \textit{Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.18.664368}{doi:10.1101/2025.07.18.664368}.
\item Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL. (2025). \textit{The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.06.012}{doi:10.1016/j.neuron.2025.06.012}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI. (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Fernández-Borkel T, Borkel LF, Rojas-Hernández J, Hernández-Álvarez E, Quintana-Hernández DJ, Ponti LG, Henríquez-Hernández LA. (2025). \textit{The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00445}{doi:10.1021/acsptsci.5c00445}.
\item Cheung K, Propes C, Graziosi M, Patch K, Yaden DB. (2025). \textit{Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/23294515.2025.2526339}{doi:10.1080/23294515.2025.2526339}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Nadeem Z, Parker S, McGovern H, Sebben B, Oestreich LK. (2025). \textit{Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674251346679}{doi:10.1177/00048674251346679}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR. (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Lacey C. (2025). \textit{Equitable access to psilocybin-assisted psychotherapy in New Zealand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26635/6965.e1618}{doi:10.26635/6965.e1618}.
\item Cohen ZZ, Blest-Hopley G (2025). \textit{Females in Psychedelic Research: A Perspective for Advancing Research and Practice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00255}{doi:10.1021/acsptsci.5c00255}.
\item Swieczkowski D, Kwaśny A, Ciurkowska P, Pruc M, Szarpak L, Cubała WJ. (2025). \textit{Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251353250}{doi:10.1177/02698811251353250}.
\item Glenn DL, Choi SH, Zimmerman RS. (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Pereira Galdino T, Oliveira LC, Luz MA, Costa Barbosa R, Torres MCM, Sivieri K, Fernandes PA, Santos ML, Lima AGB, Silva SML, Fook MVL. (2025). \textit{Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.5c02751}{doi:10.1021/acsomega.5c02751}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL. (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Larsen JK, Kølbæk P, Østergaard SD. (2025). \textit{Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/08039488.2025.2529449}{doi:10.1080/08039488.2025.2529449}.
\item Muller S, Cavanna F, de la Fuente L, Bruno N, D'Amelio TA, Pallavicini C, Tagliazucchi E. (2025). \textit{Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-025-10206-8}{doi:10.1038/s41598-025-10206-8}.
\item Rajwani K, Almonte MT, Feroz F, Hokanson J, Jacobs E, Savulescu J, Singh I, Yaden DB, Earp BD. (2025). \textit{Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.24181.1}{doi:10.12688/wellcomeopenres.24181.1}.
\item Kato K, Kleinhenz JM, Shin YJ, Coarfa C, Zarrabi AJ, Hecker L. (2025). \textit{Psilocybin treatment extends cellular lifespan and improves survival of aged mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41514-025-00244-x}{doi:10.1038/s41514-025-00244-x}.
\item Zhang M, Zhai H, Yang L, Li H, Wang X, Wang X. (2025). \textit{The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00324}{doi:10.1021/acsptsci.5c00324}.
\item Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S. (2025). \textit{Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.healthpol.2025.105392}{doi:10.1016/j.healthpol.2025.105392}.
\item Szigeti B. (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/97cqx\_v1}{doi:10.31234/osf.io/97cqx\_v1}.
\item Jylkkä J, Väyrynen H, Lin E, Walldén C, Krabbe A, Kähönen J, Sikka P. (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: a qualitative-quantitative approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.concog.2025.103901}{doi:10.1016/j.concog.2025.103901}.
\item Unknown authors (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/97cqx\_v1}{source link}.
\item Gregory NS, Girard TE, Ram A, Casey AB, Malenka RC, Tawfik VL, Heifets BD. (2025). \textit{Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.06.663398}{doi:10.1101/2025.07.06.663398}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW. (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Ahmed KE, Abu Nasrieh D, Banihani HA, Obaidat MF, Mazzawi T, Al-Tarawneh AK, Bani Mustafa R, Al Kayed Z. (2025). \textit{Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2526403}{doi:10.1080/02791072.2025.2526403}.
\item Braekow P, Neumann J, Kirchhefer U, Gergs U. (2025). \textit{Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18071009}{doi:10.3390/ph18071009}.
\item Danda H, Mazochová K, Šíchová K, Mazoch V, Olejníková-Ladislavová L, Syrová K, Jurásek B, Cihlářová P, Jurok R, Páleníček T, Kuchař M. (2025). \textit{Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111439}{doi:10.1016/j.pnpbp.2025.111439}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Johnson-Groh M. (2025). \textit{Is There More to Magic Mushrooms than Psilocybin?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acscentsci.5c01146}{doi:10.1021/acscentsci.5c01146}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Pego AMF, Schoffner M, Sammeta VR, Naeem M, Manke DR, Chadeayne A, Glatfelter GC, Baumann MH, Concheiro-Guisán M. (2025). \textit{Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkaf045}{doi:10.1093/jat/bkaf045}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L. (2025). \textit{Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03066-1}{doi:10.1038/s41380-025-03066-1}.
\item Wu Y, Ran J, Mo J, Wang J. (2025). \textit{4-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.70063}{doi:10.1111/adb.70063}.
\item Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, Roseman L, Kettner H, Carhart-Harris R. (2025). \textit{Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/brb3.70660}{doi:10.1002/brb3.70660}.
\item Beneš M, Páleníček T, Horáček J. (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Stirn J, Klein CD. (2025). \textit{Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ardp.70022}{doi:10.1002/ardp.70022}.
\item Sofuoglu M, De Aquino JP, MacLean RR (2025). \textit{Psychedelic drugs for the treatment of substance use disorders.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2541103}{doi:10.1080/17512433.2025.2541103}.
\item Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC, Afonso VI, Fook MVL, Lima AGB, Silva SML, Torres MCM. (2025). \textit{Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18070989}{doi:10.3390/ph18070989}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J. (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Brown R, Hamilton NM, Mallon C, Stevenson J, Faley MT, Kargbo RB, Sherwood AM, Upeandran B. (2025). \textit{Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jlcr.4155}{doi:10.1002/jlcr.4155}.
\item Christen SE, Bekka E, Schmid Y, Benowitz NL, Liakoni E. (2025). \textit{Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.57187/s.4346}{doi:10.57187/s.4346}.
\item Islam S, Liden T, Goff R, Schug KA. (2025). \textit{Untargeted analysis of psilocybin and non-psilocybin mushrooms using liquid chromatography quadrupole time of flight mass spectrometry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609270047}{source link}.
\item Modlin NL, Jessica L MK, Sarang M, Siebenaler L, Maggio C, Pick S, Williamson V, Cleare A, Rucker J. (2025). \textit{Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5152/pcp.2025.24934}{doi:10.5152/pcp.2025.24934}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L. (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Brudner RM, Kaczmarek E, Blainey MG, Schulz-Quach C, Meshkat S, Doyle Z, Lipsitz O, Offman H, Sethi R, Weiglein G, McIntyre RS, Rosenblat JD. (2025). \textit{Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251346697}{doi:10.1177/02698811251346697}.
\item Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D. (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE. (2025). \textit{Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/curroncol32070380}{doi:10.3390/curroncol32070380}.
\item Luo W, Dai Q, van Beek TA, Zuilhof H, Chen B, Chen Z, Salentijn GI. (2025). \textit{Paper spray and direct mushroom spray mass spectrometry methods for the analysis of psycho-neurological disorder toxins.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.foodchem.2025.145369}{doi:10.1016/j.foodchem.2025.145369}.
\item Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ. (2025). \textit{A Scoping Review of Research in Naturalistic Studies with Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2520221}{doi:10.1080/02791072.2025.2520221}.
\item University of Minnesota (2025). \textit{Visual Surround Suppression and Perceptual Expectation Under Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04424225}{source link}.
\item Bayes A. (2025). \textit{Australia's psychedelic experiment: reflections from a psychiatrist clinical researcher.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10398562251347890}{doi:10.1177/10398562251347890}.
\item Stoliker D, Bernasconi F, Blanke O, Razi A. (2025). \textit{Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body Experiences}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.24.25330245}{doi:10.1101/2025.06.24.25330245}.
\item De Gasperi R, Perez Garcia G, Gama Sosa MA, Perez GM, Abutarboush R, Kawoos U, Hof PR, Zhu CW, Ahlers ST, Elder GA. (2025). \textit{Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fneur.2025.1594335}{doi:10.3389/fneur.2025.1594335}.
\item Kim A, Morato NM, Saha P, Eyimegwu PN, Niyaz AA, Huang R, Cooks RG, Phelan RM, Lewis JC. (2025). \textit{Selective Phosphorylation of Phenols and Benzenediols by the Kinase PsiK and Variants Thereof.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/anie.202503538}{doi:10.1002/anie.202503538}.
\item Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S. (2025). \textit{The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.86659}{doi:10.7759/cureus.86659}.
\item Vinarcsik L, Smoller C, Grossberg G. (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Koolen M, Wirsching A, Krediet E, van Elk M. (2025). \textit{Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2508156}{doi:10.1080/02791072.2025.2508156}.
\item Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T. (2025). \textit{The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.06.003}{doi:10.1016/j.euroneuro.2025.06.003}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Subramanian S, Reneau TR, Perry D, Chacko R, Laumann TO, Flavin K, Horan C, Schweiger J, Metcalf N, Lenze EJ, Snyder AZ, Dosenbach NUF, Nicol G, Siegel JS (2025). \textit{Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.}. Scientific data. [published; PubMed]. \href{https://doi.org/10.1038/s41597-025-05397-8}{doi:10.1038/s41597-025-05397-8}.
\item Greenway KT, Garel N, Dinh-Williams LL, Thibault Lévesque J, Kaelen M, Dagenais-Beaulé V, de la Salle S, Erritzoe D, Looper K, Turecki G, Rej S, Richard-Devantoy S. (2025). \textit{The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.2025.102}{doi:10.1192/bjp.2025.102}.
\item Zhang Y, Yang L, Zhang Q, Li C, Mao F, Zhuo C. (2025). \textit{The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03410-7}{doi:10.1038/s41398-025-03410-7}.
\item Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T. (2025). \textit{The phenomenology of psilocybin's experience mediates subsequent persistent psychological effects independently of sex, previous experience, or setting.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-025-00742-5}{doi:10.1007/s43440-025-00742-5}.
\item Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE. (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item COMPASS Pathways (2025). \textit{The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05312151}{source link}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2025). \textit{Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03428-x}{doi:10.1038/s41398-025-03428-x}.
\item Pepe M, Hesami M, Fleishmann L, Hsiang T, Jones AMP. (2025). \textit{Mycelium Growth and Development of Psilocybe spp. Mother Cultures on Agar-Based Media.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof11060450}{doi:10.3390/jof11060450}.
\item MycoMedica Life Sciences PBC (2025). \textit{A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06643637}{source link}.
\item Agin-Liebes G, Petridis P, Zeifman R, Link M, Cordova MJ, Bogenschutz M. (2025). \textit{Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f27jm\_v1}{doi:10.31234/osf.io/f27jm\_v1}.
\item University of California, San Francisco (2025). \textit{Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05317689}{source link}.
\item Unknown authors (2025). \textit{Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f27jm\_v1}{source link}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T. (2025). \textit{Psilocybin and hallucinogenic mushrooms - ERRATUM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852925100291}{doi:10.1017/s1092852925100291}.
\item Ellis S, Bostian C, Donnelly A, Feng W, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T. (2025). \textit{Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.119655}{doi:10.1016/j.jad.2025.119655}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J. (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item Beck SA, Barlow C, Engel L, Barratt MJ. (2025). \textit{"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.toxicon.2025.108450}{doi:10.1016/j.toxicon.2025.108450}.
\item Joshua Woolley, MD, PhD (2025). \textit{Psilocybin With Intracranial Neural Sensing}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06919640}{source link}.
\item Jylkkä J. (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ugr69\_v2}{doi:10.31234/osf.io/ugr69\_v2}.
\item Wall MB, Carhart-Harris RL. (2025). \textit{Human neuroimaging: fMRI.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.013}{doi:10.1016/bs.irn.2025.04.013}.
\item Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2025). \textit{Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2025.1580663}{doi:10.3389/fpsyg.2025.1580663}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A. (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Unknown authors (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ugr69\_v2}{source link}.
\item Matthew Hicks (2025). \textit{Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06372197}{source link}.
\item National University of Natural Medicine (2025). \textit{Optimizing Microdosing and Meditation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06560658}{source link}.
\item Won NY, Wang A, Athay R, Striley CW, Cottler LB. (2025). \textit{Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021-2023.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/10826084.2025.2511242}{doi:10.1080/10826084.2025.2511242}.
\item Subramanian S, Reneau TR, Perry D, Chacko R, Laumann TO, Flavin K, Horan C, Schweiger J, Metcalf N, Lenze EJ, Snyder AZ, Dosenbach NUF, Nicol G, Siegel JS. (2025). \textit{Psilocybin's acute and persistent brain effects: a precision imaging drug trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41597-025-05189-0}{doi:10.1038/s41597-025-05189-0}.
\item Ross BM. (2025). \textit{Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/frai.2025.1589086}{doi:10.3389/frai.2025.1589086}.
\item Zschoche N, Schober S, Walther K, Chadeayne AR, Gressler M, Bartram S, O'Connor SE, Hoffmeister D. (2025). \textit{Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202500167}{doi:10.1002/cbic.202500167}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H. (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Frautschi PC, Singh AP, Stowe NA, Grady SM, Zahid Z, Banks MI, Yu JJ. (2025). \textit{Effects of Psilocybin on Mouse Brain Microstructure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a8634}{doi:10.3174/ajnr.a8634}.
\item Blanton AM, Parikh P, Zhou S, Mohamed M, Ufret-Vincenty RL, Mancini R. (2025). \textit{Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajoc.2025.102359}{doi:10.1016/j.ajoc.2025.102359}.
\item Cali James (2025). \textit{In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assays}. Drug Metabolism and Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1016/j.dmpk.2025.101231}{doi:10.1016/j.dmpk.2025.101231}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06654-1}{doi:10.1007/s00213-024-06654-1}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Klim C, VanDreese B, Meyerhoefer T, Breitinger S (2025). \textit{Innovation and inequity in psychedelic research at the Mayo Clinic.}. History of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0957154x251318489}{doi:10.1177/0957154x251318489}.
\item Fonzo GA, Doss MK, Nemeroff CB. (2025). \textit{There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20250247}{doi:10.1176/appi.ajp.20250247}.
\item Erkizia-Santamaría I, Martínez-Álvarez N, Salinas-Novoa L, Meana JJ, Ortega JE. (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Slot J, Hoffmeister D. (2025). \textit{Psychedelic fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2025.02.026}{doi:10.1016/j.cub.2025.02.026}.
\item Agrawal M, Roddy K, Jenkins B, Leeks C, Emanuel E. (2025). \textit{Long-term benefits of single-dose psilocybin in depressed patients with cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.35889}{doi:10.1002/cncr.35889}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R. (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Biba B, O'Shea BA. (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2511750}{doi:10.1080/02791072.2025.2511750}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Yale University (2025). \textit{Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160284}{source link}.
\item Fitzgerald PB, Webb SL, Denning NC, Dowie T, Schweickle MM, Modak A, Chan G, Knight J, Waldron M, Gainsford K, Hawkes H, Zammit S, Sutanto NC, Fitzgibbon BM, Bailey NW. (2025). \textit{Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.05.28.25328532}{doi:10.1101/2025.05.28.25328532}.
\item Abboud A, Schiebrel C, Nahhas RW, Durkin S, Hua K, Redding H, Gainer D. (2025). \textit{Patients' Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2511752}{doi:10.1080/02791072.2025.2511752}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL. (2025). \textit{The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00208}{doi:10.1021/acsptsci.5c00208}.
\item University Hospital, Basel, Switzerland (2025). \textit{Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796361}{source link}.
\item Paracha N. (2025). \textit{Navigating Intentional and Attentional Practices for Healing Across Psychedelic and Biofield Settings: A Comparative Ethnographic Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jicm.2024.0713}{doi:10.1089/jicm.2024.0713}.
\item Vella Y, Syrová K, Petrušková A, Koutrouli I, Kútna V, Pala J, Šíchová K, Nikolič M, Mazoch V, Jurok R, Kuchař M, Bendová Z, Páleníček T. (2025). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251338232}{doi:10.1177/02698811251338232}.
\item Prostko S, Wu A, Maddams S, Szpak V, Rosenblum N, Hilt LM, Suzuki J. (2025). \textit{Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/adm.0000000000001517}{doi:10.1097/adm.0000000000001517}.
\item Menge J, Evitt B. (2025). \textit{Pharmacologic interventions for alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/01.jaa.0000000000000106}{doi:10.1097/01.jaa.0000000000000106}.
\item Rogers SA, Heller EA, Corder G. (2025). \textit{Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-025-01964-9}{doi:10.1038/s41593-025-01964-9}.
\item Wang Z, Robbins B, Zhuang R, van Bruggen R, Sandini T, Li XM, Zhang Y. (2025). \textit{Psilocybin mitigates behavioral despair and cognitive impairment in treatment-resistant depression model using wistar kyoto rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-025-03383-z}{doi:10.1038/s41598-025-03383-z}.
\item Peck SK, Brewerton TD, Fisher H, Trim J, Shao S, Modlin NL, Kim J, Finn DM, Kaye WH. (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Palmer C, Ferber AT, Greenwald BD. (2025). \textit{The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15060572}{doi:10.3390/brainsci15060572}.
\item Viña SM. (2025). \textit{Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0021}{doi:10.1089/psymed.2024.0021}.
\item Laabi S, LeMmon C, Vogel C, Chacon M, Jimenez VM. (2025). \textit{Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.intimp.2025.114940}{doi:10.1016/j.intimp.2025.114940}.
\item Andersen KAA, Holmøy B, Kvam TM, Johnson MW. (2025). \textit{Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2025.05.062}{doi:10.1016/j.jpsychires.2025.05.062}.
\item Johns Hopkins University (2025). \textit{Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01943994}{source link}.
\item Charles Raison (2025). \textit{An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512194}{source link}.
\item Vogt SB, Liechti ME. (2025). \textit{Clinical pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item Han C, Baek H, Lim JY, Kim E, Tran CK, Freeman E, Chen Z, Yoo SH, Burish MJ. (2025). \textit{Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s10194-025-02008-0}{doi:10.1186/s10194-025-02008-0}.
\item Dumenil M, Cordova G, El-Hage W. (2025). \textit{[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2025.02.007}{doi:10.1016/j.encep.2025.02.007}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v1}{doi:10.31234/osf.io/dczw2\_v1}.
\item Unknown authors (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v1}{source link}.
\item Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2025). \textit{Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116559}{doi:10.1016/j.psychres.2025.116559}.
\item Hellman M (2025). \textit{We need to talk about shrooms.}. Nordisk alkohol- \& narkotikatidskrift: NAT. [published; PubMed]. \href{https://doi.org/10.1177/14550725251341722}{doi:10.1177/14550725251341722}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item Gao JL, Wu XP, Zhou YL, Yu WJ, Fan YG. (2025). \textit{Additions to the Inocybe sect. Leptocybe (Agaricales) in China: new species from tropical rainforests, new geographical distributions, and toxin detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fmicb.2025.1540570}{doi:10.3389/fmicb.2025.1540570}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR. (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item McGriff SA, Hecker JC, Maitland AD, Partilla JS, Baumann MH, Glatfelter GC. (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C. (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6hjkm\_v1}{doi:10.31234/osf.io/6hjkm\_v1}.
\item University of Wisconsin, Madison (2025). \textit{Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05592379}{source link}.
\item Unknown authors (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6hjkm\_v1}{source link}.
\item Viña SM. (2025). \textit{The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare13101158}{doi:10.3390/healthcare13101158}.
\item Hooper JF, Gyongyosi EL, Hutchison KE, Mueller RL. (2025). \textit{Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2025.1533055}{doi:10.3389/fpsyg.2025.1533055}.
\item Zhai H, Wang H, Li H, Wang X. (2025). \textit{The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00234}{doi:10.1021/acsptsci.5c00234}.
\item Abrahms ZN, Sen AK, Jones JA. (2025). \textit{Pathway engineering for the biosynthesis of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.copbio.2025.103314}{doi:10.1016/j.copbio.2025.103314}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Morris R, Keeler J, Treasure J, Himmerich H. (2025). \textit{The pharmacological treatment of anxiety in people with eating disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2025.107782}{doi:10.1016/j.phrs.2025.107782}.
\item Yang L, Li H, Wang X, Wang X. (2025). \textit{Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic Horizons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12264-025-01415-2}{doi:10.1007/s12264-025-01415-2}.
\item Queen's University (2025). \textit{A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06969170}{source link}.
\item Muller S, Cavanna F, de la Fuente LA, Bruno N, D’Amelio TA, Pallavicini C, Tagliazucchi E. (2025). \textit{Psilocybin-induced modulation of visual salience processing}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.10.652897}{doi:10.1101/2025.05.10.652897}.
\item Estric C, Duron T, Kabani S, Lopez-Castroman J. (2025). \textit{Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251338214}{doi:10.1177/02698811251338214}.
\item Syed OA, Petranker R, Tsang B. (2025). \textit{The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106204}{doi:10.1016/j.neubiorev.2025.106204}.
\item Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD. (2025). \textit{Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116532}{doi:10.1016/j.psychres.2025.116532}.
\item Wang H, Wang X (2025). \textit{Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00247}{doi:10.1021/acschemneuro.5c00247}.
\item Jones G. (2025). \textit{Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0321461}{doi:10.1371/journal.pone.0321461}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2025). \textit{Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230751}{doi:10.1176/appi.ajp.20230751}.
\item Sharmin Ghaznavi (2025). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06247839}{source link}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B. (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ. (2025). \textit{The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.psychotherapy.20240025}{doi:10.1176/appi.psychotherapy.20240025}.
\item Neitzke-Spruill L, Beit CS, Robinson JO, Singh N, Kambala S, Ramesh R, McGuire AL. (2025). \textit{A landscape analysis of psychedelic retreat organizations advertising online.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0321648}{doi:10.1371/journal.pone.0321648}.
\item Vejmola Č, Šíchová K, Syrová K, Janečková L, Koudelka V, Tesař M, Nikolič M, Viktorinová M, Tylš F, Korčák J, Viktorin V, Kelemen E, Nekovářová T, Brunovský M, Horáček J, Kuchař M, Páleníček T. (2025). \textit{Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsgos.2025.100524}{doi:10.1016/j.bpsgos.2025.100524}.
\item de Lannoy Ines, Magomedova Lilia, Izhakova Julia, de Rivera Christina, Lanthier James, Atkinson Jason, Higgins Guy A., Slassi Malik, Araujo Joseph A. (2025). \textit{Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogs}. Journal of Pharmacological and Toxicological Methods. [published; Crossref]. \href{https://doi.org/10.1016/j.vascn.2025.107663}{doi:10.1016/j.vascn.2025.107663}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Bezo A, Piolino P, Benyamina A (2025). \textit{The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106086}{doi:10.1016/j.neubiorev.2025.106086}.
\item Fuini E, Chang A, Ortiz RJ, Nasseef T, Edwards J, Latta M, Gonzalez E, Woodward TJ, Axe B, Maheswari A, Cavallaro N, Bradshaw HB, Kulkarni PP, Ferris CF. (2025). \textit{Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2025.1554049}{doi:10.3389/fnins.2025.1554049}.
\item Weintraub MJ, Miklowitz DJ, Jeffrey JK. (2025). \textit{Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000853}{doi:10.1097/pra.0000000000000853}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Lazar M, Brownstien M, Botvinnik A, Shevakh C, Shahar O, Lifschytz T, Lerer B. (2025). \textit{Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyaf022}{doi:10.1093/ijnp/pyaf022}.
\item Islam S, Liden T, Goff R, Schug KA. (2025). \textit{Untargeted analysis of psilocybin and non-psilocybin mushrooms using liquid chromatography quadrupole time of flight mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.chroma.2025.466009}{doi:10.1016/j.chroma.2025.466009}.
\item Wang Y, Li T, Reynolds E, Wang Z, Torrens-Spence M, Weng J. (2025). \textit{Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6329392/v1}{doi:10.21203/rs.3.rs-6329392/v1}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L. (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Centre for Addiction and Mental Health (2025). \textit{Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06518720}{source link}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2025). \textit{Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2495937}{doi:10.1080/02791072.2025.2495937}.
\item Metastasio A, Prevete E, Venturini S, Garofalo A, Cecconello B, De Pisapia N, Corazza O. (2025). \textit{The phenomenology of psilocybin: transformative insights for research and clinical practice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2025.1455902}{doi:10.3389/fpsyg.2025.1455902}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2025). \textit{Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00912174251337572}{doi:10.1177/00912174251337572}.
\item Williams ML, Rudin D, Schmid Y, von Salm J. (2025). \textit{Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1600812}{doi:10.3389/fpsyt.2025.1600812}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD. (2025). \textit{5-HT2A receptors: Pharmacology and functional selectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2025). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.2}{doi:10.12688/wellcomeopenres.22543.2}.
\item Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD. (2025). \textit{Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152500032x}{doi:10.1017/s147895152500032x}.
\item Cohen J, Sulimani L, Procaccia S, Lerenthal Y, Milay L, Taran I, Shapira A, Meiri D. (2025). \textit{Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-025-97710-z}{doi:10.1038/s41598-025-97710-z}.
\item Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D. (2025). \textit{Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-025-02091-6}{doi:10.1038/s41386-025-02091-6}.
\item Rockhill KM, Black JC, Ladka MS, Sumbundu KB, Olsen HA, Jewell JS, Hunt J, Wolf RC, Nerurkar K, Dart RC, Monte AA. (2025). \textit{The Rise of Psilocybin Use in the United States: A Multisource Observational Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7326/annals-24-03145}{doi:10.7326/annals-24-03145}.
\item Godfrey K, Luan LX, Timmermann C. (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item DuPont CM, Johnson MW. (2025). \textit{Psychedelics and substance use disorder treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.03.005}{doi:10.1016/bs.irn.2025.03.005}.
\item Thaoboonruang N, Lohitnavy O, Ya K, Lohitnavy M. (2025). \textit{Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-025-98202-w}{doi:10.1038/s41598-025-98202-w}.
\item Schäfer T, Sherwood A, Kirkland T, Krüger T, Worbs J, Kniemeyer O, Gressler M, Hoffmeister D. (2025). \textit{In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.202501037}{doi:10.1002/chem.202501037}.
\item Mimms C, Sotelo K, Khaliq AS. (2025). \textit{Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.82532}{doi:10.7759/cureus.82532}.
\item Dorval M, Chang SL, Farzin H, Nguyen O, Stephan JF, Tapp D, Deschamps P, Joly Y, Moureaux F, Foxman R, Masse-Grenier M, Fallu JS, Fallu JS, P3A Research Group. (2025). \textit{Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/pmr.2024.0108}{doi:10.1089/pmr.2024.0108}.
\item Pałasz A, Pukowiec M, Bogus K, Suszka-Świtek A, Filipczyk Ł, Mordecka-Chamera K, Worthington JJ, Sygidus M, Wojtas A, Bysiek A, Gołembiowska K. (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Keller MR, McKinney MG, Sen AK, Guagliardo FG, Hellwarth EB, Islam KN, Kaplan NA, Gibbons WJ, Kemmerly GE, Meers C, Wang X, Jones JA. (2025). \textit{Psilocybin biosynthesis enhancement through gene source optimization.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ymben.2025.04.003}{doi:10.1016/j.ymben.2025.04.003}.
\item Seillier L, Čechová B, Seillier A, Šlamberová R. (2025). \textit{Psilocybin has a narrow therapeutic window as an antidepressant treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111368}{doi:10.1016/j.pnpbp.2025.111368}.
\item Beesley VL, Kennedy TJ, Maccallum F, Ross M, Harvey R, Rossell SL, Sarris J, Perkins D, Neale RE, Bennett-Levy J, Johnson S, Beebe H, Roset N, Strobel J, Parker S. (2025). \textit{Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2024-095992}{doi:10.1136/bmjopen-2024-095992}.
\item Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V. (2025). \textit{Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106163}{doi:10.1016/j.neubiorev.2025.106163}.
\item Afrooghe A, Ahmadi E, Lesani A, Mehranjani MS, Elahi M, Babaei M, Shayan M, Shafaroodi H, Jafari RM, Foroumadi A, Manavi MA, Dehpour AR. (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item Felix Mueller (2025). \textit{The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05570708}{source link}.
\item Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM. (2025). \textit{Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647757}{doi:10.1101/2025.04.08.647757}.
\item Novelli L, Stoliker D, Barta T, Greaves MD, Chopra S, Jackson J, Kwee J, Williams ML, Razi A. (2025). \textit{PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.11.643415}{doi:10.1101/2025.04.11.643415}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05695495}{source link}.
\item Turizo Smith AD, Botero Jsramillo N, Berrio Cuartas DM. (2025). \textit{Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202504.0888.v1}{doi:10.20944/preprints202504.0888.v1}.
\item Ardini M, Angelucci F, Rea F, Paluzzi L, Gabriele F, Palerma M, Di Leandro L, Ippoliti R, Pitari G. (2025). \textit{Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13062-025-00632-z}{doi:10.1186/s13062-025-00632-z}.
\item Kargbo RB. (2025). \textit{Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00182}{doi:10.1021/acsmedchemlett.5c00182}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH. (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item University of Otago (2025). \textit{Psilocybin-assisted Interpersonal Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05581797}{source link}.
\item Omidian H, Omidian A. (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Lu OD, White K, Raymond K, Liu C, Klein AS, Green N, Vaillancourt S, Gallagher A, Shindy L, Li A, Wallquist K, Li R, Zou M, Casey AB, Cameron LP, Pomrenze MB, Sohal V, Kheirbek MA, Gomez AM, Lammel S, Heifets BD, Malenka R. (2025). \textit{A multi-institutional investigation of psilocybin’s effects on mouse behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647810}{doi:10.1101/2025.04.08.647810}.
\item Bradley ER, Sakai K, Fernandes-Osterhold G, Szigeti B, Ludwig C, Ostrem JL, Tanner CM, Bock MA, Llerena K, Finley PR, O'Donovan A, Zuzuarregui JRP, Busby Z, McKernan A, Penn AD, Wang ACC, Rosen RC, Woolley JD. (2025). \textit{Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-025-02097-0}{doi:10.1038/s41386-025-02097-0}.
\item Ammineni D, Park R. (2025). \textit{The compulsive eating paradigm: can psychedelics help in treating obesity?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01186-7}{doi:10.1186/s40337-024-01186-7}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2025). \textit{Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03005-0}{doi:10.1038/s41380-025-03005-0}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.03.002}{doi:10.1016/bs.irn.2025.03.002}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D. (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC. (2025). \textit{Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41586-025-08813-6}{doi:10.1038/s41586-025-08813-6}.
\item Unknown authors (2025). \textit{Psilocybin mushrooms (“Magic Mushrooms”)}. Organization of Teratology Information Specialists (OTIS), Brentwood (TN). [published; Europe PMC]. \href{https://europepmc.org/article/MED/35952083}{source link}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001113}{doi:10.1097/njh.0000000000001113}.
\item Balabandian M, Manavi MA, Lesani A, Mohammad Jafari R, Shafaroodi H, Heidari N, Mirnajafi-Zadeh J, Foroumadi A, Afrooghe A, Dehpour AR. (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Matsukubo J, Dickson S, Xiao J, Friesen EL, Solmi M, Fiedorowicz JG, Fischer B, Myran DT. (2025). \textit{Psilocybin Dispensaries and Online Health Claims in Canada.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.2853}{doi:10.1001/jamanetworkopen.2025.2853}.
\item Hutson PR. (2025). \textit{Psilocybin Dispensaries and Advertising-Buyer Beware.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.2858}{doi:10.1001/jamanetworkopen.2025.2858}.
\item Huang Z, Yao Y, Di R, Zhang J, Pan Y, Liu G. (2025). \textit{De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1751-7915.70135}{doi:10.1111/1751-7915.70135}.
\item Penzenstadler L, Baudois S, Lingenberg A, Catalano Chiuvé S, Tomkova E, Fleury V. (2025). \textit{[Treatment with psychedelics: potential benefits in Parkinson's disease].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.53738/revmed.2025.21.915.47180}{doi:10.53738/revmed.2025.21.915.47180}.
\item Majić T, Schmidt TT, Gröticke A, Gasser P, Richards WA, Riemer TG, Evens R. (2025). \textit{The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251326937}{doi:10.1177/02698811251326937}.
\item Keenan R, Haque R, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds S, Foldi C, Cowley M. (2025). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6225000/v1}{doi:10.21203/rs.3.rs-6225000/v1}.
\item Thomson S, Thomacos N. (2025). \textit{Utilizing Psychedelics to Enhance Well-Being: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2484380}{doi:10.1080/02791072.2025.2484380}.
\item Reiche S, Hirschfeld T, Gröticke AL, Traub M, Hafiz NJ, Haas R, Sedlaczek L, Ortlieb L, Leistenschneider G, Basedow LA, Lohse A, Bermpohl F, Riemer TG, Majić T. (2025). \textit{Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111353}{doi:10.1016/j.pnpbp.2025.111353}.
\item Unity Health Toronto (2025). \textit{Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731335}{source link}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK. (2025). \textit{Do undergraduates' views of psychedelics relate to the context for psychedelic use?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20503245241308747}{doi:10.1177/20503245241308747}.
\item Turkia M. (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/mzkyv\_v1}{doi:10.31234/osf.io/mzkyv\_v1}.
\item University Hospital, Basel, Switzerland (2025). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899334}{source link}.
\item Unknown authors (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mzkyv\_v1}{source link}.
\item Bysiek A, Wojtas A, Szpręgiel I, Wawrzczak-Bargieła A, Maćkowiak M, Gołembiowska K. (2025). \textit{The effect of low-dose psilocybin on brain neurotransmission and rat behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111347}{doi:10.1016/j.pnpbp.2025.111347}.
\item Bires J. (2025). \textit{Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/07347332.2025.2482917}{doi:10.1080/07347332.2025.2482917}.
\item Silverstein BH, Kolbman N, Nelson A, Liu T, Guzzo P, Gilligan J, Lee U, Mashour GA, Vanini G, Pal D. (2025). \textit{Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03308-4}{doi:10.1038/s41398-025-03308-4}.
\item Meshkat S, Al-Shamali H, Perivolaris A, Tullu T, Zeifman RJ, Zhang Y, Burback L, Winkler O, Greenshaw A, Husain MI, C Reichelt A, Vermetten E, Jha MK, Jetly R, Loebenberg R, Bhat V. (2025). \textit{Pharmacokinetics of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/pharmaceutics17040411}{doi:10.3390/pharmaceutics17040411}.
\item Chisamore N, Kaczmarek ES, Doyle Z, Johnson DE, Weiglein G, Meshkat S, Brudner RM, Blainey MG, Riva-Cambrin J, McIntyre RS, Rosenblat JD. (2025). \textit{Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/07067437251328316}{doi:10.1177/07067437251328316}.
\item Jerotic S. (2025). \textit{Is there room for ethics of authenticity in psilocybin research?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105519}{doi:10.1016/j.nsa.2025.105519}.
\item Ghaznavi S, Richter SG. (2025). \textit{Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-025-02172-2}{doi:10.1007/s40265-025-02172-2}.
\item Serretti A. (2025). \textit{Anhedonia: Current and future treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item Robinson GI, Gerasymchuk M, Zanikov T, Gojani EG, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cruz C, Cameron M, Zahoruiko Y, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I. (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Meng C, Guo W, Xiao C, Wen Y, Zhu X, Zhang Q, Liang Y, Li H, Xu S, Qiu Y, Chen H, Lin WJ, Wu B. (2025). \textit{Structural basis for psilocybin biosynthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-025-58239-x}{doi:10.1038/s41467-025-58239-x}.
\item Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T. (2025). \textit{The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.03.17.25324123}{doi:10.1101/2025.03.17.25324123}.
\item Portes MAM, Werle I, Bertoglio LJ. (2025). \textit{Is there a place for psychedelics in sports practice?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.13}{doi:10.1017/neu.2025.13}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY. (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Eklund J, Bremberg U, Larsson J, Torkelsson E, Wennerberg J, Zandelin S, Odell LR. (2025). \textit{Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jmedchem.4c02612}{doi:10.1021/acs.jmedchem.4c02612}.
\item Rockhill KM, Black JC, Iwanicki J, Abraham A. (2025). \textit{Polysubstance Use Profiles Among the General Adult Population, United States, 2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2105/ajph.2024.307979}{doi:10.2105/ajph.2024.307979}.
\item McMaster University (2025). \textit{An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06225232}{source link}.
\item Insel Gruppe AG, University Hospital Bern (2025). \textit{Molecular Imaging Study of Harmine/DMT: a Basic Research Approach}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06252506}{source link}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Psilocybin in Alcohol Use Disorder With Comorbid Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06235411}{source link}.
\item Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Geller J, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF. (2025). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpain.2025.1527783}{doi:10.3389/fpain.2025.1527783}.
\item University of Washington (2025). \textit{A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05163496}{source link}.
\item Harari R, Getselter D, Elliott E. (2025). \textit{The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13041-025-01191-0}{doi:10.1186/s13041-025-01191-0}.
\item Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L. (2025). \textit{Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111333}{doi:10.1016/j.pnpbp.2025.111333}.
\item Dino F. (2025). \textit{A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.80707}{doi:10.7759/cureus.80707}.
\item Koseli E, Buzzi B, Honaker T, Rakholia Y, Lewis M, Gaines-Smith M, Jaster AM, Gonzalez-Maeso J, Damaj MI. (2025). \textit{IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2025.107699}{doi:10.1016/j.phrs.2025.107699}.
\item Bobak L, Dorney I, Kovacevich A, Barnett BS. (2025). \textit{Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2478097}{doi:10.1080/02791072.2025.2478097}.
\item Rieser NM, Bitar R, Halm S, Rossgoderer C, Gubser LP, Thévenaz M, Kreis Y, von Rotz R, Nordt C, Visentini M, Moujaes F, Engeli EJE, Ort A, Seifritz E, Vollenweider FX, Herdener M, Preller KH. (2025). \textit{Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2025.103149}{doi:10.1016/j.eclinm.2025.103149}.
\item Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2025). \textit{Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00302744}{source link}.
\item Bjurenfalk Z, Cosmo A, Simonsson O, Ran C. (2025). \textit{Lifetime classic psychedelic use and headaches: A cross-sectional study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251324372}{doi:10.1177/02698811251324372}.
\item Kangaslampi S, Lietz MP. (2025). \textit{Psychedelics and autobiographical memory - Six open questions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/su7ch\_v2}{doi:10.31234/osf.io/su7ch\_v2}.
\item Stoliker D, Novelli L, Khajehnejad M, Biabani M, Greaves MD, Barta T, Williams M, Chopra S, Bazin O, Simonsson O, Chambers R, Barrett F, Deco G, Preller KH, Carhart-Harris R, Seth A, Sundram S, Egan GF, Razi A. (2025). \textit{Psychedelics Align Brain Activity with Context}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.09.642197}{doi:10.1101/2025.03.09.642197}.
\item Song C, Chang T, Buchborn T, Knöpfel T. (2025). \textit{Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibition}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.10.642385}{doi:10.1101/2025.03.10.642385}.
\item Unknown authors (2025). \textit{Psychedelics and autobiographical memory - Six open questions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/su7ch\_v2}{source link}.
\item Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M. (2025). \textit{Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.05.641592}{doi:10.1101/2025.03.05.641592}.
\item Cardone P, Núñez P, Alnagger NLN, Martial C, van der Lande GJM, Sandell R, Carhart-Harris R, Gosseries O. (2025). \textit{Psilocybin for disorders of consciousness: A case-report study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.clinph.2025.02.264}{doi:10.1016/j.clinph.2025.02.264}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A. (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Biba B, O'Shea B. (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6xgu8\_v2}{doi:10.31234/osf.io/6xgu8\_v2}.
\item Galdino TP, Oliveira LC, Luz MA, Jesus RA, Lima EPN, Torres MCM, Sivieri K, Afonso VI, Delgado JMPQ, Lima AGB, Silva SML, Fook MVL. (2025). \textit{Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18030380}{doi:10.3390/ph18030380}.
\item Hu S, Lin C, Wang H, Wang X. (2025). \textit{Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00094}{doi:10.1021/acsptsci.5c00094}.
\item Unknown authors (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6xgu8\_v2}{source link}.
\item Modzelewski S, Stankiewicz A, Waszkiewicz N, Łukasiewicz K. (2025). \textit{Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110402}{doi:10.1016/j.neuropharm.2025.110402}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05523401}{source link}.
\item Aicher HD, Müller F, Gasser P. (2025). \textit{Further education in psychedelic-assisted therapy - experiences from Switzerland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-025-06871-y}{doi:10.1186/s12909-025-06871-y}.
\item Yalovitser J, Levine J, Zweber C, Tien L, Stultz M, Mitchell H, Cote E, MacLean CD. (2025). \textit{Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2474246}{doi:10.1080/02791072.2025.2474246}.
\item Al-Imam A, Lora R, Motyka MA, Marletta E, Vezzaro M, Moczko J, Younus M, Michalak M. (2025). \textit{Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40264-025-01530-z}{doi:10.1007/s40264-025-01530-z}.
\item Barnett BS, Mauney EE, King F. (2025). \textit{Psychedelic-assisted therapy: An overview for the internist.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3949/ccjm.92a.24032}{doi:10.3949/ccjm.92a.24032}.
\item Kepner W, Yang KH, Dionicio P, Bailey K, Satybaldiyeva N, Moore A, Han BH, Palamar JJ. (2025). \textit{Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2474243}{doi:10.1080/02791072.2025.2474243}.
\item Goodwin GM, Nowakowska A, Atli M, Dunlop BW, Feifel D, Hellerstein DJ, Marwood L, Shabir Z, Mistry S, Stansfield SC, Teoh E, Tsai J, Young MB, Malievskaia E. (2025). \textit{Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.24m15449}{doi:10.4088/jcp.24m15449}.
\item Dutcher EG, Krystal AD. (2025). \textit{Treatment Expectancies and Psilocybin vs Escitalopram for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.4387}{doi:10.1001/jamapsychiatry.2024.4387}.
\item Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. (2025). \textit{Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-025-01487-3}{doi:10.1007/s40262-025-01487-3}.
\item Petrušková A, Guhathakurta D, Akdaş EY, Perelló-Amorós B, Frischknecht R, Weiss EM, Páleníček T, Fejtová A. (2025). \textit{Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.70020}{doi:10.1111/jnc.70020}.
\item Kovacevich A, Dorney I, Bobak L, Kaelber DC, Barnett BS. (2025). \textit{Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2474239}{doi:10.1080/02791072.2025.2474239}.
\item Somers M, Scheepers FE. (2025). \textit{Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20240121}{doi:10.1176/appi.ajp.20240121}.
\item Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB. (2025). \textit{Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cam4.70586}{doi:10.1002/cam4.70586}.
\item Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H. (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/26tz7\_v1}{doi:10.31234/osf.io/26tz7\_v1}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v3}{doi:10.31234/osf.io/93x5h\_v3}.
\item Unknown authors (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/26tz7\_v1}{source link}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v2}{doi:10.31234/osf.io/93x5h\_v2}.
\item Unknown authors (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/93x5h\_v3}{source link}.
\item Perna J, Trop J, Palitsky R, Bosshardt Z, Vantine H, Dunlop BW, Zarrabi AJ. (2025). \textit{Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-024-06303-z}{doi:10.1186/s12888-024-06303-z}.
\item Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A. (2025). \textit{Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251319457}{doi:10.1177/02698811251319457}.
\item Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME. (2025). \textit{Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.3618}{doi:10.1002/cpt.3618}.
\item Gold ND, Pagni BA, Petridis PD, Bogenschutz MP. (2025). \textit{Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0030}{doi:10.1089/psymed.2024.0030}.
\item Modlin NL, McPhee T, Zazon N, Sarang M, Hignett R, Pick S, Cleare A, Williamson V, Rucker J. (2025). \textit{Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0027}{doi:10.1089/psymed.2024.0027}.
\item Meshkat S, Kaczmarek E, Doyle Z, Brudner RM, Gomes FA, Blainey MG, Weiglein G, McIntyre RS, Mansur RB, Rosenblat JD. (2025). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0032}{doi:10.1089/psymed.2024.0032}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME. (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P. (2025). \textit{A review of psychedelics trials completed in depression, informed by European regulatory perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105516}{doi:10.1016/j.nsa.2025.105516}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2025). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0271678x251323364}{doi:10.1177/0271678x251323364}.
\item Hitchins K, Reynolds J. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/48yg7\_v2}{doi:10.31234/osf.io/48yg7\_v2}.
\item Unknown authors (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/48yg7\_v2}{source link}.
\item Hitchins K, Reynolds J. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/48yg7\_v1}{doi:10.31234/osf.io/48yg7\_v1}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A. (2025). \textit{Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111300}{doi:10.1016/j.pnpbp.2025.111300}.
\item Yasmo Perez JP, Chegwin Angarita C, Saldarriaga Ochoa OD, Urrego Restrepo SA. (2025). \textit{Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2025.127777}{doi:10.1016/j.talanta.2025.127777}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V. (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Correia MS, Gonzaga MJ, Temple C, Gerona RR. (2025). \textit{Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15563650.2025.2450240}{doi:10.1080/15563650.2025.2450240}.
\item Savickaitė E, Laubner-Sakalauskienė G. (2025). \textit{Emerging Risks of Amanita Muscaria: Case Reports on Increasing Consumption and Health Risks.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15388/amed.2025.32.1.23}{doi:10.15388/amed.2025.32.1.23}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D. (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Mauney E, King F, Burton-Murray H, Kuo B. (2025). \textit{Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/mcg.0000000000002149}{doi:10.1097/mcg.0000000000002149}.
\item Ahuja S, Zaher F, Palaniyappan L. (2025). \textit{Quantitative natural language processing markers of psychoactive drug effects: A pre-registered systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251319455}{doi:10.1177/02698811251319455}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Adamczyk S, Paczyńska M, Ruban A, Szczypiński J, Bola M, Orłowski P. (2025). \textit{Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2464797}{doi:10.1080/02791072.2025.2464797}.
\item Aboharb F, Davoudian PA, Shao LX, Liao C, Rzepka GN, Wojtasiewicz C, Indajang J, Dibbs M, Rondeau J, Sherwood AM, Kaye AP, Kwan AC. (2025). \textit{Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-025-56850-6}{doi:10.1038/s41467-025-56850-6}.
\item Hartter N, Däumichen M, Schmidt C, Wolff M, Gründer G, Jungaberle H. (2025). \textit{[Acceptance of psilocybin-assisted therapy in German-speaking countries].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-024-01792-5}{doi:10.1007/s00115-024-01792-5}.
\item Glynos NG, Baker A, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P. (2025). \textit{Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20494637251319497}{doi:10.1177/20494637251319497}.
\item Unknown authors (2025). \textit{CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.r111}{doi:10.1136/bmj.r111}.
\item Wang X, Lin C, Wang X. (2025). \textit{Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00034}{doi:10.1021/acsptsci.5c00034}.
\item Aqil M, de Hollander G, Vreugdenhil N, Knapen T, Dumoulin SO. (2025). \textit{Psilocybin alters visual contextual computations}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.06.636848}{doi:10.1101/2025.02.06.636848}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson MW, Lowe MX, Jackson H, Garcia-Romeu A. (2025). \textit{Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2461997}{doi:10.1080/02791072.2025.2461997}.
\item Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL. (2025). \textit{A qualitative analysis of the psychedelic mushroom come-up and come-down.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s44184-024-00095-6}{doi:10.1038/s44184-024-00095-6}.
\item Fuini E, Chang A, Ortiz RJ, Nasseef T, Edwards J, Latta M, Gonzalez E, Woodward TJ, Bradshaw HB, Axe B, Maheswari A, Cavallaro N, Kulkarni PP, Ferris CF. (2025). \textit{Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.01.636078}{doi:10.1101/2025.02.01.636078}.
\item Lucido MJ, Dunlop BW. (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T. (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF. (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ. (2025). \textit{Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.24m15521}{doi:10.4088/jcp.24m15521}.
\item de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL. (2025). \textit{Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2025.2460674}{doi:10.1080/17460441.2025.2460674}.
\item Rosales CA, Lepinsky NA, Gebeyehu W, Wasslen KV, Colquhoun F, Warnes BB, Chihabi J, Manthorpe JM, Smith JC. (2025). \textit{Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jasms.4c00382}{doi:10.1021/jasms.4c00382}.
\item Fleury V, Tomkova E, Catalano Chiuvé S, Penzenstadler L. (2025). \textit{Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/1877718x241312604}{doi:10.1177/1877718x241312604}.
\item Unknown authors (2025). \textit{PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814968}{source link}.
\item Unknown authors (2025). \textit{ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815219}{source link}.
\item Unknown authors (2025). \textit{BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815225}{source link}.
\item Unknown authors (2025). \textit{ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814992}{source link}.
\item Unknown authors (2025). \textit{EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814656}{source link}.
\item Bogenschutz MP (2025). \textit{A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16647}{doi:10.1111/add.16647}.
\item Kilmer B (2025). \textit{How psychedelics legalization debates could differ from cannabis.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16644}{doi:10.1111/add.16644}.
\item Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G (2025). \textit{Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2024.2445016}{doi:10.1080/14737175.2024.2445016}.
\item Louie E, Towers E, Morse AR, Watt J, Bryant Z, Haber P, Morley K. (2025). \textit{The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/inm.70010}{doi:10.1111/inm.70010}.
\item Shaughnessy AF. (2025). \textit{Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/39964936}{source link}.
\item Mori-Kreiner A, Aggarwal A, Bordoloi M. (2025). \textit{Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.64719/pb.4525}{doi:10.64719/pb.4525}.
\item Noback M, Kenton JA, Klein AK, Hughes ZA, Kruegel AC, Schmid Y, Halberstadt AL, Young JW. (2025). \textit{Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110334}{doi:10.1016/j.neuropharm.2025.110334}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS. (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J. (2025). \textit{Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.16762}{doi:10.1111/add.16762}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D. (2025). \textit{Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.c209}{doi:10.7759/cureus.c209}.
\item Cuttler C, Stueber A, Simone J, Mayo LM. (2025). \textit{Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2452226}{doi:10.1080/02791072.2025.2452226}.
\item Zeifman RJ, Spriggs MJ, Kettner H, Lyons T, Rosas FE, Mediano PAM, Erritzoe D, Carhart-Harris RL. (2025). \textit{From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-023-28111-3}{doi:10.1038/s41598-023-28111-3}.
\item Luoma JB, Hoffman K, Wilson-Poe AR, Levander XA, Bazinet A, Cook RR, McCarty D, Pertl K, Bielavitz S, Gregoire D, Wolf RC, Des Jarlais DC, Harrison HV, Stauffer CS, Korthuis PT. (2025). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2454474}{doi:10.1080/02791072.2025.2454474}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D. (2025). \textit{Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Kinderlehrer DA. (2025). \textit{Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s500337}{doi:10.2147/ndt.s500337}.
\item Kargbo RB. (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Müller F, Sauer T, Hänny C, Mühlhauser M, Lang UE. (2025). \textit{Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116381}{doi:10.1016/j.psychres.2025.116381}.
\item Kurzbaum E, Páleníček T, Shrchaton A, Azerrad S, Dekel Y. (2025). \textit{Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof11020099}{doi:10.3390/jof11020099}.
\item Gattuso JJ, Wilson C, Li S, Hannan AJ, Renoir T. (2025). \textit{Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejphar.2025.177304}{doi:10.1016/j.ejphar.2025.177304}.
\item Viohl N, Hakami Zanjani AA, Khandelia H. (2025). \textit{Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqα.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1873-3468.15099}{doi:10.1002/1873-3468.15099}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S. (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Ganguly A, James M, Alici Y (2025). \textit{When death is desired: A case of MAiD \& the CL psychiatrist.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951524002037}{doi:10.1017/s1478951524002037}.
\item Central Institute of Mental Health, Mannheim (2025). \textit{A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04670081}{source link}.
\item Liebnau J, Betzler F, Kerber A. (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M. (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Meshkat S, J Zeifman R, Stewart K, Janssen-Aguilar R, Lou W, Jetly R, Monson CM, Bhat V. (2025). \textit{Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0313741}{doi:10.1371/journal.pone.0313741}.
\item Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A. (2025). \textit{Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-med-050423-095712}{doi:10.1146/annurev-med-050423-095712}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA. (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC (2025). \textit{Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16767}{doi:10.1111/add.16767}.
\item Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. (2025). \textit{Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-024-01454-4}{doi:10.1007/s40262-024-01454-4}.
\item Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M. (2025). \textit{Age- and estrous-dependent effects of psilocybin in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.10.632408}{doi:10.1101/2025.01.10.632408}.
\item Palitsky R, Maples-Keller JL, Peacock C, Dunlop BW, Mletzko T, Grant GH, Raison CL, Chao S, Shub I, Mendelbaum-Kweller M, Smolyar L, Kaplan DM, Rothbaum BO, Zarrabi AJ. (2025). \textit{A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/pst0000551}{doi:10.1037/pst0000551}.
\item Destoop M, Mohr P, Butlen F, Kéri P, Samochowiec J, De Picker L, Fiorillo A, Kuypers KPC, Dom G. (2025). \textit{Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/j.eurpsy.2024.1806}{doi:10.1192/j.eurpsy.2024.1806}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM. (2025). \textit{Social pain: A systematic review on interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J. (2025). \textit{A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116359}{doi:10.1016/j.psychres.2025.116359}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Espi Forcen F. (2025). \textit{A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2449918}{doi:10.1080/02791072.2025.2449918}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J. (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Han XX, Phurbu D, Cao B, Li JX, Zhu XY, Liu LH, Thongklang N, Hyde KD, Zhao RL. (2025). \textit{Molecular Phylogeny and Morphology Reveal Four New Species of Conocybe (Bolbitiaceae, Agaricales) from the Qinghai-Xizang Plateau, China.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof11010045}{doi:10.3390/jof11010045}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA. (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Irrmischer M, Puxty D, Yıldırım BO, Deijen JB, Engelbregt H. (2025). \textit{Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06733-3}{doi:10.1007/s00213-024-06733-3}.
\item Cook SG, Lee S, Ference E, Shi Y, Rojas-Carvajal M, Hen R, Bains JS, Füzesi T, Turi GF. (2025). \textit{Psilocybin induces sex- and context-specific recruitment of the stress axis}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.06.631556}{doi:10.1101/2025.01.06.631556}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE. (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Sutherland I, Ho MF, Croarkin PE. (2025). \textit{Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/cap.2024.0082}{doi:10.1089/cap.2024.0082}.
\item Liao C, O’Farrell E, Weiner AM, Qalieh Y, Savalia NK, Girgenti MJ, Kwan KY, Kwan AC. (2025). \textit{Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.04.631335}{doi:10.1101/2025.01.04.631335}.
\item Wang Z, Robbins B, Zhuang R, Sandini T, van Bruggen R, Li XM, Zhang Y. (2025). \textit{Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111243}{doi:10.1016/j.pnpbp.2024.111243}.
\item Chen J, Wang Z, Yong CY, Goh EML, Moy HY, Chan ECY. (2025). \textit{Elucidating the Phase I metabolism of psilocin in vitro.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-024-03952-7}{doi:10.1007/s00204-024-03952-7}.
\item Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G. (2025). \textit{Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.01.631011}{doi:10.1101/2025.01.01.631011}.
\item Tuğcan MO, Akpınar AA. (2025). \textit{Mushroom poisoning: An updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Joshua Woolley, MD, PhD (2024). \textit{Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04932434}{source link}.
\item Hadley M, Halliday A, Stone JM (2024). \textit{Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2287081}{doi:10.1080/02791072.2023.2287081}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2024). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Katragunta K, Avula B, Chittiboyina AG, Lata H, Khan IA. (2024). \textit{Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1615/intjmedmushrooms.2024056373}{doi:10.1615/intjmedmushrooms.2024056373}.
\item Kirlić N, Lennard-Jones M, Atli M, Malievskaia E, Modlin NL, Peck SK, Gaillard A, Goodwin GM, Koelpin D. (2024). \textit{Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230884}{doi:10.1176/appi.ajp.20230884}.
\item O'Donnell KC, Grigsby J, Grob CS (2024). \textit{Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230785}{doi:10.1176/appi.ajp.20230785}.
\item Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB. (2024). \textit{Psilocybin: From Psychiatric Pariah to Perceived Panacea.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230682}{doi:10.1176/appi.ajp.20230682}.
\item Ramaekers JG, Reckweg JT, Mason NL. (2024). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Suppes T, Sackeim HA. (2024). \textit{Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20231063}{doi:10.1176/appi.ajp.20231063}.
\item Wolfgang AS, McClair VL, Schnurr PP, Holtzheimer PE, Woolley JD, Stauffer CS, Wolf RC, States LJ, Benedek DM, Capaldi VF, Bradley J, Fuller MA, Smyth MJ, Hermes EDA, Tenhula W, Wiechers IR (2024). \textit{Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20240751}{doi:10.1176/appi.ajp.20240751}.
\item Pagni BA, Zeifman RJ, Mennenga SE, Carrithers BM, Goldway N, Bhatt S, O'Donnell KC, Ross S, Bogenschutz MP. (2024). \textit{Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230887}{doi:10.1176/appi.ajp.20230887}.
\item Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM. (2024). \textit{Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/wnf.0000000000000617}{doi:10.1097/wnf.0000000000000617}.
\item Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL. (2024). \textit{Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.12.31.24319806}{doi:10.1101/2024.12.31.24319806}.
\item Cohen IG, Marks M (2024). \textit{Psychedelic Medicine Exceptionalism.}. The American journal of bioethics: AJOB. [published; PubMed]. \href{https://doi.org/10.1080/15265161.2025.2434398}{doi:10.1080/15265161.2025.2434398}.
\item Wijesekara T, Xu B. (2024). \textit{Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/09603271251323134}{doi:10.1177/09603271251323134}.
\item Nogueira M, García-Hernández S, Roberto GS, Marques LZ. (2024). \textit{Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1615/intjmedmushrooms.2024057053}{doi:10.1615/intjmedmushrooms.2024057053}.
\item Cumming P, Egger K, Knudsen GM (2024). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Bostoen T, Tap S, Breeksema J, Schoevers R (2024). \textit{Post-traumatic stress disorder in psychedelic research.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.004}{doi:10.1016/bs.irn.2025.02.004}.
\item Tap S, Bostoen T, Breeksema J, Schoevers R (2024). \textit{Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.001}{doi:10.1016/bs.irn.2025.03.001}.
\item Sommer WH, Spanagel R (2024). \textit{Behavioral Neurobiology of Alcohol Addiction: A Decade of Great Challenges, New Hopes, and Hypes.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2025\_586}{doi:10.1007/7854\_2025\_586}.
\item D M Schuman H, Barkova S, Mina R, Deleemans JM, Nguyen T, Carlson LE (2024). \textit{"" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.}. Integrative cancer therapies. [published; PubMed]. \href{https://doi.org/10.1177/15347354251370982}{doi:10.1177/15347354251370982}.
\item Norouzkhani F, Gojani E, Wang B, Li D, Shujat S, Shrestha A, Rodriguez-Juarez R, Kovalchuk O, Kovalchuk I. (2024). \textit{Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1139/bcb-2025-0250}{doi:10.1139/bcb-2025-0250}.
\item Zamaria JA, Fernandes-Osterhold G, Shedler J, Yehuda R (2024). \textit{Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1505894}{doi:10.3389/fpsyg.2025.1505894}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2024). \textit{Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1508811}{doi:10.3389/fpsyt.2025.1508811}.
\item Tunstad PA, Kvam TM, Uthaug MV, Stewart LH, Andersen KAA, Grønnerød C (2024). \textit{Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1556299}{doi:10.3389/fphar.2025.1556299}.
\item Dwyer J, Johnston RB, O'Callaghan C, Kallianis V, Ross ML (2024). \textit{Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1541528}{doi:10.3389/fpsyt.2025.1541528}.
\item Marek J, Domek-Gumprecht M, Macionga A, Szafoni S, Więckiewicz G (2024). \textit{PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591658}{doi:10.3389/fpsyt.2025.1591658}.
\item Davis AK, Bates M, Lund EM, Sepeda ND, Levin AW, Armstrong SB, Koffman R, Hooyer K, Yehuda R (2024). \textit{The Epidemiology of Psychedelic Use Among United States Military Veterans.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2401977}{doi:10.1080/02791072.2024.2401977}.
\item Mikellides G, Kyriazis M (2024). \textit{Psychedelics and mental health: reimagining care through science, insight, and compassion.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1649929}{doi:10.3389/fphar.2025.1649929}.
\item Burmeister JR, Jung JK. (2024). \textit{High Risk, Low Key: The New Face of Drug Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/29768357251389682}{doi:10.1177/29768357251389682}.
\item McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J (2024). \textit{The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251377191}{doi:10.1177/20451253251377191}.
\item Leistenschneider G, Majić T, Reiche S, Riemer TG. (2024). \textit{Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-82216-x}{doi:10.1038/s41598-024-82216-x}.
\item Unknown authors (2024). \textit{Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified Electrode}. Letters in Applied NanoBioScience. [published; Crossref]. \href{https://doi.org/10.33263/lianbs134.173}{doi:10.33263/lianbs134.173}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E. (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Bollinger IM, Singer H, Jacobs J, Tyler M, Scott K, Pauli CS, Miller DR, Barlow C, Rockefeller A, Slot JC, Angel-Mosti V. (2024). \textit{High-quality draft genomes of ecologically and geographically diverse Psilocybe species.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1128/mra.00250-24}{doi:10.1128/mra.00250-24}.
\item Farinha-Ferreira M, Miranda-Lourenço C, Galipeau C, Lenkei Z, Sebastião AM. (2024). \textit{Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2024.110280}{doi:10.1016/j.neuropharm.2024.110280}.
\item Syed OA, Petranker R, Fewster EC, Sobolenko V, Beidas Z, Husain MI, Lake S, Lucas P. (2024). \textit{Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2446445}{doi:10.1080/02791072.2024.2446445}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2024). \textit{Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116337}{doi:10.1016/j.psychres.2024.116337}.
\item Vohryzek J, Garcia Guzman E, Kringelbach ML, Lopez-Sola E, Timmermann C, Roseman L, Tagliazucchi E, Ruffini G, Carhart-Harris R, Deco G, Sanz Perl Y. (2024). \textit{Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.21.629922}{doi:10.1101/2024.12.21.629922}.
\item García-Cabrerizo R, Beruete-Fresnillo I, García-Fuster MJ. (2024). \textit{Characterizing psilocybin as an antidepressant for adolescence in male and female rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.20.629571}{doi:10.1101/2024.12.20.629571}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R. (2024). \textit{ALSUntangled \#77: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Geller J, Whitney E. (2024). \textit{Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01577-2}{doi:10.1007/s11920-024-01577-2}.
\item Calder AE, Qualls C, Hasler G, Elmiger D, Strassman R. (2024). \textit{The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsgos.2024.100436}{doi:10.1016/j.bpsgos.2024.100436}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE. (2024). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/njh.0000000000001096}{doi:10.1097/njh.0000000000001096}.
\item Croarkin PE, Sutherland I, Ho MF. (2024). \textit{Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaac.2024.12.003}{doi:10.1016/j.jaac.2024.12.003}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E. (2024). \textit{The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.12.061}{doi:10.1016/j.jad.2024.12.061}.
\item Jungwirth J, von Rotz R, Dziobek I, Vollenweider FX, Preller KH. (2024). \textit{Psilocybin increases emotional empathy in patients with major depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Ferreira AE, Reis-Pina P. (2024). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Froudist-Walsh S, Jones MW. (2024). \textit{Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.10.627734}{doi:10.1101/2024.12.10.627734}.
\item Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB. (2024). \textit{The safety of psilocybin-assisted psychotherapy: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241289024}{doi:10.1177/00048674241289024}.
\item Meyer TD, Ibrahim M, Vale LN, Soares JC. (2024). \textit{Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.12.044}{doi:10.1016/j.jad.2024.12.044}.
\item Schonholz SM, Appel JM, Bursztajn HJ, Nair M, MacIntyre MR. (2024). \textit{Legal and Ethics Concerns of Psilocybin as Medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.29158/jaapl.240089-24}{doi:10.29158/jaapl.240089-24}.
\item Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A. (2024). \textit{The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002268}{doi:10.1017/s1092852924002268}.
\item Wahba M, Hayes C, Kletter M, McAllister-Williams RH. (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2024.768}{doi:10.1192/bjo.2024.768}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM. (2024). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ. (2024). \textit{Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(24)00333-x}{doi:10.1016/s2215-0366(24)00333-x}.
\item Noah S, Shen M, Erowid E, Erowid F, Silver M. (2024). \textit{A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2024.1397064}{doi:10.3389/fpsyg.2024.1397064}.
\item Brett J, Knock E, Watson K, Albert S, Siefried KJ, Guss J. (2024). \textit{Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1490907}{doi:10.3389/fpsyt.2024.1490907}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03189-z}{doi:10.1038/s41398-024-03189-z}.
\item Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH, Johansen A, Fisher P, Knudsen GM, Frokjaer VG, Sankar A. (2024). \textit{Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.2024.143}{doi:10.1192/bjp.2024.143}.
\item COMPASS Pathways (2024). \textit{Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05481736}{source link}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Terao I, Kodama W. (2024). \textit{Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70042}{doi:10.1002/pcn5.70042}.
\item Humphreys K, Todd Korthuis P, Stjepanović D, Hall W. (2024). \textit{Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-psych-020124-023532}{doi:10.1146/annurev-psych-020124-023532}.
\item Menon V, Ramamurthy P, Venu S, Andrade C. (2024). \textit{Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13778}{doi:10.1111/acps.13778}.
\item Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, McGregor BA, Harvey K, Tai M, Kollefrath A, Thomas BJ, Sorta D, Kaelen M, Kelmendi B, Gooley TA. (2024). \textit{Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2024.49026}{doi:10.1001/jamanetworkopen.2024.49026}.
\item Unknown authors (2024). \textit{Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18-26; doi: 10.1089/psymed.2022.0002.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0002.correx}{doi:10.1089/psymed.2022.0002.correx}.
\item Back A, Myers S, Guy J, Perez J, Lazar Thorn L, McGregor B. (2024). \textit{Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0069}{doi:10.1089/psymed.2023.0069}.
\item Piercey CJ, Gray B, Sung A, Henry D, Karoly HC. (2024). \textit{Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0052}{doi:10.1089/psymed.2023.0052}.
\item Godfrey K, Weiss B, Zhang X, Spriggs M, Peill J, Lyons T, Carhart-Harris R, Erritzoe D. (2024). \textit{An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2024.104092}{doi:10.1016/j.nsa.2024.104092}.
\item Hinkle JT, Graziosi M, Nayak SM, Yaden DB. (2024). \textit{Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.2546}{doi:10.1001/jamapsychiatry.2024.2546}.
\item Collins HM. (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T. (2024). \textit{Psilocybin and hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002487}{doi:10.1017/s1092852924002487}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G. (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item de Jonge D, van der Meer PB, Kramers C, Schellekens A. (2024). \textit{Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01567-4}{doi:10.1007/s11920-024-01567-4}.
\item Calder AE, Hase A, Hasler G. (2024). \textit{Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02830-z}{doi:10.1038/s41380-024-02830-z}.
\item Bagdasarian FA, Larsen K, Larsen K, Deng HP, Fisher PM, Mandeville JB, Sander CY, Wey HY, Hansen HD. (2024). \textit{Neurochemical characterization of 5-HT2AR partial agonists with simultaneous PET-MRI.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0271678x241302937}{doi:10.1177/0271678x241302937}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2024). \textit{Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.28.625811}{doi:10.1101/2024.11.28.625811}.
\item Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M. (2024). \textit{Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02800-5}{doi:10.1038/s41380-024-02800-5}.
\item Miller CE, Zoladz PR. (2024). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Wood MJ, McAlpine RG, Kamboj SK. (2024). \textit{Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-79931-w}{doi:10.1038/s41598-024-79931-w}.
\item Yale University (2024). \textit{Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03356483}{source link}.
\item TRYP Therapeutics (2024). \textit{A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05035927}{source link}.
\item Wang E, Mathai DS, Gukasyan N, Nayak S, Garcia-Romeu A. (2024). \textit{Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-78736-1}{doi:10.1038/s41598-024-78736-1}.
\item Zech JM, Yaden DB, Jones GM. (2024). \textit{Associations between psychedelic use and cannabis use disorder in a nationally representative sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112502}{doi:10.1016/j.drugalcdep.2024.112502}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R. (2024). \textit{Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01539-8}{doi:10.1007/s11920-024-01539-8}.
\item Ghaffarzadegan R, Karimi M, Hedayatjoo B, Behnoud H, Jasemi E, Mohammadi M, Roustaei S, Razmi A, Vaseghi S. (2024). \textit{The Effect of Psilocybe cubensis on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2428241}{doi:10.1080/02791072.2024.2428241}.
\item University of Utah (2024). \textit{PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05557643}{source link}.
\item Unknown authors (2024). \textit{Mushroom Therapy: Psilocybin's Role in Treating Substance Use Disorders (P3-9.018).}. Neurology. [published; PubMed]. \href{https://doi.org/10.1212/wnl.0000000000209686}{doi:10.1212/wnl.0000000000209686}.
\item Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X. (2024). \textit{Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejmech.2024.117049}{doi:10.1016/j.ejmech.2024.117049}.
\item Kargbo RB. (2024). \textit{Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00519}{doi:10.1021/acsmedchemlett.4c00519}.
\item Kargbo RB. (2024). \textit{Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00521}{doi:10.1021/acsmedchemlett.4c00521}.
\item Hudspeth J, Rogge K, Wagner T, Müll M, Hoffmeister D, Rupp B, Werten S. (2024). \textit{The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202400497}{doi:10.1002/cbic.202400497}.
\item Lee J, Philip K, Wijeysundera DN, Clarke H, Pritlove C, Katz J, Ritvo P, Goel A, Husain MI, Ladha KS. (2024). \textit{Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/24740527.2024.2406285}{doi:10.1080/24740527.2024.2406285}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h}{doi:10.31234/osf.io/93x5h}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v1}{doi:10.31234/osf.io/93x5h\_v1}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Gribben A, Burke T, Harrington C, Husein A, Murnane KS, Hendricks PS, Tobin K, Ivers JH, Thuery G, Harkin A, Kelly JR. (2024). \textit{Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/ipm.2024.49}{doi:10.1017/ipm.2024.49}.
\item Imperial College London (2024). \textit{PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06258031}{source link}.
\item Barstowe A, Kajonius PJ. (2024). \textit{Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2424272}{doi:10.1080/02791072.2024.2424272}.
\item Syed OA, Petranker R, Fewster EC, Sobolenko V, Beidas Z, Husain MI, Lake S, Lucas P. (2024). \textit{Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2424284}{doi:10.1080/02791072.2024.2424284}.
\item Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph17111484}{doi:10.3390/ph17111484}.
\item Negrine JJ, Puljević C, Ferris J, Liknaitzky P, Perlman C, Piatkowski T. (2024). \textit{Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/dar.13973}{doi:10.1111/dar.13973}.
\item Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF. (2024). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/j8zb5}{doi:10.31234/osf.io/j8zb5}.
\item Unknown authors (2024). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/j8zb5\_v1}{source link}.
\item Shao L, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu R, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC. (2024). \textit{Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug action}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.02.621692}{doi:10.1101/2024.11.02.621692}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2024). \textit{Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2024.110202}{doi:10.1016/j.neuropharm.2024.110202}.
\item Janevska S, Weiser S, Huang Y, Lin J, Hoefgen S, Jojić K, Barber AE, Schäfer T, Fricke J, Hoffmeister D, Regestein L, Valiante V, Kufs JE. (2024). \textit{Optimized psilocybin production in tryptophan catabolism-repressed fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1751-7915.70039}{doi:10.1111/1751-7915.70039}.
\item Forte V, Shaughnessy AF, Kurotschka PK. (2024). \textit{[Depression and effectiveness of psychedelics: high-dose psilocybin has shown benefits in improving symptoms.]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1701/4365.43590}{doi:10.1701/4365.43590}.
\item Jeanblanc J, Bordy R, Fouquet G, Jeanblanc V, Naassila M. (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Swanson LR, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson JL, Schallmo MP. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1167/jov.24.12.5}{doi:10.1167/jov.24.12.5}.
\item Adams DR, Allen H, Nicol GE, Cabassa LJ. (2024). \textit{Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/tbm/ibae053}{doi:10.1093/tbm/ibae053}.
\item Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P. (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dwhcu\_v1}{doi:10.31234/osf.io/dwhcu\_v1}.
\item Unknown authors (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dwhcu\_v1}{source link}.
\item Aghajanian S, Shafiee A, Parvizi Omran S, Rezaei Nejad A, Jafarabady K, Kohandel Gargari O, Rajai S, Mohammadi I, Bahrami Babaheidari T, Bakhtiyari M. (2024). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Filament Health Corp. (2024). \textit{A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06666010}{source link}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT. (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Wiens KR, Brooks NAH, Riar I, Greuel BK, Lindhout IA, Klegeris A. (2024). \textit{Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules29215084}{doi:10.3390/molecules29215084}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2024). \textit{Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.23.619763}{doi:10.1101/2024.10.23.619763}.
\item Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC. (2024). \textit{Expert recommendations for Germany's integration of psychedelic-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-024-06141-3}{doi:10.1186/s12909-024-06141-3}.
\item Kim K, Yusuf A, Sud A, Persaud N, Kirubarajan A, Moller M, Lloyd T, O'Neill B. (2024). \textit{Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0309911}{doi:10.1371/journal.pone.0309911}.
\item Rogge K, Wagner TJ, Hoffmeister D, Rupp B, Werten S. (2024). \textit{Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1873-3468.15042}{doi:10.1002/1873-3468.15042}.
\item Majic T, Schmidt TT, Gröticke A, Gasser P, Richards WA, Riemer TG, Evens R. (2024). \textit{The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/s6bzc}{doi:10.31234/osf.io/s6bzc}.
\item Mallaroni P, Singleton P, Mason NL, Satterthwaite TD, Ramaekers JG. (2024). \textit{The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.22.619393}{doi:10.1101/2024.10.22.619393}.
\item Jones G, Lowe MX, Nayak S, Sepeda N, Kettner H, Carhart-Harris R, Jackson H, Garcia-Romeu A. (2024). \textit{Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.10.058}{doi:10.1016/j.jad.2024.10.058}.
\item Unknown authors (2024). \textit{The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/s6bzc\_v1}{source link}.
\item Fleury S, Nautiyal KM. (2024). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.18.618582}{doi:10.1101/2024.10.18.618582}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE. (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02788-y}{doi:10.1038/s41380-024-02788-y}.
\item Enriquez-Geppert S, Krc J, O'Higgins FJ, Lietz M. (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item Kopra EI, Penttinen J, Rucker JJ, Copeland CS. (2024). \textit{Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111177}{doi:10.1016/j.pnpbp.2024.111177}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg\_v1}{doi:10.31234/osf.io/u9yeg\_v1}.
\item University Health Network, Toronto (2024). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg}{doi:10.31234/osf.io/u9yeg}.
\item Unknown authors (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u9yeg\_v1}{source link}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-74810-w}{doi:10.1038/s41598-024-74810-w}.
\item Valdez T, Patel V, Senesombath D, Hatahet-Donovan Z, Hornick MG. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202410.1406.v1}{doi:10.20944/preprints202410.1406.v1}.
\item Szpręgiel I, Bysiek A. (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Kargbo RB. (2024). \textit{Expanding the Therapeutic Horizons of Psilocybin in Mental Health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00488}{doi:10.1021/acsmedchemlett.4c00488}.
\item Lyons T, Spriggs M, Kerkelä L, Rosas F, Roseman L, Mediano P, Timmermann C, Oestreich L, Pagni B, Zeifman R, Hampshire A, Trender W, Douglass H, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall M, Erritzoe D, Nutt D, Carhart-Harris R. (2024). \textit{Human brain changes after first psilocybin use}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617955}{doi:10.1101/2024.10.11.617955}.
\item Barnett BS. (2024). \textit{A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelics}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.10.12.24315367}{doi:10.1101/2024.10.12.24315367}.
\item Véliz-García O, Domic-Siede M. (2024). \textit{Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-74590-3}{doi:10.1038/s41598-024-74590-3}.
\item Karthiyayini B, Kalyani NN, Gowdhami B, Muthuselvam M, Dharumadurai D. (2024). \textit{Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12088-024-01396-2}{doi:10.1007/s12088-024-01396-2}.
\item de la Fuente Revenga M, González-Maeso J. (2024). \textit{Snapshot of 5-HT2A receptor activation in the mouse brain via IP1 detection}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B. (2024). \textit{Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02786-0}{doi:10.1038/s41380-024-02786-0}.
\item Marwood L, Croal M, Mistry S, Simmons H, Tsai J, Young MB, Goodwin GM. (2024). \textit{The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2024.10.009}{doi:10.1016/j.jpsychires.2024.10.009}.
\item MycoMedica Life Sciences PBC (2024). \textit{A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06326606}{source link}.
\item Imperio CG, Levin FR, Martinez D. (2024). \textit{The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20231023}{doi:10.1176/appi.ajp.20231023}.
\item Li JR, Chiang KT, Kao YC, Yu CL, Yang FC, Liang CS, Hsu TW. (2024). \textit{The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.10.016}{doi:10.1016/j.jad.2024.10.016}.
\item Yu SJ, Wu KJ, Wang YS, Bae E, Chianelli F, Bambakidis N, Wang Y. (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Pincombe J, Williams M, Carruthers S, Rossell S. (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ga9p2}{doi:10.31234/osf.io/ga9p2}.
\item Unknown authors (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ga9p2\_v1}{source link}.
\item Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S. (2024). \textit{Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s44220-024-00331-0}{doi:10.1038/s44220-024-00331-0}.
\item Dahan JDC, Dadiomov D, Bostoen T, Dahan A. (2024). \textit{Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s44184-024-00091-w}{doi:10.1038/s44184-024-00091-w}.
\item Ivan VE, Tomàs-Cuesta DP, Esteves IM, Luczak A, Mohajerani M, McNaughton BL, Gruber AJ. (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Junges LH, Müller-Santos M. (2024). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Choi C, Johnson DE, Chen-Li D, Rosenblat J. (2024). \textit{Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241286771}{doi:10.1177/02698811241286771}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7}{doi:10.31234/osf.io/uxhv7}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7\_v1}{doi:10.31234/osf.io/uxhv7\_v1}.
\item Nadeem Z, Parker S, McGovern H, Oestreich LK (2024). \textit{Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674241261779}{doi:10.1177/00048674241261779}.
\item Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D (2024). \textit{Artificial intelligence and psychedelic medicine.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15229}{doi:10.1111/nyas.15229}.
\item Masse-Grenier M, Chang SL, Bélanger A, Stephan JF, Hébert J, Deschamps P, Plourde L, Provost F, Farzin H, Fallu JS, Dorval M, P3A Research Group. (2024). \textit{What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1478951524001494}{doi:10.1017/s1478951524001494}.
\item Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V. (2024). \textit{Impact of psilocybin on cognitive function: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/pcn.13741}{doi:10.1111/pcn.13741}.
\item Unknown authors (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1002/prp2.70097}{doi:10.1002/prp2.70097}.
\item Lane CP, Tarka VM, Valentin O, Lehmann A, Hamel E, de Villers-Sidani E. (2024). \textit{Psilocybin prevents habituation to familiar stimuli and preserves sensitivity to sound following repeated stimulation in mouse primary auditory cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.27.614985}{doi:10.1101/2024.09.27.614985}.
\item Fisher EL, Smith R, Conn K, Corcoran AW, Milton LK, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Lafrance A, Spriggs MJ, Gukasyan N, Peck SK (2024). \textit{Beyond the numbers: reimagining healing with psychedelics for eating disorders.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01111-y}{doi:10.1186/s40337-024-01111-y}.
\item Colloca L, Fava M. (2024). \textit{What should constitute a control condition in psychedelic drug trials?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s44220-024-00321-2}{doi:10.1038/s44220-024-00321-2}.
\item Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D. (2024). \textit{Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.3459}{doi:10.1002/cpt.3459}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C. (2024). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Western University, Canada (2024). \textit{The Effects of Psilocybin on Shared Experience in Film Processing}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06529939}{source link}.
\item Meling D, Egger K, Aicher HD, Jareño Redondo J, Mueller J, Dornbierer J, Temperli E, Vasella EA, Caflisch L, Pfeiffer DJ, Schlomberg JT, Smallridge JW, Dornbierer DA, Scheidegger M. (2024). \textit{Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241282637}{doi:10.1177/02698811241282637}.
\item Lee J, Tantillo DJ, Wang LP, Fiehn O. (2024). \textit{Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jcim.4c00761}{doi:10.1021/acs.jcim.4c00761}.
\item Ellis S, Bostian C, Feng W, Fischer E, Schwartz G, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T. (2024). \textit{Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.09.133}{doi:10.1016/j.jad.2024.09.133}.
\item Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A. (2024). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4492873/v1}{doi:10.21203/rs.3.rs-4492873/v1}.
\item University of California, San Francisco (2024). \textit{An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05065294}{source link}.
\item Vamvakopoulou IA, Nutt DJ. (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Zhu X, Zhang C, Hellerstein D, Feusner JD, Wheaton MG, Gomez GJ, Schneier F. (2024). \textit{Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.61373/pp024r.0028}{doi:10.61373/pp024r.0028}.
\item Lazar M, Brownstien M, Botvinnik A, Shevakh C, Shahar O, Lifschytz T, Lerer B. (2024). \textit{Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin Treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.22.614317}{doi:10.1101/2024.09.22.614317}.
\item Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W. (2024). \textit{Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1416420}{doi:10.3389/fpsyt.2024.1416420}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2024). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.19.24313958}{doi:10.1101/2024.09.19.24313958}.
\item Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R. (2024). \textit{Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2024.102799}{doi:10.1016/j.eclinm.2024.102799}.
\item Askey T, Allen-Ross D, Lasrado R, Gilmour G, Hunt S, Tamagnini F, Ahmed M, Stephens G, Maiarú M. (2024). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5026806/v1}{doi:10.21203/rs.3.rs-5026806/v1}.
\item Calder AE, Rausch B, Liechti ME, Holze F, Hasler G. (2024). \textit{Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241278873}{doi:10.1177/02698811241278873}.
\item Rucker J, Butler M, Hambleton S, Bird C, Seynaeve M, Cheema S, Campbell-Coker K, Maggio C, Dunbar F, Lambru G, Matharu M. (2024). \textit{Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/head.14837}{doi:10.1111/head.14837}.
\item University Hospital, Ghent (2024). \textit{Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06378229}{source link}.
\item Gobbi G. (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Armstrong SB, Davis AK. (2024). \textit{Psychedelic research at a crossroads.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adt1024}{doi:10.1126/science.adt1024}.
\item Werle I, Bertoglio LJ. (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item Glynos NG, Baker A, Aday JS, Pouyan N, Barron J, Herberholz M, Kruger D, Boehnke KF. (2024). \textit{Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2405685}{doi:10.1080/02791072.2024.2405685}.
\item Mageean S, Daniel A, Tai S. (2024). \textit{Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4862438/v1}{doi:10.21203/rs.3.rs-4862438/v1}.
\item Spoelstra SK, Schoevers RA, Venema SD, Knegtering H. (2024). \textit{Psychedelics as a potential treatment for tobacco use disorder: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s44192-024-00095-0}{doi:10.1007/s44192-024-00095-0}.
\item Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S. (2024). \textit{Exploring the regulatory framework of psychedelics in the US \& Europe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104242}{doi:10.1016/j.ajp.2024.104242}.
\item Savides IA, Outhoff K. (2024). \textit{Less is more? A review of psilocybin microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241278769}{doi:10.1177/02698811241278769}.
\item Li G, Facchini PJ. (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Gartner HT, Wan HZ, Simmons RE, Sollee DR, Sheikh S. (2024). \textit{Psychedelic mushroom-containing chocolate exposures: Case series.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajem.2024.09.038}{doi:10.1016/j.ajem.2024.09.038}.
\item Wilson-Poe A, Hoffman K, Pertl K, Luoma J, Bazinet A, Stauffer C, McCarty D, Korthuis P. (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2401982}{doi:10.1080/02791072.2024.2401982}.
\item Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C. (2024). \textit{Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/14651858.cd015383.pub2}{doi:10.1002/14651858.cd015383.pub2}.
\item Nicholas CR, Banks MI, Lennertz RC, Wenthur CJ, Krause BM, Riedner BA, Smith RF, Hutson PR, Sauder CJ, Dunne JD, Roseman L, Raison CL. (2024). \textit{Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03059-8}{doi:10.1038/s41398-024-03059-8}.
\item Jevotovsky DS, Chopra H, Wing C, Spotswood CJ, Castellanos J. (2024). \textit{Refractory CRPS pain treated with psilocybin: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ccr3.9421}{doi:10.1002/ccr3.9421}.
\item Stephan JF, Karam S. (2024). \textit{Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2024.0277}{doi:10.1089/jpm.2024.0277}.
\item Nikolic M, Mediano P, Froese T, Reydellet D, Palenicek T. (2024). \textit{Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.09.24313316}{doi:10.1101/2024.09.09.24313316}.
\item Thaoboonruang N, Lohitnavy M, Lohitnavy O. (2024). \textit{Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2399128}{doi:10.1080/02791072.2024.2399128}.
\item Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y. (2024). \textit{The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111139}{doi:10.1016/j.pnpbp.2024.111139}.
\item Anderson K, Elf P, Isham A. (2024). \textit{Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2024.104571}{doi:10.1016/j.drugpo.2024.104571}.
\item Pohořalá V, Kuchař M, Spanagel R, Bernardi RE. (2024). \textit{Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroscience.2024.09.006}{doi:10.1016/j.neuroscience.2024.09.006}.
\item Zhen Z, Sun X, Yuan S, Zhang J. (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Woollacott M, Riddle J, Hermansson N, Sacchet MD, Ingram DM. (2024). \textit{Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.explore.2024.103056}{doi:10.1016/j.explore.2024.103056}.
\item Korthuis PT, Wilson-Poe AR, Black JC, Monte A (2024). \textit{Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16589}{doi:10.1111/add.16589}.
\item Rogers J. (2024). \textit{Psilocybin desynchronization persists in the human brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41583-024-00854-6}{doi:10.1038/s41583-024-00854-6}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Treviranus GRS. (2024). \textit{Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/39378462}{source link}.
\item Loizaga-Velder A, Loizaga Pazzi A. (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J (2024). \textit{Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0074}{doi:10.1089/psymed.2023.0074}.
\item University of Arizona (2024). \textit{Psilocybin for Treatment of Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03300947}{source link}.
\item Martial C, Carhart-Harris R, Timmermann C. (2024). \textit{Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/nc/niae033}{doi:10.1093/nc/niae033}.
\item Federico S, Geo M, Entela M, Bachmann S, Elisa R, Silvio C, Zoë D, Louise P, Gabriel T, Joël B, Daniele Z. (2024). \textit{Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ccr3.9305}{doi:10.1002/ccr3.9305}.
\item Yoo M, Sakopoulos S. (2024). \textit{The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.172496618.87990987/v1}{doi:10.22541/au.172496618.87990987/v1}.
\item Jungwirth J, Bavato F, Quednow BB. (2024). \textit{[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-024-01727-0}{doi:10.1007/s00115-024-01727-0}.
\item Najib J. (2024). \textit{The role of psilocybin in depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2396536}{doi:10.1080/03007995.2024.2396536}.
\item Tsang V. (2024). \textit{A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11860442}{source link}.
\item Tsang V, Roney C. (2024). \textit{Improving Access to Psilocybin-Assisted Therapy: Barriers, Challenges, and Recommendations}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11861878}{source link}.
\item Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T. (2024). \textit{The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.08.26.24311611}{doi:10.1101/2024.08.26.24311611}.
\item Frye MA, Singh B, Breitinger SA, Oesterle TS. (2024). \textit{Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.24cr15378}{doi:10.4088/jcp.24cr15378}.
\item Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A. (2024). \textit{­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4947184/v1}{doi:10.21203/rs.3.rs-4947184/v1}.
\item Lodetti G, de Bitencourt RM, Rico EP. (2024). \textit{Classic psychedelics and the treatment for alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111129}{doi:10.1016/j.pnpbp.2024.111129}.
\item Gray BA, Bolts OL, Fidler D, Prince M. (2024). \textit{Identifying Three Psilocybin Use Patterns by Frequency and Quantity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15288/jsad.23-00312}{doi:10.15288/jsad.23-00312}.
\item Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS. (2024). \textit{Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078607}{doi:10.1136/bmj-2023-078607}.
\item Kargbo RB. (2024). \textit{Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00412}{doi:10.1021/acsmedchemlett.4c00412}.
\item Kargbo RB. (2024). \textit{Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00414}{doi:10.1021/acsmedchemlett.4c00414}.
\item Calder AE, Hasler G. (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.08.091}{doi:10.1016/j.jad.2024.08.091}.
\item Alnagger NL, Cardone P, Martial C, Sanz Perl Y, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason NL, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Nunez P, Annen J. (2024). \textit{A virtual clinical trial of psychedelics to treat patients with disorders of consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.16.608251}{doi:10.1101/2024.08.16.608251}.
\item Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M. (2024). \textit{Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14080829}{doi:10.3390/brainsci14080829}.
\item Kim A, Halton B, Shah A, Seecof OM, Ross S. (2024). \textit{Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21037/apm-24-35}{doi:10.21037/apm-24-35}.
\item Clairvoyant Therapeutics (2024). \textit{A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05646303}{source link}.
\item Holas P, Kaminska J. (2024). \textit{Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4860906/v1}{doi:10.21203/rs.3.rs-4860906/v1}.
\item Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS. (2024). \textit{The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1439347}{doi:10.3389/fpsyt.2024.1439347}.
\item Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A. (2024). \textit{Psilocybin for clinical indications: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241269751}{doi:10.1177/02698811241269751}.
\item Hovmand OR, Madsen MK, Fisher PM, Stenbæk DS. (2024). \textit{Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241269669}{doi:10.1177/02698811241269669}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF. (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Sheppard Pratt Health System (2024). \textit{An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433858}{source link}.
\item Ottawa Hospital Research Institute (2024). \textit{PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04754061}{source link}.
\item Vella Y, Syrova K, Petruskova A, Koutrouli I, Kutna V, Pala J, Nikolic M, Sichova K, Mazoch V, Jurok R, Kuchar M, Bendova Z, Palenicek T. (2024). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.07.606965}{doi:10.1101/2024.08.07.606965}.
\item Yang X, Kuang W. (2024). \textit{Letter to editor regarding "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116136}{doi:10.1016/j.psychres.2024.116136}.
\item Brugmann University Hospital (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy \& (Neuro)Cognitive Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160232}{source link}.
\item VanderZwaag B, Garcia-Romeu A, Garcia-Barrera MA. (2024). \textit{Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253241264812}{doi:10.1177/20451253241264812}.
\item Zhang R, Anguiano M, Aarrestad IK, Lin S, Chandra J, Vadde SS, Olson DE, Kim CK. (2024). \textit{Rapid, biochemical tagging of cellular activity history in vivo.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41592-024-02375-7}{doi:10.1038/s41592-024-02375-7}.
\item Mehtani NJ, Johnson MO, Hendricks PS, Mitchell J, Anderson BT. (2024). \textit{Psilocybin-assisted therapy and HIV-related shame.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-68908-4}{doi:10.1038/s41598-024-68908-4}.
\item Véliz-García O, Domic M. (2024). \textit{Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4706910/v1}{doi:10.21203/rs.3.rs-4706910/v1}.
\item Nutt D, Crome I, Young AH. (2024). \textit{Is it now time to prepare psychiatry for a psychedelic future?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.2024.76}{doi:10.1192/bjp.2024.76}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item Kaiserman A, Vanderjist L, Kornreich C. (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item Woodburn SC, Levitt CM, Koester AM, Kwan AC. (2024). \textit{Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.4c00279}{doi:10.1021/acschemneuro.4c00279}.
\item Owe-Larsson M, Kamińska K, Buchalska B, Mirowska-Guzel D, Cudnoch-Jędrzejewska A. (2024). \textit{Psilocybin in pharmacotherapy of obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00633-1}{doi:10.1007/s43440-024-00633-1}.
\item O'Leary K. (2024). \textit{How psilocybin affects the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/d41591-024-00055-9}{doi:10.1038/d41591-024-00055-9}.
\item david J, Berkovich-Ohana A, Dor-Ziderman Y. (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/tmeb3}{doi:10.31234/osf.io/tmeb3}.
\item Unknown authors (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/tmeb3\_v1}{source link}.
\item Washington University School of Medicine (2024). \textit{Psilocybin for the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05675800}{source link}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.1}{doi:10.12688/wellcomeopenres.22543.1}.
\item Viohl N, Zanjani AAH, Khandelia H. (2024). \textit{Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit Gqα}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.23.604750}{doi:10.1101/2024.07.23.604750}.
\item Bhagavan C, Kanaan R, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, McKernon D, Roebuck G, Rucker J, Butler M, Bryson A. (2024). \textit{Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.prcp.20240047}{doi:10.1176/appi.prcp.20240047}.
\item Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A. (2024). \textit{Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-024-01101-3}{doi:10.1007/s40263-024-01101-3}.
\item McTaggart AR, Scarlett K, Slot JC, Barlow C, Appleyard C, Gardiner DM, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording WJ, Lloyd RA, Shuey LS, Drenth A, James TY. (2024). \textit{Wood-loving magic mushrooms from Australia are saprotrophic invaders in the Northern Hemisphere.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3114/fuse.2024.14.14}{doi:10.3114/fuse.2024.14.14}.
\item de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT. (2024). \textit{Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-66817-0}{doi:10.1038/s41598-024-66817-0}.
\item Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, Reneau TR, Metcalf NV, Chacko RV, Gratton C, Horan C, Krimmel SR, Shimony JS, Schweiger JA, Wong DF, Bender DA, Scheidter KM, Whiting FI, Padawer-Curry JA, Shinohara RT, Chen Y, Moser J, Yacoub E, Nelson SM, Vizioli L, Fair DA, Lenze EJ, Carhart-Harris R, Raison CL, Raichle ME, Snyder AZ, Nicol GE, Dosenbach NUF. (2024). \textit{Psilocybin desynchronizes the human brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41586-024-07624-5}{doi:10.1038/s41586-024-07624-5}.
\item Do A, Michaud V, Stephan JF, Moreau M, Benoît É, Bérubé FA, Bibaud-De Serres A, Taillefer A, Vincent P. (2024). \textit{Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1394962}{doi:10.3389/fpsyt.2024.1394962}.
\item Anders Fink-Jensen, MD, DMSci (2024). \textit{Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04718792}{source link}.
\item Nogueira M, García-Hernández S, Roberto GS, Marques LZ. (2024). \textit{Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.07.11.24310147}{doi:10.1101/2024.07.11.24310147}.
\item Ahuja S, Zaher F, Palaniyappan L. (2024). \textit{Quantitative Natural Language Processing Markers of Psychoactive Drug Effects: A Pre-Registered Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4534997/v1}{doi:10.21203/rs.3.rs-4534997/v1}.
\item Zarankin M, Pellegrini MS, Zenteno F. (2024). \textit{Psilocybin fungi microdose treatment in major depressive disorder: a case report}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.53680/vertex.v35i164.544}{doi:10.53680/vertex.v35i164.544}.
\item Zheng S, Ma R, Yang Y, Li G. (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Bhave A. (2024). \textit{Magic of the Mushrooms: Effects of Psilocybin Decriminalization.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2376755}{doi:10.1080/02791072.2024.2376755}.
\item West CL, Imai F, Bastos G, Hornick MA, Rachmany L, Duran A, Nadeem S, Ricci D, Rader Groves AM, Wargo JA, Van Leeuwen N, Sershen H, Yaragudri Vinod K, Peterka DS, Hamm JP. (2024). \textit{Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.03.601959}{doi:10.1101/2024.07.03.601959}.
\item Khajavinia A, Michel D, Ezeaka UC, Purves RW, Laprairie RB, El-Aneed A. (2024). \textit{Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.chroma.2024.465123}{doi:10.1016/j.chroma.2024.465123}.
\item Yao Y, Zhang YZ, Liang JQ, Liu F, Li ZF, Li HJ, Xu F. (2024). \textit{Mushroom poisoning of Panaeolus subbalteatus from Ningxia, northwest China, with species identification and tryptamine detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.toxicon.2024.107849}{doi:10.1016/j.toxicon.2024.107849}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A. (2024). \textit{Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Poulin JM, Bigford GE, Lanctôt KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, Husain MI, Rosenblat JD, Cao X, MacIntosh BJ, Nestor SM. (2024). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13063-024-08268-6}{doi:10.1186/s13063-024-08268-6}.
\item Shakir J, Pedicini M, Bullock BC, Hoen PW, Macias LK, Freiman J, Pletnikov MV, Tamashiro KLK, Cordner ZA. (2024). \textit{Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.physbeh.2024.114627}{doi:10.1016/j.physbeh.2024.114627}.
\item Singleton SP, Kuceyeski A. (2024). \textit{Bridging Psilocybin-Induced Changes in the Brain's Dynamic Functional Connectome With an Individual's Subjective Experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.05.003}{doi:10.1016/j.bpsc.2024.05.003}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Kozlov M. (2024). \textit{Your brain on shrooms - how psilocybin resets neural networks.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-024-02275-y}{doi:10.1038/d41586-024-02275-y}.
\item Hanstein AP, Felchlin C. (2024). \textit{Treating Anxiety and Depression With Psilocybin Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/39079732}{source link}.
\item DeBattista C, Schatzberg AF. (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Bader H, Farraj H, Maghnam J, Abu Omar Y. (2024). \textit{Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5306/wjco.v15.i7.908}{doi:10.5306/wjco.v15.i7.908}.
\item Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B. (2024). \textit{Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.25.600634}{doi:10.1101/2024.06.25.600634}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ. (2024). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.focus.24022012}{doi:10.1176/appi.focus.24022012}.
\item Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, Finn DM, Kaye WH. (2024). \textit{Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.focus.24022013}{doi:10.1176/appi.focus.24022013}.
\item Downey AE, Gorrell S. (2024). \textit{Innovative and Emerging Treatments for Anorexia Nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.focus.20230041}{doi:10.1176/appi.focus.20230041}.
\item Lake S, Lucas P. (2024). \textit{The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2024.104507}{doi:10.1016/j.drugpo.2024.104507}.
\item Doss MK, Mallaroni P, Mason NL, Ramaekers JG. (2024). \textit{Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.06.008}{doi:10.1016/j.bpsc.2024.06.008}.
\item Van Maldegem M, Vohryzek J, Atasoy S, Alnagger N, Cardone P, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Kringelbach ML, Stamatakis EA, Luppi AI. (2024). \textit{Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.20.599885}{doi:10.1101/2024.06.20.599885}.
\item Bagdasarian FA, Hansen HD, Chen J, Yoo CH, Placzek MS, Hooker JM, Wey HY. (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item Clark MP. (2024). \textit{Psilocybin: Medicine for My Soul. Relief from Emotional and Spiritual Pain as a Hospice Nurse Diagnosed with Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2024.0066}{doi:10.1089/jpm.2024.0066}.
\item Empower Research Inc (2024). \textit{Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06471959}{source link}.
\item Jones GM, Ricard JA, Nock MK. (2024). \textit{Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1169686}{doi:10.3389/fpsyt.2024.1169686}.
\item Effinger DP, Hoffman JL, Mott SE, Magee SN, Quadir SG, Rollison CS, Toedt D, Echeveste Sanchez M, High MW, Hodge CW, Herman MA. (2024). \textit{Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-024-49741-9}{doi:10.1038/s41467-024-49741-9}.
\item Jacobs DS, Bogachuk AP, Le Moing CL, Moghaddam B. (2024). \textit{Effects of psilocybin on uncertain punishment learning.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nlm.2024.107954}{doi:10.1016/j.nlm.2024.107954}.
\item Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA. (2024). \textit{Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2368617}{doi:10.1080/02791072.2024.2368617}.
\item Fluyau D, Kailasam VK, Revadigar N. (2024). \textit{Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.06.17.24308787}{doi:10.1101/2024.06.17.24308787}.
\item Appiani FJ, Caroff SN. (2024). \textit{The cyclical revival of psychedelics in psychiatric treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2368725}{doi:10.1080/03007995.2024.2368725}.
\item Guo Q, Guo L, Wang Y, Shang S. (2024). \textit{Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116018}{doi:10.1016/j.psychres.2024.116018}.
\item Johns Hopkins University (2024). \textit{Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02243813}{source link}.
\item Korthuis PT, Hoffman K, Wilson-Poe AR, Luoma JB, Bazinet A, Pertl K, Morgan DL, Cook RR, Bielavitz S, Myers R, Wolf RC, McCarty D, Stauffer CS. (2024). \textit{Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241257839}{doi:10.1177/02698811241257839}.
\item Kanis FC, Broude CN, Hellwarth EB, Gibbons WJ, Sen AK, Adams AM, Wang X, Jones JA. (2024). \textit{Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/btpr.3492}{doi:10.1002/btpr.3492}.
\item Imperial College London (2024). \textit{Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04505189}{source link}.
\item Torrado Pacheco A, Moghaddam B. (2024). \textit{Licit use of illicit drugs for treating depression: the pill and the process.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1172/jci180217}{doi:10.1172/jci180217}.
\item Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J. (2024). \textit{A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0051}{doi:10.1089/psymed.2023.0051}.
\item DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR. (2024). \textit{Impact of Psilocybin on Peripheral Cytokine Production.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0039}{doi:10.1089/psymed.2023.0039}.
\item Stanger MK, Soffer HO, Bryan AD, Skrzynski CJ. (2024). \textit{Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/can.2024.0059}{doi:10.1089/can.2024.0059}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Polito V, Liknaitzky P. (2024). \textit{Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241254831}{doi:10.1177/02698811241254831}.
\item Nicholas CR, Banks MI, Lennertz RL, Wenthur CJ, Krause BM, Riedner BA, Smith RF, Hutson PR, Sauder CJ, Dunne JD, Roseman L, Raison CL. (2024). \textit{Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.598878}{doi:10.1101/2024.06.13.598878}.
\item Neumann J, Dimov K, Azatsian K, Hofmann B, Gergs U. (2024). \textit{Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.toxlet.2024.06.006}{doi:10.1016/j.toxlet.2024.06.006}.
\item Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G. (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2024). \textit{Neural mechanisms of psychedelic visual imagery.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02632-3}{doi:10.1038/s41380-024-02632-3}.
\item Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK. (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/adnpg}{doi:10.31234/osf.io/adnpg}.
\item University of Sydney (2024). \textit{A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06444243}{source link}.
\item Unknown authors (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/adnpg\_v1}{source link}.
\item Turkia M. (2024). \textit{5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/bvk2f}{doi:10.31234/osf.io/bvk2f}.
\item Calder A, Hasler G. (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/um2cy}{doi:10.31234/osf.io/um2cy}.
\item Unknown authors (2024). \textit{5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/bvk2f\_v1}{source link}.
\item Unknown authors (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/um2cy\_v1}{source link}.
\item Ramos L, Vicente SG. (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Andrews CM, Hall W, Humphreys K, Marsden J. (2024). \textit{Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.16575}{doi:10.1111/add.16575}.
\item Bornemann J, Close JB, Ahmad K, Barba T, Godfrey K, Macdonald L, Erritzoe D, Nutt D, Carhart-Harris R. (2024). \textit{Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1320780}{doi:10.3389/fpsyt.2024.1320780}.
\item Holikulov U, Kazachenko AS, Issaoui N, Kazachenko AS, Raja M, Al-Dossary OM, Xiang Z. (2024). \textit{The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.saa.2024.124600}{doi:10.1016/j.saa.2024.124600}.
\item Xu M, Kiss AJ, Jones JA, McMurray MS, Shi H. (2024). \textit{Effect of oral tryptamines on the gut microbiome of rats-a preliminary study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7717/peerj.17517}{doi:10.7717/peerj.17517}.
\item Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM. (2024). \textit{A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1387158}{doi:10.3389/fphar.2024.1387158}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Wells HG, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Jones JA, McMurray MS. (2024). \textit{Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/bph.16466}{doi:10.1111/bph.16466}.
\item Yaden DB, Gukasyan N, Nayak SM. (2024). \textit{Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4680}{doi:10.1001/jamapsychiatry.2023.4680}.
\item Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T. (2024). \textit{Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4685}{doi:10.1001/jamapsychiatry.2023.4685}.
\item Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11847495}{source link}.
\item Fried EI, Cristea IA, Naudet F. (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0420}{doi:10.1001/jamapsychiatry.2024.0420}.
\item Aaronson ST, van der Vaart A, Sackeim HA. (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0423}{doi:10.1001/jamapsychiatry.2024.0423}.
\item Parker C, Wood BM. (2024). \textit{At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE. (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Vohryzek J, Luppi A, Atasoy S, Deco G, Timmermann C, Carhart-Harris RL, Kringelbach ML. (2024). \textit{Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.30.596410}{doi:10.1101/2024.05.30.596410}.
\item Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD. (2024). \textit{Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2024.05.051}{doi:10.1016/j.jpsychires.2024.05.051}.
\item Brockett AT, Francis NA. (2024). \textit{Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1152/jn.00124.2024}{doi:10.1152/jn.00124.2024}.
\item Harris E (2024). \textit{Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days.}. JAMA. [published; PubMed]. \href{https://doi.org/10.1001/jama.2024.6733}{doi:10.1001/jama.2024.6733}.
\item Ghaznavi S, Bernardez LM, Stern TA. (2024). \textit{Medical Uses and Adverse Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/pcc.23f03652}{doi:10.4088/pcc.23f03652}.
\item Chopra H, Furnish T, Verduzco-Gutierrez M, Jevotovsky DS, Castellanos J. (2024). \textit{Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ccr3.8791}{doi:10.1002/ccr3.8791}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Unknown authors (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Aboharb F, Davoudian PA, Shao L, Liao C, Rzepka GN, Wojtasiewicz C, Indajang J, Dibbs M, Rondeau J, Sherwood AM, Kaye AP, Kwan AC. (2024). \textit{Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.23.590306}{doi:10.1101/2024.05.23.590306}.
\item Hoyer D. (2024). \textit{On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171648613.31141136/v1}{doi:10.22541/au.171648613.31141136/v1}.
\item Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB. (2024). \textit{Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2024.2357668}{doi:10.1080/09540261.2024.2357668}.
\item Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X. (2024). \textit{Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115960}{doi:10.1016/j.psychres.2024.115960}.
\item Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB. (2024). \textit{Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13063-024-08174-x}{doi:10.1186/s13063-024-08174-x}.
\item Korkmaz ND, Cikrikcili U, Akan M, Yucesan E. (2024). \textit{Psychedelic therapy in depression and substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.16421}{doi:10.1111/ejn.16421}.
\item Darke S, Duflou J, Peacock A, Farrell M, Hall W, Lappin J. (2024). \textit{A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.16518}{doi:10.1111/add.16518}.
\item Morris SL. (2024). \textit{A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.24.1180}{doi:10.9758/cpn.24.1180}.
\item Casanova AF, Ort A, Smallridge JW, Preller KH, Seifritz E, Vollenweider FX. (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Jackson ES, Goldway N, Gerlach-Houck H, Gold ND. (2024). \textit{Stutterers' experiences on classic psychedelics: A preliminary self-report study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jfludis.2024.106062}{doi:10.1016/j.jfludis.2024.106062}.
\item Marinis J, Clarke ST, Bedi G. (2024). \textit{Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4bk2p}{doi:10.31234/osf.io/4bk2p}.
\item Unknown authors (2024). \textit{Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4bk2p\_v1}{source link}.
\item Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.16.594614}{doi:10.1101/2024.05.16.594614}.
\item Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD. (2024). \textit{RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.4c00058}{doi:10.1021/acschemneuro.4c00058}.
\item Vina SM. (2024). \textit{Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40615-024-02023-y}{doi:10.1007/s40615-024-02023-y}.
\item Zeller M, Parent S, Schultheiss N. (2024). \textit{Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hy-droxy-N,N-di-methyl-tryptamine).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1107/s2056989024004201}{doi:10.1107/s2056989024004201}.
\item Yu Z, Burback L, Winkler O, Xu L, Dennett L, Vermetten E, Greenshaw A, Li XM, Milne M, Wang F, Cao B, Winship IR, Zhang Y, Chan AW. (2024). \textit{Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1386321}{doi:10.3389/fpsyt.2024.1386321}.
\item Viña S. (2024). \textit{Psychedelics Use and the Risk of Reduced Formal Mental Health Care}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4378944/v1}{doi:10.21203/rs.3.rs-4378944/v1}.
\item Jeffrey JK, Weintraub MJ, Grob CS. (2024). \textit{Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaac.2024.03.021}{doi:10.1016/j.jaac.2024.03.021}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D. (2024). \textit{Structural pharmacology and therapeutic potential of 5-methoxytryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41586-024-07403-2}{doi:10.1038/s41586-024-07403-2}.
\item Kargbo RB. (2024). \textit{Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00181}{doi:10.1021/acsmedchemlett.4c00181}.
\item University of Calgary (2024). \textit{Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05995769}{source link}.
\item Xenakis SN, Shannon SM. (2024). \textit{What is needed for the roll-out of psychedelic treatments?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000946}{doi:10.1097/yco.0000000000000946}.
\item Nayak SM, White SH, Hilbert SN, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2024). \textit{Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2346130}{doi:10.1080/02791072.2024.2346130}.
\item Woodburn SC, Levitt CM, Koester AM, Kwan AC. (2024). \textit{Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.04.592469}{doi:10.1101/2024.05.04.592469}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.02.592231}{doi:10.1101/2024.05.02.592231}.
\item Unknown authors (2024). \textit{EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.q1025}{doi:10.1136/bmj.q1025}.
\item Unknown authors (2024). \textit{PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38740403}{source link}.
\item Schmid Y, Bershad AK (2024). \textit{Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.001}{doi:10.1016/j.bpsc.2024.02.001}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2024). \textit{Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115880}{doi:10.1016/j.psychres.2024.115880}.
\item De Giorgi R, Ede R. (2024). \textit{Psilocybin for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.q798}{doi:10.1136/bmj.q798}.
\item Metaxa AM, Clarke M. (2024). \textit{Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078084}{doi:10.1136/bmj-2023-078084}.
\item Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N. (2024). \textit{New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41420-024-01974-9}{doi:10.1038/s41420-024-01974-9}.
\item Zeller M, Parent S, Schultheiss N. (2024). \textit{Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hy­droxy-N,N-di­methyl­tryptamine)}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11151301}{source link}.
\item Sakai K, Bradley ER, Zamaria JA, Agin-Liebes G, Kelley DP, Fish A, Martini V, Ferris MC, Morton E, Michalak EE, O'Donovan A, Woolley JD. (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Thomann J, Kolaczynska KE, Stoeckmann OV, Rudin D, Vizeli P, Hoener MC, Pryce CR, Vollenweider FX, Liechti ME, Duthaler U. (2024). \textit{In vitro and in vivo metabolism of psilocybin's active metabolite psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL. (2024). \textit{In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06598-6}{doi:10.1007/s00213-024-06598-6}.
\item Zhao X, Du Y, Yao Y, Dai W, Yin Y, Wang G, Li Y, Zhang L. (2024). \textit{Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241249436}{doi:10.1177/02698811241249436}.
\item Bellman V. (2024). \textit{Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cancers16091702}{doi:10.3390/cancers16091702}.
\item Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ. (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item University Hospital, Basel, Switzerland (2024). \textit{Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05384678}{source link}.
\item Whelan TP, Daly E, Puts NA, Smith P, Allison C, Baron-Cohen S, Malievskaia E, Murphy DGM, McAlonan GM. (2024). \textit{The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Seibold PS, Dörner S, Fricke J, Schäfer T, Beemelmanns C, Hoffmeister D. (2024). \textit{Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40694-024-00173-6}{doi:10.1186/s40694-024-00173-6}.
\item Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK. (2024). \textit{Do undergraduates’ views of psychedelics relate to the context for psychedelic use?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xnu5c}{doi:10.31234/osf.io/xnu5c}.
\item Pagni B, Petridis P, Podrebarac S, Grinband J, Claus E, Bogenschutz M. (2024). \textit{300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11033768}{source link}.
\item Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M. (2024). \textit{Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01005-z}{doi:10.1186/s40337-024-01005-z}.
\item Unknown authors (2024). \textit{Do undergraduates’ views of psychedelics relate to the context for psychedelic use?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xnu5c\_v1}{source link}.
\item Singer B, Meling D, Hirsch-Hoffmann M, Michels L, Kometer M, Smigielski L, Dornbierer D, Seifritz E, Vollenweider FX, Scheidegger M. (2024). \textit{Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-59897-5}{doi:10.1038/s41598-024-59897-5}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL. (2024). \textit{The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.19.590212}{doi:10.1101/2024.04.19.590212}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL. (2024). \textit{Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jmedchem.4c00082}{doi:10.1021/acs.jmedchem.4c00082}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG. (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2024). \textit{The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04630964}{source link}.
\item Lerer E, Botvinnik A, Shahar O, Grad M, Blakolmer K, Shomron N, Lotan A, Lerer B, Lifschytz T. (2024). \textit{Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1391412}{doi:10.3389/fphar.2024.1391412}.
\item Wang JR, Mendez Araque SJ, Micciche G, McMillan A, Coughlin E, Mattiola R, English D, Kaliebe K. (2024). \textit{Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1301960}{doi:10.3389/fpsyt.2024.1301960}.
\item Köhne S, Hillemacher T, Glahn A, Bach P. (2024). \textit{Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2024.2342951}{doi:10.1080/14728214.2024.2342951}.
\item Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC. (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Rahman SM, Salem Y, Hussain A. (2024). \textit{Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/derm.2023.0292}{doi:10.1089/derm.2023.0292}.
\item Hatfield SP, Thornton NL, Greenstien K, Glozier N. (2024). \textit{A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241240597}{doi:10.1177/00048674241240597}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R. (2024). \textit{Psychedelics and the 'inner healer': Myth or mechanism?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241239206}{doi:10.1177/02698811241239206}.
\item Norring SA, Spigarelli MG. (2024). \textit{The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/dddt.s443177}{doi:10.2147/dddt.s443177}.
\item Harari R, Chatterjee I, Getselter D, Elliott E. (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Maloney G, Ching T, Kichuk SA, Pittenger C, Kelmendi B. (2024). \textit{Mechanisms of therapeutic change after psychedelic treatment in OCD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115907}{doi:10.1016/j.psychres.2024.115907}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item Mortaheb S, Fort LD, Mason NL, Mallaroni P, Ramaekers JG, Demertzi A. (2024). \textit{Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.04.001}{doi:10.1016/j.bpsc.2024.04.001}.
\item Miller DR, Jacobs JT, Rockefeller A, Singer H, Bollinger IM, Conway J, Slot JC, Cliffel DE. (2024). \textit{Cultivation, chemistry, and genome of Psilocybe zapotecorum.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1556/2054.2023.00332}{doi:10.1556/2054.2023.00332}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. (2024). \textit{[Psychedelic psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38572715}{source link}.
\item University Health Network, Toronto (2024). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06341426}{source link}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Flynn LT, Zhu Y, Pittman BP, Cozzi NV, D'Souza DC. (2024). \textit{Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2024.122993}{doi:10.1016/j.jns.2024.122993}.
\item Wilson Lavonne, Babumon Muthiramalil T., Irvine William, Morrison Isaac, Foster Kimberly, Delgoda Rupika (2024). \textit{Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactions}. Drug Metabolism and Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1016/j.dmpk.2023.100829}{doi:10.1016/j.dmpk.2023.100829}.
\item Rucker JJ. (2024). \textit{Evidence versus expectancy: the development of psilocybin therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjb.2023.28}{doi:10.1192/bjb.2023.28}.
\item Simonsson O, Osika W, Stenfors CUD, Goldberg SB, Honk L, Hendricks PS (2024). \textit{Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723003082}{doi:10.1017/s0033291723003082}.
\item Gerlai R (2024). \textit{Magic mushroom and zebrafish: A new recipe?}. Lab animal. [published; PubMed]. \href{https://doi.org/10.1038/s41684-024-01350-1}{doi:10.1038/s41684-024-01350-1}.
\item Tolle HM, Farah JC, Mallaroni P, Mason NL, Ramaekers JG, Amico E. (2024). \textit{The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/netn\_a\_00349}{doi:10.1162/netn\_a\_00349}.
\item Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. (2024). \textit{Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2024.5960}{doi:10.1001/jamanetworkopen.2024.5960}.
\item Tap SC. (2024). \textit{The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13386}{doi:10.1111/adb.13386}.
\item Wilkes R, Roberts DM, Liknaitzky P, Brett J. (2024). \textit{The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15563650.2024.2346612}{doi:10.1080/15563650.2024.2346612}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS. (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Smedfors G, Jennysdotter Olofsgård F, Steinberg A, Waldenlind E, Ran C, Belin AC. (2024). \textit{Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14040348}{doi:10.3390/brainsci14040348}.
\item Hudspeth J, Rogge K, Dörner S, Müll M, Hoffmeister D, Rupp B, Werten S. (2024). \textit{Methyl transfer in psilocybin biosynthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-024-46997-z}{doi:10.1038/s41467-024-46997-z}.
\item Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y. (2024). \textit{Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115886}{doi:10.1016/j.psychres.2024.115886}.
\item Singer B, Meling D, Hirsch-Hoffmann M, Michels L, Kometer M, Smigielski L, Dornbierer D, Seifritz E, Vollenweider FX, Scheidegger M. (2024). \textit{Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-55726-x}{doi:10.1038/s41598-024-55726-x}.
\item Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R. (2024). \textit{Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241237870}{doi:10.1177/02698811241237870}.
\item University of Utah (2024). \textit{A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04522804}{source link}.
\item Hoener S, Wolfgang A, Nissan D, Howe E. (2024). \textit{Ethical considerations for psychedelic-assisted therapy in military clinical settings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/jme-2023-108943}{doi:10.1136/jme-2023-108943}.
\item Yang WQ, Li JX, He MQ, Wang SH, Zhu XY, Phurbu D, Yun JM, Zhao RL. (2024). \textit{Five New Species of Gymnopilus from Xizang Autonomous Region of China and Surrounding Areas.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof10030220}{doi:10.3390/jof10030220}.
\item Straumann I, Holze F, Becker AM, Ley L, Halter N, Liechti ME. (2024). \textit{Safety pharmacology of acute psilocybin administration in healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2024.104060}{doi:10.1016/j.nsa.2024.104060}.
\item Kulikov Aleksandr V., Zheleznyak Ilya Yu. (2024). \textit{Problems of Qualification of Trafficking in Plants and Plant Parts Containing Psychoactive Substances and Mushrooms Containing Psilocybin and (or) Psilocin}. Drug control. [published; Crossref]. \href{https://doi.org/10.18572/2072-4160-2024-1-23-26}{doi:10.18572/2072-4160-2024-1-23-26}.
\item Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK. (2024). \textit{The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0300501}{doi:10.1371/journal.pone.0300501}.
\item Song-Smith C, Jacobs E, Rucker J, Saint M, Cooke J, Schlosser M. (2024). \textit{UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2023-083595}{doi:10.1136/bmjopen-2023-083595}.
\item Strickland JC, Garcia-Romeu A, Johnson MW. (2024). \textit{The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0046}{doi:10.1089/psymed.2023.0046}.
\item Hibicke M, Billac G, Nichols CD. (2024). \textit{Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0037}{doi:10.1089/psymed.2023.0037}.
\item Robinson CL, Fonseca ACG, Diejomaoh EM, D'Souza RS, Schatman ME, Orhurhu V, Emerick T. (2024). \textit{Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/jpr.s439348}{doi:10.2147/jpr.s439348}.
\item Ho C, Crawford JR. (2024). \textit{Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bcr-2024-259721}{doi:10.1136/bcr-2024-259721}.
\item Çatal Y, Northoff G. (2024). \textit{Where do the symptoms come from in depression? Topography and dynamics matter.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/braincomms/fcae067}{doi:10.1093/braincomms/fcae067}.
\item Velit-Salazar MR, Shiroma PR, Cherian E. (2024). \textit{A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14030248}{doi:10.3390/brainsci14030248}.
\item Wood ME, Brown GJ, Karschner EL, Seither JZ, Brown JT, Knittel JL, Walterscheid JP. (2024). \textit{Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkae002}{doi:10.1093/jat/bkae002}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/mjt.0000000000001727}{doi:10.1097/mjt.0000000000001727}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Barnett BS, Arakelian M, Beebe D, Ontko J, Riegal C, Siu WO, Weleff J, Pope HG (2024). \textit{American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0036}{doi:10.1089/psymed.2023.0036}.
\item Amarnani AD, Free MF, Baweja R. (2024). \textit{Psilocybin and the Development of Serotonin Toxicity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/pcc.23cr03648}{doi:10.4088/pcc.23cr03648}.
\item Norred MA, Zuschlag ZD, Hamner MB. (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E. (2024). \textit{Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.02.089}{doi:10.1016/j.jad.2024.02.089}.
\item Hashimoto K. (2024). \textit{Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-024-01770-7}{doi:10.1007/s00406-024-01770-7}.
\item Farah R, Kerns AF, Murray AC, Holstege CP. (2024). \textit{Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jadohealth.2024.01.027}{doi:10.1016/j.jadohealth.2024.01.027}.
\item Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL. (2024). \textit{The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3941205/v1}{doi:10.21203/rs.3.rs-3941205/v1}.
\item Laabi S, LeMmon C, Vogel C, Chacon M, Jimenez VM. (2024). \textit{Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.intimp.2024.111753}{doi:10.1016/j.intimp.2024.111753}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Vandevelde M, Simoens A, Vandekerckhove B, Stevens C. (2024). \textit{Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d4md00043a}{doi:10.1039/d4md00043a}.
\item Bhatt KV, Weissman CR. (2024). \textit{The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s44184-023-00053-8}{doi:10.1038/s44184-023-00053-8}.
\item Szigeti B, Heifets BD. (2024). \textit{Expectancy Effects in Psychedelic Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.02.004}{doi:10.1016/j.bpsc.2024.02.004}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Golding P, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lotan A, Lerer L, Lerer B, Lifschytz T. (2024). \textit{Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02477-w}{doi:10.1038/s41380-024-02477-w}.
\item McAlpine RG, Sacchet MD, Simonsson O, Khan M, Krajnovic K, Morometescu L, Kamboj SK. (2024). \textit{Development of a digital intervention for psychedelic preparation (DIPP).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-54642-4}{doi:10.1038/s41598-024-54642-4}.
\item Agor D, Knettel BA, Daici K, Meanley S. (2024). \textit{The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cnur.2024.01.005}{doi:10.1016/j.cnur.2024.01.005}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B. (2024). \textit{Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1372373}{doi:10.3389/fpsyt.2024.1372373}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ. (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Fang S, Yang X, Zhang W. (2024). \textit{Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1359088}{doi:10.3389/fpsyt.2024.1359088}.
\item Vohryzek J, Cabral J, Lord LD, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2024). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/braincomms/fcae049}{doi:10.1093/braincomms/fcae049}.
\item Aaronson ST, Kozak Z. (2024). \textit{New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.medj.2024.01.014}{doi:10.1016/j.medj.2024.01.014}.
\item Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS. (2024). \textit{Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.medj.2024.01.005}{doi:10.1016/j.medj.2024.01.005}.
\item Shenvi RA. (2024). \textit{Natural Product Synthesis in the 21st Century: Beyond the Mountain Top.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acscentsci.3c01518}{doi:10.1021/acscentsci.3c01518}.
\item Kargbo RB. (2024). \textit{Pioneering Methods in Brain Optimization and Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00058}{doi:10.1021/acsmedchemlett.4c00058}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Silverstein BH, Kolbman N, Nelson A, Liu T, Guzzo P, Gilligan J, Lee U, Mashour GA, Vanini G, Pal D. (2024). \textit{Psilocybin induces dose-dependent changes in functional network organization in rat cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.02.09.579718}{doi:10.1101/2024.02.09.579718}.
\item Harlow AF, Hendricks PS, Leventhal AM, Barrington-Trimis JL. (2024). \textit{Psychedelic Microdosing among Young Adults from Southern California.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2313684}{doi:10.1080/02791072.2024.2313684}.
\item Yale University (2024). \textit{Repeat Dosing of Psilocybin in Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04218539}{source link}.
\item McAlpine RG, Blackburne G, Kamboj SK. (2024). \textit{Development and psychometric validation of a novel scale for measuring 'psychedelic preparedness'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-53829-z}{doi:10.1038/s41598-024-53829-z}.
\item Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2024). \textit{Effects of DMT on mental health outcomes in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-53363-y}{doi:10.1038/s41598-024-53363-y}.
\item Pagni BA, Petridis PD, Podrebarac SK, Grinband J, Claus ED, Bogenschutz MP. (2024). \textit{Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-52967-8}{doi:10.1038/s41598-024-52967-8}.
\item Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B. (2024). \textit{Psychedelics and sexual functioning: a mixed-methods study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-023-49817-4}{doi:10.1038/s41598-023-49817-4}.
\item Palamar JJ, Fitzgerald ND, Carr TH, Rutherford C, Keyes KM, Cottler LB. (2024). \textit{National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111086}{doi:10.1016/j.drugalcdep.2024.111086}.
\item Breeksema JJ, Niemeijer A, Krediet E, Karsten T, Kamphuis J, Vermetten E, van den Brink W, Schoevers R. (2024). \textit{Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-53188-9}{doi:10.1038/s41598-024-53188-9}.
\item Sandbrink JD, Johnson K, Gill M, Yaden DB, Savulescu J, Hannikainen IR, Earp BD. (2024). \textit{Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/21507740.2024.2303154}{doi:10.1080/21507740.2024.2303154}.
\item Dong L, Li L, Wu Y, Zhao X, Zhong H, Cheng X, Liu L, Cheng C, Ouyang M, Tao L. (2024). \textit{A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12529-024-10262-w}{doi:10.1007/s12529-024-10262-w}.
\item Rogers SA, Heller EA, Corder G. (2024). \textit{Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.02.04.578811}{doi:10.1101/2024.02.04.578811}.
\item Johns Hopkins University (2024). \textit{A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05242029}{source link}.
\item Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U. (2024). \textit{Effects of hallucinogenic drugs on the human heart.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1334218}{doi:10.3389/fphar.2024.1334218}.
\item Borissova A, Rucker JJ. (2024). \textit{The development of psilocybin therapy for treatment-resistant depression: an update.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjb.2023.25}{doi:10.1192/bjb.2023.25}.
\item Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM (2024). \textit{The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2023.2296968}{doi:10.1080/03007995.2023.2296968}.
\item Cho M, Rosenbaum D, Schneider E, Hales S. (2024). \textit{Letter to the Editor: Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2023.0668}{doi:10.1089/jpm.2023.0668}.
\item Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK. (2024). \textit{Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.arr.2024.102211}{doi:10.1016/j.arr.2024.102211}.
\item Holze F, Singh N, Liechti ME, D'Souza DC. (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Unknown authors (2024). \textit{Psychedelic psilocybin-assisted therapy reduces depressive symptoms in adults with cancer and depression.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38309742}{source link}.
\item Borkel LF, Rojas-Hernández J, Henríquez-Hernández LA, Santana Del Pino Á, Quintana-Hernández DJ. (2024). \textit{Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2023.2295997}{doi:10.1080/17512433.2023.2295997}.
\item Gojani EG, Wang B, Li DP, Kovalchuk O, Kovalchuk I. (2024). \textit{The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/genes15020183}{doi:10.3390/genes15020183}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-024-05502-y}{doi:10.1186/s12888-024-05502-y}.
\item University Hospital, Basel, Switzerland (2024). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04227756}{source link}.
\item Massachusetts General Hospital (2024). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05381974}{source link}.
\item Plourde L, Chang SL, Farzin H, Gagnon P, Hébert J, Foxman R, Deschamps P, Provost F, Masse-Grenier M, Stephan JF, Cheung K, Joly Y, Fallu JS, Dorval M, P3A Study Group. (2024). \textit{Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02692163231222430}{doi:10.1177/02692163231222430}.
\item Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R. (2024). \textit{Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291723003653}{doi:10.1017/s0033291723003653}.
\item Brockett AT, Francis NA. (2024). \textit{Psilocybin biphasically modulates cortical and behavioral activity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.18.576229}{doi:10.1101/2024.01.18.576229}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V. (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Imperial College London (2024). \textit{Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05548075}{source link}.
\item Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y. (2024). \textit{Older adults in psychedelic-assisted therapy trials: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231215420}{doi:10.1177/02698811231215420}.
\item Ghofrani-Jahromi Z, Nouri-Darehno S, Rahimi-Danesh M, Talaee N, Jasemi E, Razmi A, Vaseghi S. (2024). \textit{Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/bne0000579}{doi:10.1037/bne0000579}.
\item Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS. (2024). \textit{A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.01.142}{doi:10.1016/j.jad.2024.01.142}.
\item Braun D, Rosenberg AM, Rabaniam E, Haruvi R, Malamud D, Barbara R, Aiznkot T, Levavi-Sivan B, Kawashima T. (2024). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02391-7}{doi:10.1038/s41380-023-02391-7}.
\item Lo DF, Zia H, Rajkumar P, Thakur A, O'Donnell H. (2024). \textit{Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/pcc.23r03581}{doi:10.4088/pcc.23r03581}.
\item Hovmand OR, Ebbesen Jensen M, Søgaard Juul T, Korsbak Madsen M, MacDonald Fisher P, Siggaard Stenbæk D. (2024). \textit{Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2302186}{doi:10.1080/02791072.2024.2302186}.
\item Kaadt E, Søkilde R, Hansen H, Raval N, Lundgaard L, Just J, Knudsen G, Elfving B. (2024). \textit{MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brain}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3787179/v1}{doi:10.21203/rs.3.rs-3787179/v1}.
\item De Filippo R, Schmitz D. (2024). \textit{Synthetic surprise as the foundation of the psychedelic experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2024.105538}{doi:10.1016/j.neubiorev.2024.105538}.
\item Rouaud A, Calder AE, Hasler G. (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5rm62}{doi:10.31234/osf.io/5rm62}.
\item Unknown authors (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5rm62\_v1}{source link}.
\item E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM. (2024). \textit{Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2024.103938}{doi:10.1016/j.nsa.2024.103938}.
\item Reed F, Foldi CJ. (2024). \textit{Do the therapeutic effects of psilocybin involve actions in the gut?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2023.12.007}{doi:10.1016/j.tips.2023.12.007}.
\item Sekssaoui M, Bockaert J, Marin P, Bécamel C. (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Hinchcliffe JK, Stuart SA, Wood CM, Bartlett J, Kamenish K, Arban R, Thomas CW, Selimbeyoglu A, Hurley S, Hengerer B, Gilmour G, Robinson ESJ. (2024). \textit{Rapid-acting antidepressant drugs modulate affective bias in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/scitranslmed.adi2403}{doi:10.1126/scitranslmed.adi2403}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2024). \textit{Aesthetic chills mitigate maladaptive cognition in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-023-05476-3}{doi:10.1186/s12888-023-05476-3}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B. (2024). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item Bradshaw AJ, Ramírez-Cruz V, Awan AR, Furci G, Guzmán-Dávalos L, Dentinger BTM. (2024). \textit{Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.2311245121}{doi:10.1073/pnas.2311245121}.
\item Jones NT, Wagner L, Hahn MCP, Scarlett CO, Wenthur CJ. (2024). \textit{In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1303365}{doi:10.3389/fpsyt.2023.1303365}.
\item Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC. (2024). \textit{Psychedelic-like Activity of Norpsilocin Analogues.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.3c00610}{doi:10.1021/acschemneuro.3c00610}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. (2024). \textit{Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2024.01.002}{doi:10.1016/j.biopsych.2024.01.002}.
\item Johns Hopkins University (2024). \textit{Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05562973}{source link}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3829237/v1}{doi:10.21203/rs.3.rs-3829237/v1}.
\item Funk D, Araujo J, Slassi M, Lanthier J, Atkinson J, Feng D, Lau W, Lê A, Higgins GA. (2024). \textit{Effect of a single psilocybin treatment on Fos protein expression in male rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroscience.2024.01.001}{doi:10.1016/j.neuroscience.2024.01.001}.
\item Kolesnik E., Navarro M. López, Raval N.R., Ozenne B., Hansen H.D. (2023). \textit{Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2024.105133}{doi:10.1016/j.nsa.2024.105133}.
\item Gukasyan N, Narayan SK (2023). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Gonzales SAB, Alexopoulos C, Arkfeld DG. (2023). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Jacobs E, Murphy-Beiner A, Rouiller I, Nutt D, Spriggs MJ (2023). \textit{When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.}. Neuroethics. [published; PubMed]. \href{https://doi.org/10.1007/s12152-023-09536-z}{doi:10.1007/s12152-023-09536-z}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D. (2023). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Jerotic K, Vuust P, Kringelbach ML (2023). \textit{Psychedelia: The interplay of music and psychedelics.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15082}{doi:10.1111/nyas.15082}.
\item Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde JS, Nayak S, Johnson MW, Garcia-Romeu A (2023). \textit{IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106998}{doi:10.1016/j.phrs.2023.106998}.
\item Simonsson O, Hendricks PS, Stenfors CU, Goldberg SB, Honk L, Osika W (2023). \textit{Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231218931}{doi:10.1177/02698811231218931}.
\item O'Donnell KC, Anderson BT, Barrett FS, Bogenschutz MP, Grob CS, Hendricks PS, Kelmendi B, Nayak SM, Nicholas CR, Paleos CA, Stauffer CS, Gukasyan N. (2023). \textit{Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230661}{doi:10.1176/appi.ajp.20230661}.
\item Schenberg EE, King F, da Fonseca JE, Roseman L. (2023). \textit{Is Poorly Assisted Psilocybin Treatment an Increasing Risk?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230664}{doi:10.1176/appi.ajp.20230664}.
\item Earleywine M, De Leo J, Bhayana D, Rajanna B, Scott K. (2023). \textit{Psilocybin Without Psychotherapy: A Cart Without a Horse?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230572}{doi:10.1176/appi.ajp.20230572}.
\item Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB. (2023). \textit{Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230905}{doi:10.1176/appi.ajp.20230905}.
\item Smith WR, Sisti DA, Appelbaum PS. (2023). \textit{The safety of supported psilocybin use in Oregon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-023-02727-4}{doi:10.1038/s41591-023-02727-4}.
\item Madsen MK, Petersen AS, Stenbaek DS, Sørensen IM, Schiønning H, Fjeld T, Nykjaer CH, Larsen SMU, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM. (2023). \textit{CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/head.14656}{doi:10.1111/head.14656}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. (2023). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Cheung K, Earp BD, Yaden DB. (2023). \textit{Valuing the Acute Subjective Experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1353/pbm.2024.a919717}{doi:10.1353/pbm.2024.a919717}.
\item Ibi D. (2023). \textit{[Up-to-Date on clinical and preclinical studies of psilocybin therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.24007}{doi:10.1254/fpj.24007}.
\item Olivier B, Olivier JDA. (2023). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item Martire G, Sipple D, Baron D, Gold MS, Lewandowski KU, Dennen CA, Sharafshah A, Elman I, Thanos PK, Modestino EJ, Badgaiyan RD, Pinhasov A, Bowirrat A, Makale M, Roy AK, Sunder K, Murphy KT, Mahajan S, Mahajan Y, Levin C, Blum K (2023). \textit{Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.}. Journal of addiction psychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39634920/}{source link}.
\item Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P (2023). \textit{Keeping the promise: a critique of the current state of microdosing research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1217102}{doi:10.3389/fpsyt.2024.1217102}.
\item Glynos NG, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P (2023). \textit{Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1349565}{doi:10.3389/fpsyt.2024.1349565}.
\item Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT (2023). \textit{Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201244}{doi:10.1080/02791072.2023.2201244}.
\item Žuljević MF, Breški N, Kaliterna M, Hren D (2023). \textit{Attitudes of European psychiatrists on psychedelics: a qualitative study.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1411234}{doi:10.3389/fpsyt.2024.1411234}.
\item DeBonis K (2023). \textit{Revisiting psychiatry's relationship with spirituality.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1441922}{doi:10.3389/fpsyt.2024.1441922}.
\item Amberger C, Szczesniak L (2023). \textit{[The nursing role in psychedelic-assisted psychotherapy].}. Revue de l'infirmiere. [published; PubMed]. \href{https://doi.org/10.1016/j.revinf.2024.07.014}{doi:10.1016/j.revinf.2024.07.014}.
\item Armand S, Larsen K, Madsen MK, Ozenne B, Preller KH, Knudsen GM, Stenbæk DS, Fisher PM. (2023). \textit{Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2023.103934}{doi:10.1016/j.nsa.2023.103934}.
\item Danias G, Appel J. (2023). \textit{Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2196/43850}{doi:10.2196/43850}.
\item Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM. (2023). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3474764/v1}{doi:10.21203/rs.3.rs-3474764/v1}.
\item Fletcher PJ, Li Z, Ji XD, Lê AD. (2023). \textit{Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2023.173703}{doi:10.1016/j.pbb.2023.173703}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/byms6}{doi:10.31234/osf.io/byms6}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Multidisciplinary Association for Psychedelic Studies (2023). \textit{Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00979693}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/byms6\_v1}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Śladowska K, Kawalec P, Brzostek T, Pilc A. (2023). \textit{Potential use of psilocybin drugs in the treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2023.2264180}{doi:10.1080/14728214.2023.2264180}.
\item Wojtas A, Gołembiowska K. (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Gomonit MM, Skillman B, Swortwood MJ. (2023). \textit{Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1556-4029.15454}{doi:10.1111/1556-4029.15454}.
\item Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F. (2023). \textit{Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.12.006}{doi:10.1016/j.euroneuro.2023.12.006}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010100}{doi:10.3390/ijms25010100}.
\item Nogueira GN, Vasconcelos MMA, Souza FGM, Bisol LW. (2023). \textit{Is there credible evidence to assert psilocybin-assisted therapy for depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.11.003}{doi:10.1016/j.euroneuro.2023.11.003}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. (2023). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Steward T. (2023). \textit{Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.molmed.2023.12.001}{doi:10.1016/j.molmed.2023.12.001}.
\item Goff R, Smith M, Islam S, Sisley S, Ferguson J, Kuzdzal S, Badal S, Kumar AB, Sreenivasan U, Schug KA. (2023). \textit{Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.aca.2023.342161}{doi:10.1016/j.aca.2023.342161}.
\item Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders JJ, Ljuslin M, Guérin B, Thambi P, Tulsky JA, Agrawal M. (2023). \textit{Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.35024}{doi:10.1002/cncr.35024}.
\item Thrul J, Kozak Z, Carducci MA, Garcia-Romeu A, Yaden DB. (2023). \textit{Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.35127}{doi:10.1002/cncr.35127}.
\item Agrawal M, Richards W, Beaussant Y, Shnayder S, Ameli R, Roddy K, Stevens N, Richards B, Schor N, Honstein H, Jenkins B, Bates M, Thambi P. (2023). \textit{Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.35010}{doi:10.1002/cncr.35010}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02981173}{source link}.
\item Robinson GI, Li D, Wang B, Rahman T, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I. (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM. (2023). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item Reinwald JR, Schmitz CN, Skorodumov I, Kuchar M, Weber-Fahr W, Spanagel R, Meinhardt MW. (2023). \textit{Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-023-02690-1}{doi:10.1038/s41398-023-02690-1}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A. (2023). \textit{Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0035}{doi:10.1089/psymed.2023.0035}.
\item Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ. (2023). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0018}{doi:10.1089/psymed.2023.0018}.
\item Brennan W, Kelman AR, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0007}{doi:10.1089/psymed.2023.0007}.
\item Nicholas CR, Horton DM, Malicki J, Baltes A, Hutson PR, Brown RT. (2023). \textit{Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0012}{doi:10.1089/psymed.2023.0012}.
\item Trần Nguyên Hà, Đặng Đức Khanh, Phạm Đức Trọng, Nguyễn Xuân Trường (2023). \textit{CHIẾT XUẤT PSILOCIN TỪ NẤM THỨC THẦN LÀM NGUYÊN LIỆU THIẾT LẬP CHUẨN}. Tạp chí Y học Quân sự. [published; Crossref]. \href{https://doi.org/10.59459/1859-1655/jmm.282}{doi:10.59459/1859-1655/jmm.282}.
\item Unknown authors (2023). \textit{Drugs for depressionr.}. The Medical letter on drugs and therapeutics. [published; PubMed]. \href{https://doi.org/10.58347/tml.2023.1691a}{doi:10.58347/tml.2023.1691a}.
\item Foster K, Morrison I, Tyler M, Delgoda R. (2023). \textit{The effect of casing and gypsum on the yield and psychoactive tryptamine content of Psilocybe cubensis (Earle) Singer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.funbio.2023.12.001}{doi:10.1016/j.funbio.2023.12.001}.
\item Starkey J, Carhart-Harris RL, Pigorini A, Nobili L, Barrett AB. (2023). \textit{Statistical diversity distinguishes global states of consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.05.570101}{doi:10.1101/2023.12.05.570101}.
\item Marseille E, Stauffer CS, Agrawal M, Thambi P, Roddy K, Mithoefer M, Bertozzi SM, Kahn JG. (2023). \textit{Group psychedelic therapy: empirical estimates of cost-savings and improved access.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1293243}{doi:10.3389/fpsyt.2023.1293243}.
\item Kolasa M, Faron-Górecka A (2023). \textit{Preclinical models of treatment-resistant depression: challenges and perspectives.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00542-9}{doi:10.1007/s43440-023-00542-9}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Boudreau E, Orlowski K. (2023). \textit{Psilocybin therapy to reduce depression following a terminal diagnosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/01.jaa.0000994952.07847.2d}{doi:10.1097/01.jaa.0000994952.07847.2d}.
\item Ahlskog G. (2023). \textit{Psilocybin's Erasure of EGO.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1521/prev.2023.110.4.457}{doi:10.1521/prev.2023.110.4.457}.
\item McTaggart AR, McLaughlin S, Slot JC, McKernan K, Appleyard C, Bartlett TL, Weinert M, Barlow C, Warne LN, Shuey LS, Drenth A, James TY. (2023). \textit{Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2023.10.059}{doi:10.1016/j.cub.2023.10.059}.
\item Cardoso MS, da Cunha KF, Silva IG, Fiorentin TR, de Campos EG, Costa JL. (2023). \textit{Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkad064}{doi:10.1093/jat/bkad064}.
\item Kolbman N, Liu T, Guzzo P, Gilligan J, Mashour GA, Vanini G, Pal D. (2023). \textit{Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2023.10.016}{doi:10.1016/j.cub.2023.10.016}.
\item Duan W, Cao D, Wang S, Cheng J. (2023). \textit{Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM. (2023). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item Apex Labs Ltd. (2023). \textit{A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06141876}{source link}.
\item Waldbillig A, Baranova M, Neumann S, Andrade J, Sidhu S. (2023). \textit{Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/ffunb.2023.1295223}{doi:10.3389/ffunb.2023.1295223}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2023). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item van der Schuur-Saleem R, Visser E, Robben H, Zwols M, den Besten-Berthololee D. (2023). \textit{[Feeling unwell after eating a piece of chocolate].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38175555}{source link}.
\item Geyer MA. (2023). \textit{A Brief Historical Overview of Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item McAlpine R, Krajnović K, Khan M, Morometescu L, Simonsson O, Sacchet M, Kamboj S. (2023). \textit{Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9ev27}{doi:10.31234/osf.io/9ev27}.
\item Unknown authors (2023). \textit{Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9ev27\_v1}{source link}.
\item Tasker NR, Pazur EJ, Wipf P. (2023). \textit{Biological studies of clavine alkaloids targeting CNS receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1286941}{doi:10.3389/fpsyt.2023.1286941}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, Dhananjaya D, Jensen G, Lee JB, Cai C, Gallant J, Bains J, Tucker JE, Facchini PJ. (2023). \textit{Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jmedchem.3c01225}{doi:10.1021/acs.jmedchem.3c01225}.
\item McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording W, Lloyd R, Shuey L, Drenth A, James T. (2023). \textit{Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.170019739.91075425/v1}{doi:10.22541/au.170019739.91075425/v1}.
\item Hovmand OR, Poulsen ED, Arnfred S. (2023). \textit{Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231200019}{doi:10.1177/02698811231200019}.
\item Hernandez-Leon A, Escamilla-Orozco RI, Tabal-Robles AR, Martínez-Vargas D, Romero-Bautista L, Escamilla-Soto G, González-Romero OS, Torres-Valencia M, González-Trujano ME. (2023). \textit{Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jep.2023.117415}{doi:10.1016/j.jep.2023.117415}.
\item Bahji A, Lunsky I, Gutierrez G, Vazquez G. (2023). \textit{Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2278586}{doi:10.1080/02791072.2023.2278586}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2023). \textit{Aesthetic Chills Mitigate Maladaptive Cognition In Depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3582420/v1}{doi:10.21203/rs.3.rs-3582420/v1}.
\item Kvam TM, Uthaug MV, Andersen KAA, Refsum BB, Tunstad PA, Stewart LH, Jacobsen HB, Grønnerød C. (2023). \textit{Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1287196}{doi:10.3389/fpsyt.2023.1287196}.
\item Raj P, Rauniyar S, Sapkale B. (2023). \textit{Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.48719}{doi:10.7759/cureus.48719}.
\item Wolinsky D, Barrett FS, Vandrey R. (2023). \textit{The psychedelic effects of cannabis: A review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04739865}{source link}.
\item Rosas FE, Mediano PA, Timmermann C, Luppi AI, Candia-Rivera D, Abbasi-Asl R, Gazzaley A, Kringelbach ML, Muthukumaraswamy S, Bor D, Garfinkel S, Carhart-Harris RL. (2023). \textit{The entropic heart: Tracking the psychedelic state via heart rate dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.11.07.566008}{doi:10.1101/2023.11.07.566008}.
\item Heresco-Levy U, Lerer B. (2023). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A. (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ. (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Iorgu AM, Vasilescu AN, Pfeiffer N, Spanagel R, Mallien AS, Inta D, Gass P. (2023). \textit{Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-023-01699-3}{doi:10.1007/s00406-023-01699-3}.
\item Van Der Walt J, Parker R. (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Žuljević MF, Mijatović A, Marušić SL, Kudrjavets G, Buljan I, Hren D. (2023). \textit{Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2274382}{doi:10.1080/02791072.2023.2274382}.
\item Schäfer E, Seibold PS, Bartram S, Trottmann F, Haensch VG, Gressler M, Chadeayne AR, Hertweck C, O'Connor SE, Hoffmeister D (2023). \textit{A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202300511}{doi:10.1002/cbic.202300511}.
\item Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST. (2023). \textit{Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drudis.2023.103818}{doi:10.1016/j.drudis.2023.103818}.
\item Miller DR, Jacobs JT, Rockefeller A, Singer H, Bollinger IM, Conway J, Slot JC, Cliffel DE. (2023). \textit{Cultivation, chemistry, and genome of Psilocybe zapotecorum}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.11.01.564784}{doi:10.1101/2023.11.01.564784}.
\item Filer CN. (2023). \textit{The remarkable reimagining of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14786419.2023.2272285}{doi:10.1080/14786419.2023.2272285}.
\item Muller S, Cavanna F, de la Fuente L, Bruno N, D’Amelio TA, Pallavicini C, Tagliazucchi E. (2023). \textit{Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.27.564413}{doi:10.1101/2023.10.27.564413}.
\item Olafsson RP, Kvaran K, Ketilsdottir K, Hallgrimsdottir K, Sigurdsson EL, Sigurdsson E. (2023). \textit{[Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17992/lbl.2023.11.766}{doi:10.17992/lbl.2023.11.766}.
\item Liu LQ, Chen JZ, Fu WS, Tang CY. (2023). \textit{[Determination of amanita peptide and tryptamine toxins in wild mushrooms by high performance liquid chromatography-tandem mass spectrometry].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3724/sp.j.1123.2023.07013}{doi:10.3724/sp.j.1123.2023.07013}.
\item Gray JC, Murphy M, Carter SE, Johnson MW, Wolfgang AS, Roy MJ, Maples-Keller JL. (2023). \textit{Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/milmed/usac400}{doi:10.1093/milmed/usac400}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. (2023). \textit{Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Stocker K, Hartmann M, Ley L, Becker AM, Holze F, Liechti ME. (2023). \textit{The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231199112}{doi:10.1177/02698811231199112}.
\item Kaminski D, Reinert JP. (2023). \textit{The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280231205645}{doi:10.1177/10600280231205645}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Unknown authors (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00210-023-02778-x}{doi:10.1007/s00210-023-02778-x}.
\item Wsół A. (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS. (2023). \textit{Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.19.563138}{doi:10.1101/2023.10.19.563138}.
\item Rahbarnia A, Li Z, Fletcher PJ. (2023). \textit{Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Malikowska-Racia N, Koniewski M, Golebiowska J, Popik P. (2023). \textit{Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231205692}{doi:10.1177/02698811231205692}.
\item Watford T, Masood N. (2023). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M, Lowe MX, Jackson H, Garcia-Romeu A. (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hm6jn}{doi:10.31234/osf.io/hm6jn}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M, Lowe MX, Jackson H, Garcia-Romeu A. (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hm6jn\_v1}{doi:10.31234/osf.io/hm6jn\_v1}.
\item Rieser NM, Gubser LP, Moujaes F, Duerler P, Lewis CR, Michels L, Vollenweider FX, Preller KH. (2023). \textit{Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-023-44153-z}{doi:10.1038/s41598-023-44153-z}.
\item Unknown authors (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hm6jn\_v1}{source link}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03806985}{source link}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03341689}{source link}.
\item Keeler JL, Kan C, Treasure J, Himmerich H. (2023). \textit{Novel treatments for anorexia nervosa: Insights from neuroplasticity research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/erv.3039}{doi:10.1002/erv.3039}.
\item Enriquez-Geppert S, Krc J, O'Higgins F, Lietz MP. (2023). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/jqasf}{doi:10.31234/osf.io/jqasf}.
\item Unknown authors (2023). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/jqasf\_v1}{source link}.
\item Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115531}{doi:10.1016/j.psychres.2023.115531}.
\item Card KG, Grewal A, Closson K, Martin G, Baracaldo L, Allison S, Kruger DJ, Walsh Z. (2023). \textit{Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2268640}{doi:10.1080/02791072.2023.2268640}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S. (2023). \textit{An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40814-023-01399-8}{doi:10.1186/s40814-023-01399-8}.
\item Ko K, Carter B, Cleare AJ, Rucker JJ. (2023). \textit{Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s426193}{doi:10.2147/ndt.s426193}.
\item Linguiti S, Vogel JW, Sydnor VJ, Pines A, Wellman N, Basbaum A, Eickhoff CR, Eickhoff SB, Edwards RR, Larsen B, McKinstry-Wu A, Scott JC, Roalf DR, Sharma V, Strain EC, Corder G, Dworkin RH, Satterthwaite TD. (2023). \textit{Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105421}{doi:10.1016/j.neubiorev.2023.105421}.
\item Müller T. (2023). \textit{Psilocybin kann offenbar Depressionen lindern.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-023-3025-6}{doi:10.1007/s15006-023-3025-6}.
\item Vejmola Cestmir, Syrová Kateřina, Šíchová Klára, Koudelka Vlastimil, Hubený Jan, Kluckova Tereza, Nikolic Marek, Kelemen Eduard, Páleníček Tomáš (2023). \textit{CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS}. IBRO Neuroscience Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1471}{doi:10.1016/j.ibneur.2023.08.1471}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. (2023). \textit{Neuroimaging in psychedelic drug development: past, present, and future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02271-0}{doi:10.1038/s41380-023-02271-0}.
\item University of New Mexico (2023). \textit{Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01534494}{source link}.
\item Chiu Y, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer K, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2023). \textit{A suite of engineered mice for interrogating psychedelic drug actions}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.25.559347}{doi:10.1101/2023.09.25.559347}.
\item Carter S, Packard G, Coghlan C, George JR, Brown AJ, Ching THW, Julian J, Maples-Keller JL. (2023). \textit{Perceptions of psychedelic-assisted therapy among Black Americans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.xjmad.2023.100023}{doi:10.1016/j.xjmad.2023.100023}.
\item Kelly TJ, Bonniwell EM, Mu L, Liu X, Hu Y, Friedman V, Yu H, Su W, McCorvy JD, Liu QS. (2023). \textit{Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-023-01744-8}{doi:10.1038/s41386-023-01744-8}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202309.1649.v1}{doi:10.20944/preprints202309.1649.v1}.
\item Padawer-Curry JA, Krentzman OJ, Kuo C, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ. (2023). \textit{Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.23.559145}{doi:10.1101/2023.09.23.559145}.
\item Halim HJ, Burk BG, Fargason RE, Birur B. (2023). \textit{Manic episode following psilocybin use in a man with bipolar II disorder: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1221131}{doi:10.3389/fpsyt.2023.1221131}.
\item Milan Scheidegger (2023). \textit{Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05780216}{source link}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Black T. (2023). \textit{Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the "high-risk" addiction patient.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1159843}{doi:10.3389/fpsyt.2023.1159843}.
\item Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A. (2023). \textit{Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1199642}{doi:10.3389/fpsyt.2023.1199642}.
\item Mortaheb S, Fort LD, Mason NL, Mallaroni P, Ramaekers JG, Demertzi A. (2023). \textit{Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.18.558309}{doi:10.1101/2023.09.18.558309}.
\item Heinzerling KG, Sergi K, Linton M, Rich R, Youssef B, Bentancourt I, Bramen J, Siddarth P, Schwartzberg L, Kelly DF. (2023). \textit{Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1215972}{doi:10.3389/fpsyt.2023.1215972}.
\item Tyagi R, Saraf TS, Canal CE. (2023). \textit{The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.3c00137}{doi:10.1021/acsptsci.3c00137}.
\item Kargbo RB. (2023). \textit{Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00390}{doi:10.1021/acsmedchemlett.3c00390}.
\item Lobe Sciences Ltd. (2023). \textit{Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06035900}{source link}.
\item Bhuiya NMA, Jacobs RJ, Wang K, Sun Y, Nava B, Sampiere L, Yerubandi A, Caballero J. (2023). \textit{Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.45169}{doi:10.7759/cureus.45169}.
\item Pagán AF, Lex C, Soares JC, Meyer TD. (2023). \textit{Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0022}{doi:10.1089/psymed.2023.0022}.
\item Wolfgang AS, Hoge CW. (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Zhang R, Anguiano M, Aarrestad IK, Lin S, Chandra J, Vadde SS, Olson DE, Kim CK. (2023). \textit{Rapid, biochemical tagging of cellular activity history in vivo}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.06.556431}{doi:10.1101/2023.09.06.556431}.
\item Syed OA, Tsang B, Gerlai R. (2023). \textit{The zebrafish for preclinical psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Mason NL, Szabo A, Kuypers KPC, Mallaroni PA, de la Torre Fornell R, Reckweg JT, Tse DHY, Hutten NRPW, Feilding A, Ramaekers JG. (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Costa A.M., Silva-Carvalho M., Madureira-Carvalho A., Dinis-Oliveira R.J., Dias-da-Silva D. (2023). \textit{P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro study}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/s0378-4274(23)00499-x}{doi:10.1016/s0378-4274(23)00499-x}.
\item Szigeti B, Phillips LD, Nutt D (2023). \textit{Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.}. British journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bcp.15841}{doi:10.1111/bcp.15841}.
\item Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA. (2023). \textit{Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000729}{doi:10.1097/pra.0000000000000729}.
\item Dubus Z, Grandgeorge E, Verroust V. (2023). \textit{History of the administration of psychedelics in France.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2023.1131565}{doi:10.3389/fpsyg.2023.1131565}.
\item Miller M, Rosa WE, Doerner Rinaldi A, Addicott K, Spence D, Beaussant Y (2023). \textit{Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0009}{doi:10.1089/psymed.2022.0009}.
\item Kiilerich KF, Lorenz J, Scharff MB, Speth N, Brandt TG, Czurylo J, Xiong M, Jessen NS, Casado-Sainz A, Shalgunov V, Kjaerby C, Satała G, Bojarski AJ, Jensen AA, Herth MM, Cumming P, Overgaard A, Palner M. (2023). \textit{Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02280-z}{doi:10.1038/s41380-023-02280-z}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH. (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. (2023). \textit{Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.2023.14530}{doi:10.1001/jama.2023.14530}.
\item Attia E, Steinglass JE. (2023). \textit{Psilocybin for anorexia nervosa: If it helps, let's learn how.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.medj.2023.08.003}{doi:10.1016/j.medj.2023.08.003}.
\item Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S (2023). \textit{Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0030}{doi:10.1089/psymed.2023.0030}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP. (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ. (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Kovacevich A, Weleff J, Claytor B, Barnett BS. (2023). \textit{Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2253538}{doi:10.1080/02791072.2023.2253538}.
\item Videira NB, Nair V, Paquet V, Calhoun D. (2023). \textit{The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jat.4533}{doi:10.1002/jat.4533}.
\item Kolbman N, Liu T, Guzzo P, Gilligan JP, Mashour GA, Vanini G, Pal D. (2023). \textit{Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic pain}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.08.26.554802}{doi:10.1101/2023.08.26.554802}.
\item Jones G, Al-Suwaidi M, Castro-Ramirez F, McGuire TC, Mair P, Nock MK. (2023). \textit{Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1169692}{doi:10.3389/fpsyt.2023.1169692}.
\item Siegel JS, Subramanian S, Perry D, Kay B, Gordon E, Laumann T, Reneau R, Gratton C, Horan C, Metcalf N, Chacko R, Schweiger J, Wong D, Bender D, Padawer-Curry J, Raison C, Raichle M, Lenze EJ, Snyder AZ, Dosenbach NU, Nicol G. (2023). \textit{Psilocybin desynchronizes brain networks}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.08.22.23294131}{doi:10.1101/2023.08.22.23294131}.
\item Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI. (2023). \textit{Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2251133}{doi:10.1080/02791072.2023.2251133}.
\item Dougherty RF, Clarke P, Atli M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin GM, Ryslik GA. (2023). \textit{Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-023-06432-5}{doi:10.1007/s00213-023-06432-5}.
\item Zeifman RJ, Kettner H, Pagni BA, Mallard A, Roberts DE, Erritzoe D, Ross S, Carhart-Harris RL. (2023). \textit{Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-023-40856-5}{doi:10.1038/s41598-023-40856-5}.
\item Abrams SK, Rabinovitch BS, Zafar R, Aziz AS, Cherup NP, McMillan DW, Nielson JL, Lewis EC. (2023). \textit{Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/neur.2023.0022}{doi:10.1089/neur.2023.0022}.
\item Palamar JJ, Rutherford C, Le A, Keyes KM. (2023). \textit{Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2240322}{doi:10.1080/02791072.2023.2240322}.
\item Cavarra M, Mason NL, Kuypers KPC, Bonnelle V, Smith WJ, Feilding A, Kryskow P, Ramaekers JG. (2023). \textit{Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ejp.2171}{doi:10.1002/ejp.2171}.
\item Escamilla R, González-Trujano ME, González Mariscal JM, Torres-Valencia JM, Guzmán-González H, Vega JL, Loizaga-Velder A. (2023). \textit{A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2246459}{doi:10.1080/02791072.2023.2246459}.
\item Crowe M, Manuel J, Carlyle D, Lacey C. (2023). \textit{Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/inm.13214}{doi:10.1111/inm.13214}.
\item Gramling R, Bennett E, Curtis K, Richards W, Rizzo DM, Arnoldy F, Hegg L, Porter J, Honstein H, Pratt S, Tarbi E, Reblin M, Thambi P, Agrawal M. (2023). \textit{Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2023.0189}{doi:10.1089/jpm.2023.0189}.
\item Rebecchi K. (2023). \textit{“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/c9fpj}{doi:10.31234/osf.io/c9fpj}.
\item Unknown authors (2023). \textit{“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/c9fpj\_v1}{source link}.
\item Usona Institute (2023). \textit{A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05478278}{source link}.
\item Robinson GI, Li D, Wang B, Zahoruiko Y, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I. (2023). \textit{Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cimb45080427}{doi:10.3390/cimb45080427}.
\item Thase ME. (2023). \textit{Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.mulmdd3048sho}{doi:10.4088/jcp.mulmdd3048sho}.
\item Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R. (2023). \textit{The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190865}{doi:10.1177/02698811231190865}.
\item Jones G, Herrmann F, Wang E. (2023). \textit{Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.abrep.2023.100513}{doi:10.1016/j.abrep.2023.100513}.
\item Jordan A. (2023). \textit{Emerging Perspectives in Addiction Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp. muladx3048sho}{doi:10.4088/jcp. muladx3048sho}.
\item Bonny-Noach H, Shapira B, Baumol P, Tadmor N, Rosca P, Shoshan S, Harel-Fisch Y, Caduri A. (2023). \textit{Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12954-023-00845-3}{doi:10.1186/s12954-023-00845-3}.
\item Downey AE, Boyd M, Chaphekar AV, Woolley J, Raymond-Flesch M. (2023). \textit{"But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/eat.24041}{doi:10.1002/eat.24041}.
\item Yaniv D, Ramondetta LM, Cohen L, Amit M. (2023). \textit{Psilocybin-assisted psychotherapy for cancer-related anxiety and depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/ijgc-2023-004659}{doi:10.1136/ijgc-2023-004659}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.07.011}{doi:10.1016/j.euroneuro.2023.07.011}.
\item Schindler EAD. (2023). \textit{The Potential of Psychedelics for the Treatment of Episodic Migraine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-023-01145-y}{doi:10.1007/s11916-023-01145-y}.
\item Mamat R, Rashid RA, Shin SM, Ibrahim B, Wahab S, Ahmad A. (2023). \textit{Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/10550887.2023.2240932}{doi:10.1080/10550887.2023.2240932}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Razidlo J, Banks MI, Wenthur CJ. (2023). \textit{Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.3c00123}{doi:10.1021/acsptsci.3c00123}.
\item Jing X, Hoeh NR, Menkes DB. (2023). \textit{Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152300069x}{doi:10.1017/s147895152300069x}.
\item Majić T, Ehrlich S. (2023). \textit{Psilocybin for the treatment of anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-023-02458-6}{doi:10.1038/s41591-023-02458-6}.
\item Ibrahim IB, Videbech P, Straszek SPV. (2023). \textit{Psychedelic drugs in the treatment of psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37615227}{source link}.
\item Korman BA. (2023). \textit{On the mushrooming reports of "quiet quitting": Employees' lifetime psilocybin use predicts their overtime hours worked.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2242358}{doi:10.1080/02791072.2023.2242358}.
\item Brain and Cognition Discovery Foundation (2023). \textit{The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05029466}{source link}.
\item Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S. (2023). \textit{“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3189970/v1}{doi:10.21203/rs.3.rs-3189970/v1}.
\item The Roots to Thrive Society for Psychedelic Therapy (2023). \textit{An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05958758}{source link}.
\item Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM, Ortiz A, Kloiber S, Wang W, Rosenblat JD, Mulsant BH. (2023). \textit{Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2023.535}{doi:10.1192/bjo.2023.535}.
\item Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, Finn DM, Kaye WH. (2023). \textit{Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-023-02455-9}{doi:10.1038/s41591-023-02455-9}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A. (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB. (2023). \textit{Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115349}{doi:10.1016/j.psychres.2023.115349}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lerer L, Lerer B, Lifschytz T. (2023). \textit{Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3146433/v1}{doi:10.21203/rs.3.rs-3146433/v1}.
\item Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E. (2023). \textit{Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10595939}{source link}.
\item Husain M, Blumberger D, Castle D, Kloiber S, Ortiz A, Rosenblat J, Mulsant B. (2023). \textit{A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660879}{source link}.
\item Kuypers K. (2023). \textit{Psychedelics for depression: from neurobiology to treatment}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10417770}{source link}.
\item Sousa R, Costa L, Brás J, Vaz R, Martins J, Abreu J, Almeida E, Castro N, Andrade R, Cunha N. (2023). \textit{Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10596667}{source link}.
\item Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E. (2023). \textit{The therapeutic potential of psilocybin in depression resistant to psychotropic drugs}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10479004}{source link}.
\item Bhanot S, Lin M, Bains S, Monroe A, Tsang V. (2023). \textit{A systematic review to assess the use of psilocybin in the treatment of headaches}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660046}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Zeiss R. (2023). \textit{Psilocybin as an antidepressant strategy - a review of safety aspects}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10405689}{source link}.
\item Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D. (2023). \textit{Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291723002039}{doi:10.1017/s0033291723002039}.
\item Unknown authors (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1089/psymed.2023.00071}{doi:10.1089/psymed.2023.00071}.
\item Brennan B, Kelman A, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2ab59}{doi:10.31234/osf.io/2ab59}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Moujaes F, Rieser NM, Phillips C, de Matos NMP, Brügger M, Dürler P, Smigielski L, Stämpfli P, Seifritz E, Vollenweider FX, Anticevic A, Preller KH. (2023). \textit{Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2023.07.003}{doi:10.1016/j.bpsc.2023.07.003}.
\item Davis AK, Timmermann C, Ortiz Bernal AM, Lancelotta R, Nayak S, Sepeda ND, Nikolaidis A, Griffiths RR. (2023). \textit{Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2232379}{doi:10.1080/02791072.2023.2232379}.
\item Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E. (2023). \textit{Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-023-01648-7}{doi:10.1038/s41386-023-01648-7}.
\item Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB. (2023). \textit{Must Psilocybin Always "Assist Psychotherapy"?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20221043}{doi:10.1176/appi.ajp.20221043}.
\item Nogrady B. (2023). \textit{Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.p1599}{doi:10.1136/bmj.p1599}.
\item Więckiewicz G, Stokłosa I, Stokłosa M, Więckiewicz W, Gorczyca P, Gondek TM. (2023). \textit{Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1184023}{doi:10.3389/fpsyt.2023.1184023}.
\item Chernoff T, Kliger B, Venturini DH. (2023). \textit{Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.53680/vertex.v34i160.463}{doi:10.53680/vertex.v34i160.463}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3138705/v1}{doi:10.21203/rs.3.rs-3138705/v1}.
\item Tetem J, Fischmann T, Möller TJ. (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztyxh}{doi:10.31234/osf.io/ztyxh}.
\item Cybin Therapeutics Inc. (2023). \textit{Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05594667}{source link}.
\item Unknown authors (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztyxh\_v1}{source link}.
\item Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ. (2023). \textit{Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231180276}{doi:10.1177/02698811231180276}.
\item McCulloch DE, Olsen AS, Ozenne B, Stenbaek DS, Armand S, Madsen MK, Knudsen GM, Fisher PM. (2023). \textit{Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.07.03.23292164}{doi:10.1101/2023.07.03.23292164}.
\item Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA. (2023). \textit{Psilocybin's effects on cognition and creativity: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231179801}{doi:10.1177/02698811231179801}.
\item Haridy R. (2023). \textit{Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-023-02093-8}{doi:10.1038/d41586-023-02093-8}.
\item McIntyre RS. (2023). \textit{Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2023.2248883}{doi:10.1080/14740338.2023.2248883}.
\item McIntyre RS. (2023). \textit{Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2023.2253144}{doi:10.1080/14740338.2023.2253144}.
\item Schindler EAD, Hendricks PS. (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Kozak Z, Johnson MW, Aaronson ST. (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Lawrence DW. (2023). \textit{Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37817818}{source link}.
\item Gwyther M, Aspell JE. (2023). \textit{Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8ncj6}{doi:10.31234/osf.io/8ncj6}.
\item Unknown authors (2023). \textit{Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8ncj6\_v1}{source link}.
\item Jachimowski A, Kucia K. (2023). \textit{Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12740/pp/150053}{doi:10.12740/pp/150053}.
\item Skosnik PD, Sloshower J, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC. (2023). \textit{Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231179800}{doi:10.1177/02698811231179800}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C. (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Halucenex Life Sciences Inc. (2023). \textit{Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05243329}{source link}.
\item De La Haye W, Walcott G, Eaton J, Beckford J, Greene J. (2023). \textit{Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1136990}{doi:10.3389/fpsyt.2023.1136990}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO. (2023). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Rakić V. (2023). \textit{Psilocybin: The most effective moral bio-enhancer?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/bioe.13196}{doi:10.1111/bioe.13196}.
\item Hecker L, kato k, Kleinhenz JMK, Shin Y, Papageorgiou J, Zarrabi A. (2023). \textit{Psilocybin decelerates cellular senescence}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2921423/v1}{doi:10.21203/rs.3.rs-2921423/v1}.
\item Cheung K, Patch K, Earp BD, Yaden DB. (2023). \textit{Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0963180123000270}{doi:10.1017/s0963180123000270}.
\item Zhornitsky S, Oliva HNP, Jayne LA, Allsop ASA, Kaye AP, Potenza MN, Angarita GA. (2023). \textit{Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1197890}{doi:10.3389/fpsyt.2023.1197890}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L. (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Tylš F, Vejmola Č, Koudelka V, Piorecká V, Kadeřábek L, Bochin M, Novák T, Kuchař M, Bendová Z, Brunovský M, Horáček J, Pálení Ček T. (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item Bienemann B, Barbosa AR, Cruz LVMD, Multedo M, Mograbi D. (2023). \textit{Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2226414}{doi:10.1080/02791072.2023.2226414}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G. (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Flower JE, Gibbons WJ, Adams AM, Wang X, Broude CN, Jones JA. (2023). \textit{"Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/bit.28480}{doi:10.1002/bit.28480}.
\item Nikolič M, Viktorin V, Zach P, Tylš F, Dudysová D, Janků K, Kopřivová J, Kuchař M, Brunovský M, Horáček J, Páleníček T. (2023). \textit{Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.04.019}{doi:10.1016/j.euroneuro.2023.04.019}.
\item Ratkovic G, Sosteric M, Sosteric T. (2023). \textit{A case-study evaluation of the "Copenhagen Music Program" for psilocybin-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2023.1156852}{doi:10.3389/fpsyg.2023.1156852}.
\item Lake S, Lucas P. (2023). \textit{The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0002}{doi:10.1089/psymed.2023.0002}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NLN, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2023). \textit{In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/sciadv.adf8332}{doi:10.1126/sciadv.adf8332}.
\item Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KPC, Ramaekers JG. (2023). \textit{Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.2958}{doi:10.1002/cpt.2958}.
\item Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P. (2023). \textit{HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpainsymman.2023.06.006}{doi:10.1016/j.jpainsymman.2023.06.006}.
\item Turkia M. (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/pw2tf}{doi:10.31234/osf.io/pw2tf}.
\item Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/auycp}{doi:10.31234/osf.io/auycp}.
\item Turkia M. (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/qyce5}{doi:10.31234/osf.io/qyce5}.
\item Unknown authors (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pw2tf\_v1}{source link}.
\item Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/auycp\_v1}{doi:10.31234/osf.io/auycp\_v1}.
\item Unknown authors (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/auycp\_v1}{source link}.
\item Unknown authors (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/qyce5\_v1}{source link}.
\item O'Grady C. (2023). \textit{No trip needed for psychedelics to lift mood?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adj1031}{doi:10.1126/science.adj1031}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine DG, Nayak SM. (2023). \textit{Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231179910}{doi:10.1177/02698811231179910}.
\item Keyes KM, Patrick ME. (2023). \textit{Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.16259}{doi:10.1111/add.16259}.
\item Nkadimeng SM, Steinmann CM, Eloff JN. (2023). \textit{Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202306.0362.v1}{doi:10.20944/preprints202306.0362.v1}.
\item Koning E, Brietzke E. (2023). \textit{Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.47626/2237-6089-2022-0597}{doi:10.47626/2237-6089-2022-0597}.
\item Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, Antenucci L, Kot EF, Goncharuk SA, Kaurinkoski K, Kuutti M, Fred SM, Elsilä LV, Sakson S, Cannarozzo C, Diniz CRAF, Seiffert N, Rubiolo A, Haapaniemi H, Meshi E, Nagaeva E, Öhman T, Róg T, Kankuri E, Vilar M, Varjosalo M, Korpi ER, Permi P, Mineev KS, Saarma M, Vattulainen I, Casarotto PC, Castrén E. (2023). \textit{Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-023-01316-5}{doi:10.1038/s41593-023-01316-5}.
\item Agin-Liebes G, Nielson EM, Zingman M, Kim K, Haas A, Owens LT, Rogers U, Bogenschutz M. (2023). \textit{Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/adb0000935}{doi:10.1037/adb0000935}.
\item Schmidt TT, Costines C, Tagliazucchi E, Millière R, Garrido JM, Cuiule JI. (2023). \textit{The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/45z7w}{doi:10.31234/osf.io/45z7w}.
\item Polito V, Liknaitzky P. (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3ykst\_v1}{doi:10.31234/osf.io/3ykst\_v1}.
\item Unknown authors (2023). \textit{The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/45z7w\_v1}{source link}.
\item Polito V, Liknaitzky P. (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3ykst}{doi:10.31234/osf.io/3ykst}.
\item Unknown authors (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/3ykst\_v1}{source link}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2023). \textit{Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.29.23290667}{doi:10.1101/2023.05.29.23290667}.
\item Benvenuti F, Colombo D, Soverchia L, Cannella N, Domi E, Ciccocioppo R. (2023). \textit{Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-023-06384-w}{doi:10.1007/s00213-023-06384-w}.
\item McCrone P, Fisher H, Knight C, Harding R, Schlag AK, Nutt DJ, Neill JC. (2023). \textit{Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291723001411}{doi:10.1017/s0033291723001411}.
\item Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D. (2023). \textit{Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291723001514}{doi:10.1017/s0033291723001514}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus Panaeolus}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND608043020}{source link}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Agrawal M, Emanuel E, Richards B, Richards W, Roddy K, Thambi P. (2023). \textit{Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamaoncol.2023.0351}{doi:10.1001/jamaoncol.2023.0351}.
\item Holoyda B. (2023). \textit{The Perilous Policy of Oregon's Psilocybin Services.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.29158/jaapl.230023-23}{doi:10.29158/jaapl.230023-23}.
\item Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD (2023). \textit{Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0011}{doi:10.1089/psymed.2022.0011}.
\item Rijsketic DR, Casey AB, Barbosa DAN, Zhang X, Hietamies TM, Ramirez-Ovalle G, Pomrenze MB, Halpern CH, Williams LM, Malenka RC, Heifets BD. (2023). \textit{UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-023-01613-4}{doi:10.1038/s41386-023-01613-4}.
\item Evens R, Schmidt ME, Majić T, Schmidt TT. (2023). \textit{The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253231172254}{doi:10.1177/20451253231172254}.
\item Brown O. (2023). \textit{Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.05.088}{doi:10.1016/j.jad.2023.05.088}.
\item Heal DJ, Smith SL, Belouin SJ, Henningfield JE. (2023). \textit{Psychedelics: Threshold of a Therapeutic Revolution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109610}{doi:10.1016/j.neuropharm.2023.109610}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Combat Stress (2023). \textit{Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05876481}{source link}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN. (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME. (2023). \textit{Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-023-01607-2}{doi:10.1038/s41386-023-01607-2}.
\item Qasim S, Zaheer Z, Jawad MY, Shad MU. (2023). \textit{Neurobiological Correlates of Psilocybin Response in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/pcc.22r03419}{doi:10.4088/pcc.22r03419}.
\item Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R. (2023). \textit{Acute psilocybin increased cortical activities in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item University of Wisconsin, Madison (2023). \textit{Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04842045}{source link}.
\item Fonseka LN, Woo BK. (2023). \textit{Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5498/wjp.v13.i5.182}{doi:10.5498/wjp.v13.i5.182}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A. (2023). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ. (2023). \textit{Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.16.540994}{doi:10.1101/2023.05.16.540994}.
\item Meyer M, Slot J. (2023). \textit{The evolution and ecology of psilocybin in nature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus Panaeolus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.heliyon.2023.e16338}{doi:10.1016/j.heliyon.2023.e16338}.
\item Davis O. (2023). \textit{Henri Michaux's program for the psychedelic humanities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2023.1152896}{doi:10.3389/fpsyg.2023.1152896}.
\item University of Wisconsin, Madison (2023). \textit{A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05467761}{source link}.
\item THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C, ZULLINO D. (2023). \textit{Exposure therapy under psilocybin for general anxiety disorder and claustrophobia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2859973/v1}{doi:10.21203/rs.3.rs-2859973/v1}.
\item Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A. (2023). \textit{Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.11.540409}{doi:10.1101/2023.05.11.540409}.
\item Purohit P, Dutta P, Roy PK. (2023). \textit{Empirically validated theoretical analysis of visual-spatial perception under change of nervous system arousal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fncom.2023.1136985}{doi:10.3389/fncom.2023.1136985}.
\item Kargbo RB. (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lerer B, Lifschytz T. (2023). \textit{Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-023-02456-9}{doi:10.1038/s41398-023-02456-9}.
\item Kisely S. (2023). \textit{The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674231174171}{doi:10.1177/00048674231174171}.
\item Więckiewicz G, Marek J, Stokłosa I, Szafoni S, Pluta S, Smukowska K, Żebrowska G, Stokłosa M, Gorczyca P, Pudlo R. (2023). \textit{The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/medicina59050908}{doi:10.3390/medicina59050908}.
\item Bae S, Vaysblat M, Bae E, Dejanovic I, Pierce M. (2023). \textit{Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.38669}{doi:10.7759/cureus.38669}.
\item Johns Hopkins University (2023). \textit{Effects of Psilocybin in Anorexia Nervosa}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04052568}{source link}.
\item Davis AK, Levin AW, Nagib PB, Armstrong SB, Lancelotta RL. (2023). \textit{Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2022-068884}{doi:10.1136/bmjopen-2022-068884}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. (2023). \textit{Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2023.120130}{doi:10.1016/j.neuroimage.2023.120130}.
\item Rossell SL, Meikle SE, Williams ML, Castle DJ. (2023). \textit{Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674231172691}{doi:10.1177/00048674231172691}.
\item Zeifman RJ, Wagner AC, Monson CM, Carhart-Harris RL. (2023). \textit{How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.04.105}{doi:10.1016/j.jad.2023.04.105}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Uchida H. (2023). \textit{[Drugs in the Developmental Stage (Psychotropics)].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.11477/mf.1416202356}{doi:10.11477/mf.1416202356}.
\item McAlpine R, Blackburne G, Kamboj S. (2023). \textit{Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gw9jp}{doi:10.31234/osf.io/gw9jp}.
\item Unknown authors (2023). \textit{Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gw9jp\_v1}{source link}.
\item Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B. (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Weiss B, Erritzoe D, Giribaldi B, Nutt DJ, Carhart-Harris RL. (2023). \textit{A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231167848}{doi:10.1177/02698811231167848}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03775200}{source link}.
\item Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL. (2023). \textit{Increased low-frequency brain responses to music after psilocybin therapy for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.04.081}{doi:10.1016/j.jad.2023.04.081}.
\item Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R. (2023). \textit{A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.04.12.23288325}{doi:10.1101/2023.04.12.23288325}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S. (2023). \textit{Psilocybin in Palliative Care: An Update.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13670-023-00383-7}{doi:10.1007/s13670-023-00383-7}.
\item Wang K, Sun Y, Nava B, Sampiere L, Jacobs RJ. (2023). \textit{Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.37450}{doi:10.7759/cureus.37450}.
\item Effinger DP, Quadir SG, Ramage MC, Cone MG, Herman MA. (2023). \textit{Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-023-02414-5}{doi:10.1038/s41398-023-02414-5}.
\item Ort A, Smallridge JW, Sarasso S, Casarotto S, von Rotz R, Casanova A, Seifritz E, Preller KH, Tononi G, Vollenweider FX. (2023). \textit{TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.isci.2023.106589}{doi:10.1016/j.isci.2023.106589}.
\item Volodymyr Tkach, Kucher Mykhailo, Kushnir Marta, Ivanushko Yana, Akınay Yüksel, Karakoyun Necdet, Yagodynets Petro, Kormosh Zholt (2023). \textit{The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide}. Orbital: The Electronic Journal of Chemistry. [published; Crossref]. \href{https://doi.org/10.17807/orbital.v15i1.18012}{doi:10.17807/orbital.v15i1.18012}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A. (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Woodburn SC, Wehrle PH, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2023). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-023-01572-w}{doi:10.1038/s41386-023-01572-w}.
\item Hakami Zanjani AA, Nguyen TQT, Jacobsen L, Khandelia H. (2023). \textit{The molecular basis of the antidepressant action of the magic mushroom extract, psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbapap.2023.140914}{doi:10.1016/j.bbapap.2023.140914}.
\item Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A. (2023). \textit{Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109528}{doi:10.1016/j.neuropharm.2023.109528}.
\item Julia Mertens L. (2023). \textit{Psilocybin zeigt Wirkung bei Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-023-2540-9}{doi:10.1007/s15006-023-2540-9}.
\item Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB (2023). \textit{Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.01.073}{doi:10.1016/j.jad.2023.01.073}.
\item Simpson GHR, Chatwin C, van Hellemont E (2023). \textit{Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2023.103973}{doi:10.1016/j.drugpo.2023.103973}.
\item Wang Y, Sun H, Ji Q, Wei J, Zhu P. (2023). \textit{Systematic Review of Interventions for Demoralization in Patients With Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/nmd.0000000000001615}{doi:10.1097/nmd.0000000000001615}.
\item Simonsson C, Chambers R, Hendricks PS, Goldberg SB, Osika W, Schlosser M, Ryde A, Christersson E, Simonsson O (2023). \textit{Classic psychedelic use and current meditation practice.}. Mindfulness. [published; PubMed]. \href{https://doi.org/10.1007/s12671-023-02103-w}{doi:10.1007/s12671-023-02103-w}.
\item Dawood Hristova JJ, Pérez-Jover V. (2023). \textit{Psychotherapy with Psilocybin for Depression: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/bs13040297}{doi:10.3390/bs13040297}.
\item Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM. (2023). \textit{The need for establishing best practices and gold standards in psychedelic medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.03.083}{doi:10.1016/j.jad.2023.03.083}.
\item Du Y, Li Y, Zhao X, Yao Y, Wang B, Zhang L, Wang G. (2023). \textit{Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/cm9.0000000000002647}{doi:10.1097/cm9.0000000000002647}.
\item University Hospital, Basel, Switzerland (2023). \textit{Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04849013}{source link}.
\item Ibi D. (2023). \textit{[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, Hellerstein DJ. (2023). \textit{Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2023.03.031}{doi:10.1016/j.jpsychires.2023.03.031}.
\item Kamal S, Jha MK, Radhakrishnan R. (2023). \textit{Role of Psychedelics in Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psc.2023.02.004}{doi:10.1016/j.psc.2023.02.004}.
\item Irvine W, Tyler M, Delgoda R. (2023). \textit{In silico characterization of the psilocybin biosynthesis pathway.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.compbiolchem.2023.107854}{doi:10.1016/j.compbiolchem.2023.107854}.
\item Domanegg K, Sommer WH, Meinhardt MW. (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS. (2023). \textit{Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20220835}{doi:10.1176/appi.ajp.20220835}.
\item Tolle HM, Farah JC, Mallaroni P, Mason NL, Ramaekers JG, Amico E. (2023). \textit{The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.03.20.532894}{doi:10.1101/2023.03.20.532894}.
\item Karow A. (2023). \textit{[Psychedelic Therapy with Psilocybin and Psychotherapy - Where do we Stand?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2010-7640}{doi:10.1055/a-2010-7640}.
\item Optimi Health Corporation (2023). \textit{Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05252598}{source link}.
\item Sloshower J, Skosnik PD, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC. (2023). \textit{Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231154852}{doi:10.1177/02698811231154852}.
\item Sharma R, Batchelor R, Sin J. (2023). \textit{Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2190319}{doi:10.1080/02791072.2023.2190319}.
\item Ching THW, Grazioplene R, Pittenger C, Kelmendi B. (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ba42z}{doi:10.31234/osf.io/ba42z}.
\item Unknown authors (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ba42z\_v1}{source link}.
\item Palamar JJ, Le A, Cleland CM, Keyes KM. (2023). \textit{Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2023.104001}{doi:10.1016/j.drugpo.2023.104001}.
\item Ryan RS, Copello A, Fox AP (2023). \textit{Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-023-04628-9}{doi:10.1186/s12888-023-04628-9}.
\item Zanikov T, Gerasymchuk M, Ghasemi Gojani E, Robinson GI, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cameron M, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I. (2023). \textit{The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules28062624}{doi:10.3390/molecules28062624}.
\item Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS. (2023). \textit{Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1123424}{doi:10.3389/fpsyt.2023.1123424}.
\item New York State Psychiatric Institute (2023). \textit{Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04656301}{source link}.
\item Hibicke M, Kramer HM, Nichols CD. (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-Osterhold G, Woolley JD. (2023). \textit{Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0004}{doi:10.1089/psymed.2022.0004}.
\item Wulff AB, Nichols CD, Thompson SM. (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Turkia M. (2023). \textit{Understanding psychedelic 'mystical experience'-A case example}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dh92g}{doi:10.31234/osf.io/dh92g}.
\item Turkia M. (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/wupvy}{doi:10.31234/osf.io/wupvy}.
\item Turkia M. (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/t6k9b}{doi:10.31234/osf.io/t6k9b}.
\item Unknown authors (2023). \textit{Understanding psychedelic 'mystical experience'-A case example}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dh92g\_v1}{source link}.
\item Unknown authors (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/wupvy\_v1}{source link}.
\item Unknown authors (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/t6k9b\_v1}{source link}.
\item Chen MH, Tu PC, Su TP. (2023). \textit{Next generation antidepressants with novel mechanisms for treatment resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2023.02.005}{doi:10.1016/bs.pbr.2023.02.005}.
\item Glatfelter GC, Naeem M, Pham DNK, Golen JA, Chadeayne AR, Manke DR, Baumann MH. (2023). \textit{Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.2c00222}{doi:10.1021/acsptsci.2c00222}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Kopra EI, Ferris JA, Winstock AR, Kuypers KP, Young AH, Rucker JJ. (2023). \textit{Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231158245}{doi:10.1177/02698811231158245}.
\item Kinderlehrer DA. (2023). \textit{The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/imcrj.s395342}{doi:10.2147/imcrj.s395342}.
\item Emmerich N, Humphries B. (2023). \textit{Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0963180123000099}{doi:10.1017/s0963180123000099}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B. (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Otterman LS (2023). \textit{Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.}. Journal of bioethical inquiry. [published; PubMed]. \href{https://doi.org/10.1007/s11673-022-10220-9}{doi:10.1007/s11673-022-10220-9}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Jha MK, Mathew SJ. (2023). \textit{Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230025}{doi:10.1176/appi.ajp.20230025}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J. (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Xi D, Berger A, Shurtleff D, Zia FZ, Belouin S. (2023). \textit{National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109467}{doi:10.1016/j.neuropharm.2023.109467}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2023). \textit{Synapses, predictions, and prediction errors: A neocortical computational study of MDD using the temporal memory algorithm of HTM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.976921}{doi:10.3389/fpsyt.2023.976921}.
\item Rijsketic DR, Casey AB, Barbosa DA, Zhang X, Hietamies TM, Ramirez-Ovalle G, Pomrenze M, Halpern CH, Williams LM, Malenka RC, Heifets BD. (2023). \textit{UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.02.19.528997}{doi:10.1101/2023.02.19.528997}.
\item Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B. (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-023-01545-z}{doi:10.1038/s41386-023-01545-z}.
\item Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KP, Ramaekers JG. (2023). \textit{Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.02.16.528808}{doi:10.1101/2023.02.16.528808}.
\item Chen Y, Liu J, Yao Y, Yan H, Su R. (2023). \textit{Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2023.1021729}{doi:10.3389/fphar.2023.1021729}.
\item Crowe M, Manuel J, Carlyle D, Lacey C. (2023). \textit{Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/inm.13127}{doi:10.1111/inm.13127}.
\item Jones G, Lipson J, Wang E. (2023). \textit{Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-023-29763-x}{doi:10.1038/s41598-023-29763-x}.
\item van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A. (2023). \textit{Therapeutic effect of psilocybin in addiction: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1134454}{doi:10.3389/fpsyt.2023.1134454}.
\item Ragnhildstveit A, Kaiyo M, Snyder MB, Jackson LK, Lopez A, Mayo C, Miranda AC, August RJ, Seli P, Robison R, Averill LA. (2023). \textit{Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1051542}{doi:10.3389/fpsyt.2023.1051542}.
\item Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, Páleníček T, Redjep O, Repantis D, Schoevers RA, Septimus B, Simmons HJ, Soares JC, Somers M, Stansfield SC, Stuart JR, Tadley HH, Thiara NK, Tsai J, Wahba M, Williams S, Winzer RI, Young AH, Young MB, Zisook S, Malievskaia E. (2023). \textit{Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.01.108}{doi:10.1016/j.jad.2023.01.108}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF. (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE (2023). \textit{5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.2c00718}{doi:10.1021/acschemneuro.2c00718}.
\item Rucker JJ. (2023). \textit{Psilocybin therapy for depression. A good trip?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09638237.2023.2183492}{doi:10.1080/09638237.2023.2183492}.
\item Østergaard SD, Hieronymus F. (2023). \textit{Psilocybin for Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmc2215459}{doi:10.1056/nejmc2215459}.
\item Oster E, Čudina N, Pavasović H, Prevendar Crnić A, Božić F, Fadel C, Giorgi M. (2023). \textit{Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.vas.2023.100288}{doi:10.1016/j.vas.2023.100288}.
\item Washington University School of Medicine (2023). \textit{SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05601648}{source link}.
\item von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX. (2023). \textit{Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2023.101841}{doi:10.1016/j.eclinm.2023.101841}.
\item Modlin NL, Miller TM, Rucker JJ, Kirlic N, Lennard-Jones M, Schlosser D, Aaronson ST. (2023). \textit{Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.01.077}{doi:10.1016/j.jad.2023.01.077}.
\item Low F, Earleywine M. (2023). \textit{Educational Materials and Image Induction Increase Treatment Credibility.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2154722}{doi:10.1080/02791072.2022.2154722}.
\item Sellers EM, Romach MK. (2023). \textit{Psychedelics: Science sabotaged by Social Media.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109426}{doi:10.1016/j.neuropharm.2023.109426}.
\item Rudin D, Areesanan A, Liechti ME, Gründemann C. (2023). \textit{Classic psychedelics do not affect T cell and monocyte immune responses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1042440}{doi:10.3389/fpsyt.2023.1042440}.
\item Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P. (2023). \textit{Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijerph20031870}{doi:10.3390/ijerph20031870}.
\item Keith Heinzerling (2023). \textit{Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04410913}{source link}.
\item Pedicini M, Cordner ZA. (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item White CM, Weisman N, Dalo J. (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Capaldi JM, Shabanian J, Finster LB, Asher A, Wertheimer JC, Zebrack BJ, Shirazipour CH. (2023). \textit{Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17437199.2022.2162947}{doi:10.1080/17437199.2022.2162947}.
\item Berlowitz I, García Torres E, Maake C, Wolf U, Martin-Soelch C. (2023). \textit{Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/plants12020346}{doi:10.3390/plants12020346}.
\item Davoudian PA, Shao LX, Kwan AC. (2023). \textit{Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.2c00637}{doi:10.1021/acschemneuro.2c00637}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI. (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Rabinowitz J, Lev-Ran S, Gross R. (2023). \textit{The association between naturalistic use of psychedelics and co-occurring substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1066369}{doi:10.3389/fpsyt.2022.1066369}.
\item Wang J, Liang M, Shang Q, Qian H, An R, Liu H, Shao G, Li T, Liu X. (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Bhadoria Poonam, Ramanathan Venkatnarayan (2023). \textit{Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights}. ChemistrySelect. [published; Crossref]. \href{https://doi.org/10.1002/slct.202203994}{doi:10.1002/slct.202203994}.
\item Pacheco AT, Olson RJ, Garza G, Moghaddam B. (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.01.09.523291}{doi:10.1101/2023.01.09.523291}.
\item Martinovic J. (2023). \textit{When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1590/s0104-59702022000500007}{doi:10.1590/s0104-59702022000500007}.
\item Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D. (2023). \textit{Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221146356}{doi:10.1177/02698811221146356}.
\item Baker KM, Ulrich CM, Meghani SH. (2023). \textit{An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10499091221147700}{doi:10.1177/10499091221147700}.
\item Andersen S. (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f26ce}{doi:10.31234/osf.io/f26ce}.
\item Unknown authors (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f26ce\_v1}{source link}.
\item Alper K, Cange J, Sah R, Schreiber-Gregory D, Sershen H, Vinod KY. (2023). \textit{Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.1074633}{doi:10.3389/fphar.2022.1074633}.
\item Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T. (2022). \textit{Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2023.103662}{doi:10.1016/j.nsa.2023.103662}.
\item Simonsson O, Goldberg SB (2022). \textit{Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022816}{doi:10.1080/02791072.2021.2022816}.
\item Hadar A, David J, Shalit N, Roseman L, Gross R, Sessa B, Lev-Ran S (2022). \textit{The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022254}{doi:10.1080/02791072.2021.2022254}.
\item Kious B, Schwartz Z, Lewis B (2022). \textit{Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221133461}{doi:10.1177/02698811221133461}.
\item Siegel JS, Daily JE, Perry DA, Nicol GE. (2022). \textit{Psychedelic Drug Legislative Reform and Legalization in the US.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2022.4101}{doi:10.1001/jamapsychiatry.2022.4101}.
\item Henningfield JE, Ashworth J, Heal DJ, Smith SL. (2022). \textit{Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221140004}{doi:10.1177/02698811221140004}.
\item Ezeaka UC, Kim HJJ, Laprairie RB. (2022). \textit{Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026623666230705151922}{doi:10.2174/1568026623666230705151922}.
\item Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA (2022). \textit{Functional MRI markers for treatment-resistant depression: Insights and challenges.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.04.001}{doi:10.1016/bs.pbr.2023.04.001}.
\item Rivera-García MT, Cruz SL. (2022). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Unzueta-Larrinaga P, Urigüen L. (2022). \textit{Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-1-0716-3307-6\_5}{doi:10.1007/978-1-0716-3307-6\_5}.
\item Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG. (2022). \textit{Biological embedding of early trauma: the role of higher prefrontal synaptic strength.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/20008066.2023.2246338}{doi:10.1080/20008066.2023.2246338}.
\item Ahmed H, Mushahid H, Arshad T. (2022). \textit{UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37992112}{source link}.
\item Feulner L, Sermchaiwong T, Rodland N, Galarneau D. (2022). \textit{Efficacy and Safety of Psychedelics in Treating Anxiety Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.31486/toj.23.0076}{doi:10.31486/toj.23.0076}.
\item Edelsohn GA, Sisti D. (2022). \textit{Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1353/pbm.2023.0007}{doi:10.1353/pbm.2023.0007}.
\item Gukasyan N. (2022). \textit{On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.medj.2022.12.003}{doi:10.1016/j.medj.2022.12.003}.
\item Mann JJ. (2022). \textit{Is psilocybin an effective antidepressant and what is its Mechanism of action?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.xcrm.2022.100906}{doi:10.1016/j.xcrm.2022.100906}.
\item Lewis CR, McMurray M, Mennenga SE, Helms Tillery S (2022). \textit{Editorial: What is up with psychedelics anyway?}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1161868}{doi:10.3389/fnins.2023.1161868}.
\item Vorobyeva N, Kozlova AA (2022). \textit{Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1184726}{doi:10.3389/fphar.2023.1184726}.
\item Shaw L, Rea K, Lachowsky NJ, Roth EA (2022). \textit{Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2054746}{doi:10.1080/02791072.2022.2054746}.
\item Fauvel B, Kangaslampi S, Strika-Bruneau L, Roméo B, Piolino P (2022). \textit{Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2059796}{doi:10.1080/02791072.2022.2059796}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2022). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I. (2022). \textit{The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37387703}{source link}.
\item Rankaduwa S, Owen AM (2022). \textit{Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niad001}{doi:10.1093/nc/niad001}.
\item Mosurinjohn S, Roseman L, Girn M (2022). \textit{Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1077311}{doi:10.3389/fpsyt.2023.1077311}.
\item Urban MM, Stingl MR, Meinhardt MW (2022). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Blest-Hopley G, Amit BH, O'Neill A, Ruffell SGD (2022). \textit{Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1191970}{doi:10.3389/fpsyt.2023.1191970}.
\item Phan AN, Terry GE (2022). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item Li I, Fong R, Hagen M, Tabaac B (2022). \textit{Medical student attitudes and perceptions of psychedelic-assisted therapies.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1190507}{doi:10.3389/fpsyt.2023.1190507}.
\item Blond BN, Schindler EAD (2022). \textit{Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.}. Frontiers in neurology. [published; PubMed]. \href{https://doi.org/10.3389/fneur.2023.1214969}{doi:10.3389/fneur.2023.1214969}.
\item Hartong V, van Emmerik A (2022). \textit{Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2080616}{doi:10.1080/02791072.2022.2080616}.
\item Lawson K (2022). \textit{What is the progress of experimental drug development for fibromyalgia?}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2023.2230118}{doi:10.1080/13543784.2023.2230118}.
\item Simonsson O, Stenfors CUD, Goldberg SB, Hendricks PS, Osika W (2022). \textit{Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1151626}{doi:10.3389/fpsyg.2023.1151626}.
\item Boehnke KF, Cox K, Weston C, Herberholz M, Glynos N, Kolbman N, Fields CW, Barron J, Kruger DJ (2022). \textit{Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1224551}{doi:10.3389/fpsyt.2023.1224551}.
\item Longo MSC, Bienemann B, Multedo M, Negreiros MA, Schenberg E, Mograbi DC (2022). \textit{The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2112788}{doi:10.1080/02791072.2022.2112788}.
\item Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ (2022). \textit{Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2125467}{doi:10.1080/02791072.2022.2125467}.
\item Kruger DJ, Glynos NG, Fields CW, Herberholz M, Boehnke KF (2022). \textit{An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2142709}{doi:10.1080/02791072.2022.2142709}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2022). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Barnett BS, Bassir Nia A, Sackett NB, Weleff J (2022). \textit{Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1305478}{doi:10.3389/fpsyt.2023.1305478}.
\item Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF (2022). \textit{"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201263}{doi:10.1080/02791072.2023.2201263}.
\item Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC (2022). \textit{Psychedelics, epilepsy, and seizures: a review.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1326815}{doi:10.3389/fphar.2023.1326815}.
\item Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G. (2022). \textit{Psilocybin for Depression: From Credibility to Feasibility, What's Missing?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph16010068}{doi:10.3390/ph16010068}.
\item Holze F, Becker AM, Kolaczynska KE, Duthaler U, Liechti ME. (2022). \textit{Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.2821}{doi:10.1002/cpt.2821}.
\item McTaggart AR, James TY, Slot JC, Barlow C, Fechner N, Shuey LS, Drenth A. (2022). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S (2022). \textit{A Review of Synthetic Access to Therapeutic Compounds Extracted from.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph16010040}{doi:10.3390/ph16010040}.
\item von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX. (2022). \textit{Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2022.101809}{doi:10.1016/j.eclinm.2022.101809}.
\item Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ. (2022). \textit{Canalization and plasticity in psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109398}{doi:10.1016/j.neuropharm.2022.109398}.
\item Meccia J, Lopez J, Bagot RC. (2022). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Marks M. (2022). \textit{The varieties of psychedelic law.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109399}{doi:10.1016/j.neuropharm.2022.109399}.
\item Jones G, Arias D, Nock M. (2022). \textit{Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-25658-5}{doi:10.1038/s41598-022-25658-5}.
\item Meir P, Taylor L, Soares JC, Meyer TD. (2022). \textit{Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2022.12.050}{doi:10.1016/j.jad.2022.12.050}.
\item Heal DJ, Gosden J, Smith SL, Atterwill CK. (2022). \textit{Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109375}{doi:10.1016/j.neuropharm.2022.109375}.
\item Bradshaw AJ, Ramírez-Cruz V, Awan AR, Furci G, Guzmán-Dávalos L, Stamets P, Dentinger BT. (2022). \textit{Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.12.13.520147}{doi:10.1101/2022.12.13.520147}.
\item Roberts BF, Zylko AL, Waters CE, Crowder JD, Gibbons WJ, Sen AK, Jones JA, McMurray MS. (2022). \textit{Effect of psilocybin on decision-making and motivation in the healthy rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbr.2022.114262}{doi:10.1016/j.bbr.2022.114262}.
\item DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J, Michalak E. (2022). \textit{"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0279073}{doi:10.1371/journal.pone.0279073}.
\item Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J. (2022). \textit{Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221131997}{doi:10.1177/02698811221131997}.
\item Shnayder S, Ameli R, Sinaii N, Berger A, Agrawal M. (2022). \textit{Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2022.11.046}{doi:10.1016/j.jad.2022.11.046}.
\item Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. (2022). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Kelmendi B, Kichuk SA, DePalmer G, Maloney G, Ching THW, Belser A, Pittenger C. (2022). \textit{Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.heliyon.2022.e12135}{doi:10.1016/j.heliyon.2022.e12135}.
\item Burmester DR, Madsen MK, Szabo A, Aripaka SS, Stenbæk DS, Frokjaer VG, Elfving B, Mikkelsen JD, Knudsen GM, Fisher PM. (2022). \textit{Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cpnec.2022.100163}{doi:10.1016/j.cpnec.2022.100163}.
\item Lee HJ, Stein MB. (2022). \textit{Update on treatments for anxiety-related disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Buzzelli V, Carbone E, Manduca A, Schiavi S, Feo A, Perederiy JV, Ambert KH, Hausman M, Trezza V. (2022). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Pędzich BD, Medrano M, Buckinx A, Smolders I, De Bundel D. (2022). \textit{Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms232315284}{doi:10.3390/ijms232315284}.
\item Passie T, Guss J, Krähenmann R. (2022). \textit{Lower-dose psycholytic therapy - A neglected approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1020505}{doi:10.3389/fpsyt.2022.1020505}.
\item Wang H, Wang Y. (2022). \textit{Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00216-022-04467-9}{doi:10.1007/s00216-022-04467-9}.
\item Magiatis P, Dadiotis E, Antonopoulos R K, Ioannidis K, Mitsis V, Melliou E, Gonou-Zagou Z (2022). \textit{Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens}. Planta Medica. [published; Crossref]. \href{https://doi.org/10.1055/s-0042-1759062}{doi:10.1055/s-0042-1759062}.
\item Hartogsohn I, Petranker R (2022). \textit{Set and setting in microdosing: an oft-overlooked principle.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06249-8}{doi:10.1007/s00213-022-06249-8}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Barber G, Nemeroff CB, Siegel S. (2022). \textit{A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.22010073}{doi:10.1176/appi.ajp.22010073}.
\item MacCallum CA, Lo LA, Pistawka CA, Deol JK. (2022). \textit{Therapeutic use of psilocybin: Practical considerations for dosing and administration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1040217}{doi:10.3389/fpsyt.2022.1040217}.
\item Bradshaw AJ, Backman TA, Ramírez-Cruz V, Forrister DL, Winter JM, Guzmán-Dávalos L, Furci G, Stamets P, Dentinger BTM. (2022). \textit{DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1128/aem.01498-22}{doi:10.1128/aem.01498-22}.
\item Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D. (2022). \textit{Considerations in assessing the abuse potential of psychedelics during drug development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109352}{doi:10.1016/j.neuropharm.2022.109352}.
\item Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. (2022). \textit{Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221125354}{doi:10.1177/02698811221125354}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC. (2022). \textit{Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/head.14420}{doi:10.1111/head.14420}.
\item Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. (2022). \textit{Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.31796}{doi:10.7759/cureus.31796}.
\item Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D. (2022). \textit{Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200551}{doi:10.1002/cbic.202200551}.
\item Messell C, Summer L, Bonde LO, Beck BD, Stenbæk DS. (2022). \textit{Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.873455}{doi:10.3389/fpsyg.2022.873455}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms232214148}{doi:10.3390/ijms232214148}.
\item Guss J, Krause R, Sloshower J. (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r96tc}{doi:10.31234/osf.io/r96tc}.
\item Unknown authors (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/r96tc\_v1}{source link}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Gotvaldová K, Borovička J, Hájková K, Cihlářová P, Rockefeller A, Kuchař M. (2022). \textit{Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms232214068}{doi:10.3390/ijms232214068}.
\item Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2022). \textit{Body mass index (BMI) does not predict responses to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221131994}{doi:10.1177/02698811221131994}.
\item NYU Langone Health (2022). \textit{A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02061293}{source link}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item Gutman O, Tenne D, Bretler U. (2022). \textit{Psilocin - The "real deal" or an extraction byproduct.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1556-4029.15167}{doi:10.1111/1556-4029.15167}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2022). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.03.515044}{doi:10.1101/2022.11.03.515044}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. (2022). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Iacobucci G. (2022). \textit{Psilocybin reduces symptoms in treatment resistant depression, trial results show.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.o2623}{doi:10.1136/bmj.o2623}.
\item Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH. (2022). \textit{Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.2c00177}{doi:10.1021/acsptsci.2c00177}.
\item O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP. (2022). \textit{Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cct.2022.106976}{doi:10.1016/j.cct.2022.106976}.
\item Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. (2022). \textit{Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.10.31.22281688}{doi:10.1101/2022.10.31.22281688}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Patchett-Marble R, O'Sullivan S, Tadwalkar S, Hapke E. (2022). \textit{Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.46747/cfp.6811823}{doi:10.46747/cfp.6811823}.
\item Paganin W, Signorini S, Signorini S, Leccese V, Sciarretta A. (2022). \textit{[Treatment-resistant depression. From classification to new therapies.]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1708/3922.39072}{doi:10.1708/3922.39072}.
\item Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. (2022). \textit{Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2206443}{doi:10.1056/nejmoa2206443}.
\item Madras BK. (2022). \textit{Psilocybin in Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejme2210975}{doi:10.1056/nejme2210975}.
\item Wong A, Raz A. (2022). \textit{Microdosing with classical psychedelics: Research trajectories and practical considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221129115}{doi:10.1177/13634615221129115}.
\item Li SN, Xu F, Long P, Liu F, Zhang P, Fan YG, Chen ZH. (2022). \textit{Five new species of Inosperma from China: Morphological characteristics, phylogenetic analyses, and toxin detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fmicb.2022.1021583}{doi:10.3389/fmicb.2022.1021583}.
\item Jones GM. (2022). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221127304}{doi:10.1177/02698811221127304}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM. (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2zys9}{doi:10.31234/osf.io/2zys9}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0002}{doi:10.1089/psymed.2022.0002}.
\item Unknown authors (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2zys9\_v1}{source link}.
\item Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. (2022). \textit{Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119716}{doi:10.1016/j.neuroimage.2022.119716}.
\item Sheppard Pratt Health System (2022). \textit{The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433845}{source link}.
\item Gandia A, Adamatzky A. (2022). \textit{Electrical spiking of psilocybin fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/19420889.2022.2136118}{doi:10.1080/19420889.2022.2136118}.
\item Unknown authors (2022). \textit{Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/s4qhf\_v1}{source link}.
\item Dupuis D, Veissière S. (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Balon R. (2022). \textit{Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001610}{doi:10.1097/jcp.0000000000001610}.
\item Jensen ME, Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A. (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ. (2022). \textit{Mescaline: The forgotten psychedelic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Beckley Psytech Limited (2022). \textit{An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04905121}{source link}.
\item Sottile RJ, Vida T. (2022). \textit{A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.991753}{doi:10.3389/fpsyt.2022.991753}.
\item Goel DB, Zilate S. (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Weleff J, Akiki TJ, Barnett BS. (2022). \textit{Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2133757}{doi:10.1080/02791072.2022.2133757}.
\item Jones GM, Nock MK. (2022). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-18645-3}{doi:10.1038/s41598-022-18645-3}.
\item Ko K, Kopra EI, Cleare AJ, Rucker JJ. (2022). \textit{Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2022.09.168}{doi:10.1016/j.jad.2022.09.168}.
\item Silberner J. (2022). \textit{Psilocybin: a revolution in psychedelic medicines in the US?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.o2178}{doi:10.1136/bmj.o2178}.
\item Ching THW, Kichuk S, DePalmer G, Pittenger C, Kelmendi B. (2022). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/85s9p}{doi:10.31234/osf.io/85s9p}.
\item McCartney AM, McGovern HT, De Foe A. (2022). \textit{Predictors of Psychedelic Experience: A Thematic Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2129885}{doi:10.1080/02791072.2022.2129885}.
\item Unknown authors (2022). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/85s9p\_v1}{source link}.
\item Søndergaard A, Madsen MK, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2022). \textit{Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.948729}{doi:10.3389/fpsyg.2022.948729}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2022). \textit{Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-022-33578-1}{doi:10.1038/s41467-022-33578-1}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI. (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item Timmermann C, Watts R, Dupuis D (2022). \textit{Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221082796}{doi:10.1177/13634615221082796}.
\item Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC (2022). \textit{If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.}. The journal of pain. [published; PubMed]. \href{https://doi.org/10.1016/j.jpain.2022.05.003}{doi:10.1016/j.jpain.2022.05.003}.
\item Barnett BS, Ziegler K, Doblin R, Carlo AD (2022). \textit{Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221117536}{doi:10.1177/02698811221117536}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS (2022). \textit{Prevalence and associations of classic psychedelic-related seizures in a population-based sample.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2022.109586}{doi:10.1016/j.drugalcdep.2022.109586}.
\item Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L. (2022). \textit{Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2022.2096}{doi:10.1001/jamapsychiatry.2022.2096}.
\item Butler M, Jelen L, Rucker J (2022). \textit{Expectancy in placebo-controlled trials of psychedelics: if so, so what?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06221-6}{doi:10.1007/s00213-022-06221-6}.
\item Asher BF (2022). \textit{Why Otolaryngologists Should Be Interested in Psychedelic Medicine.}. Otolaryngologic clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.otc.2022.06.002}{doi:10.1016/j.otc.2022.06.002}.
\item Odland AU, Kristensen JL, Andreasen JT. (2022). \textit{Animal Behavior in Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ (2022). \textit{Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221119388}{doi:10.1177/13634615221119388}.
\item Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML. (2022). \textit{Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/netn\_a\_00250}{doi:10.1162/netn\_a\_00250}.
\item Slomski A. (2022). \textit{Psilocybin for Treatment of Alcohol Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.2022.15436}{doi:10.1001/jama.2022.15436}.
\item Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S (2022). \textit{The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30919}{doi:10.7759/cureus.30919}.
\item Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA. (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kh3cx}{doi:10.31234/osf.io/kh3cx}.
\item Unknown authors (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kh3cx\_v1}{source link}.
\item Søgaard Juul T, Ebbesen Jensen M, Fink-Jensen A. (2022). \textit{The use of classic psychedelics among adults: a Danish online survey study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/08039488.2022.2125069}{doi:10.1080/08039488.2022.2125069}.
\item Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M. (2022). \textit{Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms231911450}{doi:10.3390/ijms231911450}.
\item COMPASS Pathways (2022). \textit{Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP001 And COMP003 Trials (P-TRD LTFU)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04519957}{source link}.
\item Barber GS, Aaronson ST. (2022). \textit{The Emerging Field of Psychedelic Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01363-y}{doi:10.1007/s11920-022-01363-y}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Calder AE, Hasler G. (2022). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS. (2022). \textit{A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-022-00944-y}{doi:10.1007/s40263-022-00944-y}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. (2022). \textit{Effective connectivity of emotion and cognition under psilocybin}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.06.22279626}{doi:10.1101/2022.09.06.22279626}.
\item Mellner C, Dahlen M, Simonsson O (2022). \textit{Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph191811353}{doi:10.3390/ijerph191811353}.
\item Lerer B, Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2001983/v1}{doi:10.21203/rs.3.rs-2001983/v1}.
\item O'Leary K. (2022). \textit{Psilocybin therapy reduces heavy drinking.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/d41591-022-00093-1}{doi:10.1038/d41591-022-00093-1}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R. (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item Walsh CA, Livne O, Shmulewitz D, Stohl M, Hasin DS. (2022). \textit{Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.abrep.2022.100454}{doi:10.1016/j.abrep.2022.100454}.
\item Johnston CB, Mangini M, Grob C, Anderson B. (2022). \textit{The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2022.08.007}{doi:10.1016/j.jagp.2022.08.007}.
\item Lyes M, Yang KH, Castellanos J, Furnish T. (2022). \textit{Microdosing psilocybin for chronic pain: a case series.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pain.0000000000002778}{doi:10.1097/j.pain.0000000000002778}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Girala N. (2022). \textit{Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567945}{source link}.
\item National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. (2022). \textit{Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop}. National Academies Press (US), Washington (DC). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36049038}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9568164}{source link}.
\item Bhadoria P, Venkatnarayan R. (2022). \textit{Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insights}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.166200851.10677416/v1}{doi:10.22541/au.166200851.10677416/v1}.
\item Shah K, Trivedi C, Kamrai D, Akbar M, Tankersley W. (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9563652}{source link}.
\item Brito-da-Costa A.M., Madureira-Carvalho A., Dinis-Oliveira R.J., Silva D. Dias da (2022). \textit{P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/j.toxlet.2022.07.280}{doi:10.1016/j.toxlet.2022.07.280}.
\item Johannesdottir A, Sigurdsson E. (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Chomynová P, Kočárová R, Kňažek F, Plevková M, Bláhová B, Valeš K, Mravčík V. (2022). \textit{Use of psychedelics in the Czech Republic: results of recent population surveys.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21101/cejph.a7079}{doi:10.21101/cejph.a7079}.
\item McManus KR, Patrick R, Striepe MI, Drury MJ, Ozonsi R, Forester BP, Weinberg MS (2022). \textit{Psychedelics for Alzheimer's Disease Palliative Care.}. Advances in psychiatry and behavioral health. [published; PubMed]. \href{https://doi.org/10.1016/j.ypsc.2022.06.001}{doi:10.1016/j.ypsc.2022.06.001}.
\item Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME (2022). \textit{The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.29167}{doi:10.7759/cureus.29167}.
\item Christensen JA, Fipps DC, Bostwick JM. (2022). \textit{To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000597}{doi:10.1037/pha0000597}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Yan YY, Zhang YZ, Vauras J, Zhao LN, Fan YG, Li HJ, Xu F. (2022). \textit{﻿ Pseudospermaarenarium (Inocybaceae), a new poisonous species from Eurasia, based on morphological, ecological, molecular and biochemical evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3897/mycokeys.92.86277}{doi:10.3897/mycokeys.92.86277}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE. (2022). \textit{Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Kaypak AC, Raz A. (2022). \textit{Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221119386}{doi:10.1177/13634615221119386}.
\item Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. (2022). \textit{Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221116926}{doi:10.1177/02698811221116926}.
\item Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR. (2022). \textit{Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0271926}{doi:10.1371/journal.pone.0271926}.
\item Doss MK, Barrett FS, Corlett PR. (2022). \textit{Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.2c00461}{doi:10.1021/acschemneuro.2c00461}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B. (2022). \textit{Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8080870}{doi:10.3390/jof8080870}.
\item Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. (2022). \textit{Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109220}{doi:10.1016/j.neuropharm.2022.109220}.
\item Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V. (2022). \textit{The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/07067437221111371}{doi:10.1177/07067437221111371}.
\item Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. (2022). \textit{Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109214}{doi:10.1016/j.neuropharm.2022.109214}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C. (2022). \textit{Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-02103-9}{doi:10.1038/s41398-022-02103-9}.
\item Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK. (2022). \textit{Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2022.103816}{doi:10.1016/j.drugpo.2022.103816}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J. (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. (2022). \textit{The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06187-5}{doi:10.1007/s00213-022-06187-5}.
\item Clifton JM, Belcher AM, Greenblatt AD, Welsh CM, Cole TO, Davis AK. (2022). \textit{Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1556/2054.2022.00214}{doi:10.1556/2054.2022.00214}.
\item Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E. (2022). \textit{Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-02039-0}{doi:10.1038/s41398-022-02039-0}.
\item Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y (2022). \textit{Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0036}{doi:10.1089/jpm.2022.0036}.
\item Polito V, Liknaitzky P (2022). \textit{The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104706}{doi:10.1016/j.neubiorev.2022.104706}.
\item Suleiman M, Basu A, Belal S, Jacob T. (2022). \textit{From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/nmd.0000000000001489}{doi:10.1097/nmd.0000000000001489}.
\item Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D (2022). \textit{Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221101061}{doi:10.1177/02698811221101061}.
\item Makin S. (2022). \textit{Mushrooms' Legal Trip: As psilocybin research ramps up, the drug's status under the law is shifting.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/scientificamerican0822-12}{doi:10.1038/scientificamerican0822-12}.
\item Gumpper RH, Fay JF, Roth BL. (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z. (2022). \textit{Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-17428-0}{doi:10.1038/s41598-022-17428-0}.
\item Golden CT, Chadderton P. (2022). \textit{Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-16325-w}{doi:10.1038/s41598-022-16325-w}.
\item University of California, San Diego (2022). \textit{Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04661514}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.22.501026}{doi:10.1101/2022.07.22.501026}.
\item Meyer TD, Meir P, Lex C, Soares JC. (2022). \textit{Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114727}{doi:10.1016/j.psychres.2022.114727}.
\item Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lerer B, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.13.498401}{doi:10.1101/2022.07.13.498401}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NL, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2022). \textit{Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.12.499688}{doi:10.1101/2022.07.12.499688}.
\item Ko K, Knight G, Rucker JJ, Cleare AJ. (2022). \textit{Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.917199}{doi:10.3389/fpsyt.2022.917199}.
\item Berens N, Kim SY. (2022). \textit{Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2022.07.003}{doi:10.1016/j.jagp.2022.07.003}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M. (2022). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM. (2022). \textit{Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.07.10.22277414}{doi:10.1101/2022.07.10.22277414}.
\item Zeifman R, Spriggs MJ, Kettner H, Lyons T, Rosas F, Mediano P, Erritzoe D, Carhart-Harris R. (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/w8j6t}{doi:10.31234/osf.io/w8j6t}.
\item Unknown authors (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/w8j6t\_v1}{source link}.
\item Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL. (2022). \textit{Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.883869}{doi:10.3389/fpsyt.2022.883869}.
\item Rajkumar RP. (2022). \textit{Pharmacotherapy for the Secondary Prevention of Suicide: Leads from the Social Pain Hypothesis}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202207.0064.v1}{doi:10.20944/preprints202207.0064.v1}.
\item Bosch OG, Halm S, Seifritz E. (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR. (2022). \textit{Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.2c03476}{doi:10.1021/acsomega.2c03476}.
\item da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. (2022). \textit{Psychedelic drugs for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120332}{doi:10.1016/j.jns.2022.120332}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2022). \textit{Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.29.498015}{doi:10.1101/2022.06.29.498015}.
\item Gandia A, Adamatzky A. (2022). \textit{Electrical spiking of psilocybin fungi}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.02.498545}{doi:10.1101/2022.07.02.498545}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119434}{doi:10.1016/j.neuroimage.2022.119434}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM, Giribaldi B, Erritzoe D, Nutt D, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sb5ur}{doi:10.31234/osf.io/sb5ur}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Pöllänen E, Osika W, Stenfors CUD, Simonsson O (2022). \textit{Classic Psychedelics and Human-Animal Relations.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph19138114}{doi:10.3390/ijerph19138114}.
\item Lyons A. (2022). \textit{Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/36204170}{source link}.
\item Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN. (2022). \textit{A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkab075}{doi:10.1093/jat/bkab075}.
\item Unknown authors (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/sb5ur\_v1}{source link}.
\item Wake Network, Inc. (2022). \textit{Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04989972}{source link}.
\item Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D. (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xwu4j}{doi:10.31234/osf.io/xwu4j}.
\item Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z. (2022). \textit{Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14512-3}{doi:10.1038/s41598-022-14512-3}.
\item Unknown authors (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xwu4j\_v1}{source link}.
\item Vorobyeva N, Kozlova AA. (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Inouye A, Wolfgang A. (2022). \textit{3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.26402}{doi:10.7759/cureus.26402}.
\item Wang Q, Ren Y, Cui Y, Gao B, Zhang H, Jiang Q, Loor JJ, Deng Z, Xu C. (2022). \textit{Bacillus subtilis Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants via the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fvets.2022.852321}{doi:10.3389/fvets.2022.852321}.
\item Rusanen SS, De S, Schindler EAD, Artto VA, Storvik M. (2022). \textit{Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-022-01063-5}{doi:10.1007/s11916-022-01063-5}.
\item Jones G, Lipson J, Nock MK. (2022). \textit{Associations between classic psychedelics and nicotine dependence in a nationally representative sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14809-3}{doi:10.1038/s41598-022-14809-3}.
\item Knudsen GM. (2022). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Schmidt C, Wolff M, Gründer G, Jungaberle H. (2022). \textit{[Attitudes of Mental Health Experts Towards Psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1846-1161}{doi:10.1055/a-1846-1161}.
\item Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T. (2022). \textit{Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jpm12061004}{doi:10.3390/jpm12061004}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K. (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Schindler EAD. (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Hibicke M, Nichols CD. (2022). \textit{Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14165-2}{doi:10.1038/s41598-022-14165-2}.
\item Dörner S, Rogge K, Fricke J, Schäfer T, Wurlitzer JM, Gressler M, Pham DNK, Manke DR, Chadeayne AR, Hoffmeister D. (2022). \textit{Genetic Survey of Psilocybe Natural Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200249}{doi:10.1002/cbic.202200249}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E. (2022). \textit{Natural language signatures of psilocybin microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06170-0}{doi:10.1007/s00213-022-06170-0}.
\item Felsch CL, Kuypers KPC. (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item Polo-Castellano C, Álvarez JÁ, Palma M, Barbero GF, Ayuso J, Ferreiro-González M. (2022). \textit{Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8060598}{doi:10.3390/jof8060598}.
\item Fulmali A, Bharate SS. (2022). \textit{Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ddr.21953}{doi:10.1002/ddr.21953}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH (2022). \textit{How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06106-8}{doi:10.1007/s00213-022-06106-8}.
\item Husain MI, Umer M, Mulsant BH (2022). \textit{Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2063274}{doi:10.1080/14740338.2022.2063274}.
\item Smausz R, Neill J, Gigg J. (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Jairaj C, Rucker JJ. (2022). \textit{Postpartum depression: A role for psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221093793}{doi:10.1177/02698811221093793}.
\item Henner RL, Keshavan MS, Hill KP. (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M. (2022). \textit{Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijerph19116619}{doi:10.3390/ijerph19116619}.
\item Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL. (2022). \textit{Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3281}{doi:10.1002/dta.3281}.
\item Sotille R, Singh H, Weisman A, Vida T. (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M. (2022). \textit{Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25235}{doi:10.7759/cureus.25235}.
\item National Institute of Mental Health, Czech Republic (2022). \textit{Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05383313}{source link}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD. (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. (2022). \textit{Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.891512}{doi:10.3389/fpsyt.2022.891512}.
\item Lenz C, Dörner S, Trottmann F, Hertweck C, Sherwood A, Hoffmeister D. (2022). \textit{Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200183}{doi:10.1002/cbic.202200183}.
\item Kotts WJ, Gamble DT, Dawson DK, Connor D. (2022). \textit{Psilocybin-induced takotsubo cardiomyopathy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bcr-2021-245863}{doi:10.1136/bcr-2021-245863}.
\item Mocanu V, Mackay L, Christie D, Argento E. (2022). \textit{Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s13011-022-00468-0}{doi:10.1186/s13011-022-00468-0}.
\item Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS. (2022). \textit{Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109127}{doi:10.1016/j.neuropharm.2022.109127}.
\item Carhart-Harris R, Daws RE, Nutt D. (2022). \textit{A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/pdbf5}{doi:10.31234/osf.io/pdbf5}.
\item Unknown authors (2022). \textit{A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pdbf5\_v1}{source link}.
\item Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H. (2022). \textit{Magic mushroom extracts in lipid membranes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbamem.2022.183957}{doi:10.1016/j.bbamem.2022.183957}.
\item Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G (2022). \textit{The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.}. Systematic reviews. [published; PubMed]. \href{https://doi.org/10.1186/s13643-022-01930-7}{doi:10.1186/s13643-022-01930-7}.
\item Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M (2022). \textit{The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.}. Journal of midwifery \& women's health. [published; PubMed]. \href{https://doi.org/10.1111/jmwh.13371}{doi:10.1111/jmwh.13371}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Effinger D, Quadir S, Ramage M, Cone M, Herman M. (2022). \textit{Sex-Specific Effects of Psychedelic Drug Exposure on Central Amygdala Reactivity and Behavioral Responding}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.04.28.489882}{doi:10.1101/2022.04.28.489882}.
\item Doss M, Barrett FS, Corlett PR. (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a25wb}{doi:10.31234/osf.io/a25wb}.
\item Unknown authors (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a25wb\_v1}{source link}.
\item Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. (2022). \textit{Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2066650}{doi:10.1080/14740338.2022.2066650}.
\item Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR. (2022). \textit{Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2022.108195}{doi:10.1016/j.pharmthera.2022.108195}.
\item Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS. (2022). \textit{The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114577}{doi:10.1016/j.psychres.2022.114577}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R. (2022). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119220}{doi:10.1016/j.neuroimage.2022.119220}.
\item Hayes C, Wahba M, Watson S. (2022). \textit{Will psilocybin lose its magic in the clinical setting?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253221090822}{doi:10.1177/20451253221090822}.
\item Rudzki S. (2022). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. (2022). \textit{Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules27082520}{doi:10.3390/molecules27082520}.
\item Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2022). \textit{Increased global integration in the brain after psilocybin therapy for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01744-z}{doi:10.1038/s41591-022-01744-z}.
\item Jones G, Ricard JA, Lipson J, Nock MK. (2022). \textit{Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-08085-4}{doi:10.1038/s41598-022-08085-4}.
\item Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. (2022). \textit{Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221084063}{doi:10.1177/02698811221084063}.
\item Costa Fernandes Joana Margarida, Filho Cesar, Machado Brito-da-Costa Andreia, Marin-Bruzos Marieta, Saayman Jean, Sanders Daniel, Dinis-Oliveira Ricardo Jorge (2022). \textit{Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.456}{doi:10.51126/revsalus.v4isup.456}.
\item Filho Cesar, Costa Fernandes Joana Margarida, Machado Brito-da-Costa Andreia, Marin-Bruzos Marieta, Saayman Jean, Sanders Daniel, Dinis-Oliveira Ricardo Jorge (2022). \textit{Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.455}{doi:10.51126/revsalus.v4isup.455}.
\item Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana (2022). \textit{Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.271}{doi:10.51126/revsalus.v4isup.271}.
\item Unknown authors (2022). \textit{Psilocybin increases brain network integration in patients with depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01769-4}{doi:10.1038/s41591-022-01769-4}.
\item Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS. (2022). \textit{Models of psychedelic drug action: modulation of cortical-subcortical circuits.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/brain/awab406}{doi:10.1093/brain/awab406}.
\item Hackl B, Todt H, Kubista H, Kubista H, Hilber K, Koenig X. (2022). \textit{Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyab085}{doi:10.1093/ijnp/pyab085}.
\item Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R. (2022). \textit{Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.788155}{doi:10.3389/fphar.2021.788155}.
\item Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y. (2022). \textit{Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3255}{doi:10.1002/dta.3255}.
\item Pots W, Chakhssi F. (2022). \textit{Psilocybin-Assisted Compassion Focused Therapy for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.812930}{doi:10.3389/fpsyg.2022.812930}.
\item Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT. (2022). \textit{Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fepid.2022.876706}{doi:10.3389/fepid.2022.876706}.
\item Earleywine M, Low F, Altman BR, De Leo J. (2022). \textit{How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2047842}{doi:10.1080/02791072.2022.2047842}.
\item Davoudian PA, Shao L, Kwan AC. (2022). \textit{Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.03.18.484437}{doi:10.1101/2022.03.18.484437}.
\item McClure-Begley TD, Roth BL. (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Dworatzyk K, Jansen T, Schmidt TT. (2022). \textit{Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0264927}{doi:10.1371/journal.pone.0264927}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA. (2022). \textit{Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item Kisely S, Connor M, Somogyi AA, Siskind D. (2022). \textit{A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674221083868}{doi:10.1177/00048674221083868}.
\item Meade E, Hehir S, Rowan N, Garvey M. (2022). \textit{Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8030290}{doi:10.3390/jof8030290}.
\item McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2022). \textit{Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.841648}{doi:10.3389/fphar.2022.841648}.
\item Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T. (2022). \textit{Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-1321542/v1}{doi:10.21203/rs.3.rs-1321542/v1}.
\item Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF. (2022). \textit{Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11864-022-00954-4}{doi:10.1007/s11864-022-00954-4}.
\item Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G. (2022). \textit{Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2022.100104}{doi:10.1016/j.nsa.2022.100104}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item Sekula AD, Downey L, Puspanathan P. (2022). \textit{Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.813746}{doi:10.3389/fpsyg.2022.813746}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.28.482395}{doi:10.1101/2022.02.28.482395}.
\item Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. (2022). \textit{Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.03.02.22271743}{doi:10.1101/2022.03.02.22271743}.
\item van Amsterdam J, van den Brink W. (2022). \textit{The therapeutic potential of psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2047929}{doi:10.1080/14740338.2022.2047929}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. (2022). \textit{Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ (2022). \textit{Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211069100}{doi:10.1177/02698811211069100}.
\item Wolff M, Mertens LJ, Walter M, Enge S, Evens R. (2022). \textit{The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211073758}{doi:10.1177/02698811211073758}.
\item Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. (2022). \textit{The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2044096}{doi:10.1080/02791072.2022.2044096}.
\item Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P, Kuehne SS, Roder MA, Duthaler U, Kolaczynska KE, Varghese N, Eckert A, Liechti ME. (2022). \textit{Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01297-2}{doi:10.1038/s41386-022-01297-2}.
\item Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2022). \textit{Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-01846-9}{doi:10.1038/s41398-022-01846-9}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E. (2022). \textit{Natural language signatures of psilocybin microdosing}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.20.481177}{doi:10.1101/2022.02.20.481177}.
\item Jones GM, Nock MK. (2022). \textit{Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-06580-2}{doi:10.1038/s41598-022-06580-2}.
\item Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL. (2022). \textit{Increased low-frequency brain responses to music after psilocybin therapy for depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.13.480302}{doi:10.1101/2022.02.13.480302}.
\item NYU Langone Health (2022). \textit{A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02421263}{source link}.
\item Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP. (2022). \textit{Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm11040938}{doi:10.3390/jcm11040938}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK. (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Maia LO, Beaussant Y, Garcia ACM. (2022). \textit{The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpainsymman.2022.01.024}{doi:10.1016/j.jpainsymman.2022.01.024}.
\item Coppola M, Bevione F, Mondola R. (2022). \textit{Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jox12010004}{doi:10.3390/jox12010004}.
\item Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. (2022). \textit{Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.1c06708}{doi:10.1021/acsomega.1c06708}.
\item Yang Y, Meng G, Ni S, Zhang H, Dong C. (2022). \textit{Genomic Analysis of Stropharia rugosoannulata Reveals Its Nutritional Strategy and Application Potential in Bioremediation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8020162}{doi:10.3390/jof8020162}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Redden WM, Paracha SU, Sheheryar Q. (2022). \textit{Hallucinogen Use and Misuse in Older Adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cger.2021.07.007}{doi:10.1016/j.cger.2021.07.007}.
\item Toby BH (2022). \textit{Crystallographic hallucinations.}. Acta crystallographica. Section C, Structural chemistry. [published; PubMed]. \href{https://doi.org/10.1107/s2053229622000511}{doi:10.1107/s2053229622000511}.
\item Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. (2022). \textit{Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211073759}{doi:10.1177/02698811211073759}.
\item Averill LA, Abdallah CG (2022). \textit{Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2035358}{doi:10.1080/13543784.2022.2035358}.
\item Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ. (2022). \textit{[Are psychedelics fast acting antidepressant agents?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01255-1}{doi:10.1007/s00115-021-01255-1}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G. (2022). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S. (2022). \textit{Structure-based discovery of nonhallucinogenic psychedelic analogs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.abl8615}{doi:10.1126/science.abl8615}.
\item Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. (2022). \textit{Comment and Response: (Lugo-Radillo \& Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1983673}{doi:10.1080/02791072.2021.1983673}.
\item Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S. (2022). \textit{Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06066-z}{doi:10.1007/s00213-022-06066-z}.
\item Miceli McMillan R, Jordens C. (2022). \textit{Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11019-022-10070-7}{doi:10.1007/s11019-022-10070-7}.
\item Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF. (2022). \textit{Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnrgo.2021.784576}{doi:10.3389/fnrgo.2021.784576}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Strous JFM. (2022). \textit{[Psilocybin compared with escitalopram for depression].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/35138714}{source link}.
\item Hase A, Erdmann M, Limbach V, Hasler G. (2022). \textit{Analysis of recreational psychedelic substance use experiences classified by substance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06062-3}{doi:10.1007/s00213-022-06062-3}.
\item Khan FI, Hassan F, Lai D. (2022). \textit{In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fimmu.2021.794780}{doi:10.3389/fimmu.2021.794780}.
\item Bender D, Hellerstein DJ. (2022). \textit{Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06049-6}{doi:10.1007/s00213-021-06049-6}.
\item Glynos NG, Pierce J, Davis AK, McAfee J, Boehnke KF. (2022). \textit{Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.2022817}{doi:10.1080/02791072.2021.2022817}.
\item Jones GM, Nock MK. (2022). \textit{MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211058923}{doi:10.1177/02698811211058923}.
\item Jones GM, Nock MK. (2022). \textit{Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211066714}{doi:10.1177/02698811211066714}.
\item Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH. (2022). \textit{The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211064720}{doi:10.1177/02698811211064720}.
\item Altman BR, Earleywine M, De Leo J. (2022). \textit{Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.2020382}{doi:10.1080/02791072.2021.2020382}.
\item Vejmola Č., Syrová K., Šíchová K., Vlastimil K., Klučková T., Kelemen E., Páleníček T. (2021). \textit{Rats hallucinate in a similar manner to humans after psilocin}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2022.100950}{doi:10.1016/j.nsa.2022.100950}.
\item Bhadoria Poonam, Venkatnarayan Ramanathan (2021). \textit{Unravelling a New Conformer of Psilocin Through Computational Methods}. SSRN Electronic Journal. [published; Crossref]. \href{https://doi.org/10.2139/ssrn.4162669}{doi:10.2139/ssrn.4162669}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2021). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Liechti ME, Holze F. (2021). \textit{Dosing Psychedelics and MDMA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_270}{doi:10.1007/7854\_2021\_270}.
\item Ehrmann K, Allen JJB, Moreno FA. (2021). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Agin-Liebes G, Davis AK. (2021). \textit{Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_282}{doi:10.1007/7854\_2021\_282}.
\item Sousa TR, Rema J, Machado S, Novais F. (2021). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. (2021). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Rieser NM, Herdener M, Preller KH (2021). \textit{Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_284}{doi:10.1007/7854\_2021\_284}.
\item Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR (2021). \textit{The Potential of Psychedelics for End of Life and Palliative Care.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_278}{doi:10.1007/7854\_2021\_278}.
\item Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA. (2021). \textit{Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1107/s2053229621013164}{doi:10.1107/s2053229621013164}.
\item Jones GM, Nock MK. (2021). \textit{Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211058933}{doi:10.1177/02698811211058933}.
\item Plotnik L, Gibbs G, Graham T. (2021). \textit{Psilocybin Conspectus: Status, Production Methods, and Considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1615/intjmedmushrooms.2021041921}{doi:10.1615/intjmedmushrooms.2021041921}.
\item Schindler EAD. (2021). \textit{Psychedelics in the Treatment of Headache and Chronic Pain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_365}{doi:10.1007/7854\_2022\_365}.
\item Flanagan TW, Nichols CD (2021). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW. (2021). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Khan AJ, Bradley E, O'Donovan A, Woolley J. (2021). \textit{Psilocybin for Trauma-Related Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_366}{doi:10.1007/7854\_2022\_366}.
\item Kiguchi Y. (2021). \textit{[A Novel System for Discovering High-affinity Antibody Mutants That Enables Immunoassays with Higher Sensitivities -Development and Application of Clonal Array Profiling (CAP)].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/yakushi.22-00141}{doi:10.1248/yakushi.22-00141}.
\item Devenot N, Seale-Feldman A, Smith E, Noorani T, Garcia-Romeu A, Johnson MW. (2021). \textit{Psychedelic Identity Shift: A Critical Approach to Set And Setting.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1353/ken.2022.0022}{doi:10.1353/ken.2022.0022}.
\item Raison CL, Jain R, Penn AD, Cole SP, Jain S (2021). \textit{Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.831092}{doi:10.3389/fpsyt.2022.831092}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2021). \textit{Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.877390}{doi:10.3389/fpsyt.2022.877390}.
\item Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW (2021). \textit{Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.873279}{doi:10.3389/fpsyg.2022.873279}.
\item Frymann T, Whitney S, Yaden DB, Lipson J (2021). \textit{The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.863247}{doi:10.3389/fpsyg.2022.863247}.
\item Roseman L, Preller KH, Fotiou E, Winkelman MJ (2021). \textit{Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.979764}{doi:10.3389/fphar.2022.979764}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. (2021). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J (2021). \textit{Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.1971343}{doi:10.1080/02791072.2021.1971343}.
\item Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB (2021). \textit{Classic psychedelics, health behavior, and physical health.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253221135363}{doi:10.1177/20451253221135363}.
\item Marseille E, Bertozzi S, Kahn JG (2021). \textit{The economics of psychedelic-assisted therapies: A research agenda.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1025726}{doi:10.3389/fpsyt.2022.1025726}.
\item Mayer FP, Luethi D, Areal LB, Sitte HH (2021). \textit{Editorial: Old and new psychoactive substances: Pharmacology and potential applications.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1087005}{doi:10.3389/fpsyt.2022.1087005}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2021). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Köck P, Froelich K, Walter M, Lang U, Dürsteler KM. (2021). \textit{A systematic literature review of clinical trials and therapeutic applications of ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jsat.2021.108717}{doi:10.1016/j.jsat.2021.108717}.
\item University Hospital, Basel, Switzerland (2021). \textit{LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03153579}{source link}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5d7fc}{doi:10.31234/osf.io/5d7fc}.
\item Unknown authors (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5d7fc\_v1}{source link}.
\item Niles H, Fogg C, Kelmendi B, Lazenby M (2021). \textit{Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.}. BMC palliative care. [published; PubMed]. \href{https://doi.org/10.1186/s12904-021-00889-x}{doi:10.1186/s12904-021-00889-x}.
\item McKernan K, Kane L, Helbert Y, Zhang L, Houde N, McLaughlin S. (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.55301.2}{doi:10.12688/f1000research.55301.2}.
\item Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effects}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.12.17.21267992}{doi:10.1101/2021.12.17.21267992}.
\item Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M. (2021). \textit{Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211050556}{doi:10.1177/02698811211050556}.
\item National Council of Scientific and Technical Research, Argentina (2021). \textit{Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05160220}{source link}.
\item Elman I, Pustilnik A, Borsook D. (2021). \textit{Beating pain with psychedelics: Matter over mind?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Pearson C, Siegel J, Gold JA. (2021). \textit{Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2021.120096}{doi:10.1016/j.jns.2021.120096}.
\item Johns Hopkins University (2021). \textit{Effects of Psilocybin in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03181529}{source link}.
\item McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2021). \textit{A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xqzu2}{doi:10.31234/osf.io/xqzu2}.
\item Unknown authors (2021). \textit{A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xqzu2\_v1}{source link}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL. (2021). \textit{1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E. (2021). \textit{Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.11.30.470657}{doi:10.1101/2021.11.30.470657}.
\item Whitfield HJ. (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Olejníková L., Danda H., Lhotková E., Kútná V., Šíchová K., Syrová K., Mazochová K., Páleníček T. (2021). \textit{P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in rats}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.523}{doi:10.1016/j.euroneuro.2021.10.523}.
\item Vejmola Č., Syrová K., Koudelka V., Šíchová K., Tesař M., Dodoková A., Kelemen E., Páleníček T. (2021). \textit{P.0858 Psilocin induces perceptual alterations in rats: visual discrimination study}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.715}{doi:10.1016/j.euroneuro.2021.10.715}.
\item Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA. (2021). \textit{Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/21655979.2021.1987090}{doi:10.1080/21655979.2021.1987090}.
\item Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A. (2021). \textit{Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2021-056091}{doi:10.1136/bmjopen-2021-056091}.
\item Slocum ST, DiBerto JF, Roth BL. (2021). \textit{Molecular insights into psychedelic drug action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J (2021). \textit{Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms222312995}{doi:10.3390/ijms222312995}.
\item Weleff J, Akiki TJ, Barnett BS. (2021). \textit{Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.11.22.21266718}{doi:10.1101/2021.11.22.21266718}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Molumby M, Gaynor K, Guerin S. (2021). \textit{Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6f9qp}{doi:10.31234/osf.io/6f9qp}.
\item Unknown authors (2021). \textit{Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6f9qp\_v1}{source link}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. (2021). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME. (2021). \textit{Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.2487}{doi:10.1002/cpt.2487}.
\item Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z. (2021). \textit{Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-021-01811-4}{doi:10.1038/s41598-021-01811-4}.
\item Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH. (2021). \textit{Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/sciadv.abh2399}{doi:10.1126/sciadv.abh2399}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. (2021). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Strickland JC, Johnson MW. (2021). \textit{Human behavioral pharmacology of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2021.10.003}{doi:10.1016/bs.apha.2021.10.003}.
\item Gass P, Vasilescu AN, Inta D. (2021). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Graham F. (2021). \textit{Daily briefing: Largest trial shows psilocybin is effective to treat depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-03413-6}{doi:10.1038/d41586-021-03413-6}.
\item Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. (2021). \textit{Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01706-y}{doi:10.1038/s41398-021-01706-y}.
\item Basky G. (2021). \textit{Policy in focus: Is psilocybin the next cannabis?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/cmaj.1095974}{doi:10.1503/cmaj.1095974}.
\item Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH. (2021). \textit{Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bhab202}{doi:10.1093/cercor/bhab202}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M. (2021). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2021). \textit{Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.735523}{doi:10.3389/fpsyt.2021.735523}.
\item Maryland Oncology Hematology, PA (2021). \textit{The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04593563}{source link}.
\item Radakovic C, Radakovic R, Peryer G, Geere J. (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yu7jf}{doi:10.31234/osf.io/yu7jf}.
\item Unknown authors (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yu7jf\_v1}{source link}.
\item Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS. (2021). \textit{Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.30773/pi.2021.0209}{doi:10.30773/pi.2021.0209}.
\item Barnett BS, Parker SE, Weleff J. (2021). \textit{United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103473}{doi:10.1016/j.drugpo.2021.103473}.
\item Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H. (2021). \textit{Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-05991-9}{doi:10.1007/s00213-021-05991-9}.
\item Vejmola Č, Tylš F, Piorecká V, Koudelka V, Kadeřábek L, Novák T, Páleníček T. (2021). \textit{Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01603-4}{doi:10.1038/s41398-021-01603-4}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Castro BN, Prata Saraiva R, Afonso João D, Dantas Costa S (2021). \textit{Magic mushroom: all is not as it seems.}. Acta chirurgica Belgica. [published; PubMed]. \href{https://doi.org/10.1080/00015458.2021.1972590}{doi:10.1080/00015458.2021.1972590}.
\item Liu WQ, Shi Y, Xiang P, Yu F, Xie B, Dong M, Ha J, Ma CL, Wen D. (2021). \textit{Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12116/j.issn.1004-5619.2020.301001}{doi:10.12116/j.issn.1004-5619.2020.301001}.
\item Bogadi M, Kaštelan S. (2021). \textit{A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/34730895}{source link}.
\item Gonda X, Dome P, Neill JC, Tarazi FI. (2021). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M. (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Rodríguez Arce JM, Winkelman MJ. (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Zeiss R, Gahr M, Graf H. (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Aleksandrova LR, Phillips AG. (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Li NX, Hu YR, Chen WN, Zhang B. (2021). \textit{Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2021.09.041}{doi:10.1016/j.jad.2021.09.041}.
\item Morita I, Kiguchi Y, Oyama H, Takeuchi A, Tode C, Tanaka R, Ogata J, Kikura-Hanajiri R, Kobayashi N. (2021). \textit{Derivatization-assisted enzyme-linked immunosorbent assay for identifying hallucinogenic mushrooms with enhanced sensitivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d1ay01157j}{doi:10.1039/d1ay01157j}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T. (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Leger RF, Unterwald EM. (2021). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Kargbo RB. (2021). \textit{Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.1c00467}{doi:10.1021/acsmedchemlett.1c00467}.
\item de Vos CMH, Mason NL, Kuypers KPC. (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Argento E, Christie D, Mackay L, Callon C, Walsh Z. (2021). \textit{Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.716593}{doi:10.3389/fpsyt.2021.716593}.
\item Lehto RH, Miller M, Sender J. (2021). \textit{The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/08980101211039086}{doi:10.1177/08980101211039086}.
\item Kverno KS, Mangano E. (2021). \textit{Treatment-Resistant Depression: Approaches to Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20210816-01}{doi:10.3928/02793695-20210816-01}.
\item Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E. (2021). \textit{A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyab040}{doi:10.1093/ijnp/pyab040}.
\item Muthukumaraswamy SD, Forsyth A, Lumley T. (2021). \textit{Blinding and expectancy confounds in psychedelic randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2021.1933434}{doi:10.1080/17512433.2021.1933434}.
\item Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS (2021). \textit{Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab026}{doi:10.1093/ijnp/pyab026}.
\item Corneille JS, Luke D. (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2021.720579}{doi:10.3389/fpsyg.2021.720579}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R. (2021). \textit{Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14080793}{doi:10.3390/ph14080793}.
\item Mendes Rocha J, Rossi GN, Osório FL, Bouso Saiz JC, Silveira GO, Yonamine M, Crevelin EJ, Queiroz ME, Cecílio Hallak JE, Dos Santos RG. (2021). \textit{Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.688439}{doi:10.3389/fpsyt.2021.688439}.
\item Nkadimeng SM, Steinmann CML, Eloff JN. (2021). \textit{Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/jir.s317182}{doi:10.2147/jir.s317182}.
\item Lukačovič M, Masaryk R. (2021). \textit{Use of hallucinogens in Slovakia: Does it differ from global trends?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103385}{doi:10.1016/j.drugpo.2021.103385}.
\item Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1524-2794}{doi:10.1055/a-1524-2794}.
\item van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM (2021). \textit{Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.}. European journal of neurology. [published; PubMed]. \href{https://doi.org/10.1111/ene.14914}{doi:10.1111/ene.14914}.
\item Waters K. (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item DiBerto JF, Roth BL. (2021). \textit{The cranial windows of perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2021.07.017}{doi:10.1016/j.neuron.2021.07.017}.
\item Wiley JF, Bei B. (2021). \textit{Psilocybin for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmc2108082}{doi:10.1056/nejmc2108082}.
\item Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M. (2021). \textit{The Potential Role of Serotonergic Hallucinogens in Depression Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/life11080765}{doi:10.3390/life11080765}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K. (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. (2021). \textit{Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103380}{doi:10.1016/j.drugpo.2021.103380}.
\item Horton DM, Morrison B, Schmidt J. (2021). \textit{Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.psychotherapy.20200055}{doi:10.1176/appi.psychotherapy.20200055}.
\item King's College London (2021). \textit{A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04959253}{source link}.
\item Siegel V, Emmert-Aronson B. (2021). \textit{Both partners practicing orgasmic meditation report having a mystical-type experience: results using the Mystical Experience Questionnaire}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.53496.1}{doi:10.12688/f1000research.53496.1}.
\item Cox DJ, Johnson MW. (2021). \textit{Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000404}{doi:10.1037/pha0000404}.
\item Mayer CE, LeBaron VT, Acquaviva KD. (2021). \textit{Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1916659}{doi:10.1080/02791072.2021.1916659}.
\item Letheby C. (2021). \textit{Naturalistic Entheogenics: Précis of Philosophy of Psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztewb}{doi:10.31234/osf.io/ztewb}.
\item Unknown authors (2021). \textit{Naturalistic Entheogenics: Précis of Philosophy of Psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztewb\_v1}{source link}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2021.06.001}{doi:10.1016/j.euroneuro.2021.06.001}.
\item Lenz C, Dörner S, Sherwood A, Hoffmeister D. (2021). \textit{Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.202101382}{doi:10.1002/chem.202101382}.
\item Watts R. (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5x2bu}{doi:10.31234/osf.io/5x2bu}.
\item Unknown authors (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5x2bu\_v1}{source link}.
\item Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC. (2021). \textit{Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2021.06.008}{doi:10.1016/j.neuron.2021.06.008}.
\item Bao SH, Jiang H, Zhu LY, Yao G, Han PG, Wan XK, Wang K, Song TY, Liu CJ, Wang S, Zhang ZY, Zhang DY, Meng E. (2021). \textit{A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2021.109413}{doi:10.1016/j.celrep.2021.109413}.
\item Zhou Liying, Xiang Ping, Wen Di, Shen Baohua, Wang Xin, Li Le, Deng Hongxiao, Chen Hang, Yan Hui, Shen Min, Shi Yan, Liu Wanhui (2021). \textit{Sensitive quantitative analysis of psilocin and psilocybin in hair samples from suspected users and their distribution in seized hallucinogenic mushrooms}. Forensic Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s11419-020-00566-3}{doi:10.1007/s11419-020-00566-3}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL. (2021). \textit{Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.647909}{doi:10.3389/fpsyt.2021.647909}.
\item Coppola M, Bevione F, Mondola R. (2021). \textit{Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202106.0682.v1}{doi:10.20944/preprints202106.0682.v1}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9kuhs}{doi:10.31234/osf.io/9kuhs}.
\item Unknown authors (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9kuhs\_v1}{source link}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item Révész D, Ona G, Rossi GN, Rocha JM, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC. (2021). \textit{Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.687546}{doi:10.3389/fpsyt.2021.687546}.
\item McKernan K, Kane LT, Crawford S, Chin C, Trippe A, McLaughlin S. (2021). \textit{A draft reference assembly of the Psilocybe cubensis genome}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.51613.2}{doi:10.12688/f1000research.51613.2}.
\item Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR. (2021). \textit{Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11845-021-02668-2}{doi:10.1007/s11845-021-02668-2}.
\item Prochazkova L, van Elk M, Marschall JC, Rifkin BD, Fejer G, Schoen N, Fiacchino D, Kuchar M, Hommel B. (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/emcxw}{doi:10.31234/osf.io/emcxw}.
\item Unknown authors (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/emcxw\_v1}{source link}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Bambauer TP, Wagmann L, Weber AA, Meyer MR. (2021). \textit{Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3106}{doi:10.1002/dta.3106}.
\item Unknown authors (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Fradkin D. (2021). \textit{Psilocybin: A brief overview for psychiatric mental health nurse practitioners.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ppc.12888}{doi:10.1111/ppc.12888}.
\item Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT. (2021). \textit{Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000490}{doi:10.1037/pha0000490}.
\item Cox DJ, Garcia-Romeu A, Johnson MW. (2021). \textit{Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00952990.2021.1910830}{doi:10.1080/00952990.2021.1910830}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Corneille JS, Luke D. (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8aeyf}{doi:10.31234/osf.io/8aeyf}.
\item Unknown authors (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8aeyf\_v1}{source link}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL. (2021). \textit{Psychedelics and health behaviour change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item Magaraggia I, Kuiperes Z, Schreiber R. (2021). \textit{Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nlm.2021.107467}{doi:10.1016/j.nlm.2021.107467}.
\item Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2021). \textit{Decreased brain modularity after psilocybin therapy for depression.}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-513323/v1}{doi:10.21203/rs.3.rs-513323/v1}.
\item Unknown authors (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1037/pne0000290}{doi:10.1037/pne0000290}.
\item Lewis-Healey E, Laukkonen RE, van Elk M. (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q3ymd}{doi:10.31234/osf.io/q3ymd}.
\item Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD. (2021). \textit{Registered clinical studies investigating psychedelic drugs for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2021.05.019}{doi:10.1016/j.jpsychires.2021.05.019}.
\item Hendin HM, Penn AD. (2021). \textit{An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/bdi.13095}{doi:10.1111/bdi.13095}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2021). \textit{LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.05.14.444193}{doi:10.1101/2021.05.14.444193}.
\item Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. (2021). \textit{The Therapeutic Potential of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26102948}{doi:10.3390/molecules26102948}.
\item Gründer G, Jungaberle H. (2021). \textit{The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1486-7386}{doi:10.1055/a-1486-7386}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Unknown authors (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W (2021). \textit{Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.}. Hypertension (Dallas, Tex.: 1979). [published; PubMed]. \href{https://doi.org/10.1161/hypertensionaha.120.16715}{doi:10.1161/hypertensionaha.120.16715}.
\item Reynolds CF. (2021). \textit{Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2020.2901}{doi:10.1001/jamapsychiatry.2020.2901}.
\item Davis AK, Griffiths RR. (2021). \textit{Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2020.4638}{doi:10.1001/jamapsychiatry.2020.4638}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG. (2021). \textit{Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001396}{doi:10.1097/jcp.0000000000001396}.
\item Bird CIV, Modlin NL, Rucker JJH. (2021). \textit{Psilocybin and MDMA for the treatment of trauma-related psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2021.1919062}{doi:10.1080/09540261.2021.1919062}.
\item Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark (2021). \textit{Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling}. The FASEB Journal. [published; Crossref]. \href{https://doi.org/10.1096/fasebj.2021.35.s1.03168}{doi:10.1096/fasebj.2021.35.s1.03168}.
\item van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J. (2021). \textit{Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-05857-0}{doi:10.1007/s00213-021-05857-0}.
\item University of Zurich (2021). \textit{Characterization of Altered Waking States of Consciousness in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03853577}{source link}.
\item University Hospital, Basel, Switzerland (2021). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03604744}{source link}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Rucker JJ, Young AH. (2021). \textit{Psilocybin: From Serendipity to Credibility?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.659044}{doi:10.3389/fpsyt.2021.659044}.
\item Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A. (2021). \textit{[Efficacy of psychedelics in psychiatry, a systematic review of the literature].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.12.002}{doi:10.1016/j.encep.2020.12.002}.
\item Zhang X, Yu H, Wang Z, Yang Q, Xia R, Qu Y, Tao R, Shi Y, Xiang P, Zhang S, Li C. (2021). \textit{Multi-locus identification of Psilocybe cubensis by high-resolution melting (HRM).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/20961790.2021.1875580}{doi:10.1080/20961790.2021.1875580}.
\item Mason NL, Kuypers KPC, Reckweg JT, Müller F, Tse DHY, Da Rios B, Toennes SW, Stiers P, Feilding A, Ramaekers JG. (2021). \textit{Spontaneous and deliberate creative cognition during and after psilocybin exposure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01335-5}{doi:10.1038/s41398-021-01335-5}.
\item Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD. (2021). \textit{Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.04.02.21254838}{doi:10.1101/2021.04.02.21254838}.
\item Dworatzyk K, Jansen T, Schmidt TT. (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kxmgq}{doi:10.31234/osf.io/kxmgq}.
\item Unknown authors (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kxmgq\_v1}{source link}.
\item Simonsson O, Sexton JD, Hendricks PS (2021). \textit{Associations between lifetime classic psychedelic use and markers of physical health.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121996863}{doi:10.1177/0269881121996863}.
\item Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. (2021). \textit{Trial of Psilocybin versus Escitalopram for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2032994}{doi:10.1056/nejmoa2032994}.
\item Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. (2021). \textit{Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.2022489118}{doi:10.1073/pnas.2022489118}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR. (2021). \textit{Cannabis-induced oceanic boundlessness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R. (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8vks6}{doi:10.31234/osf.io/8vks6}.
\item Unknown authors (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8vks6\_v1}{source link}.
\item Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D. (2021). \textit{Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0004867421998785}{doi:10.1177/0004867421998785}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S. (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Cho SE, Jo JW, Kwag YN, Lee H, Chung JW, Oh SH, Kim CS. (2021). \textit{Complete mitochondrial genome sequence of Gymnopilus junonius.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/23802359.2021.1895692}{doi:10.1080/23802359.2021.1895692}.
\item Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE. (2021). \textit{Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.1c00020}{doi:10.1021/acsptsci.1c00020}.
\item Khan A, Singh G, Jacob J. (2021). \textit{A Rare Presentation of Anticholinergic Toxicity in a Young Patient Due to Over-The-Counter Cold Medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.13919}{doi:10.7759/cureus.13919}.
\item Musikaphongsakul P, Ya K, Subsoontorn P, Lohitnavy M. (2021). \textit{Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.28133.1}{doi:10.12688/f1000research.28133.1}.
\item Zeifman RJ, Singhal N, Breslow L, Weissman CR. (2021). \textit{On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.1c00024}{doi:10.1021/acsptsci.1c00024}.
\item Muthukumaraswamy S, Forsyth A, Lumley T. (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q2hzm}{doi:10.31234/osf.io/q2hzm}.
\item Unknown authors (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/q2hzm\_v1}{source link}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/rmhp.s300656}{doi:10.2147/rmhp.s300656}.
\item Fricke J, Sherwood AM, Halberstadt AL, Kargbo RB, Hoffmeister D. (2021). \textit{Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jnatprod.1c00087}{doi:10.1021/acs.jnatprod.1c00087}.
\item Hirschfeld T, Schmidt TT. (2021). \textit{Dose-response relationships of psilocybin-induced subjective experiences in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121992676}{doi:10.1177/0269881121992676}.
\item Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM. (2021). \textit{Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.640241}{doi:10.3389/fphar.2021.640241}.
\item Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r726d}{doi:10.31234/osf.io/r726d}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K. (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Winkelman MJ. (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Fedorova EV, Wong CF, Ataiants J, Iverson E, Conn BM, Lankenau SE. (2021). \textit{Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2021.108648}{doi:10.1016/j.drugalcdep.2021.108648}.
\item Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. (2021). \textit{Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121991822}{doi:10.1177/0269881121991822}.
\item Shao L, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC. (2021). \textit{Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.17.431629}{doi:10.1101/2021.02.17.431629}.
\item Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2021). \textit{Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.16.431276}{doi:10.1101/2021.02.16.431276}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E. (2021). \textit{Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.586682}{doi:10.3389/fpsyt.2021.586682}.
\item Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R. (2021). \textit{Trends in the Top-Cited Articles on Classic Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1874573}{doi:10.1080/02791072.2021.1874573}.
\item Elcock C. (2021). \textit{Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jhbs.22083}{doi:10.1002/jhbs.22083}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Liokaftos D. (2021). \textit{Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2020.103099}{doi:10.1016/j.drugpo.2020.103099}.
\item Bates MLS, Trujillo KA. (2021). \textit{Use and abuse of dissociative and psychedelic drugs in adolescence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2021.173129}{doi:10.1016/j.pbb.2021.173129}.
\item Higgins GA, Sellers EM. (2021). \textit{5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2021.01.007}{doi:10.1016/bs.pbr.2021.01.007}.
\item Breeksema JJ, Koolen MHB, Somers M, Schoevers RA. (2021). \textit{[Treatment with psilocybin: applications for patients with psychiatric disorders].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/33560605}{source link}.
\item Barnett BS, Greer GR. (2021). \textit{Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaclp.2020.12.011}{doi:10.1016/j.jaclp.2020.12.011}.
\item Mertens LJ, Preller KH. (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2021). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22020835}{doi:10.3390/ijms22020835}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Healy CJ. (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. (2021). \textit{Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120967878}{doi:10.1177/0269881120967878}.
\item Pham DNK, Chadeayne AR, Golen JA, Manke DR. (2021). \textit{Psilacetin derivatives: fumarate salts of the meth-yl-ethyl, meth-yl-allyl and diallyl variants of the psilocin prodrug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1107/s2056989021000116}{doi:10.1107/s2056989021000116}.
\item Joshua Woolley (2021). \textit{Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02950467}{source link}.
\item Konkel Z, Scott K, Slot JC. (2021). \textit{Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," Athelia (Fibularhizoctonia) sp. TMB Strain TB5.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1128/mra.01230-20}{doi:10.1128/mra.01230-20}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.19104}{doi:10.1176/appi.focus.19104}.
\item Gashi L, Sandberg S, Pedersen W (2020). \textit{Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2020.102997}{doi:10.1016/j.drugpo.2020.102997}.
\item Inserra A, De Gregorio D, Gobbi G. (2020). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Tullis P. (2020). \textit{How ecstasy and psilocybin are shaking up psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-00187-9}{doi:10.1038/d41586-021-00187-9}.
\item Bouso JC, Ona G, Dos Santos RG, Hallak JEC. (2020). \textit{Psychedelic Medicines in Major Depression: Progress and Future Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-33-6044-0\_26}{doi:10.1007/978-981-33-6044-0\_26}.
\item Sheppard B. (2020). \textit{A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/35026878}{source link}.
\item Castro Santos H, Gama Marques J. (2020). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J (2020). \textit{Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.645246}{doi:10.3389/fpsyg.2021.645246}.
\item Gerber K, Flores IG, Ruiz AC, Ali I, Ginsberg NL, Schenberg EE. (2020). \textit{Ethical Concerns about Psilocybin Intellectual Property.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.0c00171}{doi:10.1021/acsptsci.0c00171}.
\item Giancola NB, Korson CJ, Caplan JP, McKnight CA. (2020). \textit{A "Trip" to the Intensive Care Unit: An Intravenous Injection of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaclp.2020.12.012}{doi:10.1016/j.jaclp.2020.12.012}.
\item Kočárová R, Horáček J, Carhart-Harris R (2020). \textit{Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.661233}{doi:10.3389/fpsyt.2021.661233}.
\item Eleftheriou ME, Thomas E (2020). \textit{Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.707057}{doi:10.3389/fpsyt.2021.707057}.
\item Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE (2020). \textit{Psychedelics and Other Psychoplastogens for Treating Mental Illness.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727117}{doi:10.3389/fpsyt.2021.727117}.
\item Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J (2020). \textit{Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.737738}{doi:10.3389/fpsyt.2021.737738}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2020). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Frontiers Production Office (2020). \textit{Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.832766}{doi:10.3389/fpsyt.2021.832766}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2020). \textit{Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.780696}{doi:10.3389/fpsyt.2021.780696}.
\item Delia Sterpu (2020). \textit{Phenylketonuria with mental retardation and valproate-induced hyperammonemia}. Romanian Journal of Psychiatry \& Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.37897/rjpp.2020.4.5}{doi:10.37897/rjpp.2020.4.5}.
\item Andrian Fajar Kusumadewi (2020). \textit{Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication}. Archives of The Medicine and Case Reports. [published; OpenAlex]. \href{https://doi.org/10.37275/amcr.v1i2.505}{doi:10.37275/amcr.v1i2.505}.
\item Andrian Fajar Kusumadewi (2020). \textit{Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication}. Archives of The Medicine and Case Reports. [published; OpenAlex]. \href{https://doi.org/10.37275/amcr.v1i2.13}{doi:10.37275/amcr.v1i2.13}.
\item Strickland JC, Garcia-Romeu A, Johnson M. (2020). \textit{Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f5dmt}{doi:10.31234/osf.io/f5dmt}.
\item Michael B. Gatch, Adam C. Hoch, Theresa M. Carbonaro (2020). \textit{Discriminative Stimulus Effects of Substituted Tryptamines in Rats}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00173}{doi:10.1021/acsptsci.0c00173}.
\item Justin C. Strickland, Albert Garcia-Romeu, Matthew W. Johnson (2020). \textit{Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00187}{doi:10.1021/acsptsci.0c00187}.
\item Anna U. Odland, Jesper L. Kristensen, Jesper T. Andreasen (2020). \textit{Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice}. Behavioural Brain Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbr.2020.113093}{doi:10.1016/j.bbr.2020.113093}.
\item Savalia NK, Shao LX, Kwan AC. (2020). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Seema Kang (2020). \textit{Research Round Up}. The Lancet Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s2215-0366(20)30535-6}{doi:10.1016/s2215-0366(20)30535-6}.
\item Sanah Malomile Nkadimeng, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-79328-5}{doi:10.1038/s41598-020-79328-5}.
\item Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, Emilie I. Anderson, Simon D. Brandt, Stephen J. Chapman, John D. McCorvy, Adam L. Halberstadt (2020). \textit{Investigation of the Structure-Activity Relationships of Psilocybin Analogues}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00176}{doi:10.1021/acsptsci.0c00176}.
\item Ove Heradstveit, Jens Christoffer Skogen, Marit Edland-Gryt, Morten Hesse, Lotte Vallentin-Holbech, Kari-Jussie Lønning, Børge Sivertsen (2020). \textit{Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2020.543507}{doi:10.3389/fpsyt.2020.543507}.
\item Monnica T. Williams, Alan K. Davis, Yitong Xin, Nathan D. Sepeda, Pamela Colón Grigas, Sinead M. Sinnott, Angela M. Haeny (2020). \textit{People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2020.1854688}{doi:10.1080/09687637.2020.1854688}.
\item Timo Torsten Schmidt, Simon Reiche, Caroline L. C. Hage, Felix Bermpohl, Tomislav Majić (2020). \textit{Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-78527-4}{doi:10.1038/s41598-020-78527-4}.
\item Christopher S. Stauffer, B. Anderson, Kile Ortigo, Joshua Woolley (2020). \textit{Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00169}{doi:10.1021/acsptsci.0c00169}.
\item Karolina E. Kolaczynska, Matthias E. Liechti, Urs Duthaler (2020). \textit{Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma}. Journal of Chromatography B. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jchromb.2020.122486}{doi:10.1016/j.jchromb.2020.122486}.
\item Lene Lundgaard Donovan, Jens Vilstrup Johansen, Nídia Fernandez Ros, Elham Jaberi, Kristían Línnet, Sys Stybe Johansen, Brice Ozenne, Shohreh Issazadeh-Navikas, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Dudysová Daniela, Janku Karolina, Smotek Michal, Saifutdinova Elizaveta, Koprivova Jana, Bušková Jitka, Mander Bryce Anthony, Brunovský Martin, Zach Peter, Korčák Jakub, Andrashko Veronika, Viktorinová Michaela, Tylš Filip, Bravermanová Anna, Froese Tom, Páleníček Tomáš, Horáček Jiří (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Institutional Repositories DataBase (IRDB). [published; OpenAlex]. \href{http://id.nii.ac.jp/1394/00001681/}{source link}.
\item Benjamin Dueck (2020). \textit{Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman Language}. Journal of Posthuman Studies. [published; OpenAlex]. \href{https://doi.org/10.5325/jpoststud.4.2.0166}{doi:10.5325/jpoststud.4.2.0166}.
\item University Hospital, Basel, Switzerland (2020). \textit{Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03912974}{source link}.
\item Weston NM, Gibbs D, Bird CIV, Daniel A, Jelen LA, Knight G, Goldsmith D, Young AH, Rucker JJ (2020). \textit{Historic psychedelic drug trials and the treatment of anxiety disorders.}. Depression and anxiety. [published; PubMed]. \href{https://doi.org/10.1002/da.23065}{doi:10.1002/da.23065}.
\item Holoyda B (2020). \textit{Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.}. Psychiatric services (Washington, D.C.). [published; PubMed]. \href{https://doi.org/10.1176/appi.ps.202000213}{doi:10.1176/appi.ps.202000213}.
\item Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. (2020). \textit{Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13249}{doi:10.1111/acps.13249}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2020). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202011.0742.v1}{doi:10.20944/preprints202011.0742.v1}.
\item De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G. (2020). \textit{Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1659-20.2020}{doi:10.1523/jneurosci.1659-20.2020}.
\item Askew R, Williams L. (2020). \textit{Rethinking enhancement substance use: A critical discourse studies approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2020.102994}{doi:10.1016/j.drugpo.2020.102994}.
\item Heba Diab, Benjamin Malcolm (2020). \textit{Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT)}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2020.1847366}{doi:10.1080/02791072.2020.1847366}.
\item Lenz C, Sherwood A, Kargbo R, Hoffmeister D. (2020). \textit{Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cplu.202000581}{doi:10.1002/cplu.202000581}.
\item Agustín Lugo-Radillo, Jorge Luis Cortés-López (2020). \textit{Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2020.1849879}{doi:10.1080/02791072.2020.1849879}.
\item Felix Müller, Friederike Holze, Patrick C. Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E. Liechti, Stefan Borgwardt (2020). \textit{MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-00906-2}{doi:10.1038/s41386-020-00906-2}.
\item Elena Deligianni, Lisa A. Lione, Christos Kontogiorgis, Georgios Papazisis, Diamanto Lazari (2020). \textit{USE OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS) OF NATURAL ORIGIN: AN INTERNATIONAL SURVEY}. University of Hertfordshire Research Archive (University of Hertfordshire). [published; OpenAlex]. \href{http://hdl.handle.net/2299/24124}{source link}.
\item Al-Matrouk A, Al-Hasan M, Naqi HA, Al-Abkal N, Mohammed H, Haider M, Al-Shammeri D, Bojbarah H. (2020). \textit{Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-33143/v2}{doi:10.21203/rs.3.rs-33143/v2}.
\item Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher Gottschalk, Christina Luddy, L. Taylor Flynn, Hayley Lindsey, Brian Pittman, Nicholas V. Cozzi, Deepak Cyril D’Souza (2020). \textit{Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1007/s13311-020-00962-y}{doi:10.1007/s13311-020-00962-y}.
\item Bottemanne H, Claret A, Fossati P. (2020). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Courtney C. Walton, Paul Liknaitzky (2020). \textit{Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy}. Journal of Applied Sport Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/10413200.2020.1848941}{doi:10.1080/10413200.2020.1848941}.
\item Steven Dubovsky (2020). \textit{Psilocybin for Depression}. Journal watch. [published; OpenAlex]. \href{https://doi.org/10.1056/nejm-jw.na52780}{doi:10.1056/nejm-jw.na52780}.
\item University of Zurich (2020). \textit{Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03736980}{source link}.
\item Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL. (2020). \textit{Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s003329172000389x}{doi:10.1017/s003329172000389x}.
\item Oskar Hougaard Jefsen, Betina Elfving, Gregers Wegener, Heidi Kaastrup Müller (2020). \textit{Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959614}{doi:10.1177/0269881120959614}.
\item Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, Roland R. Griffiths (2020). \textit{Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2020.3285}{doi:10.1001/jamapsychiatry.2020.3285}.
\item EPUB Download The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms TXT,PDF,EPUB (2020). \textit{EPUB Download The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms TXT,PDF,EPUB}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.4208978}{doi:10.5281/zenodo.4208978}.
\item Best [PDF] The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms Full PDF Online (2020). \textit{Best [PDF] The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms Full PDF Online}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.4208128}{doi:10.5281/zenodo.4208128}.
\item Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.589}{doi:10.1016/j.euroneuro.2020.09.589}.
\item M. Madsen, Dea Siggaard Stenbæk, Brice Ozenne, Sophia Armand, M.R. Marstrand-Jørgensen, Albin Arvidsson, Sys Stybe Johansen, Kristían Línnet, Gitte M. Knudsen, Patrick M. Fisher (2020). \textit{P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.169}{doi:10.1016/j.euroneuro.2020.09.169}.
\item Marko Rosenholm (2020). \textit{Studies on the developmental and antidepressant-like effects of anesthetics}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/319705}{source link}.
\item Klára Gotvaldová, Kateřina Hájková, Jan Borovička, Radek Jurok, Petra Cihlářová, Martin Kuchař (2020). \textit{Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis}. Drug Testing and Analysis. [published; OpenAlex]. \href{https://doi.org/10.1002/dta.2950}{doi:10.1002/dta.2950}.
\item Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/nhbjk}{doi:10.31234/osf.io/nhbjk}.
\item Ona GS, Dos Santos RG, Hallak JEC, Bouso JC (2020). \textit{Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.0c00614}{doi:10.1021/acschemneuro.0c00614}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Melker Hagsäter (2020). \textit{Serotonin in Fear and Anxiety}. Gothenburg University Publications Electronic Archive (Gothenburg University). [published; OpenAlex]. \href{http://hdl.handle.net/2077/65128}{source link}.
\item Shi Y, Wang R, Yuan S, Qiang H, Shen M, Shen B, Drummer OH, Yu Z, Zhao Y, Xiang P. (2020). \textit{UHPLC-MS/MS method for simultaneously detecting 16 tryptamines and their metabolites in human hair and applications to real forensics cases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2020.122392}{doi:10.1016/j.jchromb.2020.122392}.
\item Joanes Grandjean, David Buehlmann, Michaela Buerge, Hannes Sigrist, Erich Seifritz, Franz X. Vollenweider, Christopher R. Pryce, Markus Rudin (2020). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2020.117456}{doi:10.1016/j.neuroimage.2020.117456}.
\item Olivia Gosseries, Charlotte Martial (2020). \textit{The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.}. Open Repository and Bibliography (University of Liège). [published; OpenAlex]. \href{https://doi.org/10.34700/gv0w-y052}{doi:10.34700/gv0w-y052}.
\item Dea Siggaard Stenbæk, M. Madsen, Brice Ozenne, Sara Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2020). \textit{Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959609}{doi:10.1177/0269881120959609}.
\item Rotem Petranker, Thomas Anderson, Larissa J. Maier, Monica J. Barratt, Jason Ferris, Adam Winstock (2020). \textit{Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120953994}{doi:10.1177/0269881120953994}.
\item Ona G, Bouso JC. (2020). \textit{Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.09.035}{doi:10.1016/j.neubiorev.2020.09.035}.
\item R. (Renu) Tyagi, R. Kalani, C. (Chandresh) Pareek (2020). \textit{Alkaloids, Biosynthesis AND Their Applications}. Neliti. [published; OpenAlex]. \href{https://www.neliti.com/publications/722050/alkaloids-biosynthesis-and-their-applications}{source link}.
\item Lawrence Silver (2020). \textit{Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship}. American Journal of Management. [published; OpenAlex]. \href{https://doi.org/10.33423/ajm.v20i3.3104}{doi:10.33423/ajm.v20i3.3104}.
\item Unknown authors (2020). \textit{109 - Novel Treatments for Resistant Depression: Comparison of Older and Younger Patients}. International Psychogeriatrics. [published; OpenAlex]. \href{https://doi.org/10.1017/s1041610220001878}{doi:10.1017/s1041610220001878}.
\item Unknown authors (2020). \textit{Psilocybin in the news}. Field Mycology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.fldmyc.2020.10.011}{doi:10.1016/j.fldmyc.2020.10.011}.
\item Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch (2020). \textit{The Role of Psychedelics and Counseling in Mental Health Treatment}. Journal of Mental Health Counseling. [published; OpenAlex]. \href{https://doi.org/10.17744/mehc.42.4.03}{doi:10.17744/mehc.42.4.03}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Peter S. Hendricks (2020). \textit{Psilocybin-assisted group therapy: A new hope for demoralization}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2020.100557}{doi:10.1016/j.eclinm.2020.100557}.
\item Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS. (2020). \textit{The emerging role of psilocybin and MDMA in the treatment of mental illness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2020.1826931}{doi:10.1080/14737175.2020.1826931}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Agata Tadeja (2020). \textit{Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.}. Farmacja Polska. [published; OpenAlex]. \href{https://doi.org/10.32383/farmpol/127922}{doi:10.32383/farmpol/127922}.
\item B. Anderson, Alicia Danforth, Prof Robert Daroff, Christopher S. Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, James Dilley, Jennifer Mitchell, Joshua Woolley (2020). \textit{Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2020.100538}{doi:10.1016/j.eclinm.2020.100538}.
\item Petter Grahl Johnstad (2020). \textit{Cannabis as entheogen: survey and interview data on the spiritual use of cannabis}. Journal of Cannabis Research. [published; OpenAlex]. \href{https://doi.org/10.1186/s42238-020-00032-2}{doi:10.1186/s42238-020-00032-2}.
\item Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML. (2020). \textit{Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2020.1817639}{doi:10.1080/02791072.2020.1817639}.
\item Shevaugn Johnson, Quentin Black (2020). \textit{Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-020-00398-7}{doi:10.1007/s11469-020-00398-7}.
\item Mollinedo-Gajate I, Song C, Sintes-Rodriguez M, Whelan T, Soula A, Selimbeyoglu A, Hurley S, Knöpfel T. (2020). \textit{Psilocybin rescues sociability deficits in an animal model of autism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.09.09.289348}{doi:10.1101/2020.09.09.289348}.
\item Ivan Permana Putra (2020). \textit{Kasus keracunan Inocybe sp. di Indonesia}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.24252/psb.v6i1.15727}{doi:10.24252/psb.v6i1.15727}.
\item Helle Kaasik, Rita C. Z. Souza, Flávia da Silva Zandonadi, Luís Fernando Tófoli, Alessandra Sussulini (2020). \textit{Chemical Composition of Traditional and Analog Ayahuasca}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2020.1815911}{doi:10.1080/02791072.2020.1815911}.
\item Vitkauskas M, Mathuru AS. (2020). \textit{Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms21186525}{doi:10.3390/ijms21186525}.
\item Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L. (2020). \textit{Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/biomedicines8090331}{doi:10.3390/biomedicines8090331}.
\item Teresa Kay Jones, Steven Lippmann (2020). \textit{Psilocybin Can Diminish Depression}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.19br02580}{doi:10.4088/pcc.19br02580}.
\item Greif A, Šurkala M. (2020). \textit{Compassionate use of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11019-020-09958-z}{doi:10.1007/s11019-020-09958-z}.
\item Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. (2020). \textit{Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-020-00748-y}{doi:10.1007/s40263-020-00748-y}.
\item Kuglae Kim, Tao Che, Ouliana Panova, Jeffrey F. DiBerto, Jiankun Lyu, B. Krumm, Daniel Wacker, Michael J. Robertson, Alpay B. Seven, David E. Nichols, Brian K. Shoichet, Georgios Skiniotis, Bryan L. Roth (2020). \textit{Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor}. Cell. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cell.2020.08.024}{doi:10.1016/j.cell.2020.08.024}.
\item Sanah Malomile Nkadimeng, Alice Nabatanzi, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom}. Plants. [published; OpenAlex]. \href{https://doi.org/10.3390/plants9091127}{doi:10.3390/plants9091127}.
\item Kuypers KPC. (2020). \textit{The therapeutic potential of microdosing psychedelics in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320950567}{doi:10.1177/2045125320950567}.
\item M. Madsen, Gitte M. Knudsen (2020). \textit{Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-00823-4}{doi:10.1038/s41386-020-00823-4}.
\item Júlia Nagy, Tibor Veress (2020). \textit{Systematic Error for Extraction of Controlled Substances from Plant/Fungal Materials}. Journal of Chromatographic Science. [published; OpenAlex]. \href{https://doi.org/10.1093/chromsci/bmaa067}{doi:10.1093/chromsci/bmaa067}.
\item Vann Jones SA, O'Kelly A. (2020). \textit{Psychedelics as a Treatment for Alzheimer's Disease Dementia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnsyn.2020.00034}{doi:10.3389/fnsyn.2020.00034}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Cornelia Stress, Katrin H. Preller, Thomas Koenig, Franz X. Vollenweider (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item Lin Denise S (2020). \textit{Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms}. Journal of Healthcare. [published; OpenAlex]. \href{https://doi.org/10.36959/569/456}{doi:10.36959/569/456}.
\item John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane (2020). \textit{Psychedelic science in post-COVID-19 psychiatry}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item James D. Tucker (2020). \textit{Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3783484\_code4550530.pdf?abstractid=3783484\&mirid=1}{source link}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI, Wenthur CJ. (2020). \textit{Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.08.12.248229}{doi:10.1101/2020.08.12.248229}.
\item Guss J, Krause R, Sloshower J. (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u6v9y}{doi:10.31234/osf.io/u6v9y}.
\item Unknown authors (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u6v9y\_v1}{source link}.
\item Callie Munson, Elyse Sunshine (2020). \textit{Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic}. Unknown journal. [published; OpenAlex]. \href{https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419}{source link}.
\item B.L. Roth, R.H.J. Olsen, J.D. McCorvy (2020). \textit{Psilocybin for depression and anxiety associated with life-threatening illnesses}. Carolina Digital Repository (University of North Carolina at Chapel Hill). [published; OpenAlex]. \href{https://doi.org/10.17615/zjm5-am83}{doi:10.17615/zjm5-am83}.
\item Mitina O, Mirsaidov M, Molchanova N, Tutrin A. (2020). \textit{Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/b7mnz}{doi:10.31234/osf.io/b7mnz}.
\item Unknown authors (2020). \textit{Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/b7mnz\_v1}{source link}.
\item Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL. (2020). \textit{Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2020.1794811}{doi:10.1080/17512433.2020.1794811}.
\item Nige Netzband, Simon Ruffell, Sabriya Linton, WaiFung Tsang, Tom Wolff (2020). \textit{Modulatory effects of ayahuasca on personality structure in a traditional framework}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-020-05601-0}{doi:10.1007/s00213-020-05601-0}.
\item Izumi Morita, Hiroyuki Oyama, Yuki Kiguchi, Akari Oguri, Natsumi Fujimoto, Atsuko Takeuchi, Rie Tanaka, Jun Ogata, Ruri Kikura-Hanajiri, Norihiro Kobayashi (2020). \textit{Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms}. Journal of Pharmaceutical and Biomedical Analysis. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpba.2020.113485}{doi:10.1016/j.jpba.2020.113485}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item Carl Roberts, Isaac Osborne-Miller, Jon C. Cole, Suzanne H. Gage, Paul Christiansen (2020). \textit{Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120936508}{doi:10.1177/0269881120936508}.
\item Anthony L. Back (2020). \textit{What Psilocybin Taught Me, One Year Later}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2020.0018}{doi:10.1089/jpm.2020.0018}.
\item Michael Specka, Thomas Kuhlmann, Jürgen Sawazki, Udo Bonnet, Renate Steinert, Monika Cybulska-Rycicki, Helmut Eich, Benita Zeiske, Antje Niedersteberg, Luzia Schaaf, Norbert Scherbaum (2020). \textit{Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2020.00569}{doi:10.3389/fpsyt.2020.00569}.
\item O'Callaghan C, Hubik DJ, Dwyer J, Williams M, Ross M. (2020). \textit{Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jmt/thaa006}{doi:10.1093/jmt/thaa006}.
\item Nicholas V. Cozzi, Paul F. Daley (2020). \textit{Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials}. Drug Testing and Analysis. [published; OpenAlex]. \href{https://doi.org/10.1002/dta.2889}{doi:10.1002/dta.2889}.
\item Robert B. Kargbo, Alexander M. Sherwood, Andrew J. Walker, Nicholas V. Cozzi, Raymond E. Dagger, Jessica Sable, Kelsey O’Hern, Kristi W. Kaylo, Tura Patterson, Gary Tarpley, Poncho Meisenheimer (2020). \textit{Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.0c02387}{doi:10.1021/acsomega.0c02387}.
\item Dennis Ioffe (2020). \textit{The Grand Narrative of the Mukhomor}. The Soviet and Post-Soviet Review. [published; OpenAlex]. \href{https://doi.org/10.30965/18763324-04702002}{doi:10.30965/18763324-04702002}.
\item Thomas F. Varley, Robin Carhart-Harris, Leor Roseman, David Menon, Emmanuel A. Stamatakis (2020). \textit{Serotonergic psychedelics LSD \& psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2020.117049}{doi:10.1016/j.neuroimage.2020.117049}.
\item James E, Robertshaw TL, Hoskins M, Sessa B. (2020). \textit{Psilocybin occasioned mystical-type experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.2742}{doi:10.1002/hup.2742}.
\item Hossein Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan, Maryam Yarmohammadi, Moslem Jafarisani (2020). \textit{Molecular docking and binding interaction between psychedelic drugs and human serum albumin}. BioTechnologia. [published; OpenAlex]. \href{https://doi.org/10.5114/bta.2020.94770}{doi:10.5114/bta.2020.94770}.
\item Luoma JB. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sgujx}{doi:10.31234/osf.io/sgujx}.
\item Jason B. Luoma, Christina Chwyl, Geoff J. Bathje, Alan K. Davis, Rafael Lancelotta (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2020.1769878}{doi:10.1080/02791072.2020.1769878}.
\item Hirschfeld T, Schmidt TT. (2020). \textit{How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.06.09.142802}{doi:10.1101/2020.06.09.142802}.
\item Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths (2020). \textit{Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-020-05533-9}{doi:10.1007/s00213-020-05533-9}.
\item Rafael G. dos Santos, José Carlos Bouso, Jaime E. C. Hallak (2020). \textit{Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy}. Brazilian Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1590/1516-4446-2020-1035}{doi:10.1590/1516-4446-2020-1035}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item Yaochen Wang, Minghong Liu, Xiaobin Han, Yanfen Zheng, Jianmin Chao, Chengsheng Zhang (2020). \textit{Prickly Ash Seed Kernel: A New Bio-Fumigation Material Against Tobacco Black Shank}. Agronomy. [published; OpenAlex]. \href{https://doi.org/10.3390/agronomy10060770}{doi:10.3390/agronomy10060770}.
\item Nick Zagorski (2020). \textit{Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.6a34}{doi:10.1176/appi.pn.2020.6a34}.
\item William Smith, Dominic Sisti (2020). \textit{Ethics and ego dissolution: the case of psilocybin}. Journal of Medical Ethics. [published; OpenAlex]. \href{https://doi.org/10.1136/medethics-2020-106070}{doi:10.1136/medethics-2020-106070}.
\item Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, David A. Seminowicz, Brian N. Mathur (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item Mason Marks (2020). \textit{Controlled Substance Regulation for the COVID-19 Mental Health Crisis}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3607702}{source link}.
\item Ron Shore, Nigel Barnim, Katrina Dobson, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Animal Research}. Unknown journal. [published; OpenAlex]. \href{https://qspace.library.queensu.ca/handle/1974/27834}{source link}.
\item Ron Shore, Paul Ioudovski, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Therapy Research}. Unknown journal. [published; OpenAlex]. \href{https://qspace.library.queensu.ca/jspui/handle/1974/27833}{source link}.
\item Ron Shore (2020). \textit{Psychedelics, Safety and Clinical Trial Design}. QSpace (Queen's University Library). [published; OpenAlex]. \href{http://hdl.handle.net/1974/27835}{source link}.
\item Mathias B. Forrester (2020). \textit{Hallucinogenic mushroom misuse reported to Texas poison centers}. Journal of Addictive Diseases. [published; OpenAlex]. \href{https://doi.org/10.1080/10550887.2020.1785817}{doi:10.1080/10550887.2020.1785817}.
\item Kodye L. Abbott, Kristina Gill, Patrick Flannery, Dawn M. Boothe, Muralikrishnan Dhanasekaran, Satyanarayana R. Pondugula (2020). \textit{Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.0c00241}{doi:10.1021/acschemneuro.0c00241}.
\item Nichols DE. (2020). \textit{Psilocybin: from ancient magic to modern medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41429-020-0311-8}{doi:10.1038/s41429-020-0311-8}.
\item Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J. (2020). \textit{Psychedelic treatment of functional neurological disorder: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320912125}{doi:10.1177/2045125320912125}.
\item Unknown authors (2020). \textit{Data justify further research on potential of psychedelics in treating psychiatric disorders}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30581}{doi:10.1002/pu.30581}.
\item Tehila Mishraki-Berkowitz, Esti Kochelski, Pierce V. Kavanagh, John E. O’Brien, Clodagh Dunne, Brian Talbot, Patricia Ennis, Udi Wolf (2020). \textit{The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified}. Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1111/1556-4029.14368}{doi:10.1111/1556-4029.14368}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, Lea J. Mertens, Rainer Spanagel (2020). \textit{Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0694-z}{doi:10.1038/s41386-020-0694-z}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Spreng RN. (2020). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.05.01.072314}{doi:10.1101/2020.05.01.072314}.
\item Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (2020). \textit{Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2019.107933}{doi:10.1016/j.neuropharm.2019.107933}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020). \textit{Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05477-0}{doi:10.1007/s00213-020-05477-0}.
\item Morten Hesse (2020). \textit{Klassiske psykedeliske stoffer - inkl. psilocybin og LSD}. Unknown journal. [published; OpenAlex]. \href{https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd}{source link}.
\item David E. Nichols (2020). \textit{Psychedelics}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/5pv5-2x04}{doi:10.17615/5pv5-2x04}.
\item David R. Glowacki, Mark D. Wonnacott, Rachel Freire, Becca R. Glowacki, Ella M. Gale, James E. Pike, Tiu de Haan, Mike Chatziapostolou, Oussama Metatla (2020). \textit{Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1145/3313831.3376649}{doi:10.1145/3313831.3376649}.
\item University of Wisconsin, Madison (2020). \textit{Pharmacokinetics of Psilocybin in Normal Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02163707}{source link}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Morten L. Kringelbach, Josephine Cruzat, Joana Cabral, Gitte M. Knudsen, Robin Carhart-Harris, Peter C. Whybrow, Nikos K. Logothetis, Gustavo Deco (2020). \textit{Dynamic coupling of whole-brain neuronal and neurotransmitter systems}. Proceedings of the National Academy of Sciences. [published; OpenAlex]. \href{https://doi.org/10.1073/pnas.1921475117}{doi:10.1073/pnas.1921475117}.
\item Petranker R, Anderson T, Maier L, Barratt MJ, Ferris J, Winstock A. (2020). \textit{Global Drug Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xb8ve}{doi:10.31234/osf.io/xb8ve}.
\item Unknown authors (2020). \textit{Global Drug Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xb8ve\_v1}{source link}.
\item Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu (2020). \textit{Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin}. Clinical Pharmacology in Drug Development. [published; OpenAlex]. \href{https://doi.org/10.1002/cpdd.796}{doi:10.1002/cpdd.796}.
\item Thomas W. Flanagan, Gerald Billac, Charles D. Nichols (2020). \textit{5-HT2 Receptor Activation Differentially Modulates Linker Histone Kinetics and Histone Deacetylase Activity}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.05613}{doi:10.1096/fasebj.2020.34.s1.05613}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item David Nutt, David Erritzøe, Robin Carhart-Harris (2020). \textit{Psychedelic Psychiatry’s Brave New World}. Cell. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cell.2020.03.020}{doi:10.1016/j.cell.2020.03.020}.
\item Anna Lutkajtis (2020). \textit{Lost Saints}. Fieldwork in Religion. [published; OpenAlex]. \href{https://doi.org/10.1558/firn.40554}{doi:10.1558/firn.40554}.
\item Heuschkel K, Kuypers KPC. (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Anna Poliwoda, Katarzyna Zielińska, Piotr Wieczorek (2020). \textit{Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules25071566}{doi:10.3390/molecules25071566}.
\item Richard Simoneaux (2020). \textit{Long-Term Analysis of Psilocybin in Cancer Patients With Distress}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000660232.19098.7f}{doi:10.1097/01.cot.0000660232.19098.7f}.
\item N. Milne, Philip Tinggaard Thomsen, Niels Aage Tvis Knudsen, P. Rubaszka, Mette Kristensen, Irina Borodina (2020). \textit{Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2019.12.007}{doi:10.1016/j.ymben.2019.12.007}.
\item George Deane (2020). \textit{Dissolving the self}. Philosophy and the Mind Sciences. [published; OpenAlex]. \href{https://doi.org/10.33735/phimisci.2020.i.39}{doi:10.33735/phimisci.2020.i.39}.
\item Katie O’Connor (2020). \textit{Can Psychedelics Radically Change SUD Treatment?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.2a12}{doi:10.1176/appi.pn.2020.2a12}.
\item Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK. (2020). \textit{Long-term effects of psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.03.017}{doi:10.1016/j.neubiorev.2020.03.017}.
\item Brianna R. Altman, Maha N. Mian, Mitch Earleywine (2020). \textit{The Novelty of Ayahuasca Scale and the prediction of intentions to use}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00117}{doi:10.1556/2054.2020.00117}.
\item Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissière SPL. (2020). \textit{Tripping on nothing: placebo psychedelics and contextual factors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05464-5}{doi:10.1007/s00213-020-05464-5}.
\item Brent Schnipke (2020). \textit{Trip: Psychedelics, Alienation, and Change}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2020.150310}{doi:10.1176/appi.ajp-rj.2020.150310}.
\item Benko J, Vranková S. (2020). \textit{Natural Psychoplastogens As Antidepressant Agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules25051172}{doi:10.3390/molecules25051172}.
\item Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, Zoe K. Talman, Charles D. Nichols (2020). \textit{Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.9b00493}{doi:10.1021/acschemneuro.9b00493}.
\item M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel, Tomáš Páleníček, Martin Kuchař, Claus Svarer, Brice Ozenne, Gitte M. Knudsen (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Robert B. Kargbo (2020). \textit{Psilocybin Therapeutic Research: The Present and Future Paradigm}. ACS Medicinal Chemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1021/acsmedchemlett.0c00048}{doi:10.1021/acsmedchemlett.0c00048}.
\item Wendy Kline (2020). \textit{Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s}. Gender \& History. [published; OpenAlex]. \href{https://doi.org/10.1111/1468-0424.12471}{doi:10.1111/1468-0424.12471}.
\item Jana Nenadalová, Adam Karásek (2020). \textit{What does „mystical“ mean in the context of experience withpsychedelics? Critique of perennialism in experimentalpsychology}. Unknown journal. [published; OpenAlex]. \href{https://is.muni.cz/publication/1630357/en/What-does-mystical-mean-in-the-context-of-experience-with-psychedelics-Critique-of-perennialism-in-experimental-psychology/Nenadalova-Karasek}{source link}.
\item Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, Rotem Petranker, Lê-Anh Dinh-Williams, Katrina Hui, Emma Hapke (2020). \textit{Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120908004}{doi:10.1177/0269881120908004}.
\item Janis Fricke, Robert B. Kargbo, Lars Regestein, Claudius Lenz, Gundela Peschel, Miriam A. Rosenbaum, Alexander M. Sherwood, Dirk Hoffmeister (2020). \textit{Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.202000134}{doi:10.1002/chem.202000134}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.2019.19010035}{doi:10.1176/appi.ajp.2019.19010035}.
\item Case Medical Research (2020). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04280055}{doi:10.31525/ct1-nct04280055}.
\item Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi (2020). \textit{Self-reported negative outcomes of psilocybin users: A quantitative textual analysis}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0229067}{doi:10.1371/journal.pone.0229067}.
\item Alexander M. Sherwood, Adam L. Halberstadt, Adam K. Klein, John D. McCorvy, Kristi W. Kaylo, Robert B. Kargbo, Poncho Meisenheimer (2020). \textit{Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin}. Journal of Natural Products. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jnatprod.9b01061}{doi:10.1021/acs.jnatprod.9b01061}.
\item Candace R. Lewis, Katrin H. Preller, B. Blair Braden, Cory Riecken, Franz X. Vollenweider (2020). \textit{Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience}. Biomedicines. [published; OpenAlex]. \href{https://doi.org/10.3390/biomedicines8020034}{doi:10.3390/biomedicines8020034}.
\item Bambauer TP, Wagmann L, Maurer HH, Weber AA, Meyer MR. (2020). \textit{Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2020.120847}{doi:10.1016/j.talanta.2020.120847}.
\item James Sexton, Charles D. Nichols, Peter S. Hendricks (2020). \textit{Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2019.00896}{doi:10.3389/fpsyt.2019.00896}.
\item Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, James J. Pekar, Roland R. Griffiths (2020). \textit{Emotions and brain function are altered up to one month after a single high dose of psilocybin}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-59282-y}{doi:10.1038/s41598-020-59282-y}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ. (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Maho Hirasawa (2020). \textit{Effects of psilocin on the striatal monoamine contents in mice and rats}. The Pharmaceutical Society of Japan. [published; OpenAlex]. \href{https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail}{source link}.
\item Unknown authors (2020). \textit{LSD und Psilocybin als Selbstmedikation}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1085-0309}{doi:10.1055/a-1085-0309}.
\item Rebecca Wallersteiner (2020). \textit{Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leaders}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.m407}{doi:10.1136/bmj.m407}.
\item Chi T, Gold JA. (2020). \textit{A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2020.116715}{doi:10.1016/j.jns.2020.116715}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.12.087}{doi:10.1016/j.euroneuro.2019.12.087}.
\item Heidi Bush (2020). \textit{Psychedelic therapy: Fresh promise for mental health}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.32207}{doi:10.1002/mhw.32207}.
\item Simona Zaami, Adriano Tagliabracci, Paolo Berretta, Francesco Paolo Busardò, Enrico Marinelli (2020). \textit{Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2019.01006}{doi:10.3389/fpsyt.2019.01006}.
\item Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson (2020). \textit{Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2019.00955}{doi:10.3389/fpsyt.2019.00955}.
\item Matthias Forstmann, Daniel Alexander Yudkin, Annayah Miranda Beatrice Prosser, S. Megan Heller, Molly J. Crockett (2020). \textit{Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings}. Proceedings of the National Academy of Sciences. [published; OpenAlex]. \href{https://doi.org/10.1073/pnas.1918477117}{doi:10.1073/pnas.1918477117}.
\item Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris (2020). \textit{Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119895520}{doi:10.1177/0269881119895520}.
\item Marc Vogel, Hannes Strasser, Gabriel Thorens, Daniele Zullino, Jean-Paul Humair, Olivier Simon, Barbara Broers, Caroline Haettel, Corinne Dévaud, Isabelle Gothuey, Thierry Favrod-Counej, Jean-Bernard Daeppen (2020). \textit{[Addictions].}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/31961074}{source link}.
\item Case Medical Research (2020). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04227756}{doi:10.31525/ct1-nct04227756}.
\item Michael Draper (2020). \textit{Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America}. Journal of the History of Medicine and Allied Sciences. [published; OpenAlex]. \href{https://doi.org/10.1093/jhmas/jraa002}{doi:10.1093/jhmas/jraa002}.
\item Katrin H. Preller, Patricia Duerler, Joshua B. Burt, Jie Lisa Ji, Brendan Adkinson, Philipp Stämpfli, Erich Seifritz, Grega Repovš, John H. Krystal, John D. Murray, Alan Anticevic, Franz X. Vollenweider (2020). \textit{Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.12.027}{doi:10.1016/j.biopsych.2019.12.027}.
\item Terri D’Arrigo (2020). \textit{Med Check: Sage’s Treatment; Cannabidiol Products; Pimavanserin; Cognitive Supplements}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.1a1}{doi:10.1176/appi.pn.2020.1a1}.
\item Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss, Anthony P. Bossis, Jim Grigsby, Stacy M. Fischer, Stephen Ross (2020). \textit{Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119897615}{doi:10.1177/0269881119897615}.
\item Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer, Gary Tarpley (2020). \textit{An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin}. Synthesis. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0039-1691565}{doi:10.1055/s-0039-1691565}.
\item Courtney Hutchison, Sara Bressi (2020). \textit{Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments}. Clinical Social Work Journal. [published; OpenAlex]. \href{https://doi.org/10.1007/s10615-019-00743-x}{doi:10.1007/s10615-019-00743-x}.
\item Case Medical Research (2020). \textit{Repeat Dosing of Psilocybin in Migraine Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04218539}{doi:10.31525/ct1-nct04218539}.
\item Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR. (2020). \textit{The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2020.112749}{doi:10.1016/j.psychres.2020.112749}.
\item Woollacott (2019). \textit{The mystical experience and its neural correlates.}. The Journal of near-death studies. [published; OpenAlex]. \href{https://doi.org/10.17514/jnds-2020-38-1-p3-25.}{doi:10.17514/jnds-2020-38-1-p3-25.}.
\item Marc Vogel, Hannes Strasser, Gabriel Thorens, Daniele Zullino, Jean-Paul Humair, Olivier Simon, Barbara Broers, Caroline Haettel, Corinne Dévaud, Isabelle Gothuey, Thierry Favrod-Counej, Jean-Bernard Daeppen (2019). \textit{Addictions}. Revue Médicale Suisse. [published; OpenAlex]. \href{https://doi.org/10.53738/revmed.2020.16.676-77.0008}{doi:10.53738/revmed.2020.16.676-77.0008}.
\item Kim P. C. Kuypers (2019). \textit{Microdoseren met psychedelica: wat weten we ervan?}. Data Archiving and Networked Services (DANS). [published; OpenAlex]. \href{https://cris.maastrichtuniversity.nl/en/publications/846d0214-c866-48b1-9d2f-ff053cc43e22}{source link}.
\item Brooke Reichenbach (2019). \textit{Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/531}{source link}.
\item Quinn Kalby Heck (2019). \textit{Heterologous production of biomedically relevant fungal metabolites in Aspergillus nidulans}. Unknown journal. [published; OpenAlex]. \href{https://lup.lub.lu.se/student-papers/record/9039033}{source link}.
\item Dax Oliver (2019). \textit{Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019}. CUNY Academic Works (City University of New York). [published; OpenAlex]. \href{https://academicworks.cuny.edu/gc\_etds/4074}{source link}.
\item Linus Pettersson, Hamoar Hadi Hamasaleh Karim (2019). \textit{Meetings with Mother Ayahuasca: The effects of the spiritual experience on mental processes and physiological responses}. Lund University Publications Student Papers (Lund University). [published; OpenAlex]. \href{http://lup.lub.lu.se/student-papers/record/9029898}{source link}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Kiomary Rivera Quintana (2019). \textit{Psychedelics: A Window To Mental Illness; Psilocybin And Depression}. Unknown journal. [published; OpenAlex]. \href{https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000\&context=hpd\_corx\_stuarticles}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Courtney Ledford (2019). \textit{Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/altreu\_projects/5}{source link}.
\item Katariina Sarajärvi (2019). \textit{Psilocybin's effects on the brain and implications for depression treatment}. Epubl LTU. [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481}{source link}.
\item Hossein Orcid Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan, Maryam Yarmohammadi, Moslem Jafarisani (2019). \textit{Molecular docking and binding interaction between psychedelic drugs and human serum albumin}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.5114/bta.2020.96412}{doi:10.5114/bta.2020.96412}.
\item Genís Oña (2019). \textit{Elaboración y validación de un cuestionario para la detección del riesgo de reacciones adversas graves por empleo de drogas psicodélicas en terapia}. Dialnet (Universidad de la Rioja). [published; OpenAlex]. \href{https://dialnet.unirioja.es/servlet/oaiart?codigo=7487729}{source link}.
\item Ammar Jawad (2019). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item Krista Worden (2019). \textit{The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.arcadia.edu/showcase/2020/pa/60/}{source link}.
\item Laura Sanders (2019). \textit{Psilocybin may help cancer patients with depression and anxiety for years}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031}{source link}.
\item Reham Shaba (2019). \textit{Development of an improved psilocybin synthesis}. Uppsala University Publications (Uppsala University). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295}{source link}.
\item James Rucker, Jessie Schnall, Daniel D’Hotman, David King, Timmy Davis, Joanna C. Neill (2019). \textit{Medicinal use of psilocybin: Reducing restrictions on research and treatment.}. Unknown journal. [published; OpenAlex]. \href{https://www.drugsandalcohol.ie/32599/}{source link}.
\item JEC Anthony, Adam Winstock, JA Ferris, DJ Nutt (2019). \textit{Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324520942345}{doi:10.1177/2050324520942345}.
\item Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers (2019). \textit{Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519900068}{doi:10.1177/2050324519900068}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2019). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Ho JT, Preller KH, Lenggenhager B (2019). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Joseph J. Palamar, Patricia Acosta (2019). \textit{A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines}. Human Psychopharmacology Clinical and Experimental. [published; OpenAlex]. \href{https://doi.org/10.1002/hup.2719}{doi:10.1002/hup.2719}.
\item Eric Vermetten, Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, Robert A. Schoevers, W van den Brink (2019). \textit{[Psychedelics in the treatment of PTSD].}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/32816292}{source link}.
\item Nina Schimmel, Joost J. Breeksema, Jolien K. E. Veraart, W van den Brink, Robert A. Schoevers (2019). \textit{[Psychedelics for existential distress in terminally ill patients].}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/32816294}{source link}.
\item Kim P. C. Kuypers (2019). \textit{[Microdosing with psychedelics: what do we know?]}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/32816295}{source link}.
\item Daphne Voineskos, Daskalakis ZJ, Blumberger DM (2019). \textit{Management of Treatment-Resistant Depression: Challenges and Strategies}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doaj.org/article/912b2c2cb46d40fe9cce81675290e46f}{source link}.
\item Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H (2019). \textit{Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00005}{doi:10.3389/fpsyt.2020.00005}.
\item Lea T, Amada N, Jungaberle H (2019). \textit{Psychedelic Microdosing: A Subreddit Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1683260}{doi:10.1080/02791072.2019.1683260}.
\item Müller F, Johnson MW, Borgwardt S (2019). \textit{Editorial: Hallucinogens and Entactogens: Establishing a New Class of Drugs?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00497}{doi:10.3389/fpsyt.2020.00497}.
\item Petranker R, Anderson T, Farb N (2019). \textit{Psychedelic Research and the Need for Transparency: Polishing Alice's Looking Glass.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2020.01681}{doi:10.3389/fpsyg.2020.01681}.
\item Kangaslampi S, Hausen A, Rauteenmaa T (2019). \textit{Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1767321}{doi:10.1080/02791072.2020.1767321}.
\item Nobile B, Olié E, Courtet P (2019). \textit{Commentary: Psychedelic Psychiatry's Brave New World.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.594077}{doi:10.3389/fpsyt.2020.594077}.
\item Grassi G, Cecchelli C, Vignozzi L, Pacini S. (2019). \textit{Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/jep.s255375}{doi:10.2147/jep.s255375}.
\item Viorela Nitescu (2019). \textit{New psychoactive substances and the risks of consumption in children and adolescents}. Romanian Journal of Pediatrics. [published; OpenAlex]. \href{https://doi.org/10.37897/rjp.2019.4.1}{doi:10.37897/rjp.2019.4.1}.
\item Dagmara Ona Reingardienė, Jolita Vilcinskaite, Robertas Lažauskas (2019). \textit{Hallucinogenic Mushrooms}. Princeton University Press eBooks. [published; OpenAlex]. \href{https://doi.org/10.2307/j.ctvs32r8v.16}{doi:10.2307/j.ctvs32r8v.16}.
\item Krishna Kumar Varshney (2019). \textit{Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3528349}{source link}.
\item Johns Hopkins University (2019). \textit{Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02145091}{source link}.
\item Lionel Barnett, Suresh Muthukumaraswamy, Robin Carhart-Harris, Anil K. Seth (2019). \textit{Decreased directed functional connectivity in the psychedelic state}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.116462}{doi:10.1016/j.neuroimage.2019.116462}.
\item Rosalind Watts, Jason B. Luoma (2019). \textit{The use of the psychological flexibility model to support psychedelic assisted therapy}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.12.004}{doi:10.1016/j.jcbs.2019.12.004}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR. (2019). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On. (2019). \textit{Mapping Psilocybin-Assisted Therapies: A Scoping Review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2019.12.04.19013896}{doi:10.1101/2019.12.04.19013896}.
\item Corne R, Mongeau R. (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Richard Demmler, Janis Fricke, Sebastian Dörner, Markus Gressler, Dirk Hoffmeister (2019). \textit{S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.201900649}{doi:10.1002/cbic.201900649}.
\item Dos Santos RG, Hallak JEC. (2019). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item V V, Jr. Shapovalov, A Gudzenko, S Zbrozhek, S Negretskiy, V А Shapovalova, V V Shapovalov (2019). \textit{Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychotropic psychoactive substances in Ukraine (retrospective aspect)}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doaj.org/article/0fd5aabbad1a4a6e8eb327e08a5ecdac}{source link}.
\item K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange, Mengfei Xiong, Matthias M. Herth, Agnete Overgaard, Hanne D. Hansen, Mikael Palner (2019). \textit{P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.271}{doi:10.1016/j.euroneuro.2019.09.271}.
\item Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen (2019). \textit{P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.232}{doi:10.1016/j.euroneuro.2019.09.232}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.702}{doi:10.1016/j.euroneuro.2019.09.702}.
\item Martin Andersson, Anette Kjellgren (2019). \textit{Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube}. Harm Reduction Journal. [published; OpenAlex]. \href{https://doi.org/10.1186/s12954-019-0333-3}{doi:10.1186/s12954-019-0333-3}.
\item Chinaza Godswill Awuchi (2019). \textit{The Biochemistry, Toxicology, and Uses of the Pharmacologically Active Phytochemicals: Alkaloids, Terpenes, Polyphenols, and Glycosides}. Journal of Food and Pharmaceutical Sciences. [published; OpenAlex]. \href{https://doi.org/10.22146/jfps.666}{doi:10.22146/jfps.666}.
\item Toby Lea, Nicole Amada, Henrik Jungaberle, Henrike Schecke, Michael Klein (2019). \textit{Microdosing psychedelics: Motivations, subjective effects and harm reduction}. International Journal of Drug Policy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugpo.2019.11.008}{doi:10.1016/j.drugpo.2019.11.008}.
\item Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas, Greg Murray, M.L. Williams, David Castle (2019). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, John D. McCorvy, Markus R. Meyer, Lea Wagmann, Alexander Stratford, Simon D. Brandt (2019). \textit{Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of -lysergic acid diethylamide (LSD)}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2019.107856}{doi:10.1016/j.neuropharm.2019.107856}.
\item Claudius Lenz, Jonas Wick, Daniel Braga, María García-Altares, Gerald Lackner, Christian Hertweck, Markus Gressler, Dirk Hoffmeister (2019). \textit{Injury-Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.201910175}{doi:10.1002/ange.201910175}.
\item Felix Blei, Sebastian Dörner, Janis Fricke, Florian Baldeweg, Felix Trottmann, Anna J. Komor, Florian Meyer, Christian Hertweck, Dirk Hoffmeister (2019). \textit{Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.201904363}{doi:10.1002/chem.201904363}.
\item Claudius Lenz, Jonas Wick, Daniel Braga, María García-Altares, Gerald Lackner, Christian Hertweck, Markus Gressler, Dirk Hoffmeister (2019). \textit{Injury-Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms}. Angewandte Chemie International Edition. [published; OpenAlex]. \href{https://doi.org/10.1002/anie.201910175}{doi:10.1002/anie.201910175}.
\item Case Medical Research (2019). \textit{Psilocybin-assisted Psychotherapy for Opioid Use Disorder}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04161066}{doi:10.31525/ct1-nct04161066}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. (2019). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta (2019). \textit{Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.11.002}{doi:10.1016/j.jcbs.2019.11.002}.
\item Chris Letheby (2019). \textit{The Varieties of Psychedelic Epistemology}. UWA Profiles and Research Repository (University of Western Australia). [published; OpenAlex]. \href{https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289}{source link}.
\item Case Medical Research (2019). \textit{Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04141501}{doi:10.31525/ct1-nct04141501}.
\item Nick Zagorski (2019). \textit{Johns Hopkins Opens Research Center on Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.10a16}{doi:10.1176/appi.pn.2019.10a16}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2019). \textit{Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-019-2288-z}{doi:10.1186/s12888-019-2288-z}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Rainer Krähenmann, Theo Huber, Franz X. Vollenweider (2019). \textit{Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-019-50612-3}{doi:10.1038/s41598-019-50612-3}.
\item Kernel Networks Inc. (2019). \textit{Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04123314}{doi:10.31525/ct1-nct04123314}.
\item Megha Satyanarayana (2019). \textit{Modified E. coli pump out psilocybin}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09739-scicon9}{doi:10.1021/cen-09739-scicon9}.
\item Christopher B. Germann (2019). \textit{The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2019.109406}{doi:10.1016/j.mehy.2019.109406}.
\item Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V. (2019). \textit{The psychedelic renaissance: the next trip for psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/ipm.2019.39}{doi:10.1017/ipm.2019.39}.
\item Alexandra M. Adams, Nicholas A. Kaplan, Zhangyue Wei, John D. Brinton, Chantal Monnier, Alexis L. Enacopol, Theresa A. Ramelot, J. Andrew Jones (2019). \textit{In vivo production of psilocybin in E. coli}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2019.09.009}{doi:10.1016/j.ymben.2019.09.009}.
\item Johns Hopkins University (2019). \textit{Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02971605}{source link}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers (2019). \textit{Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users}. Contemporary Drug Problems. [published; OpenAlex]. \href{https://doi.org/10.1177/0091450919863899}{doi:10.1177/0091450919863899}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item Begola MJ, Schillerstrom JE. (2019). \textit{Hallucinogens and Their Therapeutic Use: A Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000409}{doi:10.1097/pra.0000000000000409}.
\item Blake Beaton, Heith Copes, Megan Webb, Andy Hochstetler, Peter S. Hendricks (2019). \textit{Accounting for Microdosing Classic Psychedelics}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/0022042619871008}{doi:10.1177/0022042619871008}.
\item David Luke, Christopher Timmermann, Mendel Kaelen, David Schwartman, Beth Bell-Langford, Aimee Tollan, Viktor Hadzhiyski, Gabriella Bergin-Cartwright (2019). \textit{Non-drug altered states as psychedelic experiences}. Greenwich Academic Literature Archive (University of Greenwich). [published; OpenAlex]. \href{https://www.breakingconvention.co.uk/speaker-DavidLuke.html}{source link}.
\item Dustin Marlan (2019). \textit{Beyond Cannabis: Psychedelic Decriminalization and Social Justice}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawcommons.lclark.edu/lclr/vol23/iss3/4}{source link}.
\item A.R. Chadeayne, Duyen N. K. Pham, James A. Golen, David R. Manke (2019). \textit{The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin}. Acta Crystallographica Section E Crystallographic Communications. [published; OpenAlex]. \href{https://doi.org/10.1107/s2056989019011253}{doi:10.1107/s2056989019011253}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Kernel Networks Inc. (2019). \textit{Effects of Psilocybin in Anorexia Nervosa}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04052568}{doi:10.31525/ct1-nct04052568}.
\item Muttoni S, Ardissino M, John C. (2019). \textit{Classical psychedelics for the treatment of depression and anxiety: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.07.076}{doi:10.1016/j.jad.2019.07.076}.
\item Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. (2019). \textit{Decreased Directed Functional Connectivity in the Psychedelic State}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/703660}{doi:10.1101/703660}.
\item Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D. (2019). \textit{Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881119857204}{doi:10.1177/0269881119857204}.
\item Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory R. Weissman, Lê-Anh Dinh-Williams, Katrina Hui, Emma Hapke (2019). \textit{Psychedelic microdosing benefits and challenges: an empirical codebook}. Harm Reduction Journal. [published; OpenAlex]. \href{https://doi.org/10.1186/s12954-019-0308-4}{doi:10.1186/s12954-019-0308-4}.
\item Jorge Luiz Bandeira Souza (2019). \textit{A psilocibina e o seu potencial terapêutico em saúde mental}. Unknown journal. [published; OpenAlex]. \href{http://www.repositorio.ufc.br/bitstream/riufc/46077/1/2019\_tcc\_jlbsouza.pdf}{source link}.
\item Carhart-Harris RL, Friston KJ. (2019). \textit{REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.118.017160}{doi:10.1124/pr.118.017160}.
\item David Nutt (2019). \textit{Psychedelic drugs-a new era in psychiatry?}. Dialogues in Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.31887/dcns.2019.21.2/dnutt}{doi:10.31887/dcns.2019.21.2/dnutt}.
\item Richard Simoneaux (2019). \textit{The Potential of Psilocybin Administration in Terminal Cancer Patients}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000574916.46844.cf}{doi:10.1097/01.cot.0000574916.46844.cf}.
\item Boris D. Heifets, Robert C. Malenka (2019). \textit{Disruptive Psychopharmacology}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2019.1145}{doi:10.1001/jamapsychiatry.2019.1145}.
\item Greg R. Boyce, Emile Gluck-Thaler, Jason C. Slot, Jason Stajich, William J. Davis, Tim Y. James, John R. Cooley, Daniel G. Panaccione, Jørgen Eilenberg, Henrik H. De Fine Licht, Angie M. Macias, Matthew C. Berger, Kristen L. Wickert, Cameron M. Stauder, Ellie J. Spahr, Matthew D. Maust, Amy M. Metheny, Chris Simon, Gene Kritsky, Kathie T. Hodge, Richard A. Humber, Terry Gullion, Dylan P. G. Short, Teiya Kijimoto, Dan Mozgai, Nidia Arguedas, Matt T. Kasson (2019). \textit{Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens}. Fungal ecology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.funeco.2019.06.002}{doi:10.1016/j.funeco.2019.06.002}.
\item Carla Pallavicini, Martina G. Vilas, Mirta F. Villarreal, Federico Zamberlán, Suresh Muthukumaraswamy, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi (2019). \textit{Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.06.053}{doi:10.1016/j.neuroimage.2019.06.053}.
\item Suzanne L. Russ, Robin Carhart-Harris, Geoffrey Maruyama, Melody S. Elliott (2019). \textit{Replication and extension of a model predicting response to psilocybin}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-019-05279-z}{doi:10.1007/s00213-019-05279-z}.
\item Doreen M. Lewis (2019). \textit{Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments}. Addictive Disorders \& Their Treatment. [published; OpenAlex]. \href{https://doi.org/10.1097/adt.0000000000000178}{doi:10.1097/adt.0000000000000178}.
\item Jerry B. Brown, Julie M. Brown (2019). \textit{Entheogens in Christian art: Wasson, Allegro, and the Psychedelic Gospels}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.019}{doi:10.1556/2054.2019.019}.
\item Michael Winkelman (2019). \textit{Introduction: Evidence for entheogen use in prehistory and world religions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.024}{doi:10.1556/2054.2019.024}.
\item Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, Johansen SS, Lehel S, Linnet K, Svarer C, Erritzoe D, Ozenne B, Knudsen GM. (2019). \textit{Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-019-0360-5}{doi:10.1038/s41386-019-0360-5}.
\item Janis Fricke, Alexander M. Sherwood, Robert B. Kargbo, Andrew Orry, Felix Blei, Andreas Naschberger, Bernhard Rupp, Dirk Hoffmeister (2019). \textit{Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.201900358}{doi:10.1002/cbic.201900358}.
\item A.R. Chadeayne, James A. Golen, David R. Manke (2019). \textit{Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug}. Acta Crystallographica Section E Crystallographic Communications. [published; OpenAlex]. \href{https://doi.org/10.1107/s2056989019007370}{doi:10.1107/s2056989019007370}.
\item Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers (2019). \textit{Motives and Side-Effects of Microdosing With Psychedelics Among Users}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyz029}{doi:10.1093/ijnp/pyz029}.
\item John Gardner, Adrian Carter, Kerry O’Brien, Kate Seear (2019). \textit{Psychedelic-assisted therapies: The past, and the need to move forward responsibly}. International Journal of Drug Policy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugpo.2019.05.019}{doi:10.1016/j.drugpo.2019.05.019}.
\item Ole Köhler-Forsberg, Cristina Cusin, Andrew A. Nierenberg (2019). \textit{Evolving Issues in the Treatment of Depression}. JAMA. [published; OpenAlex]. \href{https://doi.org/10.1001/jama.2019.4990}{doi:10.1001/jama.2019.4990}.
\item Louis-David Lord, Paul Expert, Selen Atasoy, Leor Roseman, Kristina M. Rapuano, Renaud Lambiotte, David Nutt, Gustavo Deco, Robin Carhart-Harris, Morten L. Kringelbach, Joana Cabral (2019). \textit{Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.05.060}{doi:10.1016/j.neuroimage.2019.05.060}.
\item Oscar Espin, European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut (2019). \textit{Sacred Plants and Mental Health in Latin America}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.7235793}{doi:10.5281/zenodo.7235793}.
\item Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, Betina Elfving, David Nutt, Gregers Wegener, Heidi Kaastrup Müller (2019). \textit{Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2019.15}{doi:10.1017/neu.2019.15}.
\item S. Larrauri Monterroso, Raquel Pérez Garay, I. Martínez Roda, Jonathan Sedano, B. Vilà, Daniel J. González, A. López Urrutia (2019). \textit{Central (neurogenic) diabetes insipidus: A case report}. Clinica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cca.2019.03.479}{doi:10.1016/j.cca.2019.03.479}.
\item Izumi Morita, Hiroyuki Oyama, Rie Tanaka, Ruri Kikura-Hanajiri, Norihiro Kobayashi (2019). \textit{Generation of monoclonal antibodies for on-site analysis of psilocin and psilocybin in hallucinogenic mushrooms}. Clinica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cca.2019.03.139}{doi:10.1016/j.cca.2019.03.139}.
\item Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. (2019). \textit{Cessation and reduction in alcohol consumption and misuse after psychedelic use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881119845793}{doi:10.1177/0269881119845793}.
\item Kurt Forrer (2019). \textit{Who is the dreamer?}. University Library Heidelberg. [published; OpenAlex]. \href{https://doi.org/10.11588/ijodr.2019.2.62308}{doi:10.11588/ijodr.2019.2.62308}.
\item Megan Webb, Heith Copes, Peter S. Hendricks (2019). \textit{Narrative identity, rationality, and microdosing classic psychedelics}. International Journal of Drug Policy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugpo.2019.04.013}{doi:10.1016/j.drugpo.2019.04.013}.
\item B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley (2019). \textit{T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.03.460}{doi:10.1016/j.biopsych.2019.03.460}.
\item Paul Webster (2019). \textit{Denver votes to decriminalise psilocybin mushrooms}. The Lancet. [published; OpenAlex]. \href{https://doi.org/10.1016/s0140-6736(19)31082-7}{doi:10.1016/s0140-6736(19)31082-7}.
\item Paul Summergrad (2019). \textit{Psychedelic Medicine: Careful Studies, Regulations Are the Answer}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.5a25}{doi:10.1176/appi.pn.2019.5a25}.
\item Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG. (2019). \textit{Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125319845774}{doi:10.1177/2045125319845774}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL. (2019). \textit{Rapid-acting antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery, Stefania Bonaccorso, A Ricciardi, Norbert Scherbaum, Alessandro Vento (2019). \textit{New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-019-00249-z}{doi:10.1007/s40429-019-00249-z}.
\item Roland R. Griffiths, Ethan Hurwitz, Alan K. Davis, Matthew W. Johnson, Robert L. Jesse (2019). \textit{Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0214377}{doi:10.1371/journal.pone.0214377}.
\item McKenna Silva (2019). \textit{Attitudes Toward Medical Psychedelics}. Dominican Scholar (Dominican University of California). [published; OpenAlex]. \href{https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83}{source link}.
\item Kernel Networks Inc. (2019). \textit{Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03912974}{doi:10.31525/ct1-nct03912974}.
\item Lukasz Smigielski, Milan Scheidegger, Michael Kometer, Franz X. Vollenweider (2019). \textit{Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.04.009}{doi:10.1016/j.neuroimage.2019.04.009}.
\item Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. (2019). \textit{Psychedelic-Assisted Group Therapy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2019.1593559}{doi:10.1080/02791072.2019.1593559}.
\item Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols (2019). \textit{Psychedelics Improve the Mental Health of Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2019.33.1\_supplement.666.1}{doi:10.1096/fasebj.2019.33.1\_supplement.666.1}.
\item de Coo IF, Naber WC, Wilbrink LA, Haan J, Ferrari MD, Fronczek R (2019). \textit{Increased use of illicit drugs in a Dutch cluster headache population.}. Cephalalgia: an international journal of headache. [published; PubMed]. \href{https://doi.org/10.1177/0333102418804160}{doi:10.1177/0333102418804160}.
\item Kuypers KPC (2019). \textit{Psychedelic medicine: The biology underlying the persisting psychedelic effects.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2019.02.029}{doi:10.1016/j.mehy.2019.02.029}.
\item Yuri Rahayu, Andi Riyanto, Agung Wibowo (2019). \textit{Relationship Of Magic Mushroom Literation As A Drug With Abuse It's Use As A Hallucination}. International Journal on Advanced Science Education and Religion. [published; OpenAlex]. \href{https://doi.org/10.33648/ijoaser.v2i1.25}{doi:10.33648/ijoaser.v2i1.25}.
\item Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge (2019). \textit{The Past and Future of Psychedelic Science: An Introduction to This Issue}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1606472}{doi:10.1080/02791072.2019.1606472}.
\item Kernel Networks Inc. (2019). \textit{A Study of Psilocybin for Major Depressive Disorder (MDD)}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03866174}{doi:10.31525/ct1-nct03866174}.
\item Jacob S. Aday, Emily K. Bloesch, Christopher C. Davoli (2019). \textit{Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20thCentury}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1581961}{doi:10.1080/02791072.2019.1581961}.
\item Rácz N, Nagy J, Jiang W, Veress T. (2019). \textit{Modeling Retention Behavior on Analysis of Hallucinogenic Mushrooms Using Hydrophilic Interaction Liquid Chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/chromsci/bmy104}{doi:10.1093/chromsci/bmy104}.
\item Nick Zagorski (2019). \textit{Is Psychedelic Medicine on the Horizon?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.1b1}{doi:10.1176/appi.pn.2019.1b1}.
\item Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug, Kim P. C. Kuypers (2019). \textit{Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1580804}{doi:10.1080/02791072.2019.1580804}.
\item Junaid KC., Mohamed Riyas Kozhikkattil., N V. Divya (2019). \textit{DRUG TOURISM IN INDIA: TRENDS AND CHALLENGES}. International Journal of Technical Research \& Science. [published; OpenAlex]. \href{https://doi.org/10.30780/ijtrs.v04.i02.004}{doi:10.30780/ijtrs.v04.i02.004}.
\item Ahmed Al-Imam, Faris Lami (2019). \textit{One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip}. Modern Applied Science. [published; OpenAlex]. \href{https://doi.org/10.5539/mas.v13n3p13}{doi:10.5539/mas.v13n3p13}.
\item Xue Qin Ng, Asimah Hamzah, Mei Ling Evelyn Goh, Hooi Yan Moy, Yi Ju Yao, Chi Pang Lui (2019). \textit{Qualitative analysis of synthetic opioids, synthetic hallucinogens and LSD in urine using LC-MS/MS}. Australian Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1080/00450618.2019.1568565}{doi:10.1080/00450618.2019.1568565}.
\item James E, Robertshaw TL, Westwell AD (2019). \textit{Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.}. Future medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.4155/fmc-2018-0447}{doi:10.4155/fmc-2018-0447}.
\item Michiel van Elk, George Fejer, Josephine Marschall, Pascal Lempe (2019). \textit{The effects of psilocybin microdosing on perception: a double-blind controlled study}. OSF Preprints (OSF Preprints). [published; OpenAlex]. \href{https://osf.io/cn8z4}{source link}.
\item M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen, Sys Stybe Johansen, Sczabolz Lehel, Kristían Línnet, Claus Svarer, David Erritzøe, Brice Ozenne, Gitte M. Knudsen (2019). \textit{Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-019-0324-9}{doi:10.1038/s41386-019-0324-9}.
\item Varley T, Carhart-Harris R, Roseman L, Menon DK, Stamatakis E. (2019). \textit{Serotonergic Psychedelics LSD \& Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal Domains}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/517847}{doi:10.1101/517847}.
\item Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, M. Madsen, Vibe G. Frøkjær, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.24511}{doi:10.1002/hbm.24511}.
\item Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus (2019). \textit{Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.}. Experimental and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1037/pha0000253}{doi:10.1037/pha0000253}.
\item Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS. (2019). \textit{Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2019.01.002}{doi:10.1016/j.pnpbp.2019.01.002}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS. (2019). \textit{Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5106-2}{doi:10.1007/s00213-018-5106-2}.
\item James Davis (2018). \textit{Personal}. Cream city review. [published; OpenAlex]. \href{https://doi.org/10.1353/ccr.2019.0049}{doi:10.1353/ccr.2019.0049}.
\item Arthur Sze (2018). \textit{Sprang}. Mānoa/Mānoa. [published; OpenAlex]. \href{https://doi.org/10.1353/man.2019.0065}{doi:10.1353/man.2019.0065}.
\item Katherine Gruppo (2018). \textit{Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial}. Unknown journal. [published; OpenAlex]. \href{https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050\&context=ysmpa\_theses}{source link}.
\item Isabella Stendahl (2018). \textit{THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749}{source link}.
\item William G. Crane (2018). \textit{Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality}. Furman University Scholar Exchange (Furman University). [published; OpenAlex]. \href{https://scholarexchange.furman.edu/furmanengaged/2019/all/522}{source link}.
\item Emma Christersson (2018). \textit{The Psychedelic Altered State of Consciousness: An Assessment of the Current Status of Psychedelic Research}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255}{source link}.
\item Kent Mathewson (2018). \textit{Substance \& Seduction: Ingested Commodities in Early Modern Mesoamerica ed. by Stacey Schwartzkopf and Kathyrn E. Sampeck}. Journal of Latin American geography. [published; OpenAlex]. \href{https://doi.org/10.1353/lag.2019.0025}{doi:10.1353/lag.2019.0025}.
\item Tina Hesman Saey (2018). \textit{These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011}{source link}.
\item Camden Grant-Howard, Joel S. Steele (2018). \textit{Use of MDMA \& Psilocybin in the Treatment of PTSD}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14}{source link}.
\item P. Dürler (2018). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item Hans Liljenström (2018). \textit{Peak experiences in a consciousness landscape - report on the science of consciousness conference in Interlaken, Switzerland, 2019}. Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)). [published; OpenAlex]. \href{https://openalex.org/W3004666318}{source link}.
\item Edward James, Thomas L Robertshaw, Michael Pascoe, Fiona Chapman, Andrew D. Westwell, Andrew Smith (2018). \textit{Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519876123}{doi:10.1177/2050324519876123}.
\item Felix Scholkmann, Lisa Holper, Katrin H. Preller, Franz X. Vollenweider (2018). \textit{Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study}. Zurich Open Repository and Archive (University of Zurich). [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-181782}{doi:10.5167/uzh-181782}.
\item MVNL Chaitanya, Asha Jose, Prakash Ramalingam, Subhash C. Mandal, PNarendra Kumar (2018). \textit{Multi-targeting cytotoxic drug leads from mushrooms}. Asian Pacific Journal of Tropical Medicine. [published; OpenAlex]. \href{https://doi.org/10.4103/1995-7645.272482}{doi:10.4103/1995-7645.272482}.
\item Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch (2018). \textit{2018: A watershed year for psychedelic science}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519872284}{doi:10.1177/2050324519872284}.
\item Kelly M. Brinsko, Dean Golemis, Meggan B. King, Gary J. Laughlin, Sebastian B. Sparenga (2018). \textit{Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin}. The Microscope. [published; OpenAlex]. \href{https://doi.org/10.59082/tnwk8166}{doi:10.59082/tnwk8166}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD. (2018). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Fadiman J, Korb S (2018). \textit{Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1593561}{doi:10.1080/02791072.2019.1593561}.
\item Gregory Scott, Robin Carhart-Harris (2018). \textit{Psychedelics as a treatment for disorders of consciousness}. Neuroscience of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1093/nc/niz003}{doi:10.1093/nc/niz003}.
\item Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC (2018). \textit{Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00672}{doi:10.3389/fpsyt.2019.00672}.
\item Vorster A, Gerber AM, van der Merwe LJ, van Zyl S (2018). \textit{Second and third year medical students' self-reported alcohol and substance use, smoking habits and academic performance at a South African medical school.}. Health SA = SA Gesondheid. [published; PubMed]. \href{https://doi.org/10.4102/hsag.v24i0.1041}{doi:10.4102/hsag.v24i0.1041}.
\item Peterson A, Tagliazucchi E, Weijer C (2018). \textit{The ethics of psychedelic research in disorders of consciousness.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niz013}{doi:10.1093/nc/niz013}.
\item M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel, Kristían Línnet, Sys Stybe Johansen, Claus Svarer, Brice Ozenne, David Erritzøe, Patrick M. Fisher, Gitte M. Knudsen (2018). \textit{Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.474}{doi:10.1016/j.euroneuro.2018.11.474}.
\item Austin E, Myron HS, Summerbell RK, Mackenzie C. (2018). \textit{Acute renal injury cause by confirmed Psilocybe cubensis mushroom ingestion.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mmcr.2018.12.007}{doi:10.1016/j.mmcr.2018.12.007}.
\item Honyiglo E, Franchi A, Cartiser N, Bottinelli C, Advenier AS, Bévalot F, Fanton L. (2018). \textit{Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1556-4029.13982}{doi:10.1111/1556-4029.13982}.
\item Torrens-Spence MP, Liu CT, Pluskal T, Chung YK, Weng JK. (2018). \textit{Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschembio.8b00821}{doi:10.1021/acschembio.8b00821}.
\item Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR. (2018). \textit{Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.02459}{doi:10.3389/fpsyg.2018.02459}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. (2018). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D. (2018). \textit{Production Options for Psilocybin: Making of the Magic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201802758}{doi:10.1002/chem.201802758}.
\item Kvam TM, Stewart LH, Andreassen OA. (2018). \textit{Psychedelic drugs in the treatment of anxiety, depression and addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4045/tidsskr.17.1110}{doi:10.4045/tidsskr.17.1110}.
\item Back AL. (2018). \textit{What Psilocybin Taught Me About Dying.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2018.0561}{doi:10.1089/jpm.2018.0561}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS. (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gk4jd}{doi:10.31234/osf.io/gk4jd}.
\item Unknown authors (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gk4jd\_v1}{source link}.
\item Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML. (2018). \textit{Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.08.009}{doi:10.1016/bs.pbr.2018.08.009}.
\item Lyons T, Carhart-Harris RL. (2018). \textit{More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.01721}{doi:10.3389/fpsyg.2018.01721}.
\item Wasko MJ, Witt-Enderby PA, Surratt CK. (2018). \textit{DARK Classics in Chemical Neuroscience: Ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00294}{doi:10.1021/acschemneuro.8b00294}.
\item Jalal B. (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Blei F, Fricke J, Wick J, Slot JC, Hoffmeister D. (2018). \textit{Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.201800336}{doi:10.1002/cbic.201800336}.
\item Müller F, Liechti ME, Lang UE, Borgwardt S. (2018). \textit{Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.08.004}{doi:10.1016/bs.pbr.2018.08.004}.
\item Bayne T, Carter O. (2018). \textit{Dimensions of consciousness and the psychedelic state.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/nc/niy008}{doi:10.1093/nc/niy008}.
\item Leonard JB, Anderson B, Klein-Schwartz W. (2018). \textit{Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118793086}{doi:10.1177/0269881118793086}.
\item Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A. (2018). \textit{Psychedelics, Meditation, and Self-Consciousness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.01475}{doi:10.3389/fpsyg.2018.01475}.
\item Cowan AF, Elkins KM (2018). \textit{Detection and Identification of Psilocybe cubensis DNA Using a Real-Time Polymerase Chain Reaction High Resolution Melt Assay.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1111/1556-4029.13714}{doi:10.1111/1556-4029.13714}.
\item Horsley RR, Páleníček T, Kolin J, Valeš K. (2018). \textit{Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000394}{doi:10.1097/fbp.0000000000000394}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Solano J, Anabalón L, Figueroa S, Lizama C, Reyes LC, Gangitano D. (2018). \textit{Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.scijus.2018.08.005}{doi:10.1016/j.scijus.2018.08.005}.
\item Flanagan TW, Nichols CD. (2018). \textit{Psychedelics as anti-inflammatory agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S. (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Barrett FS, Preller KH, Kaelen M (2018). \textit{Psychedelics and music: neuroscience and therapeutic implications.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1484342}{doi:10.1080/09540261.2018.1484342}.
\item Hendricks PS (2018). \textit{Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1474185}{doi:10.1080/09540261.2018.1474185}.
\item Garcia-Romeu A, Richards WA (2018). \textit{Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1486289}{doi:10.1080/09540261.2018.1486289}.
\item Puschner B, Wegenast C. (2018). \textit{Mushroom Poisoning Cases in Dogs and Cats: Diagnosis and Treatment of Hepatotoxic, Neurotoxic, Gastroenterotoxic, Nephrotoxic, and Muscarinic Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cvsm.2018.06.008}{doi:10.1016/j.cvsm.2018.06.008}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Lord L, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J. (2018). \textit{Altered trajectories in the dynamical repertoire of functional network states under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/376491}{doi:10.1101/376491}.
\item Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT. (2018). \textit{Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/374199}{doi:10.1101/374199}.
\item Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT. (2018). \textit{Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/375105}{doi:10.1101/375105}.
\item Cameron LP, Olson DE. (2018). \textit{Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00101}{doi:10.1021/acschemneuro.8b00101}.
\item Johns Hopkins University (2018). \textit{Psychopharmacology of Psilocybin in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00465595}{source link}.
\item Geiger HA, Wurst MG, Daniels RN. (2018). \textit{DARK Classics in Chemical Neuroscience: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00186}{doi:10.1021/acschemneuro.8b00186}.
\item Schenberg EE. (2018). \textit{Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00733}{doi:10.3389/fphar.2018.00733}.
\item Barnby JM, Mehta MA. (2018). \textit{Psilocybin and Mental Health-Don't Lose Control.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2018.00293}{doi:10.3389/fpsyt.2018.00293}.
\item Skryabin VY, Vinnikova M, Nenastieva A, Alekseyuk V. (2018). \textit{Hallucinogen persisting perception disorder: A literature review and three case reports.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/10550887.2019.1673655}{doi:10.1080/10550887.2019.1673655}.
\item Nicholas CR, Henriquez KM, Gassman MC, Cooper KM, Muller D, Hetzel S, Brown RT, Cozzi NV, Thomas C, Hutson PR. (2018). \textit{High dose psilocybin is associated with positive subjective effects in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118780713}{doi:10.1177/0269881118780713}.
\item Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. (2018). \textit{Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118780612}{doi:10.1177/0269881118780612}.
\item Blei F, Baldeweg F, Fricke J, Hoffmeister D. (2018). \textit{Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201801047}{doi:10.1002/chem.201801047}.
\item Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL. (2018). \textit{Effects of psilocybin therapy on personality structure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.12904}{doi:10.1111/acps.12904}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC. (2018). \textit{Psychedelics and Personality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Vigerelli H, Sciani JM, Eula MAC, Sato LA, Antoniazzi MM, Jared C, Pimenta DC. (2018). \textit{Biological Effects and Biodistribution of Bufotenine on Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1155/2018/1032638}{doi:10.1155/2018/1032638}.
\item Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA. (2018). \textit{Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-018-26656-2}{doi:10.1038/s41598-018-26656-2}.
\item Thiessen MS, Walsh Z, Bird BM, Lafrance A. (2018). \textit{Psychedelic use and intimate partner violence: The role of emotion regulation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118771782}{doi:10.1177/0269881118771782}.
\item Hoefgen S, Lin J, Fricke J, Stroe MC, Mattern DJ, Kufs JE, Hortschansky P, Brakhage AA, Hoffmeister D, Valiante V. (2018). \textit{Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ymben.2018.05.014}{doi:10.1016/j.ymben.2018.05.014}.
\item Whelan A, Johnson MI. (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX. (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S. (2018). \textit{Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00256}{doi:10.3389/fphar.2018.00256}.
\item Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL. (2018). \textit{Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2018.01.006}{doi:10.1016/j.jad.2018.01.006}.
\item Ramachandran V, Chunharas C, Marcus Z, Furnish T, Lin A. (2018). \textit{Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13554794.2018.1468469}{doi:10.1080/13554794.2018.1468469}.
\item Dorsen C, Palamar J, Shedlin MG. (2018). \textit{Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/16066359.2018.1455187}{doi:10.1080/16066359.2018.1455187}.
\item Kuypers KPC. (2018). \textit{Out of the box: A psychedelic model to study the creative mind.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2018.03.010}{doi:10.1016/j.mehy.2018.03.010}.
\item Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R. (2018). \textit{"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/can.2017.0052}{doi:10.1089/can.2017.0052}.
\item Nichols DE. (2018). \textit{Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00043}{doi:10.1021/acschemneuro.8b00043}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2018). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/evl3.42}{doi:10.1002/evl3.42}.
\item Nielson EM, May DG, Forcehimes AA, Bogenschutz MP. (2018). \textit{The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00132}{doi:10.3389/fphar.2018.00132}.
\item Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE. (2018). \textit{Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00100}{doi:10.3389/fphar.2018.00100}.
\item Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R. (2018). \textit{The hidden therapist: evidence for a central role of music in psychedelic therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4820-5}{doi:10.1007/s00213-017-4820-5}.
\item Byock I. (2018). \textit{Taking Psychedelics Seriously.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2017.0684}{doi:10.1089/jpm.2017.0684}.
\item Roseman L, Nutt DJ, Carhart-Harris RL. (2018). \textit{Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2017.00974}{doi:10.3389/fphar.2017.00974}.
\item Lyons T, Carhart-Harris RL. (2018). \textit{Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117748902}{doi:10.1177/0269881117748902}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T. (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Lord L. (2017). \textit{Integration and segregation in whole-brain networks: implications for altered states of consciousness}. University of Oxford. [published; Europe PMC]. \href{https://europepmc.org/article/ETH/770691}{source link}.
\item Kometer M, Vollenweider FX. (2017). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2017). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2017). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Barrett FS, Griffiths RR. (2017). \textit{Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_474}{doi:10.1007/7854\_2017\_474}.
\item Bogenschutz MP, Ross S. (2017). \textit{Therapeutic Applications of Classic Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD. (2017). \textit{The Effects of Hallucinogens on Gene Expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J. (2017). \textit{Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Sherwood AM, Prisinzano TE (2017). \textit{Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1415755}{doi:10.1080/17512433.2018.1415755}.
\item Canal CE. (2017). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item Swanson LR (2017). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item Brandenburg WE, Ward KJ (2017). \textit{Mushroom poisoning epidemiology in the United States.}. Mycologia. [published; PubMed]. \href{https://doi.org/10.1080/00275514.2018.1479561}{doi:10.1080/00275514.2018.1479561}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S. (2017). \textit{Rapid-Acting Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL. (2017). \textit{Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.041}{doi:10.1016/j.neuropharm.2017.12.041}.
\item Rucker JJH, Iliff J, Nutt DJ. (2017). \textit{Psychiatry \& the psychedelic drugs. Past, present \& future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.040}{doi:10.1016/j.neuropharm.2017.12.040}.
\item University of Helsinki (2017). \textit{Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03380442}{source link}.
\item Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR. (2017). \textit{Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-017-0540-6}{doi:10.1007/s40262-017-0540-6}.
\item Rocchi R, Simeoni MC, Montesano C, Vannutelli G, Curini R, Sergi M, Compagnone D. (2017). \textit{Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.2330}{doi:10.1002/dta.2330}.
\item Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. (2017). \textit{The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2017.00240}{doi:10.3389/fpsyt.2017.00240}.
\item Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2017). \textit{LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2017.00814}{doi:10.3389/fphar.2017.00814}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. (2017). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. (2017). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL. (2017). \textit{Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4754-y}{doi:10.1007/s00213-017-4754-y}.
\item Hendricks PS, Crawford MS, Cropsey KL, Copes H, Sweat NW, Walsh Z, Pavela G. (2017). \textit{The relationships of classic psychedelic use with criminal behavior in the United States adult population.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117735685}{doi:10.1177/0269881117735685}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. (2017). \textit{Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117731279}{doi:10.1177/0269881117731279}.
\item Di Giovanni G, De Deurwaerdère P. (2017). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Dolder PC, Schmid Y, Steuer AE, Kraemer T, Rentsch KM, Hammann F, Liechti ME (2017). \textit{Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.}. Clinical pharmacokinetics. [published; PubMed]. \href{https://doi.org/10.1007/s40262-017-0513-9}{doi:10.1007/s40262-017-0513-9}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. (2017). \textit{Psychedelic Drugs in Biomedicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. (2017). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Andersson M, Persson M, Kjellgren A. (2017). \textit{Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12954-017-0186-6}{doi:10.1186/s12954-017-0186-6}.
\item Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. (2017). \textit{Effect of Psilocybin on Empathy and Moral Decision-Making.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyx047}{doi:10.1093/ijnp/pyx047}.
\item Fricke J, Blei F, Hoffmeister D. (2017). \textit{Enzymatic Synthesis of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/anie.201705489}{doi:10.1002/anie.201705489}.
\item Sellers EM, Leiderman DB. (2017). \textit{Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.776}{doi:10.1002/cpt.776}.
\item Sessa B. (2017). \textit{The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4713-7}{doi:10.1007/s00213-017-4713-7}.
\item Al-Imam A. (2017). \textit{Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1155/2017/2503762}{doi:10.1155/2017/2503762}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2017). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/176347}{doi:10.1101/176347}.
\item Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR. (2017). \textit{Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2017.01238}{doi:10.3389/fpsyg.2017.01238}.
\item Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. (2017). \textit{Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2017.07.020}{doi:10.1016/j.neuroimage.2017.07.020}.
\item Larsen JK. (2017). \textit{LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/08039488.2017.1336251}{doi:10.1080/08039488.2017.1336251}.
\item Johnson MW, Griffiths RR. (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. (2017). \textit{[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0043-103085}{doi:10.1055/s-0043-103085}.
\item Feng LY, Battulga A, Han E, Chung H, Li JH (2017). \textit{New psychoactive substances of natural origin: A brief review.}. Journal of food and drug analysis. [published; PubMed]. \href{https://doi.org/10.1016/j.jfda.2017.04.001}{doi:10.1016/j.jfda.2017.04.001}.
\item Forstmann M, Sagioglou C. (2017). \textit{Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117714049}{doi:10.1177/0269881117714049}.
\item Barrett FS, Johnson MW, Griffiths RR. (2017). \textit{Neuroticism is associated with challenging experiences with psilocybin mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.paid.2017.06.004}{doi:10.1016/j.paid.2017.06.004}.
\item Fabregat-Safont D, Barneo-Muñoz M, Martinez-Garcia F, Sancho JV, Hernández F, Ibáñez M. (2017). \textit{Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.chroma.2017.06.010}{doi:10.1016/j.chroma.2017.06.010}.
\item Strauss N. (2017). \textit{Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5694/mja17.00081}{doi:10.5694/mja17.00081}.
\item Sellers EM. (2017). \textit{Psilocybin: Good Trip or Bad Trip.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.697}{doi:10.1002/cpt.697}.
\item Thomas K, Malcolm B, Lastra D. (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Carhart-Harris RL, Goodwin GM. (2017). \textit{The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2017.84}{doi:10.1038/npp.2017.84}.
\item Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD. (2017). \textit{Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/srep46421}{doi:10.1038/srep46421}.
\item Schenk-Jaeger KM, Hofer-Lentner KE, Plenert B, Eckart D, Haberl B, Schulze G, Borchert-Avalone J, Stedtler U, Pfab R (2017). \textit{No clinically relevant effects in children after accidental ingestion of Panaeolina foenisecii (lawn mower's mushroom).}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2016.1271129}{doi:10.1080/15563650.2016.1271129}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Huestis MA, Tyndale RF. (2017). \textit{Designer Drugs 2.0.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.575}{doi:10.1002/cpt.575}.
\item Dinis-Oliveira RJ. (2017). \textit{Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03602532.2016.1278228}{doi:10.1080/03602532.2016.1278228}.
\item Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. (2017). \textit{The fibrinolytic system: A new target for treatment of depression with psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2017.01.013}{doi:10.1016/j.mehy.2017.01.013}.
\item Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. (2017). \textit{An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116684335}{doi:10.1177/0269881116684335}.
\item Golden C. (2016). \textit{Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation}. Imperial College London. [published; Europe PMC]. \href{https://doi.org/10.25560/45527}{doi:10.25560/45527}.
\item Kraehenmann R. (2016). \textit{Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1573413713666170619092629}{doi:10.2174/1573413713666170619092629}.
\item Letheby C, Gerrans P (2016). \textit{Self unbound: ego dissolution in psychedelic experience.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/nix016}{doi:10.1093/nc/nix016}.
\item Daniel J, Haberman M. (2016). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Nichols DE, Johnson MW, Nichols CD. (2016). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Nutt D. (2016). \textit{Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675754}{doi:10.1177/0269881116675754}.
\item Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. (2016). \textit{Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675512}{doi:10.1177/0269881116675512}.
\item Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. (2016). \textit{Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675513}{doi:10.1177/0269881116675513}.
\item Goodwin GM. (2016). \textit{Psilocybin: Psychotherapy or drug?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675757}{doi:10.1177/0269881116675757}.
\item Summergrad P. (2016). \textit{Psilocybin in end of life care: Implications for further research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675758}{doi:10.1177/0269881116675758}.
\item Shelton RC, Hendricks PS. (2016). \textit{Psilocybin and palliative end-of-life care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675764}{doi:10.1177/0269881116675764}.
\item McCorvy JD, Olsen RH, Roth BL. (2016). \textit{Psilocybin for depression and anxiety associated with life-threatening illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675771}{doi:10.1177/0269881116675771}.
\item Kelmendi B, Corlett P, Ranganathan M, D'Souza C, Krystal JH. (2016). \textit{The role of psychedelics in palliative care reconsidered: A case for psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675781}{doi:10.1177/0269881116675781}.
\item Spiegel D. (2016). \textit{Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675783}{doi:10.1177/0269881116675783}.
\item Breckenridge A, Grobbee DE. (2016). \textit{Psilocybin: promising results in double-blind trials require confirmation by real-world evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675784}{doi:10.1177/0269881116675784}.
\item Bodnar Willard MA, McGuffin VL, Smith RW. (2016). \textit{Statistical comparison of mass spectra for identification of amphetamine-type stimulants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2016.11.013}{doi:10.1016/j.forsciint.2016.11.013}.
\item Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. (2016). \textit{The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116678781}{doi:10.1177/0269881116678781}.
\item Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. (2016). \textit{Psychedelics in the treatment of unipolar mood disorders: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116679368}{doi:10.1177/0269881116679368}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Mahapatra A, Gupta R. (2016). \textit{Role of psilocybin in the treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316676092}{doi:10.1177/2045125316676092}.
\item Liechti ME, Dolder PC, Schmid Y. (2016). \textit{Alterations of consciousness and mystical-type experiences after acute LSD in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-016-4453-0}{doi:10.1007/s00213-016-4453-0}.
\item Jeanne G, Purper-Ouakil D, Rigole H, Franc N. (2016). \textit{[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2016.05.012}{doi:10.1016/j.encep.2016.05.012}.
\item Hendrie C, Pickles A. (2016). \textit{Psilocybin: panacea or placebo?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30103-1}{doi:10.1016/s2215-0366(16)30103-1}.
\item Dijkstra FM, Jacobs GE, Cohen AF. (2016). \textit{Question-based Drug Development for psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30214-0}{doi:10.1016/s2215-0366(16)30214-0}.
\item Carhart-Harris RL, Nutt DJ. (2016). \textit{Question-based Drug Development for psilocybin - Authors' reply.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30217-6}{doi:10.1016/s2215-0366(16)30217-6}.
\item Dasgupta A. (2016). \textit{Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.acc.2016.07.004}{doi:10.1016/bs.acc.2016.07.004}.
\item Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. (2016). \textit{Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116662634}{doi:10.1177/0269881116662634}.
\item Bogenschutz MP. (2016). \textit{It's time to take psilocybin seriously as a possible treatment for substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00952990.2016.1200060}{doi:10.1080/00952990.2016.1200060}.
\item Patra S. (2016). \textit{Return of the psychedelics: Psilocybin for treatment resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2016.08.010}{doi:10.1016/j.ajp.2016.08.010}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR. (2016). \textit{Psilocybin for treating substance use disorders?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Tófoli LF, de Araujo DB. (2016). \textit{Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2016.06.005}{doi:10.1016/bs.irn.2016.06.005}.
\item Johnson MW, Garcia-Romeu A, Griffiths RR. (2016). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00952990.2016.1170135}{doi:10.3109/00952990.2016.1170135}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J. (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Hardaway R, Schweitzer J, Suzuki J (2016). \textit{Hallucinogen Use Disorders.}. Child and adolescent psychiatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.chc.2016.03.006}{doi:10.1016/j.chc.2016.03.006}.
\item Howland RH. (2016). \textit{Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20160616-09}{doi:10.3928/02793695-20160616-09}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201633131}{doi:10.1002/chin.201633131}.
\item Pietsch J, Scheffel K, Acquarone D, Koch I, Deters M, Hermanns-Clausen M. (2016). \textit{[Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0042-108644}{doi:10.1055/s-0042-108644}.
\item Unknown authors (2016). \textit{Magic mushroom compound is a potential treatment for patients with major depression.}. Nursing standard (Royal College of Nursing (Great Britain): 1987). [published; PubMed]. \href{https://doi.org/10.7748/ns.30.41.15.s18}{doi:10.7748/ns.30.41.15.s18}.
\item Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J. (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC5616440}{source link}.
\item Palenicek T, Tyls F, Viktorinova M, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J. (2016). \textit{PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC5616436}{source link}.
\item Rickli A, Moning OD, Hoener MC, Liechti ME. (2016). \textit{Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.05.001}{doi:10.1016/j.euroneuro.2016.05.001}.
\item Shebloski KL, Broadway JM. (2016). \textit{Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2016.00736}{doi:10.3389/fpsyg.2016.00736}.
\item Hawkes N. (2016). \textit{Sixty seconds on... psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.i2775}{doi:10.1136/bmj.i2775}.
\item Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ. (2016). \textit{Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30065-7}{doi:10.1016/s2215-0366(16)30065-7}.
\item Cowen P. (2016). \textit{Altered states: psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30087-6}{doi:10.1016/s2215-0366(16)30087-6}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2016.03.007}{doi:10.1016/j.tet.2016.03.007}.
\item Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX. (2016). \textit{Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.1524187113}{doi:10.1073/pnas.1524187113}.
\item Mithoefer MC, Grob CS, Brewerton TD. (2016). \textit{Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(15)00576-3}{doi:10.1016/s2215-0366(15)00576-3}.
\item Nichols DE. (2016). \textit{Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.115.011478}{doi:10.1124/pr.115.011478}.
\item Gambaro V, Roda G, Visconti GL, Arnoldi S, Casagni E, Dell'Acqua L, Farè F, Paladino E, Rusconi C, Arioli S, Mora D. (2016). \textit{DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpba.2016.03.043}{doi:10.1016/j.jpba.2016.03.043}.
\item Kyzar EJ, Kalueff AV. (2016). \textit{Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/zeb.2016.1251}{doi:10.1089/zeb.2016.1251}.
\item Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. (2016). \textit{Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316638008}{doi:10.1177/2045125316638008}.
\item Suzuki K. (2016). \textit{[Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/27255023}{source link}.
\item Johns Hopkins University (2016). \textit{Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00802282}{source link}.
\item Davenport WJ. (2016). \textit{Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/cmaj.1150082}{doi:10.1503/cmaj.1150082}.
\item Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. (2016). \textit{Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.01.005}{doi:10.1016/j.euroneuro.2016.01.005}.
\item Letheby C (2015). \textit{The epistemic innocence of psychedelic states.}. Consciousness and cognition. [published; PubMed]. \href{https://doi.org/10.1016/j.concog.2015.11.012}{doi:10.1016/j.concog.2015.11.012}.
\item Sweat NW, Bates LW, Hendricks PS (2015). \textit{The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2016.1234090}{doi:10.1080/02791072.2016.1234090}.
\item Nagy Julia, Veress Tibor (2015). \textit{HPLC Analysis of Hallucinogenic Mushroom Alkaloids (Psilocin and Psilocybin) Applying Hydrophilic Interaction Chromatography (HILIC)}. Journal of Forensic Research. [published; Crossref]. \href{https://doi.org/10.4172/2157-7145.1000356}{doi:10.4172/2157-7145.1000356}.
\item Schindler EA, Gottschalk CH, Weil MJ, Shapiro RE, Wright DA, Sewell RA. (2015). \textit{Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2015.1107664}{doi:10.1080/02791072.2015.1107664}.
\item Barrett FS, Johnson MW, Griffiths RR. (2015). \textit{Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881115609019}{doi:10.1177/0269881115609019}.
\item Lowe LM, Peterson BL, Couper FJ. (2015). \textit{A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkv092}{doi:10.1093/jat/bkv092}.
\item Geyer MA. (2015). \textit{Lysergic Acid Diethylamide and Psilocybin Revisited.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2015.08.003}{doi:10.1016/j.biopsych.2015.08.003}.
\item Dydak K, Śliwińska-Mossoń M, Milnerowicz H. (2015). \textit{[Psilocybin - public available psychodysleptic].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/26400885}{source link}.
\item Hendricks PS, Johnson MW, Griffiths RR. (2015). \textit{Psilocybin, psychological distress, and suicidality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881115598338}{doi:10.1177/0269881115598338}.
\item Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. (2015). \textit{The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nicl.2015.08.009}{doi:10.1016/j.nicl.2015.08.009}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX. (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Spain A, Howarth C, Khrapitchev AA, Sharp T, Sibson NR, Martin C. (2015). \textit{Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2015.07.018}{doi:10.1016/j.neuropharm.2015.07.018}.
\item Gallimore AR. (2015). \textit{Restructuring consciousness -the psychedelic state in light of integrated information theory.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2015.00346}{doi:10.3389/fnhum.2015.00346}.
\item Wiltshire PE, Hawksworth DL, Edwards KJ. (2015). \textit{Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jflm.2015.05.010}{doi:10.1016/j.jflm.2015.05.010}.
\item Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. (2015). \textit{Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.22833}{doi:10.1002/hbm.22833}.
\item Di Lorenzo C, Coppola G, Di Lorenzo G, Bracaglia M, Rossi P, Pierelli F. (2015). \textit{The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0333102415583145}{doi:10.1177/0333102415583145}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M. (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Baumeister D, Tojo LM, Tracy DK. (2015). \textit{Legal highs: staying on top of the flood of novel psychoactive substances.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125314559539}{doi:10.1177/2045125314559539}.
\item Zhuk O, Jasicka-Misiak I, Poliwoda A, Kazakova A, Godovan VV, Halama M, Wieczorek PP. (2015). \textit{Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/toxins7041018}{doi:10.3390/toxins7041018}.
\item Bogenschutz MP, Johnson MW. (2015). \textit{Classic hallucinogens in the treatment of addictions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item Johansen PØ, Krebs TS. (2015). \textit{Psychedelics not linked to mental health problems or suicidal behavior: a population study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114568039}{doi:10.1177/0269881114568039}.
\item Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW (2015). \textit{Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114565653}{doi:10.1177/0269881114565653}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Cirriez JP. (2015). \textit{[Ilicit drugs frequently used by drug addicts].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/26571792}{source link}.
\item Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB. (2015). \textit{The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0118143}{doi:10.1371/journal.pone.0118143}.
\item Steeds H, Carhart-Harris RL, Stone JM (2015). \textit{Drug models of schizophrenia.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314557797}{doi:10.1177/2045125314557797}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Sessa B, Johnson MW. (2014). \textit{Can psychedelic compounds play a part in drug dependence therapy?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.bp.114.148031}{doi:10.1192/bjp.bp.114.148031}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS. (2014). \textit{Recreational use, analysis and toxicity of tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Unknown authors (2014). \textit{Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and Psilocin}. Journal of Analytical \& Bioanalytical Techniques. [published; Crossref]. \href{https://doi.org/10.4172/2155-9872.1000277}{doi:10.4172/2155-9872.1000277}.
\item Martin R, Schürenkamp J, Gasse A, Pfeiffer H, Köhler H. (2014). \textit{Analysis of psilocin, bufotenine and LSD in hair.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bku141}{doi:10.1093/jat/bku141}.
\item Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F. (2014). \textit{Homological scaffolds of brain functional networks.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1098/rsif.2014.0873}{doi:10.1098/rsif.2014.0873}.
\item Wilcox JA. (2014). \textit{Psilocybin and Obsessive Compulsive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2014.963754}{doi:10.1080/02791072.2014.963754}.
\item Sakashita Y, Abe K, Katagiri N, Kambe T, Saitoh T, Utsunomiya I, Horiguchi Y, Taguchi K. (2014). \textit{Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Borovička J, Oborník M, Stříbrný J, Noordeloos ME, Parra Sánchez LA, Gryndler M. (2014). \textit{Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3767/003158515x685283}{doi:10.3767/003158515x685283}.
\item Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. (2014). \textit{Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114548296}{doi:10.1177/0269881114548296}.
\item Pichini S, Marchei E, García-Algar O, Gomez A, Di Giovannandrea R, Pacifici R. (2014). \textit{Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpba.2014.08.006}{doi:10.1016/j.jpba.2014.08.006}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Law Francis, Poon Grace, Chui Y. C., He Shao-Xiong (2014). \textit{14C-Psilocin tissue distribution in pregnant rats after intravenous administration}. Functional Foods in Health and Disease. [published; Crossref]. \href{https://doi.org/10.31989/ffhd.v4i6.9}{doi:10.31989/ffhd.v4i6.9}.
\item Halberstadt AL. (2014). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR. (2014). \textit{Enhanced repertoire of brain dynamical states during the psychedelic experience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.22562}{doi:10.1002/hbm.22562}.
\item Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL. (2014). \textit{The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2014.00204}{doi:10.3389/fnhum.2014.00204}.
\item Johns Hopkins University (2014). \textit{Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01988311}{source link}.
\item Rambousek L, Palenicek T, Vales K, Stuchlik A. (2014). \textit{The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnbeh.2014.00180}{doi:10.3389/fnbeh.2014.00180}.
\item Appendino G, Minassi A, Taglialatela-Scafati O. (2014). \textit{Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/c4np00010b}{doi:10.1039/c4np00010b}.
\item Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2014). \textit{Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2014.04.010}{doi:10.1016/j.biopsych.2014.04.010}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F. (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Tyls F., Palenicek T., Novakova P., Kaderabek L., Fujakova M., Kubesova A., Horacek J. (2014). \textit{P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/s0924-977x(14)70111-7}{doi:10.1016/s0924-977x(14)70111-7}.
\item Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D. (2014). \textit{The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2014.00020}{doi:10.3389/fnhum.2014.00020}.
\item dos Santos RG. (2014). \textit{Potential therapeutic effects of psilocybin/psilocin are minimized while possible adverse reactions are overrated.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ftd.0000000000000028}{doi:10.1097/ftd.0000000000000028}.
\item Martin R, Schürenkamp J, Pfeiffer H, Lehr M, Köhler H. (2014). \textit{Synthesis, hydrolysis and stability of psilocin glucuronide.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2014.01.006}{doi:10.1016/j.forsciint.2014.01.006}.
\item Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL (2013). \textit{Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881113513851}{doi:10.1177/0269881113513851}.
\item Nichols DE. (2013). \textit{The Heffter Research Institute: past and hopeful future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2014.873688}{doi:10.1080/02791072.2014.873688}.
\item Garcia-Romeu A, Griffiths RR, Johnson MW. (2013). \textit{Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874473708666150107121331}{doi:10.2174/1874473708666150107121331}.
\item Turton S, Nutt DJ, Carhart-Harris RL. (2013). \textit{A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874473708666150107120930}{doi:10.2174/1874473708666150107120930}.
\item Tylš F, Páleníček T, Horáček J. (2013). \textit{Psilocybin--summary of knowledge and new perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2013.12.006}{doi:10.1016/j.euroneuro.2013.12.006}.
\item Icaza EE, Mashour GA. (2013). \textit{Altered states: psychedelics and anesthetics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Winstock AR, Kaar S, Borschmann R. (2013). \textit{Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881113513852}{doi:10.1177/0269881113513852}.
\item Jastrzebski M, Bala A. (2013). \textit{[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/25007546}{source link}.
\item Brogaard B. (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Burdick BV, Adinoff B. (2013). \textit{A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00952990.2013.811513}{doi:10.3109/00952990.2013.811513}.
\item Carhart-Harris RL, Nutt DJ. (2013). \textit{Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2013.825034}{doi:10.1080/02791072.2013.825034}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ. (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Krebs TS, Johansen PØ. (2013). \textit{Psychedelics and mental health: a population study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0063972}{doi:10.1371/journal.pone.0063972}.
\item Halberstadt AL, Geyer MA. (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Stebelska K. (2013). \textit{Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ftd.0b013e31828741a5}{doi:10.1097/ftd.0b013e31828741a5}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. (2013). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Kjellgren A, Jonsson K. (2013). \textit{Methoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internet.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2013.803647}{doi:10.1080/02791072.2013.803647}.
\item Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. (2013). \textit{Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881113494107}{doi:10.1177/0269881113494107}.
\item Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J. (2013). \textit{Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00221-013-3579-0}{doi:10.1007/s00221-013-3579-0}.
\item Kometer M, Schmidt A, Jäncke L, Vollenweider FX. (2013). \textit{Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.3007-12.2013}{doi:10.1523/jneurosci.3007-12.2013}.
\item Kosentka P, Sprague SL, Ryberg M, Gartz J, May AL, Campagna SR, Matheny PB. (2013). \textit{Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0064646}{doi:10.1371/journal.pone.0064646}.
\item Helander A, Beck O, Hägerkvist R, Hultén P. (2013). \textit{Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00365513.2013.793817}{doi:10.3109/00365513.2013.793817}.
\item Müller K, Püschel K, Iwersen-Bergmann S. (2013). \textit{[Suicide under the influence of "magic mushrooms"].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/23878898}{source link}.
\item Cummins C, Lyke J. (2013). \textit{Peak experiences of psilocybin users and non-users.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2013.785855}{doi:10.1080/02791072.2013.785855}.
\item Krebs TS, Johansen PØ. (2013). \textit{Over 30 million psychedelic users in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12688/f1000research.2-98.v1}{doi:10.12688/f1000research.2-98.v1}.
\item Young SN. (2013). \textit{Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.120128}{doi:10.1503/jpn.120128}.
\item Bogenschutz MP. (2013). \textit{Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/15733998113099990002}{doi:10.2174/15733998113099990002}.
\item Moreno JL, Holloway T, Rayannavar V, Sealfon SC, González-Maeso J. (2013). \textit{Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2012.12.053}{doi:10.1016/j.neulet.2012.12.053}.
\item Hallock RM, Dean A, Knecht ZA, Spencer J, Taverna EC. (2012). \textit{A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2012.11.010}{doi:10.1016/j.drugalcdep.2012.11.010}.
\item Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. (2012). \textit{Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1468-5906.2012.01685.x}{doi:10.1111/j.1468-5906.2012.01685.x}.
\item Martin R, Schürenkamp J, Gasse A, Pfeiffer H, Köhler H. (2012). \textit{Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-012-0796-1}{doi:10.1007/s00414-012-0796-1}.
\item Lim TH, Wasywich CA, Ruygrok PN (2012). \textit{A fatal case of 'magic mushroom' ingestion in a heart transplant recipient.}. Internal medicine journal. [published; PubMed]. \href{https://doi.org/10.1111/j.1445-5994.2012.02955.x}{doi:10.1111/j.1445-5994.2012.02955.x}.
\item Lyvers M, Meester M. (2012). \textit{Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2012.736842}{doi:10.1080/02791072.2012.736842}.
\item Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ. (2012). \textit{Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/schbul/sbs117}{doi:10.1093/schbul/sbs117}.
\item Hanks JB, González-Maeso J. (2012). \textit{Animal models of serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Pellegrini M, Rotolo MC, Marchei E, Pacifici R, Saggio F, Pichini S. (2012). \textit{Magic truffles or Philosopher's stones: a legal way to sell psilocybin?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.1400}{doi:10.1002/dta.1400}.
\item Tennison MN. (2012). \textit{Moral transhumanism: the next step.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jmp/jhs024}{doi:10.1093/jmp/jhs024}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. (2012). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D. (2012). \textit{Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.2234}{doi:10.1002/hup.2234}.
\item Olthuis JV, Darredeau C, Barrett SP. (2012). \textit{Substance use initiation: the role of simultaneous polysubstance use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1465-3362.2012.00470.x}{doi:10.1111/j.1465-3362.2012.00470.x}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. (2012). \textit{High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-012-2680-6}{doi:10.1007/s00213-012-2680-6}.
\item Roiser JP, Rees G. (2012). \textit{Neuroimaging: a scanner, colourfully.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2012.02.033}{doi:10.1016/j.cub.2012.02.033}.
\item Studerus E, Gamma A, Kometer M, Vollenweider FX. (2012). \textit{Prediction of psilocybin response in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0030800}{doi:10.1371/journal.pone.0030800}.
\item Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ. (2012). \textit{Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.bp.111.103309}{doi:10.1192/bjp.bp.111.103309}.
\item Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ. (2012). \textit{Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.1119598109}{doi:10.1073/pnas.1119598109}.
\item Martin R, Schürenkamp J, Pfeiffer H, Köhler H. (2011). \textit{A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-011-0652-8}{doi:10.1007/s00414-011-0652-8}.
\item Johnson MW, Sewell RA, Griffiths RR. (2011). \textit{Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2011.10.029}{doi:10.1016/j.drugalcdep.2011.10.029}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX. (2011). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item MacLean KA, Johnson MW, Griffiths RR. (2011). \textit{Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881111420188}{doi:10.1177/0269881111420188}.
\item Quednow BB, Kometer M, Geyer MA, Vollenweider FX. (2011). \textit{Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.228}{doi:10.1038/npp.2011.228}.
\item Carod-Artal FJ. (2011). \textit{Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nrl.2011.07.003}{doi:10.1016/j.nrl.2011.07.003}.
\item Pettigrew J. (2011). \textit{Iconography in Bradshaw rock art: breaking the circularity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1444-0938.2011.00648.x}{doi:10.1111/j.1444-0938.2011.00648.x}.
\item Chen J, Li M, Yan X, Wu E, Zhu H, Lee KJ, Chu VM, Zhan L, Lee W, Kang JS. (2011). \textit{Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2011.07.003}{doi:10.1016/j.jchromb.2011.07.003}.
\item Móró L, Simon K, Bárd I, Rácz J. (2011). \textit{Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2011.605661}{doi:10.1080/02791072.2011.605661}.
\item Kjellgren A, Soussan C. (2011). \textit{Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2011.605699}{doi:10.1080/02791072.2011.605699}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. (2011). \textit{Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-011-2358-5}{doi:10.1007/s00213-011-2358-5}.
\item van Amsterdam J, Opperhuizen A, van den Brink W (2011). \textit{Harm potential of magic mushroom use: a review.}. Regulatory toxicology and pharmacology: RTP. [published; PubMed]. \href{https://doi.org/10.1016/j.yrtph.2011.01.006}{doi:10.1016/j.yrtph.2011.01.006}.
\item Sun-Edelstein C, Mauskop A. (2011). \textit{Alternative headache treatments: nutraceuticals, behavioral and physical treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1526-4610.2011.01846.x}{doi:10.1111/j.1526-4610.2011.01846.x}.
\item Shoda T, Fukuhara K, Goda Y, Okuda H. (2011). \textit{Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.244}{doi:10.1002/dta.244}.
\item Meyer MR, Maurer HH. (2011). \textit{Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pgs.10.171}{doi:10.2217/pgs.10.171}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J. (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J. (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item Halberstadt AL, Geyer MA. (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item Halberstadt AL, Koedood L, Powell SB, Geyer MA. (2010). \textit{Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110388326}{doi:10.1177/0269881110388326}.
\item Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. (2010). \textit{The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2010.10.002}{doi:10.1016/j.biopsych.2010.10.002}.
\item Riley S, Thompson J, Griffin C. (2010). \textit{Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2010.07.001}{doi:10.1016/j.drugpo.2010.07.001}.
\item Sumnall HR, Measham F, Brandt SD, Cole JC. (2010). \textit{Salvia divinorum use and phenomenology: results from an online survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110385596}{doi:10.1177/0269881110385596}.
\item Studerus E, Kometer M, Hasler F, Vollenweider FX. (2010). \textit{Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110382466}{doi:10.1177/0269881110382466}.
\item Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2010). \textit{Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/archgenpsychiatry.2010.116}{doi:10.1001/archgenpsychiatry.2010.116}.
\item Studerus E, Gamma A, Vollenweider FX. (2010). \textit{Psychometric evaluation of the altered states of consciousness rating scale (OAV).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0012412}{doi:10.1371/journal.pone.0012412}.
\item Vollenweider FX, Kometer M. (2010). \textit{The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/nrn2884}{doi:10.1038/nrn2884}.
\item Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR. (2010). \textit{Determining the subjective effects of TFMPP in human males.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-010-1911-y}{doi:10.1007/s00213-010-1911-y}.
\item Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ. (2010). \textit{The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110367445}{doi:10.1177/0269881110367445}.
\item Hu Chunmei, Qin Hua, Cui Yuxin, Jia Yanxing (2010). \textit{ChemInform Abstract: Palladium-Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201009186}{doi:10.1002/chin.201009186}.
\item Butelman ER, Rus S, Prisinzano TE, Kreek MJ. (2010). \textit{The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-009-1771-5}{doi:10.1007/s00213-009-1771-5}.
\item Laussmann T, Meier-Giebing S. (2010). \textit{Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2009.12.013}{doi:10.1016/j.forsciint.2009.12.013}.
\item Manevski N, Kurkela M, Höglund C, Mauriala T, Court MH, Yli-Kauhaluoma J, Finel M. (2009). \textit{Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/dmd.109.031138}{doi:10.1124/dmd.109.031138}.
\item Koçak A, De Cotiis LM, Hoffman DB. (2009). \textit{Comparative study of ATR and transflection IR spectroscopic techniques for the analysis of hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2009.11.002}{doi:10.1016/j.forsciint.2009.11.002}.
\item Morvan Y, Rouvier J, Olié JP, Lôo H, Krebs MO. (2009). \textit{[Student's use of illicit drugs: a survey in a preventive health service].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0013-7006(09)73471-2}{doi:10.1016/s0013-7006(09)73471-2}.
\item Hu Chunmei, Qin Hua, Cui Yuxin, Jia Yanxing (2009). \textit{Palladium-catalyzed synthesis of tryptamines and tryptamine homologues: synthesis of psilocin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2009.09.050}{doi:10.1016/j.tet.2009.09.050}.
\item Wark C, Galliher JF. (2009). \textit{Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2009.08.004}{doi:10.1016/j.drugpo.2009.08.004}.
\item Lott JP, Marlowe DB, Forman RF. (2009). \textit{Availability of websites offering to sell psilocybin spores and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2009.10400541}{doi:10.1080/02791072.2009.10400541}.
\item Kovacic P, Somanathan R. (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item Matsushima Y, Shirota O, Kikura-Hanajiri R, Goda Y, Eguchi F. (2009). \textit{Effects of Psilocybe argentipes on marble-burying behavior in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1271/bbb.90095}{doi:10.1271/bbb.90095}.
\item Kovacic P. (2009). \textit{Unifying electron transfer mechanism for psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2009.06.022}{doi:10.1016/j.mehy.2009.06.022}.
\item Björnstad K, Hultén P, Beck O, Helander A. (2009). \textit{Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15563650903037181}{doi:10.1080/15563650903037181}.
\item Barbee G, Berry-Cabán C, Barry J, Borys D, Ward J, Salyer S. (2009). \textit{Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf03161087}{doi:10.1007/bf03161087}.
\item Kawamura M, Kikura-Hanajiri R, Goda Y. (2009). \textit{[Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/yakushi.129.719}{doi:10.1248/yakushi.129.719}.
\item Flammer R, Schenk-Jäger KM. (2009). \textit{[Mushroom poisoning--the dark side of mycetism].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1024/0040-5930.66.5.357}{doi:10.1024/0040-5930.66.5.357}.
\item Björnstad K, Beck O, Helander A. (2009). \textit{A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2009.03.004}{doi:10.1016/j.jchromb.2009.03.004}.
\item Gonmori K, Yokoyama K (2009). \textit{[Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan].}. Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/19344063/}{source link}.
\item González-Maeso J, Sealfon SC. (2008). \textit{Agonist-trafficking and hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD. (2008). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G. (2008). \textit{GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.apradiso.2008.12.007}{doi:10.1016/j.apradiso.2008.12.007}.
\item McClintock RL, Watts DJ, Melanson S (2008). \textit{Unrecognized magic mushroom abuse in a 28-year-old man.}. The American journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.ajem.2008.01.058}{doi:10.1016/j.ajem.2008.01.058}.
\item Geyer MA, Vollenweider FX. (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item Griffiths R, Richards W, Johnson M, McCann U, Jesse R. (2008). \textit{Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881108094300}{doi:10.1177/0269881108094300}.
\item Hermle L, Kovar KA, Hewer W, Ruchsow M. (2008). \textit{[Hallucinogen-induced psychological disorders].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2008-1038191}{doi:10.1055/s-2008-1038191}.
\item Heekeren K, Daumann J, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E. (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A. (2008). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item Lee IK, Cho SM, Seok SJ, Yun BS. (2008). \textit{Chemical Constituents of Gymnopilus spectabilis and Their Antioxidant Activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4489/myco.2008.36.1.055}{doi:10.4489/myco.2008.36.1.055}.
\item Bray JK, Goddard WA. (2008). \textit{The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jmgm.2008.02.006}{doi:10.1016/j.jmgm.2008.02.006}.
\item González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC. (2008). \textit{Identification of a serotonin/glutamate receptor complex implicated in psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/nature06612}{doi:10.1038/nature06612}.
\item Wackermann J, Wittmann M, Hasler F, Vollenweider FX. (2008). \textit{Effects of varied doses of psilocybin on time interval reproduction in human subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2008.02.006}{doi:10.1016/j.neulet.2008.02.006}.
\item Riley SC, Blackman G (2007). \textit{Between prohibitions: patterns and meanings of magic mushroom use in the UK.}. Substance use \& misuse. [published; PubMed]. \href{https://doi.org/10.1080/10826080701772363}{doi:10.1080/10826080701772363}.
\item Attema-de Jonge ME, Portier CB, Franssen EJ. (2007). \textit{[Automutilation after consumption of hallucinogenic mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/18257429}{source link}.
\item del Mar Ramirez Fernandez M, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P, Samyn N. (2007). \textit{Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/31.8.497}{doi:10.1093/jat/31.8.497}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC. (2007). \textit{Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.09.007}{doi:10.1016/j.pbb.2007.09.007}.
\item Winter JC. (2007). \textit{Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.07.007}{doi:10.1016/j.pbb.2007.07.007}.
\item Adamczyk A, Sadakierska-Chudy A, Janoszka J, Rymkiewicz A, Dobosz T. (2007). \textit{[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17907620}{source link}.
\item Winter JC, Rice KC, Amorosi DJ, Rabin RA. (2007). \textit{Psilocybin-induced stimulus control in the rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.06.003}{doi:10.1016/j.pbb.2007.06.003}.
\item Marona-Lewicka D, Nichols DE. (2007). \textit{Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.06.001}{doi:10.1016/j.pbb.2007.06.001}.
\item Heekeren K, Neukirch A, Daumann J, Stoll M, Obradovic M, Kovar KA, Geyer MA, Gouzoulis-Mayfrank E. (2007). \textit{Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881107077734}{doi:10.1177/0269881107077734}.
\item Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. (2007). \textit{The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1301324}{doi:10.1038/sj.npp.1301324}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA. (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item McCambridge J, Winstock A, Hunt N, Mitcheson L. (2006). \textit{5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000095816}{doi:10.1159/000095816}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A. (2006). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/20143700}{source link}.
\item Ondra P, Zedníková K, Válka I. (2006). \textit{Detection and determination of abused hallucinogens in biological material.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17159796}{source link}.
\item Frecska E, Luna LE. (2006). \textit{The adverse effects of hallucinogens from intramural perspective.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17211054}{source link}.
\item Sempere AP, Berenguer-Ruiz L, Almazán F. (2006). \textit{[Chronic cluster headache: Response to psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.33588/rn.4309.2006432}{doi:10.33588/rn.4309.2006432}.
\item Moreno FA, Wiegand CB, Taitano EK, Delgado PL. (2006). \textit{Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.v67n1110}{doi:10.4088/jcp.v67n1110}.
\item Griffiths RR, Richards WA, McCann U, Jesse R. (2006). \textit{Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-006-0457-5}{doi:10.1007/s00213-006-0457-5}.
\item Kamata Tooru, Nishikawa Mayumi, Katagi Munehiro, Tsuchihashi Hitoshi (2006). \textit{Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user}. Forensic Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s11419-006-0006-2}{doi:10.1007/s11419-006-0006-2}.
\item Barrett SP, Darredeau C, Pihl RO. (2006). \textit{Patterns of simultaneous polysubstance use in drug using university students.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.766}{doi:10.1002/hup.766}.
\item Lerner M, Lyvers M. (2006). \textit{Values and beliefs of psychedelic drug users: a cross-cultural study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2006.10399838}{doi:10.1080/02791072.2006.10399838}.
\item Sewell RA, Halpern JH, Pope HG. (2006). \textit{Response of cluster headache to psilocybin and LSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1212/01.wnl.0000219761.05466.43}{doi:10.1212/01.wnl.0000219761.05466.43}.
\item Tiscione NB, Miller MI. (2006). \textit{Psilocin identified in a DUID investigation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/30.5.342}{doi:10.1093/jat/30.5.342}.
\item Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX. (2006). \textit{Effects of psilocybin on time perception and temporal control of behaviour in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881106065859}{doi:10.1177/0269881106065859}.
\item Jensen N, Gartz J, Laatsch H. (2006). \textit{Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-931576}{doi:10.1055/s-2006-931576}.
\item Anastos N, Barnett NW, Pfeffer FM, Lewis SW. (2006). \textit{Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s1355-0306(06)71579-9}{doi:10.1016/s1355-0306(06)71579-9}.
\item Stamets P. (2006). \textit{Can mushrooms help save the world? Interview by Bonnie J. Horrigan.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.explore.2005.12.011}{doi:10.1016/j.explore.2005.12.011}.
\item Anastos N, Lewis SW, Barnett NW, Sims DN. (2005). \textit{The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1556-4029.2005.00033.x}{doi:10.1111/j.1556-4029.2005.00033.x}.
\item Maruyama T, Kawahara N, Yokoyama K, Makino Y, Fukiharu T, Goda Y. (2005). \textit{Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2004.10.028}{doi:10.1016/j.forsciint.2004.10.028}.
\item Bickel M, Ditting T, Watz H, Roesler A, Weidauer S, Jacobi V, Gueller S, Betz C, Fichtlscherer S, Stein J (2005). \textit{Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.}. European journal of emergency medicine: official journal of the European Society for Emergency Medicine. [published; PubMed]. \href{https://doi.org/10.1097/00063110-200512000-00011}{doi:10.1097/00063110-200512000-00011}.
\item Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA. (2005). \textit{Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2005-916185}{doi:10.1055/s-2005-916185}.
\item Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX. (2005). \textit{Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/089892905774597191}{doi:10.1162/089892905774597191}.
\item Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L. (2005). \textit{SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bmcl.2005.06.104}{doi:10.1016/j.bmcl.2005.06.104}.
\item Palenicek T., Bubenikova V., Votava M. (2005). \textit{B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/00008877-200509001-00236}{doi:10.1097/00008877-200509001-00236}.
\item Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. (2005). \textit{Hallucinogen persisting perception disorder after psilocybin consumption: a case study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eurpsy.2005.04.008}{doi:10.1016/j.eurpsy.2005.04.008}.
\item Anastos N, Barnett NW, Lewis SW, Gathergood N, Scammells PJ, Sims DN. (2005). \textit{Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection respectively.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2004.11.038}{doi:10.1016/j.talanta.2004.11.038}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX. (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Soyka M, Koch W, Möller HJ, Rüther T, Tatsch K. (2005). \textit{Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-005-0563-0}{doi:10.1007/s00406-005-0563-0}.
\item Maruyama T, Kawahara N, Fukiharu T, Yokoyama K, Makino Y, Goda Y. (2005). \textit{[DNA and chemical analyses of commercial fly agaric-related products].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3358/shokueishi.46.49}{doi:10.3358/shokueishi.46.49}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H. (2005). \textit{Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs2004276}{doi:10.1520/jfs2004276}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2005). \textit{Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/15813544/}{source link}.
\item Percy A, McAlister S, Higgins K, McCrystal P, Thornton M (2005). \textit{Response consistency in young adolescents' drug use self-reports: a recanting rate analysis.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/j.1360-0443.2004.00943.x}{doi:10.1111/j.1360-0443.2004.00943.x}.
\item Rimsza ME, Moses KS. (2005). \textit{Substance abuse on the college campus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pcl.2004.10.008}{doi:10.1016/j.pcl.2004.10.008}.
\item Saito K, Toyo'oka T, Kato M, Fukushima T, Shirota O, Goda Y. (2005). \textit{Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2004.11.031}{doi:10.1016/j.talanta.2004.11.031}.
\item He Xinsheng. (2004). \textit{Study on the biological characteristics and cultivation of panaeolus bisporus}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/CBA/602890}{source link}.
\item Saito Kimie, Toyo’oka Toshimasa, Fukushima Takeshi, Kato Masaru, Shirota Osamu, Goda Yukihiro (2004). \textit{Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry}. Analytica Chimica Acta. [published; Crossref]. \href{https://doi.org/10.1016/j.aca.2004.08.071}{doi:10.1016/j.aca.2004.08.071}.
\item Albers C, Köhler H, Lehr M, Brinkmann B, Beike J. (2004). \textit{Development of a psilocin immunoassay for serum and blood samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-004-0469-9}{doi:10.1007/s00414-004-0469-9}.
\item Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX. (2004). \textit{Psilocybin impairs high-level but not low-level motion perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00001756-200408260-00023}{doi:10.1097/00001756-200408260-00023}.
\item Beuhler M, Lee DC, Gerkin R. (2004). \textit{The Meixner test in the detection of alpha-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.annemergmed.2004.03.017}{doi:10.1016/j.annemergmed.2004.03.017}.
\item Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J. (2004). \textit{Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.addbeh.2004.02.022}{doi:10.1016/j.addbeh.2004.02.022}.
\item Halpern JH. (2004). \textit{Hallucinogens and dissociative agents naturally growing in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2004.03.003}{doi:10.1016/j.pharmthera.2004.03.003}.
\item Fantegrossi WE, Woods JH, Winger G. (2004). \textit{Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00008877-200403000-00007}{doi:10.1097/00008877-200403000-00007}.
\item Nugent KG, Saville BJ. (2004). \textit{Forensic analysis of hallucinogenic fungi: a DNA-based approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2003.11.022}{doi:10.1016/j.forsciint.2003.11.022}.
\item Nielen RJ, van der Heijden FM, Tuinier S, Verhoeven WM. (2003). \textit{Khat and mushrooms associated with psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15622970410029908}{doi:10.1080/15622970410029908}.
\item Yamaguchi Mitsune, Saito Toshiaki, Horiguchi Yoshie, Ogawa Keita, Tsuchiya Yukihiro, Hishinuma Kayoko, Chikuma Toshiyuki, Makino Yukiko, Hojo Hiroshi (2003). \textit{Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin}. Journal of Health Science. [published; Crossref]. \href{https://doi.org/10.1248/jhs.50.600}{doi:10.1248/jhs.50.600}.
\item Tsujikawa K, Kanamori T, Iwata Y, Ohmae Y, Sugita R, Inoue H, Kishi T. (2003). \textit{Morphological and chemical analysis of magic mushrooms in Japan.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2003.08.009}{doi:10.1016/j.forsciint.2003.08.009}.
\item Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. (2003). \textit{Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-003-1640-6}{doi:10.1007/s00213-003-1640-6}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H. (2003). \textit{Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2003.08.030}{doi:10.1016/j.jchromb.2003.08.030}.
\item Saviuc P, Flesch F. (2003). \textit{[Acute higher funghi mushroom poisoning and its treatment].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14534493}{source link}.
\item Ventegodt S, Merrick J. (2003). \textit{Psychoactive drugs and quality of life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1100/tsw.2003.57}{doi:10.1100/tsw.2003.57}.
\item NANBA YASUHARU, MOCHIZUKI TAKESHI, OZAKI KEIKO, HOJO HIROSHI, YAMAGUCHI MITSUMINE. (2003). \textit{METHOD FOR DETECTING IMMUNOCHROMATOGRAPHY OF PSILOCIN BY COMPETITION METHOD, AND TEST KIT}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PAT/JP2005031029}{source link}.
\item Stríbrný J, Borovicka J, Sokol M. (2003). \textit{[Levels of psilocybin and psilocin in various types of mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14631713}{source link}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF. (2003). \textit{[Hallucinogens, amphetamines and entactogens].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1024/0040-5930.60.6.323}{doi:10.1024/0040-5930.60.6.323}.
\item Shirota O, Hakamata W, Goda Y. (2003). \textit{Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/np030059u}{doi:10.1021/np030059u}.
\item Carod Artal FJ. (2003). \textit{[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.33588/rn.3610.2003019}{doi:10.33588/rn.3610.2003019}.
\item Gonmori K, Yoshioka N (2003). \textit{The examination of mushroom poisonings at Akita University.}. Legal medicine (Tokyo, Japan). [published; PubMed]. \href{https://doi.org/10.1016/s1344-6223(02)00127-x}{doi:10.1016/s1344-6223(02)00127-x}.
\item Gathergood N, Scammells PJ. (2003). \textit{Preparation of the 4-hydroxytryptamine scaffold via palladium-catalyzed cyclization: a practical and versatile synthesis of psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/ol0341039}{doi:10.1021/ol0341039}.
\item Maruyama T, Shirota O, Kawahara N, Yokoyama K, Makino Y, Goda Y. (2003). \textit{[Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3358/shokueishi.44.44}{doi:10.3358/shokueishi.44.44}.
\item Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T, Koller R. (2002). \textit{Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300005}{doi:10.1038/sj.npp.1300005}.
\item Gross ST. (2002). \textit{Psychotropic drugs in developmental mushrooms: a case study review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs15564j}{doi:10.1520/jfs15564j}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ. (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Passie T, Seifert J, Schneider U, Emrich HM. (2002). \textit{The pharmacology of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/1355621021000005937}{doi:10.1080/1355621021000005937}.
\item Hasler F, Bourquin D, Brenneisen R, Vollenweider FX. (2002). \textit{Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0731-7085(02)00278-9}{doi:10.1016/s0731-7085(02)00278-9}.
\item Albers C, Lehr M, Beike J, Köhler H, Brinkmann B. (2002). \textit{Synthesis of a psilocin hapten and a protein-hapten conjugate.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1211/002235702320402116}{doi:10.1211/002235702320402116}.
\item Gross SR, Barrett SP, Shestowsky JS, Pihl RO. (2002). \textit{Ecstasy and drug consumption patterns: a Canadian rave population study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/070674370204700606}{doi:10.1177/070674370204700606}.
\item Yamada Fumio, Tamura Mayumi, Hasegawa Atsuko, Somei Masanori (2002). \textit{ChemInform Abstract: The Chemistry of Indoles. Part 109. Synthetic Studies of Psilocin Analogues Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.200229147}{doi:10.1002/chin.200229147}.
\item ten Berge J. (2002). \textit{Jekyll and Hyde revisited: paradoxes in the appreciation of drug experiences and their effects on creativity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2002.10399961}{doi:10.1080/02791072.2002.10399961}.
\item Rabin RA, Regina M, Doat M, Winter JC. (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Moeller MR, Kraemer T. (2002). \textit{Drugs of abuse monitoring in blood for control of driving under the influence of drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00007691-200204000-00003}{doi:10.1097/00007691-200204000-00003}.
\item Bressloff PC, Cowan JD, Golubitsky M, Thomas PJ, Wiener MC. (2002). \textit{What geometric visual hallucinations tell us about the visual cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/089976602317250861}{doi:10.1162/089976602317250861}.
\item Umbricht D, Koller R, Vollenweider FX, Schmid L. (2002). \textit{Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0006-3223(01)01242-2}{doi:10.1016/s0006-3223(01)01242-2}.
\item Fukuda K. (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Gouzoulis-Mayfrank E, Thelen B, Maier S, Heekeren K, Kovar KA, Sass H, Spitzer M. (2001). \textit{Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000063672}{doi:10.1159/000063672}.
\item Yamada F, Tamura M, Hasegawa A, Somei M. (2001). \textit{Synthetic studies of psilocin analogs having either a formyl group or bromine atom at the 5- or 7-position.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/cpb.50.92}{doi:10.1248/cpb.50.92}.
\item Vollenweider FX. (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA. (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item Riley SC, James C, Gregory D, Dingle H, Cadger M. (2001). \textit{Patterns of recreational drug use at dance events in Edinburgh, Scotland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1046/j.1360-0443.2001.967103513.x}{doi:10.1046/j.1360-0443.2001.967103513.x}.
\item Grieshaber AF, Moore KA, Levine B. (2001). \textit{The detection of psilocin in human urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs15014j}{doi:10.1520/jfs15014j}.
\item Vetulani J. (2001). \textit{Drug addiction. Part I. Psychoactive substances in the past and presence.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11785921}{source link}.
\item Grieshaber AF, Moore KA, Levine B (2001). \textit{The detection of psilocin in human urine.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11373000/}{source link}.
\item Lee JC. (2000). \textit{Towards a molecular approach for the identification of fungal taxa that contain psilocybin}. University of Strathclyde. [published; Europe PMC]. \href{https://doi.org/10.48730/zty1-g223}{doi:10.48730/zty1-g223}.
\item Moldavan MG, Grodzinskaya AA, Solomko EF, Lomberh ML, Wasser SP, Storozhuk VM. (2000). \textit{The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11962085}{source link}.
\item Ho E, Karimi-Tabesh L, Koren G (2000). \textit{Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).}. Neurotoxicology and teratology. [published; PubMed]. \href{https://doi.org/10.1016/s0892-0362(01)00178-7}{doi:10.1016/s0892-0362(01)00178-7}.
\item Salomé F, Boyer P, Fayol M. (2000). \textit{The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0924-9338(00)00520-4}{doi:10.1016/s0924-9338(00)00520-4}.
\item Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE. (2000). \textit{Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm000339w}{doi:10.1021/jm000339w}.
\item Bogusz MJ. (2000). \textit{Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(00)00461-8}{doi:10.1016/s0378-4347(00)00461-8}.
\item Pierrot M, Josse P, Raspiller MF, Goulmy M, Rambourg MO, Manel J, Lambert H. (2000). \textit{[Intoxications by hallucinogenic mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11104939}{source link}.
\item Barrett SP, Archambault J, Engelberg MJ, Pihl RO. (2000). \textit{Hallucinogenic drugs attenuate the subjective response to alcohol in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}{doi:10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}.
\item Musshoff F, Madea B, Beike J. (2000). \textit{Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0379-0738(00)00211-5}{doi:10.1016/s0379-0738(00)00211-5}.
\item Sticht G, Käferstein H. (2000). \textit{Detection of psilocin in body fluids.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0379-0738(00)00213-9}{doi:10.1016/s0379-0738(00)00213-9}.
\item McBride MC. (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Adlaf EM, Paglia A, Ivis FJ, Ialomiteanu A. (2000). \textit{Nonmedical drug use among adolescent students: highlights from the 1999 Ontario Student Drug Use Survey.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10870495}{source link}.
\item Gross ST. (2000). \textit{Detecting psychoactive drugs in the developmental stages of mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs14725j}{doi:10.1520/jfs14725j}.
\item Yamada F. (2000). \textit{[Development of synthetic methods for 4-substituted indoles and their applications for the syntheses of natural products].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/yakushi1947.120.4\_363}{doi:10.1248/yakushi1947.120.4\_363}.
\item Spengos K, Schwartz A, Hennerici M (2000). \textit{Multifocal cerebral demyelination after magic mushroom abuse.}. Journal of neurology. [published; PubMed]. \href{https://doi.org/10.1007/s004150050570}{doi:10.1007/s004150050570}.
\item Schäfer AT. (1999). \textit{[Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10726173}{source link}.
\item Senn-Irlet Beatrice, Nyffenegger Adolf, Brenneisen Rudolf (1999). \textit{Panaeolus bisporus - an adventitious fungus in central Europe, rich in psilocin}. Mycologist. [published; Crossref]. \href{https://doi.org/10.1016/s0269-915x(99)80107-4}{doi:10.1016/s0269-915x(99)80107-4}.
\item Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE. (1999). \textit{Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm990325u}{doi:10.1021/jm990325u}.
\item Drummer OH. (1999). \textit{Chromatographic screening techniques in systematic toxicological analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(99)00265-0}{doi:10.1016/s0378-4347(99)00265-0}.
\item Keller T, Schneider A, Regenscheit P, Dirnhofer R, Rucker T, Jaspers J, Kisser W (1999). \textit{Analysis of psilocybin and psilocin in psilocybe subcubensis Guzman by ion mobility spectrometry and gas chromatography-mass spectrometry}. Journal of Clinical Forensic Medicine. [published; Crossref]. \href{https://doi.org/10.1016/s1353-1131(99)90073-1}{doi:10.1016/s1353-1131(99)90073-1}.
\item Nichols David E., Frescas Steward (1999). \textit{ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199933137}{doi:10.1002/chin.199933137}.
\item Sakagami Hideki, Ogasawara Kunio (1999). \textit{ChemInform Abstract: A New Synthesis of Psilocin}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199932235}{doi:10.1002/chin.199932235}.
\item Krämer E, Kovar KA. (1999). \textit{On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(99)00212-1}{doi:10.1016/s0378-4347(99)00212-1}.
\item Löhrer F, Albers M. (1999). \textit{[Biological addictive drugs--is there a change in drug taking behavior of young drug addicts?].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10457973}{source link}.
\item Yamada Fumio, Tamura Mayumi, Somei Masanori (1999). \textit{ChemInform Abstract: Chemistry of Indoles. Part 88. A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199923257}{doi:10.1002/chin.199923257}.
\item Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H. (1999). \textit{Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(98)00089-x}{doi:10.1016/s0893-133x(98)00089-x}.
\item Nichols David E. (1999). \textit{Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin}. Synthesis. [published; Crossref]. \href{https://doi.org/10.1055/s-1999-3490}{doi:10.1055/s-1999-3490}.
\item Vollenweider FX, Vontobel P, Hell D, Leenders KL. (1999). \textit{5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(98)00108-0}{doi:10.1016/s0893-133x(98)00108-0}.
\item Babakhanian RV, Ivanova GV, Kostyrko TA, Safraĭ AE, Iagmurov OD. (1999). \textit{[The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10396957}{source link}.
\item Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H. (1999). \textit{Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s002130050860}{doi:10.1007/s002130050860}.
\item Shirahama Haruhisa, Sogawa Kazuyo, Hashimoto Kimiko (1998). \textit{H-D Exchange of Psilocin and Its Analogs}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-98-s(h)87}{doi:10.3987/com-98-s(h)87}.
\item Keller T, Schneider A, Regenscheit P, Dirnhofer R, Rücker T, Jaspers J, Kisser W. (1998). \textit{Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0379-0738(98)00168-6}{doi:10.1016/s0379-0738(98)00168-6}.
\item Ogasawara Kunio, Sakagami Hideki (1998). \textit{A New Synthesis of Psilocin}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-99-8492}{doi:10.3987/com-99-8492}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. (1998). \textit{Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00001756-199812010-00024}{doi:10.1097/00001756-199812010-00024}.
\item Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass H, Geyer MA. (1998). \textit{Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00008877-199811000-00011}{doi:10.1097/00008877-199811000-00011}.
\item Babakhanian RV, Bushuev ES, Zenkevich IG, Kazankov SP, Kostyrko TA, Kuz'minykh KS. (1998). \textit{[The forensic chemical study of psilocybine-containing fungi].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/9989170}{source link}.
\item Doblin R. (1998). \textit{Dr. Leary's Concord Prison Experiment: a 34-year follow-up study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1998.10399715}{doi:10.1080/02791072.1998.10399715}.
\item Adlaf EM, Ivis FJ. (1998). \textit{Recent findings from the Ontario Student Drug Use Survey.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/9757168}{source link}.
\item Vollenweider FX. (1998). \textit{Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-979353}{doi:10.1055/s-2007-979353}.
\item Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H. (1998). \textit{Methodological issues of human experimental research with hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-979356}{doi:10.1055/s-2007-979356}.
\item Ametamey S., Vollenweider F. X., Patt J., Bourquin D., Hasler F., Beer H.-F., Schubiger P. A. (1998). \textit{11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}{doi:10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}.
\item Lindenblatt H, Krämer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar KA. (1998). \textit{Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(98)00067-x}{doi:10.1016/s0378-4347(98)00067-x}.
\item Beck O, Helander A, Karlson-Stiber C, Stephansson N. (1997). \textit{Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/22.1.45}{doi:10.1093/jat/22.1.45}.
\item Pedersen-Bjergaard S, Rasmussen KE, Sannes E. (1997). \textit{Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/elps.1150190107}{doi:10.1002/elps.1150190107}.
\item Borowiak KS, Ciechanowski K, Waloszczyk P. (1997). \textit{Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/15563659809162584}{doi:10.3109/15563659809162584}.
\item Somei Masanori, Yamada Fumio, Tamura Mayumi (1997). \textit{A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-98-s18}{doi:10.3987/com-98-s18}.
\item Pedersen-Bjergaard S, Sannes E, Rasmussen KE, Tønnesen F. (1997). \textit{Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(97)00127-8}{doi:10.1016/s0378-4347(97)00127-8}.
\item Hasler F, Bourquin D, Brenneisen R, Bär T, Vollenweider FX. (1997). \textit{Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0031-6865(97)00014-9}{doi:10.1016/s0031-6865(97)00014-9}.
\item Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J. (1997). \textit{Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(96)00246-1}{doi:10.1016/s0893-133x(96)00246-1}.
\item Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC. (1996). \textit{Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)09149-7}{doi:10.1016/s0026-895x(25)09149-7}.
\item Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F. (1996). \textit{Increased activation of indirect semantic associations under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-3223(95)00418-1}{doi:10.1016/0006-3223(95)00418-1}.
\item Hanes KR. (1996). \textit{Serotonin, psilocybin, and body dysmorphic disorder: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00004714-199604000-00011}{doi:10.1097/00004714-199604000-00011}.
\item Hughes JR. (1995). \textit{A review of the usefulness of the standard EEG in psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/155005949602700106}{doi:10.1177/155005949602700106}.
\item Bergman B, Karlsson AC. (1995). \textit{[A caution for psilocybine in wild mushrooms. A young addict acquired acute delirium].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7564628}{source link}.
\item Gartz J, Allen JW, Merlin MD. (1994). \textit{Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(94)90006-x}{doi:10.1016/0378-8741(94)90006-x}.
\item Marcano V, Morales Méndez A, Castellano F, Salazar FJ, Martinez L. (1994). \textit{Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(94)90013-2}{doi:10.1016/0378-8741(94)90013-2}.
\item Chamakura RP. (1994). \textit{Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/26270149}{source link}.
\item Cuomo MJ, Dyment PG, Gammino VM. (1994). \textit{Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/07448481.1994.9936359}{doi:10.1080/07448481.1994.9936359}.
\item Gouzoulis E, Hermle L, Sass H. (1994). \textit{[Psychedelic experiences at the onset of productive episodes of endogenous psychoses].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/8177361}{source link}.
\item Gartz J. (1993). \textit{Extraction and analysis of indole derivatives from fungal biomass.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jobm.3620340104}{doi:10.1002/jobm.3620340104}.
\item Köppel C. (1993). \textit{Clinical symptomatology and management of mushroom poisoning.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0041-0101(93)90337-i}{doi:10.1016/0041-0101(93)90337-i}.
\item Hery F, Hamon M. (1993). \textit{[Neuroleptics and serotonin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7905821}{source link}.
\item Merlin MD, Allen JW. (1993). \textit{Species identification and chemical analysis of psychoactive fungi in the Hawaiian islands.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(93)90086-k}{doi:10.1016/0378-8741(93)90086-k}.
\item Riedlinger TJ. (1993). \textit{Wasson's alternative candidates for soma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1993.10472245}{doi:10.1080/02791072.1993.10472245}.
\item Gable RS. (1992). \textit{Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00952999309001618}{doi:10.3109/00952999309001618}.
\item Strassman RJ. (1992). \textit{Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1388647}{source link}.
\item Lassen JF, Lassen NF, Skov J. (1992). \textit{[Consumption of psilocybin-containing hallucinogenic mushrooms by young people].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1413197}{source link}.
\item Smith C, Nutbeam D. (1992). \textit{Adolescent drug use in Wales.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1360-0443.1992.tb02696.x}{doi:10.1111/j.1360-0443.1992.tb02696.x}.
\item Allen JW, Merlin MD. (1991). \textit{Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(92)90020-r}{doi:10.1016/0378-8741(92)90020-r}.
\item Jones J (1990). \textit{'Magic mushroom' poisoning in a colt.}. The Veterinary record. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2075691/}{source link}.
\item Kysilka R. (1990). \textit{Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(00)82176-3}{doi:10.1016/s0378-4347(00)82176-3}.
\item Kysilka R, Wurst M. (1990). \textit{A novel extraction procedure for psilocybin and psilocin determination in mushroom samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-960970}{doi:10.1055/s-2006-960970}.
\item Buckholtz NS, Zhou DF, Freedman DX, Potter WZ. (1990). \textit{Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1969270}{source link}.
\item Kirwan AP (1990). \textit{'Magic mushroom' poisoning in a dog.}. The Veterinary record. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2316139/}{source link}.
\item Lassen JF, Ravn HB, Lassen SF. (1989). \textit{[Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/2301080}{source link}.
\item Leikin JB, Krantz AJ, Zell-Kanter M, Barkin RL, Hryhorczuk DO. (1989). \textit{Clinical features and management of intoxication due to hallucinogenic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf03259916}{doi:10.1007/bf03259916}.
\item Gartz J. (1989). \textit{Biotransformation of Tryptamine in Fruiting Mycelia of Psilocybe cubensis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-961995}{doi:10.1055/s-2006-961995}.
\item Eivindvik K, Rasmussen KE, Sund RB. (1988). \textit{Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/2610906}{source link}.
\item Gartz J. (1988). \textit{Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jobm.3620290608}{doi:10.1002/jobm.3620290608}.
\item Appel JB, Callahan PM. (1988). \textit{Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(89)90041-1}{doi:10.1016/0014-2999(89)90041-1}.
\item Callahan PM, Appel JB. (1988). \textit{Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)22199-1}{doi:10.1016/s0022-3565(25)22199-1}.
\item Schwartz RH, Smith DE. (1988). \textit{Hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/000992288802700202}{doi:10.1177/000992288802700202}.
\item Musha M, Kusano G, Tanaka F, Gotoh Y, Ishii A. (1987). \textit{[Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/3413259}{source link}.
\item Gartz J. (1987). \textit{Variation of the Amount of Alkaloids in Fruit Bodies of Inocybe aeruginascens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-962805}{doi:10.1055/s-2006-962805}.
\item Leonard HL, Rapoport JL. (1987). \textit{Relief of obsessive-compulsive symptoms by LSD and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/ajp.144.9.1239b}{doi:10.1176/ajp.144.9.1239b}.
\item Ohenoja E, Jokiranta J, Mäkinen T, Kaikkonen A, Airaksinen MM. (1987). \textit{The occurrence of psilocybin and psilocin in Finnish fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/np50052a030}{doi:10.1021/np50052a030}.
\item Gartz J. (1987). \textit{Occurrence of Psilocybin and Baeocystin in Fruit Bodies of Pluteus salicinus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-962710}{doi:10.1055/s-2006-962710}.
\item Zilker T. (1987). \textit{[Diagnosis and therapy of mushroom poisoning (1)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/3586830}{source link}.
\item Martin WR, Sloan JW. (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item Nichols DE. (1986). \textit{Studies of the relationship between molecular structure and hallucinogenic activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(86)90362-x}{doi:10.1016/0091-3057(86)90362-x}.
\item Poon Grace, Chui Yun-Cheung, Law Francis C. P. (1986). \textit{Synthesis of psilocin labelled with 14C and 3H}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/jlcr.2580230207}{doi:10.1002/jlcr.2580230207}.
\item Musha M, Ishii A, Tanaka F, Kusano G. (1985). \textit{Poisoning by hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1620/tjem.148.73}{doi:10.1620/tjem.148.73}.
\item Stijve T, Kuyper TW. (1985). \textit{Occurrence of psilocybin in various higher fungi from several European countries.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-969526}{doi:10.1055/s-2007-969526}.
\item Lee RE. (1985). \textit{A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs11028j}{doi:10.1520/jfs11028j}.
\item Lee RE (1985). \textit{A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4040953/}{source link}.
\item Siegel RK. (1985). \textit{New trends in drug use among youth in California.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/3878176}{source link}.
\item Casale JF. (1984). \textit{An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs10989j}{doi:10.1520/jfs10989j}.
\item Casale JF (1984). \textit{An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4038992/}{source link}.
\item Christiansen AL, Rasmussen KE, Høiland K. (1984). \textit{Detection of psilocybin and psilocin in norwegian species of pluteus and conocybe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-969726}{doi:10.1055/s-2007-969726}.
\item Gonzalez-Lima F, Stiehl WL, Medina R. (1984). \textit{Long-lasting behavioral effects of bromocriptine in cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(84)90259-0}{doi:10.1016/0014-2999(84)90259-0}.
\item Jokiranta J, Mustola S, Ohenoja E, Airaksinen MM. (1984). \textit{Psilocybin in Finnish Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-969703}{doi:10.1055/s-2007-969703}.
\item Badham ER. (1984). \textit{Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(84)90007-2}{doi:10.1016/0378-8741(84)90007-2}.
\item Trulson ME, Preussler DW, Trulson VM. (1983). \textit{Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)21616-0}{doi:10.1016/s0022-3565(25)21616-0}.
\item Mack RB. (1983). \textit{Phenomenally phunny phungi--psilocybin toxicity.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/6580536}{source link}.
\item Sottolano SM, Lurie IS. (1983). \textit{The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs11601j}{doi:10.1520/jfs11601j}.
\item Valdés LJ, Díaz JL, Paul AG. (1983). \textit{Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(83)90004-1}{doi:10.1016/0378-8741(83)90004-1}.
\item Peden NR, Pringle SD, Crooks J. (1982). \textit{The problem of psilocybin mushroom abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/096032718200100408}{doi:10.1177/096032718200100408}.
\item Repke David B., Ferguson Wilfred J. (1982). \textit{Psilocin analogs. III. Synthesis of 5-methoxy- and 5-hydroxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570190428}{doi:10.1002/jhet.5570190428}.
\item Beug MW, Bigwood J. (1982). \textit{Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(82)90013-7}{doi:10.1016/0378-8741(82)90013-7}.
\item Bigwood J, Beug MW. (1982). \textit{Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(82)90014-9}{doi:10.1016/0378-8741(82)90014-9}.
\item van Poorten JF, Stienstra R, Dworacek B, Moleman P, Rupreht J. (1982). \textit{Physostigmine reversal of psilocybin intoxication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00000542-198204000-00017}{doi:10.1097/00000542-198204000-00017}.
\item Koerner J, Appel JB. (1981). \textit{Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00435266}{doi:10.1007/bf00435266}.
\item McCall RB. (1981). \textit{Neurophysiological effects of hallucinogens on serotonergic neuronal systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0149-7634(82)90033-1}{doi:10.1016/0149-7634(82)90033-1}.
\item Mohan D, Mohandas E, Rajat R. (1981). \textit{Chloroquine psychosis: a chemical psychosis?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7310924}{source link}.
\item Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ (1981). \textit{Clinical toxicology of "magic mushroom" ingestion.}. Postgraduate medical journal. [published; PubMed]. \href{https://doi.org/10.1136/pgmj.57.671.543}{doi:10.1136/pgmj.57.671.543}.
\item Harries AD, Evans V (1981). \textit{Sequelae of a 'magic mushroom banquet'.}. Postgraduate medical journal. [published; PubMed]. \href{https://doi.org/10.1136/pgmj.57.671.571}{doi:10.1136/pgmj.57.671.571}.
\item REPKE D. B., FERGUSON W. J., BATES D. K. (1981). \textit{ChemInform Abstract: PSILOCIN ANALOGS. PART2. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)-, 3-(2-(N-METHYL-N-ALKYLAMINO)ETHYL)-, AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.198131198}{doi:10.1002/chin.198131198}.
\item MIGLIACCIO G. P., SHIEH T.-L. N., BYRN S. R., HATHAWAY A., NICHOLS D. E. (1981). \textit{ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPY}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.198128356}{doi:10.1002/chin.198128356}.
\item Christiansen AL, Rasmussen KE, Høiland K. (1981). \textit{The content of Psilocybin in Norwegian Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-971632}{doi:10.1055/s-2007-971632}.
\item Saupe Stephen G. (1981). \textit{Occurrence of Psilocybin/Psilocin in Pluteus Salicinus (Pluteaceae)}. Mycologia. [published; Crossref]. \href{https://doi.org/10.1080/00275514.1981.12021406}{doi:10.1080/00275514.1981.12021406}.
\item Trulson ME, Heym J, Jacobs BL. (1981). \textit{Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(81)90507-2}{doi:10.1016/0006-8993(81)90507-2}.
\item Beug MW, Bigwood J. (1981). \textit{Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0021-9673(00)88741-5}{doi:10.1016/s0021-9673(00)88741-5}.
\item Laubscher A, Pletscher A, Noll H. (1981). \textit{Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)32431-6}{doi:10.1016/s0022-3565(25)32431-6}.
\item Migliaccio GP, Shieh TL, Byrn SR, Hathaway BA, Nichols DE. (1981). \textit{Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm00134a016}{doi:10.1021/jm00134a016}.
\item Gelpke R. (1980). \textit{On travels in the universe of the soul: reports on self-experiments with delysid (LSD) and psilocybin (CY).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1981.10471454}{doi:10.1080/02791072.1981.10471454}.
\item Repke David B., Ferguson Wilfred J., Bates Dallas K. (1980). \textit{Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570180131}{doi:10.1002/jhet.5570180131}.
\item McDonald A. (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Thomson BM (1980). \textit{Analysis of Psilocybin and Psilocin in Mushroom Extracts by Reversed-Phase High Performance Liquid Chromatography}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs11292j}{doi:10.1520/jfs11292j}.
\item Järbe TU. (1980). \textit{LDS-25 as a discriminative stimulus for response selection by pigeons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(80)90279-8}{doi:10.1016/0091-3057(80)90279-8}.
\item Thomson BM. (1980). \textit{Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7191888}{source link}.
\item Dewhurst K. (1980). \textit{Psilocybin intoxication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.137.3.303a}{doi:10.1192/bjp.137.3.303a}.
\item Kaul B, Davidow B. (1980). \textit{Application of a radioimmunoassay screening test for detection and management of phencyclidine intoxication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/j.1552-4604.1980.tb02542.x}{doi:10.1002/j.1552-4604.1980.tb02542.x}.
\item Fairchild MD, Jenden DJ, Mickey MR, Yale C. (1979). \textit{EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(80)90422-0}{doi:10.1016/0091-3057(80)90422-0}.
\item Shulgin AT. (1979). \textit{Profiles of psychedelic drugs. Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1980.10471557}{doi:10.1080/02791072.1980.10471557}.
\item Mills PR, Lesinskas D, Watkinson G. (1979). \textit{The danger of hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/003693307902400413}{doi:10.1177/003693307902400413}.
\item Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL. (1979). \textit{A characteristic effect of hallucinogens on investigatory responding in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00491975}{doi:10.1007/bf00491975}.
\item Vaupel DB, Nozaki M, Martin WR, Bright LD, Morton EC. (1979). \textit{The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(79)90451-x}{doi:10.1016/0024-3205(79)90451-x}.
\item Benjamin C. (1979). \textit{Persistent psychiatric symptoms after eating psilocybin mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.1.6174.1319}{doi:10.1136/bmj.1.6174.1319}.
\item Sbordone RJ, Wingard JA, Gorelick DA, Elliott ML. (1978). \textit{Severe aggression in rats induced by mescaline but not other hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00428319}{doi:10.1007/bf00428319}.
\item Chilton WS, Bigwood J, Jensen RE. (1978). \textit{Psilocin, bufotenine and serotonin: historical and biosynthetic observations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1979.10472093}{doi:10.1080/02791072.1979.10472093}.
\item Geyer MA, Petersen LR, Rose GJ, Horwitt DD, Light RK, Adams LM, Zook JA, Hawkins RL, Mandell AJ. (1978). \textit{The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)31486-2}{doi:10.1016/s0022-3565(25)31486-2}.
\item Castellano C. (1978). \textit{Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00427746}{doi:10.1007/bf00427746}.
\item Whitaker PM, Seeman P. (1978). \textit{High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00428022}{doi:10.1007/bf00428022}.
\item Hyde C, Glancy G, Omerod P, Hall D, Taylor GS. (1978). \textit{Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.132.6.602}{doi:10.1192/bjp.132.6.602}.
\item Meltzer HY, Fessler RG, Simonovic M, Fang VS. (1978). \textit{Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00432847}{doi:10.1007/bf00432847}.
\item Martin WR, Vaupel DB, Nozaki M, Bright LD. (1978). \textit{The identification of LSD-like hallucinogens using the chronic spinal dog.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0376-8716(78)90024-8}{doi:10.1016/0376-8716(78)90024-8}.
\item Hatfield GM, Valdes LJ. (1978). \textit{The occurrence of psilocybin in Gymnopilus species.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/565861}{source link}.
\item Van Went GF. (1978). \textit{Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01923013}{doi:10.1007/bf01923013}.
\item Green JP, Weinstein H, Maayani S. (1977). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/30911}{source link}.
\item Repke DB, Leslie DT, Guzmán G. (1977). \textit{Baeocystin in psilocybe, conocybe and panaeolus.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/600026}{source link}.
\item Jacobs BL, Trulson ME, Stern WC. (1977). \textit{Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(77)90423-1}{doi:10.1016/0006-8993(77)90423-1}.
\item REPKE D. B., FERGUSON W. J., BATES D. K. (1977). \textit{ChemInform Abstract: PSILOCIN ANALOGS. 1. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)- AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197728193}{doi:10.1002/chin.197728193}.
\item Trulson ME, Stark AD, Jacobs BL. (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item Repke DB, Leslie DT, Mandell DM, Kish NG. (1977). \textit{GLC-mass spectral analysis of psilocin and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600660539}{doi:10.1002/jps.2600660539}.
\item Davis M, Walters JK. (1977). \textit{Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(77)90180-0}{doi:10.1016/0091-3057(77)90180-0}.
\item Repke David B., Ferguson Wilfred J., Bates Dallas K. (1977). \textit{Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-ols}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570140113}{doi:10.1002/jhet.5570140113}.
\item Repke DB, Leslie DT. (1976). \textit{Baeocystin in Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600660130}{doi:10.1002/jps.2600660130}.
\item Martindale C, Fischer R. (1976). \textit{The effects of psilocybin on primary process content in language.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/608346}{source link}.
\item Holt-Hansen K. (1976). \textit{Extraordinary experiences during cross-modal perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2466/pms.1976.43.3f.1023}{doi:10.2466/pms.1976.43.3f.1023}.
\item Kuhnert-Brandstätter M, Heindl W. (1976). \textit{[Polymorphe forms of psilocine and psilocybine].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ardp.19763090804}{doi:10.1002/ardp.19763090804}.
\item Ott J, Guzmán G. (1976). \textit{Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/957919}{source link}.
\item Parashos AJ. (1976). \textit{The psilocybin-induced "state of drunkenness" in normal volunteers and schizophrenics.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1052267}{source link}.
\item Cameron OG, Appel JB. (1976). \textit{Drug-induced conditioned suppression: specificity due to drug employed as UCS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(76)90020-4}{doi:10.1016/0091-3057(76)90020-4}.
\item Greenberg I, Kuhn D, Appel JB. (1975). \textit{Comparison of the discriminative stimulus properties of delta9-THC and psilocybin in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(75)90131-8}{doi:10.1016/0091-3057(75)90131-8}.
\item Hungen KV, Roberts S, Hill DF. (1975). \textit{Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(75)90876-8}{doi:10.1016/0006-8993(75)90876-8}.
\item Fischer R, Goldman H. (1975). \textit{Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1094457}{doi:10.1055/s-0028-1094457}.
\item Aghajanian GK, Hailgler HJ. (1974). \textit{Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1063421}{source link}.
\item Rech RH, Tilson HA, Marquis WJ. (1974). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1163377}{source link}.
\item GERMAIN CLAUDE, BOURDAIS JACQUES (1974). \textit{ChemInform Abstract: NEUER ZUGANG ZU PSILOCIN-DERIVATEN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197449273}{doi:10.1002/chin.197449273}.
\item Fanciullacci M, Franchi G, Sicuteri F. (1974). \textit{Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01919685}{doi:10.1007/bf01919685}.
\item PETCHER TREVOR J., WEBER HANS PETER (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART2, PSILOCIN C12H15N2O}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197435063}{doi:10.1002/chin.197435063}.
\item CAMPAIGNE E., ROGERS R. B. (1974). \textit{ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART21, ON THE PROOF OF STRUCTURE OF THE SULFUR ISOSTERE OF PSILOCIN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197428268}{doi:10.1002/chin.197428268}.
\item Aboul-Enein HY. (1974). \textit{Psilocybin: a pharmacological profile.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4853936}{source link}.
\item Ladefoged O. (1974). \textit{The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4277695}{source link}.
\item Horibe M. (1974). \textit{The effects of psilocybin on EEG and behaviour in monkeys.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4454934}{source link}.
\item Hopf A, Eckert H. (1974). \textit{Distribution patterns of 14-C-psilocin in the brains of various animals.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4454947}{source link}.
\item Petcher Trevor J., Weber Hans Peter (1973). \textit{Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 O}. J. Chem. Soc., Perkin Trans. 2. [published; Crossref]. \href{https://doi.org/10.1039/p29740000946}{doi:10.1039/p29740000946}.
\item Ono M, Shimamine M, Takahashi K, Inoue T. (1973). \textit{[Studies on hallucinogens. V. Synthesis of psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4477493}{source link}.
\item Campaigne E., Rogers R. B. (1973). \textit{Benzo[b]thiophene derivatives. XXI. On the proof of structure of the sulfur isostere of psilocin}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570100614}{doi:10.1002/jhet.5570100614}.
\item CAMPAIGNE E., ROGERS R. B. (1973). \textit{ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART19, THE SULFUR ISOSTERES OF PSILOCIN AND RELATED ISOMERS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197345337}{doi:10.1002/chin.197345337}.
\item Fabrick DM, Winefordner JD. (1973). \textit{Quantitative measurement of mixtures of hallucinogens by fluorometry and phosphorimetry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0039-9140(73)80087-6}{doi:10.1016/0039-9140(73)80087-6}.
\item Kang S, Johnson CL, Green JP. (1973). \textit{Theoretical studies on the conformations of psilocin and mescaline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)13989-8}{doi:10.1016/s0026-895x(25)13989-8}.
\item Hill RM, Fischer R. (1973). \textit{Induction and extinction of psilocybin induced transformations of visual space.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1094389}{doi:10.1055/s-0028-1094389}.
\item Kang S, Johnson CL, Green JP (1973). \textit{Theoretical studies on the conformations of psilocin and mescaline.}. Molecular pharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4788158/}{source link}.
\item Ladefoged O. (1973). \textit{The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4270656}{source link}.
\item Shaffer JH, Hill RM. (1973). \textit{Psychophysics of psilocybin and 9 -tetrahydrocannabinol.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02023852}{doi:10.1007/bf02023852}.
\item Panton Y, Fischer R. (1973). \textit{Hallucinogenic drug-induced behavior under sensory attenuation. Prediction of response to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/archpsyc.1973.01750330106017}{doi:10.1001/archpsyc.1973.01750330106017}.
\item CHAPMAN N. B., SCROWSTON R. M., SUTTON T. M. (1973). \textit{ChemInform Abstract: SYNTH. DES SCHWEFELANALOGEN VON PSILOCIN UND EINIGEN VERWANDTEN VERBINDUNGEN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197308246}{doi:10.1002/chin.197308246}.
\item Baker RW, Chothia C, Pauling P, Weber HP. (1972). \textit{Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)13703-6}{doi:10.1016/s0026-895x(25)13703-6}.
\item Ono M, Shimamine M, Takahashi K. (1972). \textit{[Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4800137}{source link}.
\item Mulkey D. (1972). \textit{Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5039020}{source link}.
\item Chapman N. B., Scrowston R. M., Sutton T. M. (1971). \textit{Synthesis of the sulphur analogue of psilocin and some related compounds}. Journal of the Chemical Society, Perkin Transactions 1. [published; Crossref]. \href{https://doi.org/10.1039/p19720003011}{doi:10.1039/p19720003011}.
\item Meldrum BS, Naquet R. (1971). \textit{Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0013-4694(71)90072-1}{doi:10.1016/0013-4694(71)90072-1}.
\item Thatcher K, Wiederholt WC, Fischer R. (1971). \textit{An electroencephalographic analysis of personality-dependent performance under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01965376}{doi:10.1007/bf01965376}.
\item Kolarík J. (1970). \textit{Different reaction of focal and diffuse epileptic EEG activity to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5000337}{source link}.
\item Kolarĩk J. (1970). \textit{EEG changes after psilocybin in organic brain lesions.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5122145}{source link}.
\item JULIA MARC, PASCAL YVES ROBERT (1970). \textit{ChemInform Abstract: INDOLE 22. MITT. INDOLSYNTH., ANWENDUNG AUF PSILOCIN}. Chemischer Informationsdienst. Organische Chemie. [published; Crossref]. \href{https://doi.org/10.1002/chin.197051318}{doi:10.1002/chin.197051318}.
\item Meldrum BS, Naquet R. (1970). \textit{Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4992165}{source link}.
\item Fischer R, Hill R, Thatcher K, Scheib J. (1970). \textit{Psilocybin-induced contraction of nearby visual space.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01965761}{doi:10.1007/bf01965761}.
\item Thatcher K, Kappeler T, Wisecup P, Fischer R. (1970). \textit{Personality trait dependent performance under psilocybin. II.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4392526}{source link}.
\item Fischer R, Kappeler T, Wisecup P, Thatcher K. (1970). \textit{Personality trait dependent performance under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5438334}{source link}.
\item Eberle P, Leuner H. (1969). \textit{[Chromosome defects in patients treated with Psilocybine].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00286993}{doi:10.1007/bf00286993}.
\item Landon M, Fischer R. (1969). \textit{On similar linguistic structures in creative performance and psilocybin-induced experience.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5478353}{source link}.
\item Robbers JE, Tyler VE, Ola'h GM. (1969). \textit{Additional evidence supporting the occurrence of psilocybin in Panaeolus foenisecii.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5390043}{source link}.
\item Bermond F, Bert J. (1969). \textit{[Electrophysiological effects of psilocybin in a cercopithecinae, Papio papio].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0013-4694(69)90108-4}{doi:10.1016/0013-4694(69)90108-4}.
\item Fischer R, Kappeler T, Wisecup P, Thatcher K. (1969). \textit{Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01990020}{doi:10.1007/bf01990020}.
\item Leung AY, Paul AG. (1969). \textit{The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5788770}{source link}.
\item Sugrue MF. (1969). \textit{A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1476-5381.1969.tb07983.x}{doi:10.1111/j.1476-5381.1969.tb07983.x}.
\item Fischer R, Hill RM, Warshay D. (1969). \textit{Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01899102}{doi:10.1007/bf01899102}.
\item Hopf A, Eckert H. (1968). \textit{Autoradiographic studies on the distribution of psychoactive drugs in the rat brain. 3. 14C-psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02456045}{doi:10.1007/bf02456045}.
\item Leung AY, Paul AG. (1968). \textit{Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600571007}{doi:10.1002/jps.2600571007}.
\item Duke RB, Keeler MH. (1968). \textit{The effects of psilocybin, dextro-amphetamine and placebo on performance of the trail making test.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1097-4679(196807)24:3<316::aid-jclp2270240310>3.0.co;2-g}{doi:10.1002/1097-4679(196807)24:3<316::aid-jclp2270240310>3.0.co;2-g}.
\item Tosi O, Rockey MA, Fischer R. (1968). \textit{Quantitative measurement of time contraction induced by psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5755879}{source link}.
\item Rynearson RR, Wilson MR, Bickford RG. (1968). \textit{Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4384806}{source link}.
\item Horibe M. (1968). \textit{[Pharmacological studies of hallucinogens. Report 3. I. Bibliographical considerations of psilocybin, with special reference to its actions on the central nervous system].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4881757}{source link}.
\item Horibe M. (1968). \textit{[Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4972692}{source link}.
\item Gessner PK, Godse DD, Krull AH, McMullan JM. (1968). \textit{Structure-activity relationships among 5-methoxy-n:n-dimethyltryptamine, 4-hydroxy-n:n-dimethyltryptamine (psilocin) and other substituted tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(68)90200-2}{doi:10.1016/0024-3205(68)90200-2}.
\item Agurell S, Nilsson JL. (1968). \textit{A biosynthetic sequence from tryptophan to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0040-4039(01)98891-4}{doi:10.1016/s0040-4039(01)98891-4}.
\item Agurell S, Nilsson JL. (1967). \textit{Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3891/acta.chem.scand.22-1210}{doi:10.3891/acta.chem.scand.22-1210}.
\item Dubanský B, Vyhmánková M. (1967). \textit{[Psilocybine in brain injured subjects and its different effects in relation to the localization of the lesion].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5612963}{source link}.
\item Dubanský B, Vyhnánková M, Setlík L. (1967). \textit{[The association of proprioceptive sensations and neurologic symptoms after psilocybine].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5612947}{source link}.
\item Dubanský B, Vyhnánsková M, Setlík L. (1967). \textit{[Psilocybine induced changes in extraoptical perception].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5612948}{source link}.
\item Snyder SH, Faillace L, Hollister L. (1967). \textit{2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.158.3801.669}{doi:10.1126/science.158.3801.669}.
\item Levine WG. (1967). \textit{Formation of blue oxidation product from psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/2151292a0}{doi:10.1038/2151292a0}.
\item Uyeno ET. (1967). \textit{Effects of mescaline and psilocybin on dominance behavior of the rat.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/6034329}{source link}.
\item Weber K. (1966). \textit{[Alteration of music perception in experimental psychosis (psilocybin)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5585740}{source link}.
\item Leung AY, Paul AG. (1966). \textit{Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis saprophytic culture.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600560132}{doi:10.1002/jps.2600560132}.
\item Gilmour LP, O'Brien RD. (1966). \textit{Psilocybin: reaction with a fraction of rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.155.3759.207}{doi:10.1126/science.155.3759.207}.
\item Agurell S, Blomkvist S, Catalfomo P. (1966). \textit{Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5948634}{source link}.
\item Fischer R, England SM, Archer RC, Dean RK. (1966). \textit{Psilocybin reactivity and time contraction as measured by psychomotor performance.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/6014013}{source link}.
\item Collins RL, Ordy JM, Samorajski T. (1966). \textit{Psilocin: effects on behaviour and brain serotonin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/209785a0}{doi:10.1038/209785a0}.
\item Hebbard FW, Fischer R. (1965). \textit{Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00404719}{doi:10.1007/bf00404719}.
\item Fischer R, Mead EL. (1965). \textit{Time contraction and psychomotor performance produced by "Psilocybin".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/209433a0}{doi:10.1038/209433a0}.
\item Keeler MH. (1965). \textit{Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4380179}{source link}.
\item Abramson HA, Rolo A. (1965). \textit{Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/02770906509106904}{doi:10.3109/02770906509106904}.
\item Dubanský B, Vyhnánková M. (1965). \textit{Pathologic laughter as manifestation of the psychotomimetic action of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5882137}{source link}.
\item KEELER MH, DOEHNE EF. (1965). \textit{CONSISTENCY OF PSILOCYBIN INDUCED CHANGES IN THE MINNESOTA MULTIPHASIC PERSONALITY INVENTORY.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1097-4679(196507)21:3<284::aid-jclp2270210319>3.0.co;2-c}{doi:10.1002/1097-4679(196507)21:3<284::aid-jclp2270210319>3.0.co;2-c}.
\item Keeler MH. (1965). \textit{The effects of psilocybin on a test of after-image perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00404173}{doi:10.1007/bf00404173}.
\item FERNANDEZ-CERDENO A, LEUNER H. (1964). \textit{[THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14301325}{source link}.
\item MIYOSHI A. (1964). \textit{[A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14286595}{source link}.
\item HOLLISTER LE, SJOBERG BM. (1964). \textit{CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(64)80030-4}{doi:10.1016/s0010-440x(64)80030-4}.
\item DUBANSKY B. (1964). \textit{[USE OF PSILOCYBIN AS A DIAGNOSTIC TEST IN NEUROLOGY].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14178690}{source link}.
\item REDA GC, VELLA G, CANCRINI L, D AGOSTINO E. (1964). \textit{[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14144273}{source link}.
\item GODET R, DUPE M, BERT J. (1963). \textit{[ACTION OF CHLORPROMAZINE AND PSILOCYBIN ON THE TELENCEPHALIC AROUSAL REACTION OF A DIPNOAN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14210583}{source link}.
\item Alnaes R. (1963). \textit{THERAPEUTIC APPLICATION OF THE CHANGE IN CONSCIOUSNESS PRODUCED BY PSYCHOLYTICA (LSD, PSILOCYBIN, ETC.). THE PSYCHEDELIC EXPERIENCE IN THE TREATEMENT OF NEUROSIS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1600-0447.1964.tb04952.x}{doi:10.1111/j.1600-0447.1964.tb04952.x}.
\item LEARY T, LITWIN GH, METZNER R. (1963). \textit{REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00005053-196312000-00007}{doi:10.1097/00005053-196312000-00007}.
\item ABRAMSON HA, GETTNER HH, ROLO A, DEAN G. (1963). \textit{LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00223980.1963.9916652}{doi:10.1080/00223980.1963.9916652}.
\item STEINER JE, SULMAN FG. (1963). \textit{SIMULTANEOUS STUDIES OF BLOOD SUGAR, BEHAVIOURAL CHANGES AND EEG ON THE WAKE RABBIT AFTER ADMINISTRATION OF PSILOCYBIN.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14067558}{source link}.
\item McKay J. B., Parkhurst R. M., Silverstein R. M., Skinner W. A. (1963). \textit{ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF3-SUBSTITUTED INDOLES}. Canadian Journal of Chemistry. [published; Crossref]. \href{https://doi.org/10.1139/v63-378}{doi:10.1139/v63-378}.
\item SOGLIANI G, RABASSINI A, BUOSO GM. (1963). \textit{[PSYCHOMIMETIC SUBSTANCES. (CONTRIBUTION TO THE CLINICAL PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14093369}{source link}.
\item HARTMAN AM, HOLLISTER LE. (1963). \textit{EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00403349}{doi:10.1007/bf00403349}.
\item UNGER SM. (1963). \textit{Mescaline, LSD, psilocybin, and personality change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00332747.1963.11023344}{doi:10.1080/00332747.1963.11023344}.
\item KANDIC B, DORDEVIC D. (1963). \textit{[COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14067329}{source link}.
\item DUBANSKY B, KOLARIK R, SEVCIK M, VYHNANKOVA M. (1963). \textit{[EFFECT OF PSILOCYBIN ON THE CLINICAL AND ELECTROENCEPHALOGRAPHIC PICTURE IN ORGANIC CNS LESIONS].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14070660}{source link}.
\item ZSIGMOND EK, FOLDES VM, FOLDES FF. (1963). \textit{THE IN VITRO INHIBITORY EFFECT OF PSILOCYBIN AND RELATED COMPOUNDS OF HUMAN CHOLINESTERASES.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02584093}{doi:10.1007/bf02584093}.
\item HORITA A. (1963). \textit{Some biochemical studies on psilocybin and psilogin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21236/ad0291057}{doi:10.21236/ad0291057}.
\item BRODEY JF, STEINER WG, HIMWICH HE. (1963). \textit{An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809).}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14015664}{source link}.
\item Brodey James F., Steiner William G., Himwich Harold E. (1963). \textit{AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/s0022-3565(25)26511-9}{doi:10.1016/s0022-3565(25)26511-9}.
\item TOSCANO AGUILAR M. (1963). \textit{[Psilocybin: prospects of its use in clinical psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13993760}{source link}.
\item ALDAHEFF BW. (1962). \textit{[The psychomimetic effects of LSD and psilocybin in the clinical exploration of the personality].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14011802}{source link}.
\item CALANCA A. (1962). \textit{[Auto-experimentation with LSD-25 and psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14017795}{source link}.
\item KRISTENSEN KK. (1962). \textit{[CLINICAL EXPERIENCES WITH PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/08039486309132763}{doi:10.3109/08039486309132763}.
\item WIART C. (1962). \textit{[AUTO-OBSERVATION OF2 EXPERIMENTAL INTOXICATIONS WITH PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14070405}{source link}.
\item DORDEVIC D. (1962). \textit{[OUR CLINICAL EXPERIENCE WITH A NEW PHARMACOLOGICAL PREPARATION PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14181869}{source link}.
\item KEELER MH. (1962). \textit{Inter-relations of the effects of psilocybin on subjective sensation, photopic critical frequency of fusion, and circulating non-esterified fatty acids.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02135348}{doi:10.1007/bf02135348}.
\item GREGORETTI L, SINISI C. (1962). \textit{[Pharmacopsychiatric observations with psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13950258}{source link}.
\item HORITA A, WEBER LJ. (1962). \textit{Dephosphorylation of psilocybin in the intact mouse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0041-008x(62)90102-3}{doi:10.1016/0041-008x(62)90102-3}.
\item ADEY WR, BELL FR, DENNIS BJ. (1962). \textit{Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1212/wnl.12.9.591}{doi:10.1212/wnl.12.9.591}.
\item HOLLISTER LE, HARTMAN AM. (1962). \textit{Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(62)80024-8}{doi:10.1016/s0010-440x(62)80024-8}.
\item REDA GC, VELLA G, CASINI-NENCINI MG, D'AGOSTINO N, CANCRINI L. (1962). \textit{[Initial results of the action of psilocybin in a group of psychiatric patients].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13973488}{source link}.
\item WOOLLEY DW, CAMPBELL NK. (1962). \textit{Serotonin-like and antiserotonin properties of psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.136.3518.777}{doi:10.1126/science.136.3518.777}.
\item MAXWELL GM, KNEEBONE GM, ELLIOTT RB. (1962). \textit{The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14471633}{source link}.
\item BENEDICT RG, BRADY LR, TYLER VE. (1962). \textit{Occurrence of psilocin in Psilocybe baeocystis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600510428}{doi:10.1002/jps.2600510428}.
\item CHRISTIANSEN A, BAUM R, WITT PN. (1962). \textit{Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)26256-5}{doi:10.1016/s0022-3565(25)26256-5}.
\item KALBERER F, KREIS W, RUTSCHMANN J. (1962). \textit{The fate of psilocin in the rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-2952(62)90050-3}{doi:10.1016/0006-2952(62)90050-3}.
\item HEIMANN H. (1961). \textit{[On the treatment of therapy-resistant neuroses with model psychoses (psilocybin)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13906023}{source link}.
\item WOLBACH AB, MINER EJ, ISBELL H. (1961). \textit{Comparison of psilocin with psilocybin, mescaline and LSD-25.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00412109}{doi:10.1007/bf00412109}.
\item DUCHE DJ. (1961). \textit{[The effects of psilocybin in a case of hysteria].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13888139}{source link}.
\item HORITA A, WEBER LJ. (1961). \textit{The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-2952(61)90124-1}{doi:10.1016/0006-2952(61)90124-1}.
\item VITEK V, VOJTECHOVSKY M, GROF S. (1961). \textit{[Serotonin metabolism in experimental psilocybin psychosis].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13926289}{source link}.
\item HOLLISTER LE. (1961). \textit{Clinical, biochemical and psychologic effects of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13715376}{source link}.
\item HEIMANN H. (1960). \textit{[Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13712866}{source link}.
\item HORITA A, WEBER LJ. (1960). \textit{Dephosphorylation of psilocybin to psilocin by alkaline phosphatase.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3181/00379727-106-26228}{doi:10.3181/00379727-106-26228}.
\item ISBELL H, WOLBACH AB, WIKLER A, MINER EJ. (1960). \textit{Cross tolerance between LSD and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00407974}{doi:10.1007/bf00407974}.
\item HOLFELD H. (1960). \textit{[Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13908338}{source link}.
\item SERCL M, KOVARIK J, JAROS O. (1960). \textit{[Clinical experiences with psilocybin (CY39 Sandoz)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13910754}{source link}.
\item SERCL M, KOVARIK J, JAROS O. (1960). \textit{[Clinical experiences with psilocybin Sandoz (CY39 Sandoz)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13910755}{source link}.
\item CHAUCHARD P, MAZOUE H. (1960). \textit{[Action of psilocybin on the excitability of the nerve centers].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/24545494}{source link}.
\item POLLARD JC, BAKKER C, UHR L, FEUERFILE DF. (1960). \textit{Controlled sensory input: a note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(60)80061-2}{doi:10.1016/s0010-440x(60)80061-2}.
\item HOLLISTER LE, PRUSMACK JJ, PAULSEN A, ROSENQUIST N. (1960). \textit{Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00005053-196011000-00007}{doi:10.1097/00005053-196011000-00007}.
\item GESSNER PK, KHAIRALLAH PA, McISAAC WM, PAGE IH. (1960). \textit{The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)25873-6}{doi:10.1016/s0022-3565(25)25873-6}.
\item Unknown authors (1960). \textit{Psilocybin, Its History and Pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/20326260}{source link}.
\item Unknown authors (1960). \textit{[PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13858316}{source link}.
\item MALITZ S, ESECOVER H, WILKENS B, HOCH PH. (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(60)80045-4}{doi:10.1016/s0010-440x(60)80045-4}.
\item ROUBICEK J, DRVOTA S. (1960). \textit{[Psilocybin, a new hallucinogen].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14439519}{source link}.
\item WEIDMANN H, CERLETTI A. (1959). \textit{Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13843476}{source link}.
\item CERLETTI A. (1959). \textit{[Teonanacatl and psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1114618}{doi:10.1055/s-0028-1114618}.
\item DELAY J, PICHOT P, LEMPERIERE T, QUETIN AM. (1959). \textit{[Therapeutic effect of psilocybin on convulsive neurosis].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13815609}{source link}.
\item MONNIER M. (1959). \textit{[The action of psilocybin on the rabbit brain].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02158550}{doi:10.1007/bf02158550}.
\item Unknown authors (1959). \textit{[PSILOCYBIN, a new psychotropic substance].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13857060}{source link}.
\item HOFMANN A, TROXLER F. (1959). \textit{[Identification of psilocin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02166696}{doi:10.1007/bf02166696}.
\item DELAY J, THUILLIER J, NAKAJIMA H, DURANDIN MC. (1958). \textit{[Effect of psilocybin on the behavior of normal mice \& waltzing mice; comparison with lysergic acid monoethylamide \& diethylamide].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13663414}{source link}.
\item GNIRSS F. (1958). \textit{[Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13850311}{source link}.
\item ISBELL H. (1958). \textit{Comparison of the reactions induced by psilocybin and LSD-25 in man.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00408109}{doi:10.1007/bf00408109}.
\item RUEMMELE W. (1958). \textit{[The place of psilocybin among other psychotropic substances].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14440055}{source link}.
\item HOFMANN A, FREY A, OTT H, PETR ZILKA T, TROXLER F. (1958). \textit{[Elucidation of the structure and the synthesis of psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02160424}{doi:10.1007/bf02160424}.
\item WEIDMANN H, TAESCHLER M, KONZETT H. (1958). \textit{[The pharmacology of psilocybin, an ac' principle from Psilocybe mexicana Heim].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02159166}{doi:10.1007/bf02159166}.
\item HOFMANN A, HEIM R, BRACK A, KOBEL H. (1958). \textit{[Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02159243}{doi:10.1007/bf02159243}.
\end{enumerate}
\end{document}
